#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Alcohol effects on globus pallidus connectivity: Role of impulsivity and binge drinking
#Text=Despite the harm caused by binge drinking, the neural mechanisms leading to risky and disinhibited intoxication-related behaviors are not well understood.
1-1	0-7	Alcohol	_	
1-2	8-15	effects	_	
1-3	16-18	on	_	
1-4	19-25	globus	_	
1-5	26-34	pallidus	_	
1-6	35-47	connectivity	_	
1-7	47-48	:	_	
1-8	49-53	Role	_	
1-9	54-56	of	_	
1-10	57-68	impulsivity	_	
1-11	69-72	and	_	
1-12	73-78	binge	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[1]	
1-13	79-87	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[1]	
1-14	88-95	Despite	_	
1-15	96-99	the	_	
1-16	100-104	harm	_	
1-17	105-111	caused	_	
1-18	112-114	by	_	
1-19	115-120	binge	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[2]	
1-20	121-129	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[2]	
1-21	129-130	,	_	
1-22	131-134	the	_	
1-23	135-141	neural	_	
1-24	142-152	mechanisms	_	
1-25	153-160	leading	_	
1-26	161-163	to	_	
1-27	164-169	risky	_	
1-28	170-173	and	_	
1-29	174-186	disinhibited	_	
1-30	187-207	intoxication-related	_	
1-31	208-217	behaviors	_	
1-32	218-221	are	_	
1-33	222-225	not	_	
1-34	226-230	well	_	
1-35	231-241	understood	_	
1-36	241-242	.	_	

#Text=Evidence suggests that the globus pallidus externus (GPe), a substructure within the basal ganglia, participates in inhibitory control processes, as examined in stop-signaling tasks.
2-1	243-251	Evidence	_	
2-2	252-260	suggests	_	
2-3	261-265	that	_	
2-4	266-269	the	_	
2-5	270-276	globus	_	
2-6	277-285	pallidus	_	
2-7	286-294	externus	_	
2-8	295-296	(	_	
2-9	296-299	GPe	_	
2-10	299-300	)	_	
2-11	300-301	,	_	
2-12	302-303	a	_	
2-13	304-316	substructure	_	
2-14	317-323	within	_	
2-15	324-327	the	_	
2-16	328-333	basal	_	
2-17	334-341	ganglia	_	
2-18	341-342	,	_	
2-19	343-355	participates	_	
2-20	356-358	in	_	
2-21	359-369	inhibitory	_	
2-22	370-377	control	_	
2-23	378-387	processes	_	
2-24	387-388	,	_	
2-25	389-391	as	_	
2-26	392-400	examined	_	
2-27	401-403	in	_	
2-28	404-418	stop-signaling	_	
2-29	419-424	tasks	_	
2-30	424-425	.	_	

#Text=In fact, studies in rodents have revealed that alcohol can change GPe activity by decreasing neuronal firing rates, suggesting that the GPe may have a central role in explaining impulsive behaviors and failures of inhibition that occur during binge drinking.
3-1	426-428	In	_	
3-2	429-433	fact	_	
3-3	433-434	,	_	
3-4	435-442	studies	_	
3-5	443-445	in	_	
3-6	446-453	rodents	_	
3-7	454-458	have	_	
3-8	459-467	revealed	_	
3-9	468-472	that	_	
3-10	473-480	alcohol	_	
3-11	481-484	can	_	
3-12	485-491	change	_	
3-13	492-495	GPe	_	
3-14	496-504	activity	_	
3-15	505-507	by	_	
3-16	508-518	decreasing	_	
3-17	519-527	neuronal	_	
3-18	528-534	firing	_	
3-19	535-540	rates	_	
3-20	540-541	,	_	
3-21	542-552	suggesting	_	
3-22	553-557	that	_	
3-23	558-561	the	_	
3-24	562-565	GPe	_	
3-25	566-569	may	_	
3-26	570-574	have	_	
3-27	575-576	a	_	
3-28	577-584	central	_	
3-29	585-589	role	_	
3-30	590-592	in	_	
3-31	593-603	explaining	_	
3-32	604-613	impulsive	_	
3-33	614-623	behaviors	_	
3-34	624-627	and	_	
3-35	628-636	failures	_	
3-36	637-639	of	_	
3-37	640-650	inhibition	_	
3-38	651-655	that	_	
3-39	656-661	occur	_	
3-40	662-668	during	_	
3-41	669-674	binge	_	
3-42	675-683	drinking	_	
3-43	683-684	.	_	

#Text=In this study, twenty-five healthy volunteers underwent intravenous alcohol infusion to achieve a blood alcohol level of 0.08 g/dl, which is equivalent to a binge drinking episode.
4-1	685-687	In	_	
4-2	688-692	this	_	
4-3	693-698	study	_	
4-4	698-699	,	_	
4-5	700-711	twenty-five	_	
4-6	712-719	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-7	720-730	volunteers	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-8	731-740	underwent	_	
4-9	741-752	intravenous	_	
4-10	753-760	alcohol	_	
4-11	761-769	infusion	_	
4-12	770-772	to	_	
4-13	773-780	achieve	_	
4-14	781-782	a	_	
4-15	783-788	blood	_	
4-16	789-796	alcohol	_	
4-17	797-802	level	_	
4-18	803-805	of	_	
4-19	806-810	0.08	_	
4-20	811-812	g	_	
4-21	812-813	/	_	
4-22	813-815	dl	_	
4-23	815-816	,	_	
4-24	817-822	which	_	
4-25	823-825	is	_	
4-26	826-836	equivalent	_	
4-27	837-839	to	_	
4-28	840-841	a	_	
4-29	842-847	binge	_	
4-30	848-856	drinking	_	
4-31	857-864	episode	_	
4-32	864-865	.	_	

#Text=A resting state functional magnetic resonance imaging scan was collected prior to the infusion and at binge-level exposure.
5-1	866-867	A	_	
5-2	868-875	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
5-3	876-881	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
5-4	882-892	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
5-5	893-901	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
5-6	902-911	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[4]	
5-7	912-919	imaging	_	
5-8	920-924	scan	_	
5-9	925-928	was	_	
5-10	929-938	collected	_	
5-11	939-944	prior	_	
5-12	945-947	to	_	
5-13	948-951	the	_	
5-14	952-960	infusion	_	
5-15	961-964	and	_	
5-16	965-967	at	_	
5-17	968-979	binge-level	_	
5-18	980-988	exposure	_	
5-19	988-989	.	_	

#Text=Functional connectivity analysis was used to investigate the association between alcohol-induced changes in GPe connectivity, drinking behaviors, and impulsivity traits.
6-1	990-1000	Functional	_	
6-2	1001-1013	connectivity	_	
6-3	1014-1022	analysis	_	
6-4	1023-1026	was	_	
6-5	1027-1031	used	_	
6-6	1032-1034	to	_	
6-7	1035-1046	investigate	_	
6-8	1047-1050	the	_	
6-9	1051-1062	association	_	
6-10	1063-1070	between	_	
6-11	1071-1086	alcohol-induced	_	
6-12	1087-1094	changes	_	
6-13	1095-1097	in	_	
6-14	1098-1101	GPe	_	
6-15	1102-1114	connectivity	_	
6-16	1114-1115	,	_	
6-17	1116-1124	drinking	_	
6-18	1125-1134	behaviors	_	
6-19	1134-1135	,	_	
6-20	1136-1139	and	_	
6-21	1140-1151	impulsivity	_	
6-22	1152-1158	traits	_	
6-23	1158-1159	.	_	

#Text=We found that individuals with greater number of drinks or heavy drinking days in the recent past had greater alcohol-induced deficits in GPe connectivity, particularly to the striatum.
7-1	1160-1162	We	_	
7-2	1163-1168	found	_	
7-3	1169-1173	that	_	
7-4	1174-1185	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-5	1186-1190	with	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-6	1191-1198	greater	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-7	1199-1205	number	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-8	1206-1208	of	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-9	1209-1215	drinks	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-10	1216-1218	or	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-11	1219-1224	heavy	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-12	1225-1233	drinking	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-13	1234-1238	days	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[5]	
7-14	1239-1241	in	_	
7-15	1242-1245	the	_	
7-16	1246-1252	recent	_	
7-17	1253-1257	past	_	
7-18	1258-1261	had	_	
7-19	1262-1269	greater	_	
7-20	1270-1285	alcohol-induced	_	
7-21	1286-1294	deficits	_	
7-22	1295-1297	in	_	
7-23	1298-1301	GPe	_	
7-24	1302-1314	connectivity	_	
7-25	1314-1315	,	_	
7-26	1316-1328	particularly	_	
7-27	1329-1331	to	_	
7-28	1332-1335	the	_	
7-29	1336-1344	striatum	_	
7-30	1344-1345	.	_	

#Text=Our data also indicated an association between impulsivity and alcohol-induced deficits in GPe—frontal/precentral connectivity.
8-1	1346-1349	Our	_	
8-2	1350-1354	data	_	
8-3	1355-1359	also	_	
8-4	1360-1369	indicated	_	
8-5	1370-1372	an	_	
8-6	1373-1384	association	_	
8-7	1385-1392	between	_	
8-8	1393-1404	impulsivity	_	
8-9	1405-1408	and	_	
8-10	1409-1424	alcohol-induced	_	
8-11	1425-1433	deficits	_	
8-12	1434-1436	in	_	
8-13	1437-1448	GPe—frontal	_	
8-14	1448-1449	/	_	
8-15	1449-1459	precentral	_	
8-16	1460-1472	connectivity	_	
8-17	1472-1473	.	_	

#Text=Moreover, alcohol induced changes in GPe-amygdala circuitry suggested greater vulnerabilities to stress-related drinking in some individuals.
9-1	1474-1482	Moreover	_	
9-2	1482-1483	,	_	
9-3	1484-1491	alcohol	_	
9-4	1492-1499	induced	_	
9-5	1500-1507	changes	_	
9-6	1508-1510	in	_	
9-7	1511-1523	GPe-amygdala	_	
9-8	1524-1533	circuitry	_	
9-9	1534-1543	suggested	_	
9-10	1544-1551	greater	_	
9-11	1552-1567	vulnerabilities	_	
9-12	1568-1570	to	_	
9-13	1571-1585	stress-related	_	
9-14	1586-1594	drinking	_	
9-15	1595-1597	in	_	
9-16	1598-1602	some	_	
9-17	1603-1614	individuals	_	
9-18	1614-1615	.	_	

#Text=Taken together, these findings suggest that alcohol may interact with impulsive personality traits and drinking patterns to drive alterations in GPe circuitry associated with behavioral inhibition, possibly indicating a neural mechanism by which binge drinking could lead to impulsive behaviors.
10-1	1616-1621	Taken	_	
10-2	1622-1630	together	_	
10-3	1630-1631	,	_	
10-4	1632-1637	these	_	
10-5	1638-1646	findings	_	
10-6	1647-1654	suggest	_	
10-7	1655-1659	that	_	
10-8	1660-1667	alcohol	_	
10-9	1668-1671	may	_	
10-10	1672-1680	interact	_	
10-11	1681-1685	with	_	
10-12	1686-1695	impulsive	_	
10-13	1696-1707	personality	_	
10-14	1708-1714	traits	_	
10-15	1715-1718	and	_	
10-16	1719-1727	drinking	_	
10-17	1728-1736	patterns	_	
10-18	1737-1739	to	_	
10-19	1740-1745	drive	_	
10-20	1746-1757	alterations	_	
10-21	1758-1760	in	_	
10-22	1761-1764	GPe	_	
10-23	1765-1774	circuitry	_	
10-24	1775-1785	associated	_	
10-25	1786-1790	with	_	
10-26	1791-1801	behavioral	_	
10-27	1802-1812	inhibition	_	
10-28	1812-1813	,	_	
10-29	1814-1822	possibly	_	
10-30	1823-1833	indicating	_	
10-31	1834-1835	a	_	
10-32	1836-1842	neural	_	
10-33	1843-1852	mechanism	_	
10-34	1853-1855	by	_	
10-35	1856-1861	which	_	
10-36	1862-1867	binge	_	
10-37	1868-1876	drinking	_	
10-38	1877-1882	could	_	
10-39	1883-1887	lead	_	
10-40	1888-1890	to	_	
10-41	1891-1900	impulsive	_	
10-42	1901-1910	behaviors	_	
10-43	1910-1911	.	_	

#Text=Introduction
#Text=Harmful drinking behaviors like binge drinking contribute to 5.9% of all global deaths.
11-1	1912-1924	Introduction	_	
11-2	1925-1932	Harmful	_	
11-3	1933-1941	drinking	_	
11-4	1942-1951	behaviors	_	
11-5	1952-1956	like	_	
11-6	1957-1962	binge	_	
11-7	1963-1971	drinking	_	
11-8	1972-1982	contribute	_	
11-9	1983-1985	to	_	
11-10	1986-1990	5.9%	_	
11-11	1991-1993	of	_	
11-12	1994-1997	all	_	
11-13	1998-2004	global	_	
11-14	2005-2011	deaths	_	
11-15	2011-2012	.	_	

#Text=This is largely due to the development of alcohol use disorder (AUD) and consequential organ damage caused by chronic drinking, intoxication-related car accidents and domestic violence.
12-1	2013-2017	This	_	
12-2	2018-2020	is	_	
12-3	2021-2028	largely	_	
12-4	2029-2032	due	_	
12-5	2033-2035	to	_	
12-6	2036-2039	the	_	
12-7	2040-2051	development	_	
12-8	2052-2054	of	_	
12-9	2055-2062	alcohol	_	
12-10	2063-2066	use	_	
12-11	2067-2075	disorder	_	
12-12	2076-2077	(	_	
12-13	2077-2080	AUD	_	
12-14	2080-2081	)	_	
12-15	2082-2085	and	_	
12-16	2086-2099	consequential	_	
12-17	2100-2105	organ	_	
12-18	2106-2112	damage	_	
12-19	2113-2119	caused	_	
12-20	2120-2122	by	_	
12-21	2123-2130	chronic	_	
12-22	2131-2139	drinking	_	
12-23	2139-2140	,	_	
12-24	2141-2161	intoxication-related	_	
12-25	2162-2165	car	_	
12-26	2166-2175	accidents	_	
12-27	2176-2179	and	_	
12-28	2180-2188	domestic	_	
12-29	2189-2197	violence	_	
12-30	2197-2198	.	_	

#Text=Binge drinking is defined as drinking that results in blood alcohol concentration (BAC) levels at or above 0.08 g/dl (estimated as consuming at least 4 or 5 standard drinks in less than two hours for women and men, respectively).
13-1	2199-2204	Binge	_	
13-2	2205-2213	drinking	_	
13-3	2214-2216	is	_	
13-4	2217-2224	defined	_	
13-5	2225-2227	as	_	
13-6	2228-2236	drinking	_	
13-7	2237-2241	that	_	
13-8	2242-2249	results	_	
13-9	2250-2252	in	_	
13-10	2253-2258	blood	_	
13-11	2259-2266	alcohol	_	
13-12	2267-2280	concentration	_	
13-13	2281-2282	(	_	
13-14	2282-2285	BAC	_	
13-15	2285-2286	)	_	
13-16	2287-2293	levels	_	
13-17	2294-2296	at	_	
13-18	2297-2299	or	_	
13-19	2300-2305	above	_	
13-20	2306-2310	0.08	_	
13-21	2311-2312	g	_	
13-22	2312-2313	/	_	
13-23	2313-2315	dl	_	
13-24	2316-2317	(	_	
13-25	2317-2326	estimated	_	
13-26	2327-2329	as	_	
13-27	2330-2339	consuming	_	
13-28	2340-2342	at	_	
13-29	2343-2348	least	_	
13-30	2349-2350	4	_	
13-31	2351-2353	or	_	
13-32	2354-2355	5	_	
13-33	2356-2364	standard	_	
13-34	2365-2371	drinks	_	
13-35	2372-2374	in	_	
13-36	2375-2379	less	_	
13-37	2380-2384	than	_	
13-38	2385-2388	two	_	
13-39	2389-2394	hours	_	
13-40	2395-2398	for	_	
13-41	2399-2404	women	_	
13-42	2405-2408	and	_	
13-43	2409-2412	men	_	
13-44	2412-2413	,	_	
13-45	2414-2426	respectively	_	
13-46	2426-2427	)	_	
13-47	2427-2428	.	_	

#Text=The mechanisms underlying binge drinking and related risky behaviors are unclear, but impulsivity or failure in inhibitory control during decision-making likely plays a role.
14-1	2429-2432	The	_	
14-2	2433-2443	mechanisms	_	
14-3	2444-2454	underlying	_	
14-4	2455-2460	binge	_	
14-5	2461-2469	drinking	_	
14-6	2470-2473	and	_	
14-7	2474-2481	related	_	
14-8	2482-2487	risky	_	
14-9	2488-2497	behaviors	_	
14-10	2498-2501	are	_	
14-11	2502-2509	unclear	_	
14-12	2509-2510	,	_	
14-13	2511-2514	but	_	
14-14	2515-2526	impulsivity	_	
14-15	2527-2529	or	_	
14-16	2530-2537	failure	_	
14-17	2538-2540	in	_	
14-18	2541-2551	inhibitory	_	
14-19	2552-2559	control	_	
14-20	2560-2566	during	_	
14-21	2567-2582	decision-making	_	
14-22	2583-2589	likely	_	
14-23	2590-2595	plays	_	
14-24	2596-2597	a	_	
14-25	2598-2602	role	_	
14-26	2602-2603	.	_	

#Text=Research into the neural correlates of failure to inhibit suggests that the basal ganglia plays an important role.
15-1	2604-2612	Research	_	
15-2	2613-2617	into	_	
15-3	2618-2621	the	_	
15-4	2622-2628	neural	_	
15-5	2629-2639	correlates	_	
15-6	2640-2642	of	_	
15-7	2643-2650	failure	_	
15-8	2651-2653	to	_	
15-9	2654-2661	inhibit	_	
15-10	2662-2670	suggests	_	
15-11	2671-2675	that	_	
15-12	2676-2679	the	_	
15-13	2680-2685	basal	_	
15-14	2686-2693	ganglia	_	
15-15	2694-2699	plays	_	
15-16	2700-2702	an	_	
15-17	2703-2712	important	_	
15-18	2713-2717	role	_	
15-19	2717-2718	.	_	

#Text=The basal ganglia are formed by several interconnected brain regions that control action selection, reward, goal-directed behavior and habitual learning.
16-1	2719-2722	The	_	
16-2	2723-2728	basal	_	
16-3	2729-2736	ganglia	_	
16-4	2737-2740	are	_	
16-5	2741-2747	formed	_	
16-6	2748-2750	by	_	
16-7	2751-2758	several	_	
16-8	2759-2773	interconnected	_	
16-9	2774-2779	brain	_	
16-10	2780-2787	regions	_	
16-11	2788-2792	that	_	
16-12	2793-2800	control	_	
16-13	2801-2807	action	_	
16-14	2808-2817	selection	_	
16-15	2817-2818	,	_	
16-16	2819-2825	reward	_	
16-17	2825-2826	,	_	
16-18	2827-2840	goal-directed	_	
16-19	2841-2849	behavior	_	
16-20	2850-2853	and	_	
16-21	2854-2862	habitual	_	
16-22	2863-2871	learning	_	
16-23	2871-2872	.	_	

#Text=Frontostriatal pathways enable inhibitory control quickly via a hyperdirect pathway through the inferior frontal gyrus (IFG) and presupplementary motor area (preSMA) that quickly “brakes”, and through indirect pathways that “suppresses” movement.
17-1	2873-2887	Frontostriatal	_	
17-2	2888-2896	pathways	_	
17-3	2897-2903	enable	_	
17-4	2904-2914	inhibitory	_	
17-5	2915-2922	control	_	
17-6	2923-2930	quickly	_	
17-7	2931-2934	via	_	
17-8	2935-2936	a	_	
17-9	2937-2948	hyperdirect	_	
17-10	2949-2956	pathway	_	
17-11	2957-2964	through	_	
17-12	2965-2968	the	_	
17-13	2969-2977	inferior	_	
17-14	2978-2985	frontal	_	
17-15	2986-2991	gyrus	_	
17-16	2992-2993	(	_	
17-17	2993-2996	IFG	_	
17-18	2996-2997	)	_	
17-19	2998-3001	and	_	
17-20	3002-3018	presupplementary	_	
17-21	3019-3024	motor	_	
17-22	3025-3029	area	_	
17-23	3030-3031	(	_	
17-24	3031-3037	preSMA	_	
17-25	3037-3038	)	_	
17-26	3039-3043	that	_	
17-27	3044-3051	quickly	_	
17-28	3052-3053	“	_	
17-29	3053-3059	brakes	_	
17-30	3059-3060	”	_	
17-31	3060-3061	,	_	
17-32	3062-3065	and	_	
17-33	3066-3073	through	_	
17-34	3074-3082	indirect	_	
17-35	3083-3091	pathways	_	
17-36	3092-3096	that	_	
17-37	3097-3098	“	_	
17-38	3098-3108	suppresses	_	
17-39	3108-3109	”	_	
17-40	3110-3118	movement	_	
17-41	3118-3119	.	_	

#Text=In particular, the globus pallidus externus (GPe), a central and highly interconnected component of the basal ganglia, may have a key role in inhibitory control.
18-1	3120-3122	In	_	
18-2	3123-3133	particular	_	
18-3	3133-3134	,	_	
18-4	3135-3138	the	_	
18-5	3139-3145	globus	_	
18-6	3146-3154	pallidus	_	
18-7	3155-3163	externus	_	
18-8	3164-3165	(	_	
18-9	3165-3168	GPe	_	
18-10	3168-3169	)	_	
18-11	3169-3170	,	_	
18-12	3171-3172	a	_	
18-13	3173-3180	central	_	
18-14	3181-3184	and	_	
18-15	3185-3191	highly	_	
18-16	3192-3206	interconnected	_	
18-17	3207-3216	component	_	
18-18	3217-3219	of	_	
18-19	3220-3223	the	_	
18-20	3224-3229	basal	_	
18-21	3230-3237	ganglia	_	
18-22	3237-3238	,	_	
18-23	3239-3242	may	_	
18-24	3243-3247	have	_	
18-25	3248-3249	a	_	
18-26	3250-3253	key	_	
18-27	3254-3258	role	_	
18-28	3259-3261	in	_	
18-29	3262-3272	inhibitory	_	
18-30	3273-3280	control	_	
18-31	3280-3281	.	_	

#Text=A specific projection from the GPe to the striatum known as the arkypallidal projection has been shown to inhibit behavior temporarily in “stop-signal”-based tasks.
19-1	3282-3283	A	_	
19-2	3284-3292	specific	_	
19-3	3293-3303	projection	_	
19-4	3304-3308	from	_	
19-5	3309-3312	the	_	
19-6	3313-3316	GPe	_	
19-7	3317-3319	to	_	
19-8	3320-3323	the	_	
19-9	3324-3332	striatum	_	
19-10	3333-3338	known	_	
19-11	3339-3341	as	_	
19-12	3342-3345	the	_	
19-13	3346-3358	arkypallidal	_	
19-14	3359-3369	projection	_	
19-15	3370-3373	has	_	
19-16	3374-3378	been	_	
19-17	3379-3384	shown	_	
19-18	3385-3387	to	_	
19-19	3388-3395	inhibit	_	
19-20	3396-3404	behavior	_	
19-21	3405-3416	temporarily	_	
19-22	3417-3419	in	_	
19-23	3420-3421	“	_	
19-24	3421-3432	stop-signal	_	
19-25	3432-3433	”	_	
19-26	3433-3434	-	_	
19-27	3434-3439	based	_	
19-28	3440-3445	tasks	_	
19-29	3445-3446	.	_	

#Text=Given this role, alterations to GPe connectivity could contribute to increased impulsivity and failure of inhibitory control.
20-1	3447-3452	Given	_	
20-2	3453-3457	this	_	
20-3	3458-3462	role	_	
20-4	3462-3463	,	_	
20-5	3464-3475	alterations	_	
20-6	3476-3478	to	_	
20-7	3479-3482	GPe	_	
20-8	3483-3495	connectivity	_	
20-9	3496-3501	could	_	
20-10	3502-3512	contribute	_	
20-11	3513-3515	to	_	
20-12	3516-3525	increased	_	
20-13	3526-3537	impulsivity	_	
20-14	3538-3541	and	_	
20-15	3542-3549	failure	_	
20-16	3550-3552	of	_	
20-17	3553-3563	inhibitory	_	
20-18	3564-3571	control	_	
20-19	3571-3572	.	_	

#Text=Alcohol has been shown to have a direct effect on GPe neurons.
21-1	3573-3580	Alcohol	_	
21-2	3581-3584	has	_	
21-3	3585-3589	been	_	
21-4	3590-3595	shown	_	
21-5	3596-3598	to	_	
21-6	3599-3603	have	_	
21-7	3604-3605	a	_	
21-8	3606-3612	direct	_	
21-9	3613-3619	effect	_	
21-10	3620-3622	on	_	
21-11	3623-3626	GPe	_	
21-12	3627-3634	neurons	_	
21-13	3634-3635	.	_	

#Text=In a mouse model, Abrahao et al. have demonstrated that acute alcohol decreases the firing rate of specific neurons in the GPe, including (1) the low frequency prototypical neurons, which project downstream to the subthalamic nucleus / substantia nigra and upstream to the striatum, and (2) the arkypallidal neurons, which project to the striatum.
22-1	3636-3638	In	_	
22-2	3639-3640	a	_	
22-3	3641-3646	mouse	_	
22-4	3647-3652	model	_	
22-5	3652-3653	,	_	
22-6	3654-3661	Abrahao	_	
22-7	3662-3664	et	_	
22-8	3665-3667	al	_	
22-9	3667-3668	.	_	
22-10	3669-3673	have	_	
22-11	3674-3686	demonstrated	_	
22-12	3687-3691	that	_	
22-13	3692-3697	acute	_	
22-14	3698-3705	alcohol	_	
22-15	3706-3715	decreases	_	
22-16	3716-3719	the	_	
22-17	3720-3726	firing	_	
22-18	3727-3731	rate	_	
22-19	3732-3734	of	_	
22-20	3735-3743	specific	_	
22-21	3744-3751	neurons	_	
22-22	3752-3754	in	_	
22-23	3755-3758	the	_	
22-24	3759-3762	GPe	_	
22-25	3762-3763	,	_	
22-26	3764-3773	including	_	
22-27	3774-3775	(	_	
22-28	3775-3776	1	_	
22-29	3776-3777	)	_	
22-30	3778-3781	the	_	
22-31	3782-3785	low	_	
22-32	3786-3795	frequency	_	
22-33	3796-3808	prototypical	_	
22-34	3809-3816	neurons	_	
22-35	3816-3817	,	_	
22-36	3818-3823	which	_	
22-37	3824-3831	project	_	
22-38	3832-3842	downstream	_	
22-39	3843-3845	to	_	
22-40	3846-3849	the	_	
22-41	3850-3861	subthalamic	_	
22-42	3862-3869	nucleus	_	
22-43	3870-3871	/	_	
22-44	3872-3882	substantia	_	
22-45	3883-3888	nigra	_	
22-46	3889-3892	and	_	
22-47	3893-3901	upstream	_	
22-48	3902-3904	to	_	
22-49	3905-3908	the	_	
22-50	3909-3917	striatum	_	
22-51	3917-3918	,	_	
22-52	3919-3922	and	_	
22-53	3923-3924	(	_	
22-54	3924-3925	2	_	
22-55	3925-3926	)	_	
22-56	3927-3930	the	_	
22-57	3931-3943	arkypallidal	_	
22-58	3944-3951	neurons	_	
22-59	3951-3952	,	_	
22-60	3953-3958	which	_	
22-61	3959-3966	project	_	
22-62	3967-3969	to	_	
22-63	3970-3973	the	_	
22-64	3974-3982	striatum	_	
22-65	3982-3983	.	_	

#Text=In humans, alcohol decreased functional magnetic resonance imaging (fMRI) signal in the GP during a stop-signal task, and this signal change was associated with slowed reaction time and impaired inhibitory control.
23-1	3984-3986	In	_	
23-2	3987-3993	humans	_	
23-3	3993-3994	,	_	
23-4	3995-4002	alcohol	_	
23-5	4003-4012	decreased	_	
23-6	4013-4023	functional	_	
23-7	4024-4032	magnetic	_	
23-8	4033-4042	resonance	_	
23-9	4043-4050	imaging	_	
23-10	4051-4052	(	_	
23-11	4052-4056	fMRI	_	
23-12	4056-4057	)	_	
23-13	4058-4064	signal	_	
23-14	4065-4067	in	_	
23-15	4068-4071	the	_	
23-16	4072-4074	GP	_	
23-17	4075-4081	during	_	
23-18	4082-4083	a	_	
23-19	4084-4095	stop-signal	_	
23-20	4096-4100	task	_	
23-21	4100-4101	,	_	
23-22	4102-4105	and	_	
23-23	4106-4110	this	_	
23-24	4111-4117	signal	_	
23-25	4118-4124	change	_	
23-26	4125-4128	was	_	
23-27	4129-4139	associated	_	
23-28	4140-4144	with	_	
23-29	4145-4151	slowed	_	
23-30	4152-4160	reaction	_	
23-31	4161-4165	time	_	
23-32	4166-4169	and	_	
23-33	4170-4178	impaired	_	
23-34	4179-4189	inhibitory	_	
23-35	4190-4197	control	_	
23-36	4197-4198	.	_	

#Text=Taken together, these findings suggest that impulsivity and behavioral disinhibition associated with alcohol consumption may be driven by alcohol-induced changes in GPe connectivity.
24-1	4199-4204	Taken	_	
24-2	4205-4213	together	_	
24-3	4213-4214	,	_	
24-4	4215-4220	these	_	
24-5	4221-4229	findings	_	
24-6	4230-4237	suggest	_	
24-7	4238-4242	that	_	
24-8	4243-4254	impulsivity	_	
24-9	4255-4258	and	_	
24-10	4259-4269	behavioral	_	
24-11	4270-4283	disinhibition	_	
24-12	4284-4294	associated	_	
24-13	4295-4299	with	_	
24-14	4300-4307	alcohol	_	
24-15	4308-4319	consumption	_	
24-16	4320-4323	may	_	
24-17	4324-4326	be	_	
24-18	4327-4333	driven	_	
24-19	4334-4336	by	_	
24-20	4337-4352	alcohol-induced	_	
24-21	4353-4360	changes	_	
24-22	4361-4363	in	_	
24-23	4364-4367	GPe	_	
24-24	4368-4380	connectivity	_	
24-25	4380-4381	.	_	

#Text=In this study, we aimed to extend the preclinical results of the Abrahao et al, 2017 study to a human paradigm by determining whether alcohol-induced changes in GPe connectivity are related to recent drinking patterns, impulsivity, and interactions between the two.
25-1	4382-4384	In	_	
25-2	4385-4389	this	_	
25-3	4390-4395	study	_	
25-4	4395-4396	,	_	
25-5	4397-4399	we	_	
25-6	4400-4405	aimed	_	
25-7	4406-4408	to	_	
25-8	4409-4415	extend	_	
25-9	4416-4419	the	_	
25-10	4420-4431	preclinical	_	
25-11	4432-4439	results	_	
25-12	4440-4442	of	_	
25-13	4443-4446	the	_	
25-14	4447-4454	Abrahao	_	
25-15	4455-4457	et	_	
25-16	4458-4460	al	_	
25-17	4460-4461	,	_	
25-18	4462-4466	2017	_	
25-19	4467-4472	study	_	
25-20	4473-4475	to	_	
25-21	4476-4477	a	_	
25-22	4478-4483	human	_	
25-23	4484-4492	paradigm	_	
25-24	4493-4495	by	_	
25-25	4496-4507	determining	_	
25-26	4508-4515	whether	_	
25-27	4516-4531	alcohol-induced	_	
25-28	4532-4539	changes	_	
25-29	4540-4542	in	_	
25-30	4543-4546	GPe	_	
25-31	4547-4559	connectivity	_	
25-32	4560-4563	are	_	
25-33	4564-4571	related	_	
25-34	4572-4574	to	_	
25-35	4575-4581	recent	_	
25-36	4582-4590	drinking	_	
25-37	4591-4599	patterns	_	
25-38	4599-4600	,	_	
25-39	4601-4612	impulsivity	_	
25-40	4612-4613	,	_	
25-41	4614-4617	and	_	
25-42	4618-4630	interactions	_	
25-43	4631-4638	between	_	
25-44	4639-4642	the	_	
25-45	4643-4646	two	_	
25-46	4646-4647	.	_	

#Text=To do so, we compared the resting-state fMRI connectivity of the GPe before and after controlled acute intravenous (IV) alcohol administration to “binge drinking” levels (BAC = 0.08 g/dl) in healthy humans, and examined the relationship between those differences, recent drinking history, and trait impulsivity.
26-1	4648-4650	To	_	
26-2	4651-4653	do	_	
26-3	4654-4656	so	_	
26-4	4656-4657	,	_	
26-5	4658-4660	we	_	
26-6	4661-4669	compared	_	
26-7	4670-4673	the	_	
26-8	4674-4687	resting-state	_	
26-9	4688-4692	fMRI	_	
26-10	4693-4705	connectivity	_	
26-11	4706-4708	of	_	
26-12	4709-4712	the	_	
26-13	4713-4716	GPe	_	
26-14	4717-4723	before	_	
26-15	4724-4727	and	_	
26-16	4728-4733	after	_	
26-17	4734-4744	controlled	_	
26-18	4745-4750	acute	_	
26-19	4751-4762	intravenous	_	
26-20	4763-4764	(	_	
26-21	4764-4766	IV	_	
26-22	4766-4767	)	_	
26-23	4768-4775	alcohol	_	
26-24	4776-4790	administration	_	
26-25	4791-4793	to	_	
26-26	4794-4795	“	_	
26-27	4795-4800	binge	_	
26-28	4801-4809	drinking	_	
26-29	4809-4810	”	_	
26-30	4811-4817	levels	_	
26-31	4818-4819	(	_	
26-32	4819-4822	BAC	_	
26-33	4823-4824	=	_	
26-34	4825-4829	0.08	_	
26-35	4830-4831	g	_	
26-36	4831-4832	/	_	
26-37	4832-4834	dl	_	
26-38	4834-4835	)	_	
26-39	4836-4838	in	_	
26-40	4839-4846	healthy	_	
26-41	4847-4853	humans	_	
26-42	4853-4854	,	_	
26-43	4855-4858	and	_	
26-44	4859-4867	examined	_	
26-45	4868-4871	the	_	
26-46	4872-4884	relationship	_	
26-47	4885-4892	between	_	
26-48	4893-4898	those	_	
26-49	4899-4910	differences	_	
26-50	4910-4911	,	_	
26-51	4912-4918	recent	_	
26-52	4919-4927	drinking	_	
26-53	4928-4935	history	_	
26-54	4935-4936	,	_	
26-55	4937-4940	and	_	
26-56	4941-4946	trait	_	
26-57	4947-4958	impulsivity	_	
26-58	4958-4959	.	_	

#Text=To our knowledge, this is the first time such an investigation has been conducted.
27-1	4960-4962	To	_	
27-2	4963-4966	our	_	
27-3	4967-4976	knowledge	_	
27-4	4976-4977	,	_	
27-5	4978-4982	this	_	
27-6	4983-4985	is	_	
27-7	4986-4989	the	_	
27-8	4990-4995	first	_	
27-9	4996-5000	time	_	
27-10	5001-5005	such	_	
27-11	5006-5008	an	_	
27-12	5009-5022	investigation	_	
27-13	5023-5026	has	_	
27-14	5027-5031	been	_	
27-15	5032-5041	conducted	_	
27-16	5041-5042	.	_	

#Text=We hypothesized that alcohol would result in greater decreases in GPe functional connectivity across the brain in individuals with more impulsive traits and higher risk drinking behaviors.
28-1	5043-5045	We	_	
28-2	5046-5058	hypothesized	_	
28-3	5059-5063	that	_	
28-4	5064-5071	alcohol	_	
28-5	5072-5077	would	_	
28-6	5078-5084	result	_	
28-7	5085-5087	in	_	
28-8	5088-5095	greater	_	
28-9	5096-5105	decreases	_	
28-10	5106-5108	in	_	
28-11	5109-5112	GPe	_	
28-12	5113-5123	functional	_	
28-13	5124-5136	connectivity	_	
28-14	5137-5143	across	_	
28-15	5144-5147	the	_	
28-16	5148-5153	brain	_	
28-17	5154-5156	in	_	
28-18	5157-5168	individuals	_	
28-19	5169-5173	with	_	
28-20	5174-5178	more	_	
28-21	5179-5188	impulsive	_	
28-22	5189-5195	traits	_	
28-23	5196-5199	and	_	
28-24	5200-5206	higher	_	
28-25	5207-5211	risk	_	
28-26	5212-5220	drinking	_	
28-27	5221-5230	behaviors	_	
28-28	5230-5231	.	_	

#Text=Moreover, we hypothesized that the interaction between recent drinking behaviors and impulsivity would contribute to alcohol-induced changes in GPe functional connectivity.
29-1	5232-5240	Moreover	_	
29-2	5240-5241	,	_	
29-3	5242-5244	we	_	
29-4	5245-5257	hypothesized	_	
29-5	5258-5262	that	_	
29-6	5263-5266	the	_	
29-7	5267-5278	interaction	_	
29-8	5279-5286	between	_	
29-9	5287-5293	recent	_	
29-10	5294-5302	drinking	_	
29-11	5303-5312	behaviors	_	
29-12	5313-5316	and	_	
29-13	5317-5328	impulsivity	_	
29-14	5329-5334	would	_	
29-15	5335-5345	contribute	_	
29-16	5346-5348	to	_	
29-17	5349-5364	alcohol-induced	_	
29-18	5365-5372	changes	_	
29-19	5373-5375	in	_	
29-20	5376-5379	GPe	_	
29-21	5380-5390	functional	_	
29-22	5391-5403	connectivity	_	
29-23	5403-5404	.	_	

#Text=Methods
#Text=This study was approved by the NIH Addictions Institutional Review Board under 12-AA-0032.
30-1	5405-5412	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
30-2	5413-5417	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-3	5418-5423	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-4	5424-5427	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-5	5428-5436	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-6	5437-5439	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-7	5440-5443	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-8	5444-5447	NIH	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-9	5448-5458	Addictions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-10	5459-5472	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-11	5473-5479	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-12	5480-5485	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-13	5486-5491	under	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-14	5492-5494	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-15	5494-5495	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-16	5495-5497	AA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-17	5497-5498	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-18	5498-5502	0032	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
30-19	5502-5503	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=All subjects provided written informed consent prior to their participation in the study.
31-1	5504-5507	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-2	5508-5516	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-3	5517-5525	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-4	5526-5533	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-5	5534-5542	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-6	5543-5550	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-7	5551-5556	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-8	5557-5559	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-9	5560-5565	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-10	5566-5579	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-11	5580-5582	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-12	5583-5586	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-13	5587-5592	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
31-14	5592-5593	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=Participants
#Text=Twenty-five healthy (13 males, 12 females; mean age: 28.85 years), light social drinkers were recruited by local advertisement, according to approved National Institutes of Health Institutional Review Board procedures.
32-1	5594-5606	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-2	5607-5618	Twenty-five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-3	5619-5626	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-4	5627-5628	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-5	5628-5630	13	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-6	5631-5636	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-7	5636-5637	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-8	5638-5640	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-9	5641-5648	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-10	5648-5649	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-11	5650-5654	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-12	5655-5658	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-13	5658-5659	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-14	5660-5665	28.85	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-15	5666-5671	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-16	5671-5672	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-17	5672-5673	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-18	5674-5679	light	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-19	5680-5686	social	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-20	5687-5695	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
32-21	5696-5700	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-22	5701-5710	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-23	5711-5713	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-24	5714-5719	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-25	5720-5733	advertisement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-26	5733-5734	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-27	5735-5744	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-28	5745-5747	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-29	5748-5756	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-30	5757-5765	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-31	5766-5776	Institutes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-32	5777-5779	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-33	5780-5786	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-34	5787-5800	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-35	5801-5807	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-36	5808-5813	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-37	5814-5824	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
32-38	5824-5825	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=The demographic data of participants is summarized in Table 1.
33-1	5826-5829	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-2	5830-5841	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-3	5842-5846	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-4	5847-5849	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-5	5850-5862	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-6	5863-5865	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-7	5866-5876	summarized	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-8	5877-5879	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-9	5880-5885	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-10	5886-5887	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
33-11	5887-5888	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	

#Text=After obtaining written informed consent, all participants underwent a comprehensive medical screen, including blood work, urinalysis, medical history, physical exam, and a Structured Clinical Interview for the DSM Axis-I Disorders (SCID-IV).
34-1	5889-5894	After	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-2	5895-5904	obtaining	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-3	5905-5912	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-4	5913-5921	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-5	5922-5929	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-6	5929-5930	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-7	5931-5934	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-8	5935-5947	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-9	5948-5957	underwent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-10	5958-5959	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-11	5960-5973	comprehensive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-12	5974-5981	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-13	5982-5988	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-14	5988-5989	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-15	5990-5999	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-16	6000-6005	blood	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-17	6006-6010	work	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-18	6010-6011	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-19	6012-6022	urinalysis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-20	6022-6023	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-21	6024-6031	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-22	6032-6039	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-23	6039-6040	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-24	6041-6049	physical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-25	6050-6054	exam	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-26	6054-6055	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-27	6056-6059	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-28	6060-6061	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
34-29	6062-6072	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-30	6073-6081	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-31	6082-6091	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-32	6092-6095	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-33	6096-6099	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-34	6100-6103	DSM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-35	6104-6110	Axis-I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-36	6111-6120	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-37	6121-6122	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-38	6122-6129	SCID-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-39	6129-6130	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
34-40	6130-6131	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	

#Text=Criteria for inclusion in this study were: healthy, 21–45 years old, consumption of 1 to 10 drinks per week for females and 1 to 14 drinks per week for males.
35-1	6132-6140	Criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-2	6141-6144	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-3	6145-6154	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-4	6155-6157	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-5	6158-6162	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-6	6163-6168	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-7	6169-6173	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-8	6173-6174	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-9	6175-6182	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-10	6182-6183	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-11	6184-6186	21	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-12	6186-6187	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-13	6187-6189	45	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-14	6190-6195	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-15	6196-6199	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-16	6199-6200	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-17	6201-6212	consumption	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-18	6213-6215	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-19	6216-6217	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-20	6218-6220	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-21	6221-6223	10	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-22	6224-6230	drinks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-23	6231-6234	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-24	6235-6239	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-25	6240-6243	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-26	6244-6251	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-27	6252-6255	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-28	6256-6257	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-29	6258-6260	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-30	6261-6263	14	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-31	6264-6270	drinks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-32	6271-6274	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-33	6275-6279	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-34	6280-6283	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-35	6284-6289	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingEpisode[12]	
35-36	6289-6290	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Subjects also had to have consumed at least two standard drinks of alcohol within one hour on at least one occasion in their lifetime.
36-1	6291-6299	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-2	6300-6304	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-3	6305-6308	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-4	6309-6311	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-5	6312-6316	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-6	6317-6325	consumed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-7	6326-6328	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-8	6329-6334	least	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-9	6335-6338	two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-10	6339-6347	standard	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-11	6348-6354	drinks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-12	6355-6357	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-13	6358-6365	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-14	6366-6372	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-15	6373-6376	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-16	6377-6381	hour	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-17	6382-6384	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-18	6385-6387	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-19	6388-6393	least	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-20	6394-6397	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-21	6398-6406	occasion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-22	6407-6409	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-23	6410-6415	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-24	6416-6424	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#DrinkingSession[13]	
36-25	6424-6425	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Criteria for exclusion included: abnormal blood or urine lab test values or findings from the medical screen, DSM-IV criteria for alcohol or other substance dependence (excluding nicotine) at any time; current or past major psychiatric disorder (DSM-IV Axis I), head injury requiring hospitalization, Body Mass Index (BMI) value over 30, inability to stop taking any medication or drugs 3 days prior to study days, and MRI contraindications.
37-1	6426-6434	Criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-2	6435-6438	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-3	6439-6448	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-4	6449-6457	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-5	6457-6458	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-6	6459-6467	abnormal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-7	6468-6473	blood	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-8	6474-6476	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-9	6477-6482	urine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-10	6483-6486	lab	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-11	6487-6491	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-12	6492-6498	values	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-13	6499-6501	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-14	6502-6510	findings	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-15	6511-6515	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-16	6516-6519	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-17	6520-6527	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-18	6528-6534	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-19	6534-6535	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-20	6536-6542	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-21	6543-6551	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-22	6552-6555	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-23	6556-6563	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-24	6564-6566	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-25	6567-6572	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-26	6573-6582	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-27	6583-6593	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-28	6594-6595	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-29	6595-6604	excluding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-30	6605-6613	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-31	6613-6614	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-32	6615-6617	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-33	6618-6621	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-34	6622-6626	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-35	6626-6627	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-36	6628-6635	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-37	6636-6638	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-38	6639-6643	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-39	6644-6649	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-40	6650-6661	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-41	6662-6670	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-42	6671-6672	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-43	6672-6678	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-44	6679-6683	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-45	6684-6685	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-46	6685-6686	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-47	6686-6687	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-48	6688-6692	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-49	6693-6699	injury	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-50	6700-6709	requiring	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-51	6710-6725	hospitalization	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-52	6725-6726	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-53	6727-6731	Body	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-54	6732-6736	Mass	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-55	6737-6742	Index	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-56	6743-6744	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-57	6744-6747	BMI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-58	6747-6748	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-59	6749-6754	value	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-60	6755-6759	over	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-61	6760-6762	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-62	6762-6763	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-63	6764-6773	inability	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-64	6774-6776	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-65	6777-6781	stop	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-66	6782-6788	taking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-67	6789-6792	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-68	6793-6803	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-69	6804-6806	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-70	6807-6812	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-71	6813-6814	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-72	6815-6819	days	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-73	6820-6825	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-74	6826-6828	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-75	6829-6834	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-76	6835-6839	days	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-77	6839-6840	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-78	6841-6844	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-79	6845-6848	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-80	6849-6866	contraindications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
37-81	6866-6867	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Also, non-drinkers were excluded from the study due to ethical concerns related to alcohol administration.
38-1	6868-6872	Also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-2	6872-6873	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-3	6874-6886	non-drinkers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-4	6887-6891	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-5	6892-6900	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-6	6901-6905	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-7	6906-6909	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-8	6910-6915	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-9	6916-6919	due	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-10	6920-6922	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-11	6923-6930	ethical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-12	6931-6939	concerns	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-13	6940-6947	related	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-14	6948-6950	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-15	6951-6958	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-16	6959-6973	administration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
38-17	6973-6974	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Demographic, drinking, and impulsivity characteristics.
39-1	6975-6986	Demographic	_	
39-2	6986-6987	,	_	
39-3	6988-6996	drinking	_	
39-4	6996-6997	,	_	
39-5	6998-7001	and	_	
39-6	7002-7013	impulsivity	_	
39-7	7014-7029	characteristics	_	
39-8	7029-7030	.	_	

#Text=Variable\tCount\t \tTotal n\t25\t \tGender (Male / Female)\t13 / 12\t \tSmokers\t1\t \t\tMean\tSD\t \tAge\t28.85\t7.40\t \tYears Of Education\t15.88\t1.88\t \tBIS: Total\t54.76\t9.62\t \tAttentional Impulsiveness\t12.96\t2.99\t \tMotor Impulsiveness\t20.92\t3.32\t \tNonplanning Impulsiveness\t19.72\t4.21\t \tUPPS-P: Positive Urgency\t1.36\t0.31\t \tNegative Urgency\t1.66\t0.44\t \tPremeditation\t1.78\t0.42\t \tPerseverence\t1.53\t0.39\t \tSensation Seeking\t2.85\t0.70\t \tDelay Discounting Rate (K)\t0.02\t0.06\t \tTLFB—Drinks Per Thirty Days\t20.19\t13.69\t \tTLFB—Heavy Drinking Days\t19.08\t10.96\t \t
#Text=Abbreviations as follow: BIS- Barratt Impulsiveness Scale; TLFB- Alcohol Timeline Followback.
40-1	7031-7039	Variable	_	
40-2	7040-7045	Count	_	
40-3	7048-7053	Total	_	
40-4	7054-7055	n	_	
40-5	7056-7058	25	_	
40-6	7061-7067	Gender	_	
40-7	7068-7069	(	_	
40-8	7069-7073	Male	_	
40-9	7074-7075	/	_	
40-10	7076-7082	Female	_	
40-11	7082-7083	)	_	
40-12	7084-7086	13	_	
40-13	7087-7088	/	_	
40-14	7089-7091	12	_	
40-15	7094-7101	Smokers	_	
40-16	7102-7103	1	_	
40-17	7107-7111	Mean	_	
40-18	7112-7114	SD	_	
40-19	7117-7120	Age	_	
40-20	7121-7126	28.85	_	
40-21	7127-7131	7.40	_	
40-22	7134-7139	Years	_	
40-23	7140-7142	Of	_	
40-24	7143-7152	Education	_	
40-25	7153-7158	15.88	_	
40-26	7159-7163	1.88	_	
40-27	7166-7169	BIS	_	
40-28	7169-7170	:	_	
40-29	7171-7176	Total	_	
40-30	7177-7182	54.76	_	
40-31	7183-7187	9.62	_	
40-32	7190-7201	Attentional	_	
40-33	7202-7215	Impulsiveness	_	
40-34	7216-7221	12.96	_	
40-35	7222-7226	2.99	_	
40-36	7229-7234	Motor	_	
40-37	7235-7248	Impulsiveness	_	
40-38	7249-7254	20.92	_	
40-39	7255-7259	3.32	_	
40-40	7262-7273	Nonplanning	_	
40-41	7274-7287	Impulsiveness	_	
40-42	7288-7293	19.72	_	
40-43	7294-7298	4.21	_	
40-44	7301-7307	UPPS-P	_	
40-45	7307-7308	:	_	
40-46	7309-7317	Positive	_	
40-47	7318-7325	Urgency	_	
40-48	7326-7330	1.36	_	
40-49	7331-7335	0.31	_	
40-50	7338-7346	Negative	_	
40-51	7347-7354	Urgency	_	
40-52	7355-7359	1.66	_	
40-53	7360-7364	0.44	_	
40-54	7367-7380	Premeditation	_	
40-55	7381-7385	1.78	_	
40-56	7386-7390	0.42	_	
40-57	7393-7405	Perseverence	_	
40-58	7406-7410	1.53	_	
40-59	7411-7415	0.39	_	
40-60	7418-7427	Sensation	_	
40-61	7428-7435	Seeking	_	
40-62	7436-7440	2.85	_	
40-63	7441-7445	0.70	_	
40-64	7448-7453	Delay	_	
40-65	7454-7465	Discounting	_	
40-66	7466-7470	Rate	_	
40-67	7471-7472	(	_	
40-68	7472-7473	K	_	
40-69	7473-7474	)	_	
40-70	7475-7479	0.02	_	
40-71	7480-7484	0.06	_	
40-72	7487-7498	TLFB—Drinks	_	
40-73	7499-7502	Per	_	
40-74	7503-7509	Thirty	_	
40-75	7510-7514	Days	_	
40-76	7515-7520	20.19	_	
40-77	7521-7526	13.69	_	
40-78	7529-7539	TLFB—Heavy	_	
40-79	7540-7548	Drinking	_	
40-80	7549-7553	Days	_	
40-81	7554-7559	19.08	_	
40-82	7560-7565	10.96	_	
40-83	7569-7582	Abbreviations	_	
40-84	7583-7585	as	_	
40-85	7586-7592	follow	_	
40-86	7592-7593	:	_	
40-87	7594-7597	BIS	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[14]	
40-88	7597-7598	-	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[14]	
40-89	7599-7606	Barratt	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[14]	
40-90	7607-7620	Impulsiveness	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[14]	
40-91	7621-7626	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[14]	
40-92	7626-7627	;	_	
40-93	7628-7632	TLFB	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[15]	
40-94	7632-7633	-	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[15]	
40-95	7634-7641	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[15]	
40-96	7642-7650	Timeline	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[15]	
40-97	7651-7661	Followback	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[15]	
40-98	7661-7662	.	_	

#Text=Measures
#Text=Alcohol drinking measures
#Text=The amount of daily alcohol consumption over the last 90 days was measured using the Alcohol Timeline-Followback (TLFB) calendar—a drinking assessment method with good psychometric characteristics for estimating retrospective daily drinking patterns.
41-1	7663-7671	Measures	_	
41-2	7672-7679	Alcohol	_	
41-3	7680-7688	drinking	_	
41-4	7689-7697	measures	_	
41-5	7698-7701	The	_	
41-6	7702-7708	amount	_	
41-7	7709-7711	of	_	
41-8	7712-7717	daily	_	
41-9	7718-7725	alcohol	_	
41-10	7726-7737	consumption	_	
41-11	7738-7742	over	_	
41-12	7743-7746	the	_	
41-13	7747-7751	last	_	
41-14	7752-7754	90	_	
41-15	7755-7759	days	_	
41-16	7760-7763	was	_	
41-17	7764-7772	measured	_	
41-18	7773-7778	using	_	
41-19	7779-7782	the	_	
41-20	7783-7790	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[16]	
41-21	7791-7810	Timeline-Followback	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[16]	
41-22	7811-7812	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[16]	
41-23	7812-7816	TLFB	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[16]	
41-24	7816-7817	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire[16]	
41-25	7818-7828	calendar—a	_	
41-26	7829-7837	drinking	_	
41-27	7838-7848	assessment	_	
41-28	7849-7855	method	_	
41-29	7856-7860	with	_	
41-30	7861-7865	good	_	
41-31	7866-7878	psychometric	_	
41-32	7879-7894	characteristics	_	
41-33	7895-7898	for	_	
41-34	7899-7909	estimating	_	
41-35	7910-7923	retrospective	_	
41-36	7924-7929	daily	_	
41-37	7930-7938	drinking	_	
41-38	7939-7947	patterns	_	
41-39	7947-7948	.	_	

#Text=The number of heavy drinking days in the last 90 days was calculated from the TLFB; a heavy drinking day is defined as 4 or more drinks per day for women and 5 or more drinks per day for men.
42-1	7949-7952	The	_	
42-2	7953-7959	number	_	
42-3	7960-7962	of	_	
42-4	7963-7968	heavy	_	
42-5	7969-7977	drinking	_	
42-6	7978-7982	days	_	
42-7	7983-7985	in	_	
42-8	7986-7989	the	_	
42-9	7990-7994	last	_	
42-10	7995-7997	90	_	
42-11	7998-8002	days	_	
42-12	8003-8006	was	_	
42-13	8007-8017	calculated	_	
42-14	8018-8022	from	_	
42-15	8023-8026	the	_	
42-16	8027-8031	TLFB	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire	
42-17	8031-8032	;	_	
42-18	8033-8034	a	_	
42-19	8035-8040	heavy	_	
42-20	8041-8049	drinking	_	
42-21	8050-8053	day	_	
42-22	8054-8056	is	_	
42-23	8057-8064	defined	_	
42-24	8065-8067	as	_	
42-25	8068-8069	4	_	
42-26	8070-8072	or	_	
42-27	8073-8077	more	_	
42-28	8078-8084	drinks	_	
42-29	8085-8088	per	_	
42-30	8089-8092	day	_	
42-31	8093-8096	for	_	
42-32	8097-8102	women	_	
42-33	8103-8106	and	_	
42-34	8107-8108	5	_	
42-35	8109-8111	or	_	
42-36	8112-8116	more	_	
42-37	8117-8123	drinks	_	
42-38	8124-8127	per	_	
42-39	8128-8131	day	_	
42-40	8132-8135	for	_	
42-41	8136-8139	men	_	
42-42	8139-8140	.	_	

#Text=We used this as a measure for binge drinking.
43-1	8141-8143	We	_	
43-2	8144-8148	used	_	
43-3	8149-8153	this	_	
43-4	8154-8156	as	_	
43-5	8157-8158	a	_	
43-6	8159-8166	measure	_	
43-7	8167-8170	for	_	
43-8	8171-8176	binge	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[17]	
43-9	8177-8185	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingBinge[17]	
43-10	8185-8186	.	_	

#Text=Total drinks in the past 30 days was also calculated from the TLFB.
44-1	8187-8192	Total	_	
44-2	8193-8199	drinks	_	
44-3	8200-8202	in	_	
44-4	8203-8206	the	_	
44-5	8207-8211	past	_	
44-6	8212-8214	30	_	
44-7	8215-8219	days	_	
44-8	8220-8223	was	_	
44-9	8224-8228	also	_	
44-10	8229-8239	calculated	_	
44-11	8240-8244	from	_	
44-12	8245-8248	the	_	
44-13	8249-8253	TLFB	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire	
44-14	8253-8254	.	_	

#Text=Past 30-day drinking was used rather than 90-day drinking given that we were interested in recent drinking, and that recent reports of drinking may be more reliable.
45-1	8255-8259	Past	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-2	8260-8262	30	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-3	8262-8263	-	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-4	8263-8266	day	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-5	8267-8275	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-6	8276-8279	was	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-7	8280-8284	used	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-8	8285-8291	rather	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-9	8292-8296	than	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-10	8297-8299	90	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-11	8299-8300	-	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-12	8300-8303	day	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-13	8304-8312	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-14	8313-8318	given	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-15	8319-8323	that	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-16	8324-8326	we	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-17	8327-8331	were	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-18	8332-8342	interested	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-19	8343-8345	in	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-20	8346-8352	recent	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-21	8353-8361	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-22	8361-8362	,	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-23	8363-8366	and	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-24	8367-8371	that	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-25	8372-8378	recent	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-26	8379-8386	reports	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-27	8387-8389	of	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-28	8390-8398	drinking	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-29	8399-8402	may	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-30	8403-8405	be	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-31	8406-8410	more	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-32	8411-8419	reliable	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	
45-33	8419-8420	.	http://maven.renci.org/NeuroBridge/neurobridge#DrinkingDay[18]	

#Text=Impulsivity measures
#Text=Impulsive behavioral traits were measured using the Barratt Impulsiveness Scale (BIS-11) and the UPPS-P Impulsive Behavior Scale, two of the most widely-used self-report tools in the evaluation of trait impulsivity.
46-1	8421-8432	Impulsivity	_	
46-2	8433-8441	measures	_	
46-3	8442-8451	Impulsive	_	
46-4	8452-8462	behavioral	_	
46-5	8463-8469	traits	_	
46-6	8470-8474	were	_	
46-7	8475-8483	measured	_	
46-8	8484-8489	using	_	
46-9	8490-8493	the	_	
46-10	8494-8501	Barratt	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-11	8502-8515	Impulsiveness	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-12	8516-8521	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-13	8522-8523	(	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-14	8523-8526	BIS	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-15	8526-8527	-	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-16	8527-8529	11	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-17	8529-8530	)	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[19]	
46-18	8531-8534	and	_	
46-19	8535-8538	the	_	
46-20	8539-8545	UPPS-P	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[20]	
46-21	8546-8555	Impulsive	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[20]	
46-22	8556-8564	Behavior	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[20]	
46-23	8565-8570	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[20]	
46-24	8570-8571	,	_	
46-25	8572-8575	two	_	
46-26	8576-8578	of	_	
46-27	8579-8582	the	_	
46-28	8583-8587	most	_	
46-29	8588-8599	widely-used	_	
46-30	8600-8611	self-report	_	
46-31	8612-8617	tools	_	
46-32	8618-8620	in	_	
46-33	8621-8624	the	_	
46-34	8625-8635	evaluation	_	
46-35	8636-8638	of	_	
46-36	8639-8644	trait	_	
46-37	8645-8656	impulsivity	_	
46-38	8656-8657	.	_	

#Text=The BIS-11 scale evaluates impulsive behavior in general, and the motor, attentional and non-planning sub-scales evaluate acting without thinking, inability to focus attention and lack of forethought, respectively.
47-1	8658-8661	The	_	
47-2	8662-8665	BIS	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[21]	
47-3	8665-8666	-	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[21]	
47-4	8666-8668	11	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[21]	
47-5	8669-8674	scale	_	
47-6	8675-8684	evaluates	_	
47-7	8685-8694	impulsive	_	
47-8	8695-8703	behavior	_	
47-9	8704-8706	in	_	
47-10	8707-8714	general	_	
47-11	8714-8715	,	_	
47-12	8716-8719	and	_	
47-13	8720-8723	the	_	
47-14	8724-8729	motor	_	
47-15	8729-8730	,	_	
47-16	8731-8742	attentional	_	
47-17	8743-8746	and	_	
47-18	8747-8759	non-planning	_	
47-19	8760-8770	sub-scales	_	
47-20	8771-8779	evaluate	_	
47-21	8780-8786	acting	_	
47-22	8787-8794	without	_	
47-23	8795-8803	thinking	_	
47-24	8803-8804	,	_	
47-25	8805-8814	inability	_	
47-26	8815-8817	to	_	
47-27	8818-8823	focus	_	
47-28	8824-8833	attention	_	
47-29	8834-8837	and	_	
47-30	8838-8842	lack	_	
47-31	8843-8845	of	_	
47-32	8846-8857	forethought	_	
47-33	8857-8858	,	_	
47-34	8859-8871	respectively	_	
47-35	8871-8872	.	_	

#Text=The UPPS-P measures personality traits conducive to impulsive behavior including Urgency (negative)—tendency to impulsively act under strong negative emotions, Premeditation (lack of)—tendency to act without thinking, Perseverance (lack of) to remain focused on a task, Sensation-seeking—tendency to seek out novel/thrilling experiences, and Positive-urgency—tendency to impulsively act under strong positive emotions.
48-1	8873-8876	The	_	
48-2	8877-8883	UPPS-P	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale	
48-3	8884-8892	measures	_	
48-4	8893-8904	personality	_	
48-5	8905-8911	traits	_	
48-6	8912-8921	conducive	_	
48-7	8922-8924	to	_	
48-8	8925-8934	impulsive	_	
48-9	8935-8943	behavior	_	
48-10	8944-8953	including	_	
48-11	8954-8961	Urgency	_	
48-12	8962-8963	(	_	
48-13	8963-8971	negative	_	
48-14	8971-8972	)	_	
48-15	8972-8973	—	_	
48-16	8973-8981	tendency	_	
48-17	8982-8984	to	_	
48-18	8985-8996	impulsively	_	
48-19	8997-9000	act	_	
48-20	9001-9006	under	_	
48-21	9007-9013	strong	_	
48-22	9014-9022	negative	_	
48-23	9023-9031	emotions	_	
48-24	9031-9032	,	_	
48-25	9033-9046	Premeditation	_	
48-26	9047-9048	(	_	
48-27	9048-9052	lack	_	
48-28	9053-9055	of	_	
48-29	9055-9056	)	_	
48-30	9056-9057	—	_	
48-31	9057-9065	tendency	_	
48-32	9066-9068	to	_	
48-33	9069-9072	act	_	
48-34	9073-9080	without	_	
48-35	9081-9089	thinking	_	
48-36	9089-9090	,	_	
48-37	9091-9103	Perseverance	_	
48-38	9104-9105	(	_	
48-39	9105-9109	lack	_	
48-40	9110-9112	of	_	
48-41	9112-9113	)	_	
48-42	9114-9116	to	_	
48-43	9117-9123	remain	_	
48-44	9124-9131	focused	_	
48-45	9132-9134	on	_	
48-46	9135-9136	a	_	
48-47	9137-9141	task	_	
48-48	9141-9142	,	_	
48-49	9143-9169	Sensation-seeking—tendency	_	
48-50	9170-9172	to	_	
48-51	9173-9177	seek	_	
48-52	9178-9181	out	_	
48-53	9182-9187	novel	_	
48-54	9187-9188	/	_	
48-55	9188-9197	thrilling	_	
48-56	9198-9209	experiences	_	
48-57	9209-9210	,	_	
48-58	9211-9214	and	_	
48-59	9215-9240	Positive-urgency—tendency	_	
48-60	9241-9243	to	_	
48-61	9244-9255	impulsively	_	
48-62	9256-9259	act	_	
48-63	9260-9265	under	_	
48-64	9266-9272	strong	_	
48-65	9273-9281	positive	_	
48-66	9282-9290	emotions	_	
48-67	9290-9291	.	_	

#Text=We also evaluated choice impulsivity with the Delay Discounting Task (DDT).
49-1	9292-9294	We	_	
49-2	9295-9299	also	_	
49-3	9300-9309	evaluated	_	
49-4	9310-9316	choice	_	
49-5	9317-9328	impulsivity	_	
49-6	9329-9333	with	_	
49-7	9334-9337	the	_	
49-8	9338-9343	Delay	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-9	9344-9355	Discounting	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-10	9356-9360	Task	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-11	9361-9362	(	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-12	9362-9365	DDT	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-13	9365-9366	)	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale[22]	
49-14	9366-9367	.	_	

#Text=The DDT measures impulsivity by presenting the subject with a series of hypothetical choices between receiving a smaller immediate monetary reward or a larger delayed reward.
50-1	9368-9371	The	_	
50-2	9372-9375	DDT	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale	
50-3	9376-9384	measures	_	
50-4	9385-9396	impulsivity	_	
50-5	9397-9399	by	_	
50-6	9400-9410	presenting	_	
50-7	9411-9414	the	_	
50-8	9415-9422	subject	_	
50-9	9423-9427	with	_	
50-10	9428-9429	a	_	
50-11	9430-9436	series	_	
50-12	9437-9439	of	_	
50-13	9440-9452	hypothetical	_	
50-14	9453-9460	choices	_	
50-15	9461-9468	between	_	
50-16	9469-9478	receiving	_	
50-17	9479-9480	a	_	
50-18	9481-9488	smaller	_	
50-19	9489-9498	immediate	_	
50-20	9499-9507	monetary	_	
50-21	9508-9514	reward	_	
50-22	9515-9517	or	_	
50-23	9518-9519	a	_	
50-24	9520-9526	larger	_	
50-25	9527-9534	delayed	_	
50-26	9535-9541	reward	_	
50-27	9541-9542	.	_	

#Text=Subjects were presented as their immediate reward values between $100 and $0 dollars in increments of $10, while the delayed reward was $100.
51-1	9543-9551	Subjects	_	
51-2	9552-9556	were	_	
51-3	9557-9566	presented	_	
51-4	9567-9569	as	_	
51-5	9570-9575	their	_	
51-6	9576-9585	immediate	_	
51-7	9586-9592	reward	_	
51-8	9593-9599	values	_	
51-9	9600-9607	between	_	
51-10	9608-9612	$100	_	
51-11	9613-9616	and	_	
51-12	9617-9619	$0	_	
51-13	9620-9627	dollars	_	
51-14	9628-9630	in	_	
51-15	9631-9641	increments	_	
51-16	9642-9644	of	_	
51-17	9645-9648	$10	_	
51-18	9648-9649	,	_	
51-19	9650-9655	while	_	
51-20	9656-9659	the	_	
51-21	9660-9667	delayed	_	
51-22	9668-9674	reward	_	
51-23	9675-9678	was	_	
51-24	9679-9683	$100	_	
51-25	9683-9684	.	_	

#Text=Delays were 0, 7, 14, 20, 25, or 30 days.
52-1	9685-9691	Delays	_	
52-2	9692-9696	were	_	
52-3	9697-9698	0	_	
52-4	9698-9699	,	_	
52-5	9700-9701	7	_	
52-6	9701-9702	,	_	
52-7	9703-9705	14	_	
52-8	9705-9706	,	_	
52-9	9707-9709	20	_	
52-10	9709-9710	,	_	
52-11	9711-9713	25	_	
52-12	9713-9714	,	_	
52-13	9715-9717	or	_	
52-14	9718-9720	30	_	
52-15	9721-9725	days	_	
52-16	9725-9726	.	_	

#Text=Subjects completed trials with all iterations of these parameters.
53-1	9727-9735	Subjects	_	
53-2	9736-9745	completed	_	
53-3	9746-9752	trials	_	
53-4	9753-9757	with	_	
53-5	9758-9761	all	_	
53-6	9762-9772	iterations	_	
53-7	9773-9775	of	_	
53-8	9776-9781	these	_	
53-9	9782-9792	parameters	_	
53-10	9792-9793	.	_	

#Text=The rate of discounting of the delayed outcome (k) was calculated and then a natural log-transformation was applied to correct for the non-normal distribution of k values.
54-1	9794-9797	The	_	
54-2	9798-9802	rate	_	
54-3	9803-9805	of	_	
54-4	9806-9817	discounting	_	
54-5	9818-9820	of	_	
54-6	9821-9824	the	_	
54-7	9825-9832	delayed	_	
54-8	9833-9840	outcome	_	
54-9	9841-9842	(	_	
54-10	9842-9843	k	_	
54-11	9843-9844	)	_	
54-12	9845-9848	was	_	
54-13	9849-9859	calculated	_	
54-14	9860-9863	and	_	
54-15	9864-9868	then	_	
54-16	9869-9870	a	_	
54-17	9871-9878	natural	_	
54-18	9879-9897	log-transformation	_	
54-19	9898-9901	was	_	
54-20	9902-9909	applied	_	
54-21	9910-9912	to	_	
54-22	9913-9920	correct	_	
54-23	9921-9924	for	_	
54-24	9925-9928	the	_	
54-25	9929-9939	non-normal	_	
54-26	9940-9952	distribution	_	
54-27	9953-9955	of	_	
54-28	9956-9957	k	_	
54-29	9958-9964	values	_	
54-30	9964-9965	.	_	

#Text=The resulting ln(k) is used to represent delay discounting, where higher ln(k) values mean greater preference for immediate rewards (see Table 1 for descriptive statistics of drinking and impulsivity scores for the sample).
55-1	9966-9969	The	_	
55-2	9970-9979	resulting	_	
55-3	9980-9982	ln	_	
55-4	9982-9983	(	_	
55-5	9983-9984	k	_	
55-6	9984-9985	)	_	
55-7	9986-9988	is	_	
55-8	9989-9993	used	_	
55-9	9994-9996	to	_	
55-10	9997-10006	represent	_	
55-11	10007-10012	delay	_	
55-12	10013-10024	discounting	_	
55-13	10024-10025	,	_	
55-14	10026-10031	where	_	
55-15	10032-10038	higher	_	
55-16	10039-10041	ln	_	
55-17	10041-10042	(	_	
55-18	10042-10043	k	_	
55-19	10043-10044	)	_	
55-20	10045-10051	values	_	
55-21	10052-10056	mean	_	
55-22	10057-10064	greater	_	
55-23	10065-10075	preference	_	
55-24	10076-10079	for	_	
55-25	10080-10089	immediate	_	
55-26	10090-10097	rewards	_	
55-27	10098-10099	(	_	
55-28	10099-10102	see	_	
55-29	10103-10108	Table	_	
55-30	10109-10110	1	_	
55-31	10111-10114	for	_	
55-32	10115-10126	descriptive	_	
55-33	10127-10137	statistics	_	
55-34	10138-10140	of	_	
55-35	10141-10149	drinking	_	
55-36	10150-10153	and	_	
55-37	10154-10165	impulsivity	_	
55-38	10166-10172	scores	_	
55-39	10173-10176	for	_	
55-40	10177-10180	the	_	
55-41	10181-10187	sample	_	
55-42	10187-10188	)	_	
55-43	10188-10189	.	_	

#Text=Experimental design and statistical analysis
#Text=Overall timeline
#Text=In this two-session study, healthy light drinkers received an IV alcohol infusion on two separate days.
56-1	10190-10202	Experimental	_	
56-2	10203-10209	design	_	
56-3	10210-10213	and	_	
56-4	10214-10225	statistical	_	
56-5	10226-10234	analysis	_	
56-6	10235-10242	Overall	_	
56-7	10243-10251	timeline	_	
56-8	10252-10254	In	_	
56-9	10255-10259	this	_	
56-10	10260-10271	two-session	_	
56-11	10272-10277	study	_	
56-12	10277-10278	,	_	
56-13	10279-10286	healthy	_	
56-14	10287-10292	light	_	
56-15	10293-10301	drinkers	_	
56-16	10302-10310	received	_	
56-17	10311-10313	an	_	
56-18	10314-10316	IV	_	
56-19	10317-10324	alcohol	_	
56-20	10325-10333	infusion	_	
56-21	10334-10336	on	_	
56-22	10337-10340	two	_	
56-23	10341-10349	separate	_	
56-24	10350-10354	days	_	
56-25	10354-10355	.	_	

#Text=The first session was conducted outside the scanner to establish the alcohol infusion rate profile to achieve and maintain the target BrAC exposure, and to ensure tolerability.
57-1	10356-10359	The	_	
57-2	10360-10365	first	_	
57-3	10366-10373	session	_	
57-4	10374-10377	was	_	
57-5	10378-10387	conducted	_	
57-6	10388-10395	outside	_	
57-7	10396-10399	the	_	
57-8	10400-10407	scanner	_	
57-9	10408-10410	to	_	
57-10	10411-10420	establish	_	
57-11	10421-10424	the	_	
57-12	10425-10432	alcohol	_	
57-13	10433-10441	infusion	_	
57-14	10442-10446	rate	_	
57-15	10447-10454	profile	_	
57-16	10455-10457	to	_	
57-17	10458-10465	achieve	_	
57-18	10466-10469	and	_	
57-19	10470-10478	maintain	_	
57-20	10479-10482	the	_	
57-21	10483-10489	target	_	
57-22	10490-10494	BrAC	_	
57-23	10495-10503	exposure	_	
57-24	10503-10504	,	_	
57-25	10505-10508	and	_	
57-26	10509-10511	to	_	
57-27	10512-10518	ensure	_	
57-28	10519-10531	tolerability	_	
57-29	10531-10532	.	_	

#Text=The alcohol infusion for the second session was conducted inside the scanner at least three days after the first session (Fig 1).
58-1	10533-10536	The	_	
58-2	10537-10544	alcohol	_	
58-3	10545-10553	infusion	_	
58-4	10554-10557	for	_	
58-5	10558-10561	the	_	
58-6	10562-10568	second	_	
58-7	10569-10576	session	_	
58-8	10577-10580	was	_	
58-9	10581-10590	conducted	_	
58-10	10591-10597	inside	_	
58-11	10598-10601	the	_	
58-12	10602-10609	scanner	_	
58-13	10610-10612	at	_	
58-14	10613-10618	least	_	
58-15	10619-10624	three	_	
58-16	10625-10629	days	_	
58-17	10630-10635	after	_	
58-18	10636-10639	the	_	
58-19	10640-10645	first	_	
58-20	10646-10653	session	_	
58-21	10654-10655	(	_	
58-22	10655-10658	Fig	_	
58-23	10659-10660	1	_	
58-24	10660-10661	)	_	
58-25	10661-10662	.	_	

#Text=Participants were asked to fast the night before each session.
59-1	10663-10675	Participants	_	
59-2	10676-10680	were	_	
59-3	10681-10686	asked	_	
59-4	10687-10689	to	_	
59-5	10690-10694	fast	_	
59-6	10695-10698	the	_	
59-7	10699-10704	night	_	
59-8	10705-10711	before	_	
59-9	10712-10716	each	_	
59-10	10717-10724	session	_	
59-11	10724-10725	.	_	

#Text=At the start of each visit, breath alcohol levels, urine pregnancy tests (if applicable) and urine drug screens were collected.
60-1	10726-10728	At	_	
60-2	10729-10732	the	_	
60-3	10733-10738	start	_	
60-4	10739-10741	of	_	
60-5	10742-10746	each	_	
60-6	10747-10752	visit	_	
60-7	10752-10753	,	_	
60-8	10754-10760	breath	_	
60-9	10761-10768	alcohol	_	
60-10	10769-10775	levels	_	
60-11	10775-10776	,	_	
60-12	10777-10782	urine	_	
60-13	10783-10792	pregnancy	_	
60-14	10793-10798	tests	_	
60-15	10799-10800	(	_	
60-16	10800-10802	if	_	
60-17	10803-10813	applicable	_	
60-18	10813-10814	)	_	
60-19	10815-10818	and	_	
60-20	10819-10824	urine	_	
60-21	10825-10829	drug	_	
60-22	10830-10837	screens	_	
60-23	10838-10842	were	_	
60-24	10843-10852	collected	_	
60-25	10852-10853	.	_	

#Text=In addition, we conducted a brief history interview about recent alcohol, medication, and nicotine use, changes in physical health, and menstruation (if applicable).
61-1	10854-10856	In	_	
61-2	10857-10865	addition	_	
61-3	10865-10866	,	_	
61-4	10867-10869	we	_	
61-5	10870-10879	conducted	_	
61-6	10880-10881	a	_	
61-7	10882-10887	brief	_	
61-8	10888-10895	history	_	
61-9	10896-10905	interview	_	
61-10	10906-10911	about	_	
61-11	10912-10918	recent	_	
61-12	10919-10926	alcohol	_	
61-13	10926-10927	,	_	
61-14	10928-10938	medication	_	
61-15	10938-10939	,	_	
61-16	10940-10943	and	_	
61-17	10944-10952	nicotine	_	
61-18	10953-10956	use	_	
61-19	10956-10957	,	_	
61-20	10958-10965	changes	_	
61-21	10966-10968	in	_	
61-22	10969-10977	physical	_	
61-23	10978-10984	health	_	
61-24	10984-10985	,	_	
61-25	10986-10989	and	_	
61-26	10990-11002	menstruation	_	
61-27	11003-11004	(	_	
61-28	11004-11006	if	_	
61-29	11007-11017	applicable	_	
61-30	11017-11018	)	_	
61-31	11018-11019	.	_	

#Text=Timeline of intravenous alcohol infusion study.
62-1	11020-11028	Timeline	_	
62-2	11029-11031	of	_	
62-3	11032-11043	intravenous	_	
62-4	11044-11051	alcohol	_	
62-5	11052-11060	infusion	_	
62-6	11061-11066	study	_	
62-7	11066-11067	.	_	

#Text=The timeline depiction of the two-session intravenous alcohol infusion study; sessions were separated at least three days from each other.
63-1	11068-11071	The	_	
63-2	11072-11080	timeline	_	
63-3	11081-11090	depiction	_	
63-4	11091-11093	of	_	
63-5	11094-11097	the	_	
63-6	11098-11109	two-session	_	
63-7	11110-11121	intravenous	_	
63-8	11122-11129	alcohol	_	
63-9	11130-11138	infusion	_	
63-10	11139-11144	study	_	
63-11	11144-11145	;	_	
63-12	11146-11154	sessions	_	
63-13	11155-11159	were	_	
63-14	11160-11169	separated	_	
63-15	11170-11172	at	_	
63-16	11173-11178	least	_	
63-17	11179-11184	three	_	
63-18	11185-11189	days	_	
63-19	11190-11194	from	_	
63-20	11195-11199	each	_	
63-21	11200-11205	other	_	
63-22	11205-11206	.	_	

#Text=The session 2 timeline indicates timepoints of resting state and BAC measurement alongside IV infusion; the first resting state scan occurred before the IV infusion at blood alcohol level of 0.0 g/dl and the second one was collected when the blood alcohol level reached the binge levels (0.08 g/dl).
64-1	11207-11210	The	_	
64-2	11211-11218	session	_	
64-3	11219-11220	2	_	
64-4	11221-11229	timeline	_	
64-5	11230-11239	indicates	_	
64-6	11240-11250	timepoints	_	
64-7	11251-11253	of	_	
64-8	11254-11261	resting	_	
64-9	11262-11267	state	_	
64-10	11268-11271	and	_	
64-11	11272-11275	BAC	_	
64-12	11276-11287	measurement	_	
64-13	11288-11297	alongside	_	
64-14	11298-11300	IV	_	
64-15	11301-11309	infusion	_	
64-16	11309-11310	;	_	
64-17	11311-11314	the	_	
64-18	11315-11320	first	_	
64-19	11321-11328	resting	_	
64-20	11329-11334	state	_	
64-21	11335-11339	scan	_	
64-22	11340-11348	occurred	_	
64-23	11349-11355	before	_	
64-24	11356-11359	the	_	
64-25	11360-11362	IV	_	
64-26	11363-11371	infusion	_	
64-27	11372-11374	at	_	
64-28	11375-11380	blood	_	
64-29	11381-11388	alcohol	_	
64-30	11389-11394	level	_	
64-31	11395-11397	of	_	
64-32	11398-11401	0.0	_	
64-33	11402-11403	g	_	
64-34	11403-11404	/	_	
64-35	11404-11406	dl	_	
64-36	11407-11410	and	_	
64-37	11411-11414	the	_	
64-38	11415-11421	second	_	
64-39	11422-11425	one	_	
64-40	11426-11429	was	_	
64-41	11430-11439	collected	_	
64-42	11440-11444	when	_	
64-43	11445-11448	the	_	
64-44	11449-11454	blood	_	
64-45	11455-11462	alcohol	_	
64-46	11463-11468	level	_	
64-47	11469-11476	reached	_	
64-48	11477-11480	the	_	
64-49	11481-11486	binge	_	
64-50	11487-11493	levels	_	
64-51	11494-11495	(	_	
64-52	11495-11499	0.08	_	
64-53	11500-11501	g	_	
64-54	11501-11502	/	_	
64-55	11502-11504	dl	_	
64-56	11504-11505	)	_	
64-57	11505-11506	.	_	

#Text=Alcohol infusion to binge level exposure
#Text=We performed the alcohol infusion procedure following previously published methods (fMRI and PET).
65-1	11507-11514	Alcohol	_	
65-2	11515-11523	infusion	_	
65-3	11524-11526	to	_	
65-4	11527-11532	binge	_	
65-5	11533-11538	level	_	
65-6	11539-11547	exposure	_	
65-7	11548-11550	We	_	
65-8	11551-11560	performed	_	
65-9	11561-11564	the	_	
65-10	11565-11572	alcohol	_	
65-11	11573-11581	infusion	_	
65-12	11582-11591	procedure	_	
65-13	11592-11601	following	_	
65-14	11602-11612	previously	_	
65-15	11613-11622	published	_	
65-16	11623-11630	methods	_	
65-17	11631-11632	(	_	
65-18	11632-11636	fMRI	_	
65-19	11637-11640	and	_	
65-20	11641-11644	PET	_	
65-21	11644-11645	)	_	
65-22	11645-11646	.	_	

#Text=In both sessions, participants received an intravenous (IV) infusion of 6% v/v ethanol solution in saline to achieve a target breath alcohol concentration (BrAC) of 0.08 ± 0.005 g/dl at 15 min after the start of the infusion, and to maintain (or clamp) the target BrAC level for 30 min (Fig 1).
66-1	11647-11649	In	_	
66-2	11650-11654	both	_	
66-3	11655-11663	sessions	_	
66-4	11663-11664	,	_	
66-5	11665-11677	participants	_	
66-6	11678-11686	received	_	
66-7	11687-11689	an	_	
66-8	11690-11701	intravenous	_	
66-9	11702-11703	(	_	
66-10	11703-11705	IV	_	
66-11	11705-11706	)	_	
66-12	11707-11715	infusion	_	
66-13	11716-11718	of	_	
66-14	11719-11721	6%	_	
66-15	11722-11723	v	_	
66-16	11723-11724	/	_	
66-17	11724-11725	v	_	
66-18	11726-11733	ethanol	_	
66-19	11734-11742	solution	_	
66-20	11743-11745	in	_	
66-21	11746-11752	saline	_	
66-22	11753-11755	to	_	
66-23	11756-11763	achieve	_	
66-24	11764-11765	a	_	
66-25	11766-11772	target	_	
66-26	11773-11779	breath	_	
66-27	11780-11787	alcohol	_	
66-28	11788-11801	concentration	_	
66-29	11802-11803	(	_	
66-30	11803-11807	BrAC	_	
66-31	11807-11808	)	_	
66-32	11809-11811	of	_	
66-33	11812-11816	0.08	_	
66-34	11817-11818	±	_	
66-35	11819-11824	0.005	_	
66-36	11825-11826	g	_	
66-37	11826-11827	/	_	
66-38	11827-11829	dl	_	
66-39	11830-11832	at	_	
66-40	11833-11835	15	_	
66-41	11836-11839	min	_	
66-42	11840-11845	after	_	
66-43	11846-11849	the	_	
66-44	11850-11855	start	_	
66-45	11856-11858	of	_	
66-46	11859-11862	the	_	
66-47	11863-11871	infusion	_	
66-48	11871-11872	,	_	
66-49	11873-11876	and	_	
66-50	11877-11879	to	_	
66-51	11880-11888	maintain	_	
66-52	11889-11890	(	_	
66-53	11890-11892	or	_	
66-54	11893-11898	clamp	_	
66-55	11898-11899	)	_	
66-56	11900-11903	the	_	
66-57	11904-11910	target	_	
66-58	11911-11915	BrAC	_	
66-59	11916-11921	level	_	
66-60	11922-11925	for	_	
66-61	11926-11928	30	_	
66-62	11929-11932	min	_	
66-63	11933-11934	(	_	
66-64	11934-11937	Fig	_	
66-65	11938-11939	1	_	
66-66	11939-11940	)	_	
66-67	11940-11941	.	_	

#Text=The infusion-rate profile was computed for each subject using a physiologically-based pharmacokinetic (PBPK) model-based algorithm, with individualized estimates of the model parameters estimated from the subject’s height, weight, age and sex.
67-1	11942-11945	The	_	
67-2	11946-11959	infusion-rate	_	
67-3	11960-11967	profile	_	
67-4	11968-11971	was	_	
67-5	11972-11980	computed	_	
67-6	11981-11984	for	_	
67-7	11985-11989	each	_	
67-8	11990-11997	subject	_	
67-9	11998-12003	using	_	
67-10	12004-12005	a	_	
67-11	12006-12027	physiologically-based	_	
67-12	12028-12043	pharmacokinetic	_	
67-13	12044-12045	(	_	
67-14	12045-12049	PBPK	_	
67-15	12049-12050	)	_	
67-16	12051-12062	model-based	_	
67-17	12063-12072	algorithm	_	
67-18	12072-12073	,	_	
67-19	12074-12078	with	_	
67-20	12079-12093	individualized	_	
67-21	12094-12103	estimates	_	
67-22	12104-12106	of	_	
67-23	12107-12110	the	_	
67-24	12111-12116	model	_	
67-25	12117-12127	parameters	_	
67-26	12128-12137	estimated	_	
67-27	12138-12142	from	_	
67-28	12143-12146	the	_	
67-29	12147-12154	subject	_	
67-30	12154-12155	’	_	
67-31	12155-12156	s	_	
67-32	12157-12163	height	_	
67-33	12163-12164	,	_	
67-34	12165-12171	weight	_	
67-35	12171-12172	,	_	
67-36	12173-12176	age	_	
67-37	12177-12180	and	_	
67-38	12181-12184	sex	_	
67-39	12184-12185	.	_	

#Text=During the first session conducted outside the scanner, serial BrACs were measured at frequent intervals (5–15 minutes) using the Alcotest 7410+ handheld breathalyzer (Drager Safety Inc., CO), to ensure that each BrAC was within 0.005 g/dl of the target, and to enable minor adjustments to the infusion rates to overcome errors in parameter estimation and experimental variability.
68-1	12186-12192	During	_	
68-2	12193-12196	the	_	
68-3	12197-12202	first	_	
68-4	12203-12210	session	_	
68-5	12211-12220	conducted	_	
68-6	12221-12228	outside	_	
68-7	12229-12232	the	_	
68-8	12233-12240	scanner	_	
68-9	12240-12241	,	_	
68-10	12242-12248	serial	_	
68-11	12249-12254	BrACs	_	
68-12	12255-12259	were	_	
68-13	12260-12268	measured	_	
68-14	12269-12271	at	_	
68-15	12272-12280	frequent	_	
68-16	12281-12290	intervals	_	
68-17	12291-12292	(	_	
68-18	12292-12293	5	_	
68-19	12293-12294	–	_	
68-20	12294-12296	15	_	
68-21	12297-12304	minutes	_	
68-22	12304-12305	)	_	
68-23	12306-12311	using	_	
68-24	12312-12315	the	_	
68-25	12316-12324	Alcotest	_	
68-26	12325-12329	7410	_	
68-27	12329-12330	+	_	
68-28	12331-12339	handheld	_	
68-29	12340-12352	breathalyzer	_	
68-30	12353-12354	(	_	
68-31	12354-12360	Drager	_	
68-32	12361-12367	Safety	_	
68-33	12368-12371	Inc	_	
68-34	12371-12372	.	_	
68-35	12372-12373	,	_	
68-36	12374-12376	CO	_	
68-37	12376-12377	)	_	
68-38	12377-12378	,	_	
68-39	12379-12381	to	_	
68-40	12382-12388	ensure	_	
68-41	12389-12393	that	_	
68-42	12394-12398	each	_	
68-43	12399-12403	BrAC	_	
68-44	12404-12407	was	_	
68-45	12408-12414	within	_	
68-46	12415-12420	0.005	_	
68-47	12421-12422	g	_	
68-48	12422-12423	/	_	
68-49	12423-12425	dl	_	
68-50	12426-12428	of	_	
68-51	12429-12432	the	_	
68-52	12433-12439	target	_	
68-53	12439-12440	,	_	
68-54	12441-12444	and	_	
68-55	12445-12447	to	_	
68-56	12448-12454	enable	_	
68-57	12455-12460	minor	_	
68-58	12461-12472	adjustments	_	
68-59	12473-12475	to	_	
68-60	12476-12479	the	_	
68-61	12480-12488	infusion	_	
68-62	12489-12494	rates	_	
68-63	12495-12497	to	_	
68-64	12498-12506	overcome	_	
68-65	12507-12513	errors	_	
68-66	12514-12516	in	_	
68-67	12517-12526	parameter	_	
68-68	12527-12537	estimation	_	
68-69	12538-12541	and	_	
68-70	12542-12554	experimental	_	
68-71	12555-12566	variability	_	
68-72	12566-12567	.	_	

#Text=The adjusted infusion rate profile from the first session was used in the imaging session to replicate the target BrAC profile for each subject.
69-1	12568-12571	The	_	
69-2	12572-12580	adjusted	_	
69-3	12581-12589	infusion	_	
69-4	12590-12594	rate	_	
69-5	12595-12602	profile	_	
69-6	12603-12607	from	_	
69-7	12608-12611	the	_	
69-8	12612-12617	first	_	
69-9	12618-12625	session	_	
69-10	12626-12629	was	_	
69-11	12630-12634	used	_	
69-12	12635-12637	in	_	
69-13	12638-12641	the	_	
69-14	12642-12649	imaging	_	
69-15	12650-12657	session	_	
69-16	12658-12660	to	_	
69-17	12661-12670	replicate	_	
69-18	12671-12674	the	_	
69-19	12675-12681	target	_	
69-20	12682-12686	BrAC	_	
69-21	12687-12694	profile	_	
69-22	12695-12698	for	_	
69-23	12699-12703	each	_	
69-24	12704-12711	subject	_	
69-25	12711-12712	.	_	

#Text=This approach has been used to successfully achieve and maintain target BrACs, as verified by blood alcohol concentrations measured in samples drawn during the scan in other neuroimaging studies.
70-1	12713-12717	This	_	
70-2	12718-12726	approach	_	
70-3	12727-12730	has	_	
70-4	12731-12735	been	_	
70-5	12736-12740	used	_	
70-6	12741-12743	to	_	
70-7	12744-12756	successfully	_	
70-8	12757-12764	achieve	_	
70-9	12765-12768	and	_	
70-10	12769-12777	maintain	_	
70-11	12778-12784	target	_	
70-12	12785-12790	BrACs	_	
70-13	12790-12791	,	_	
70-14	12792-12794	as	_	
70-15	12795-12803	verified	_	
70-16	12804-12806	by	_	
70-17	12807-12812	blood	_	
70-18	12813-12820	alcohol	_	
70-19	12821-12835	concentrations	_	
70-20	12836-12844	measured	_	
70-21	12845-12847	in	_	
70-22	12848-12855	samples	_	
70-23	12856-12861	drawn	_	
70-24	12862-12868	during	_	
70-25	12869-12872	the	_	
70-26	12873-12877	scan	_	
70-27	12878-12880	in	_	
70-28	12881-12886	other	_	
70-29	12887-12899	neuroimaging	_	
70-30	12900-12907	studies	_	
70-31	12907-12908	.	_	

#Text=After the end of the infusion, subjects were provided a meal, and BrAC was tracked until it dropped to 0.02 g/dL or below, at which time subjects were taken home by a designated driver or taxi.
71-1	12909-12914	After	_	
71-2	12915-12918	the	_	
71-3	12919-12922	end	_	
71-4	12923-12925	of	_	
71-5	12926-12929	the	_	
71-6	12930-12938	infusion	_	
71-7	12938-12939	,	_	
71-8	12940-12948	subjects	_	
71-9	12949-12953	were	_	
71-10	12954-12962	provided	_	
71-11	12963-12964	a	_	
71-12	12965-12969	meal	_	
71-13	12969-12970	,	_	
71-14	12971-12974	and	_	
71-15	12975-12979	BrAC	_	
71-16	12980-12983	was	_	
71-17	12984-12991	tracked	_	
71-18	12992-12997	until	_	
71-19	12998-13000	it	_	
71-20	13001-13008	dropped	_	
71-21	13009-13011	to	_	
71-22	13012-13016	0.02	_	
71-23	13017-13018	g	_	
71-24	13018-13019	/	_	
71-25	13019-13021	dL	_	
71-26	13022-13024	or	_	
71-27	13025-13030	below	_	
71-28	13030-13031	,	_	
71-29	13032-13034	at	_	
71-30	13035-13040	which	_	
71-31	13041-13045	time	_	
71-32	13046-13054	subjects	_	
71-33	13055-13059	were	_	
71-34	13060-13065	taken	_	
71-35	13066-13070	home	_	
71-36	13071-13073	by	_	
71-37	13074-13075	a	_	
71-38	13076-13086	designated	_	
71-39	13087-13093	driver	_	
71-40	13094-13096	or	_	
71-41	13097-13101	taxi	_	
71-42	13101-13102	.	_	

#Text=Neuroimaging acquisition and preprocessing
#Text=During session 2, after the IV catheters were placed for alcohol infusion, participants were placed in a 3T SIEMENS Skyra MR scanner at the NMR Research Center at the NIH.
72-1	13103-13115	Neuroimaging	_	
72-2	13116-13127	acquisition	_	
72-3	13128-13131	and	_	
72-4	13132-13145	preprocessing	_	
72-5	13146-13152	During	_	
72-6	13153-13160	session	_	
72-7	13161-13162	2	_	
72-8	13162-13163	,	_	
72-9	13164-13169	after	_	
72-10	13170-13173	the	_	
72-11	13174-13176	IV	_	
72-12	13177-13186	catheters	_	
72-13	13187-13191	were	_	
72-14	13192-13198	placed	_	
72-15	13199-13202	for	_	
72-16	13203-13210	alcohol	_	
72-17	13211-13219	infusion	_	
72-18	13219-13220	,	_	
72-19	13221-13233	participants	_	
72-20	13234-13238	were	_	
72-21	13239-13245	placed	_	
72-22	13246-13248	in	_	
72-23	13249-13250	a	_	
72-24	13251-13253	3T	_	
72-25	13254-13261	SIEMENS	_	
72-26	13262-13267	Skyra	_	
72-27	13268-13270	MR	_	
72-28	13271-13278	scanner	_	
72-29	13279-13281	at	_	
72-30	13282-13285	the	_	
72-31	13286-13289	NMR	_	
72-32	13290-13298	Research	_	
72-33	13299-13305	Center	_	
72-34	13306-13308	at	_	
72-35	13309-13312	the	_	
72-36	13313-13316	NIH	_	
72-37	13316-13317	.	_	

#Text=Before starting the IV infusion of alcohol, a 5-min closed eyes resting-state fMRI scan was acquired with an echo-planar imaging sequence (36 axial slices, 3.8 mm thickness, 64 × 64 matrix and repetition time of 2000 ms, echo time 30, flip angle 90).
73-1	13318-13324	Before	_	
73-2	13325-13333	starting	_	
73-3	13334-13337	the	_	
73-4	13338-13340	IV	_	
73-5	13341-13349	infusion	_	
73-6	13350-13352	of	_	
73-7	13353-13360	alcohol	_	
73-8	13360-13361	,	_	
73-9	13362-13363	a	_	
73-10	13364-13365	5	_	
73-11	13365-13366	-	_	
73-12	13366-13369	min	_	
73-13	13370-13376	closed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[23]	
73-14	13377-13381	eyes	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[23]	
73-15	13382-13395	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[23]	
73-16	13396-13400	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[23]	
73-17	13401-13405	scan	_	
73-18	13406-13409	was	_	
73-19	13410-13418	acquired	_	
73-20	13419-13423	with	_	
73-21	13424-13426	an	_	
73-22	13427-13438	echo-planar	_	
73-23	13439-13446	imaging	_	
73-24	13447-13455	sequence	_	
73-25	13456-13457	(	_	
73-26	13457-13459	36	_	
73-27	13460-13465	axial	_	
73-28	13466-13472	slices	_	
73-29	13472-13473	,	_	
73-30	13474-13477	3.8	_	
73-31	13478-13480	mm	_	
73-32	13481-13490	thickness	_	
73-33	13490-13491	,	_	
73-34	13492-13494	64	_	
73-35	13495-13496	×	_	
73-36	13497-13499	64	_	
73-37	13500-13506	matrix	_	
73-38	13507-13510	and	_	
73-39	13511-13521	repetition	_	
73-40	13522-13526	time	_	
73-41	13527-13529	of	_	
73-42	13530-13534	2000	_	
73-43	13535-13537	ms	_	
73-44	13537-13538	,	_	
73-45	13539-13543	echo	_	
73-46	13544-13548	time	_	
73-47	13549-13551	30	_	
73-48	13551-13552	,	_	
73-49	13553-13557	flip	_	
73-50	13558-13563	angle	_	
73-51	13564-13566	90	_	
73-52	13566-13567	)	_	
73-53	13567-13568	.	_	

#Text=After collecting this baseline resting-state fMRI scan, the alcohol infusion started and once the target BAC was achieved, a 10-minute waiting period was allowed to ensure the BAC was stable at the 0.08 g/dl level.
74-1	13569-13574	After	_	
74-2	13575-13585	collecting	_	
74-3	13586-13590	this	_	
74-4	13591-13599	baseline	_	
74-5	13600-13613	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[24]	
74-6	13614-13618	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[24]	
74-7	13619-13623	scan	_	
74-8	13623-13624	,	_	
74-9	13625-13628	the	_	
74-10	13629-13636	alcohol	_	
74-11	13637-13645	infusion	_	
74-12	13646-13653	started	_	
74-13	13654-13657	and	_	
74-14	13658-13662	once	_	
74-15	13663-13666	the	_	
74-16	13667-13673	target	_	
74-17	13674-13677	BAC	_	
74-18	13678-13681	was	_	
74-19	13682-13690	achieved	_	
74-20	13690-13691	,	_	
74-21	13692-13693	a	_	
74-22	13694-13696	10	_	
74-23	13696-13697	-	_	
74-24	13697-13703	minute	_	
74-25	13704-13711	waiting	_	
74-26	13712-13718	period	_	
74-27	13719-13722	was	_	
74-28	13723-13730	allowed	_	
74-29	13731-13733	to	_	
74-30	13734-13740	ensure	_	
74-31	13741-13744	the	_	
74-32	13745-13748	BAC	_	
74-33	13749-13752	was	_	
74-34	13753-13759	stable	_	
74-35	13760-13762	at	_	
74-36	13763-13766	the	_	
74-37	13767-13771	0.08	_	
74-38	13772-13773	g	_	
74-39	13773-13774	/	_	
74-40	13774-13776	dl	_	
74-41	13777-13782	level	_	
74-42	13782-13783	.	_	

#Text=During the waiting period, whole-brain structural and diffusion-weighted images of the brain were collected.
75-1	13784-13790	During	_	
75-2	13791-13794	the	_	
75-3	13795-13802	waiting	_	
75-4	13803-13809	period	_	
75-5	13809-13810	,	_	
75-6	13811-13822	whole-brain	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[25]	
75-7	13823-13833	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[25]	
75-8	13834-13837	and	_	
75-9	13838-13856	diffusion-weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[26]	
75-10	13857-13863	images	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[26]	
75-11	13864-13866	of	_	
75-12	13867-13870	the	_	
75-13	13871-13876	brain	_	
75-14	13877-13881	were	_	
75-15	13882-13891	collected	_	
75-16	13891-13892	.	_	

#Text=Then, a second eyes-closed resting-state fMRI scan was collected while the target BAC (0.08 g/dl) was maintained.
76-1	13893-13897	Then	_	
76-2	13897-13898	,	_	
76-3	13899-13900	a	_	
76-4	13901-13907	second	_	
76-5	13908-13919	eyes-closed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[27]	
76-6	13920-13933	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[27]	
76-7	13934-13938	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[27]	
76-8	13939-13943	scan	_	
76-9	13944-13947	was	_	
76-10	13948-13957	collected	_	
76-11	13958-13963	while	_	
76-12	13964-13967	the	_	
76-13	13968-13974	target	_	
76-14	13975-13978	BAC	_	
76-15	13979-13980	(	_	
76-16	13980-13984	0.08	_	
76-17	13985-13986	g	_	
76-18	13986-13987	/	_	
76-19	13987-13989	dl	_	
76-20	13989-13990	)	_	
76-21	13991-13994	was	_	
76-22	13995-14005	maintained	_	
76-23	14005-14006	.	_	

#Text=Following the MRI session, the Drug Effects Questionnaire was used to evaluate and quantify subjective effects of alcohol (DEQ).
77-1	14007-14016	Following	_	
77-2	14017-14020	the	_	
77-3	14021-14024	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
77-4	14025-14032	session	_	
77-5	14032-14033	,	_	
77-6	14034-14037	the	_	
77-7	14038-14042	Drug	http://www.case.edu/ProvCaRe/provcare#Questionnaire[28]	
77-8	14043-14050	Effects	http://www.case.edu/ProvCaRe/provcare#Questionnaire[28]	
77-9	14051-14064	Questionnaire	http://www.case.edu/ProvCaRe/provcare#Questionnaire[28]	
77-10	14065-14068	was	_	
77-11	14069-14073	used	_	
77-12	14074-14076	to	_	
77-13	14077-14085	evaluate	_	
77-14	14086-14089	and	_	
77-15	14090-14098	quantify	_	
77-16	14099-14109	subjective	_	
77-17	14110-14117	effects	_	
77-18	14118-14120	of	_	
77-19	14121-14128	alcohol	_	
77-20	14129-14130	(	_	
77-21	14130-14133	DEQ	_	
77-22	14133-14134	)	_	
77-23	14134-14135	.	_	

#Text=CONN ver.17f (http://www.conn-toolbox.org), a MATLAB/SPM-based (www.fil.ion.ucl.ac.uk/spm/) software, was used to conduct spatial/temporal preprocessing and analyses.
78-1	14136-14140	CONN	_	
78-2	14141-14144	ver	_	
78-3	14144-14148	.17f	_	
78-4	14149-14150	(	_	
78-5	14150-14154	http	_	
78-6	14154-14155	:	_	
78-7	14155-14156	/	_	
78-8	14156-14157	/	_	
78-9	14157-14177	www.conn-toolbox.org	_	
78-10	14177-14178	)	_	
78-11	14178-14179	,	_	
78-12	14180-14181	a	_	
78-13	14182-14188	MATLAB	_	
78-14	14188-14189	/	_	
78-15	14189-14198	SPM-based	_	
78-16	14199-14200	(	_	
78-17	14200-14221	www.fil.ion.ucl.ac.uk	_	
78-18	14221-14222	/	_	
78-19	14222-14225	spm	_	
78-20	14225-14226	/	_	
78-21	14226-14227	)	_	
78-22	14228-14236	software	_	
78-23	14236-14237	,	_	
78-24	14238-14241	was	_	
78-25	14242-14246	used	_	
78-26	14247-14249	to	_	
78-27	14250-14257	conduct	_	
78-28	14258-14265	spatial	_	
78-29	14265-14266	/	_	
78-30	14266-14274	temporal	_	
78-31	14275-14288	preprocessing	_	
78-32	14289-14292	and	_	
78-33	14293-14301	analyses	_	
78-34	14301-14302	.	_	

#Text=Spatial preprocessing included slice-timing correction, realignment, co-registration, normalization, and spatial smoothing (8 mm).
79-1	14303-14310	Spatial	_	
79-2	14311-14324	preprocessing	_	
79-3	14325-14333	included	_	
79-4	14334-14346	slice-timing	_	
79-5	14347-14357	correction	_	
79-6	14357-14358	,	_	
79-7	14359-14370	realignment	_	
79-8	14370-14371	,	_	
79-9	14372-14387	co-registration	_	
79-10	14387-14388	,	_	
79-11	14389-14402	normalization	_	
79-12	14402-14403	,	_	
79-13	14404-14407	and	_	
79-14	14408-14415	spatial	_	
79-15	14416-14425	smoothing	_	
79-16	14426-14427	(	_	
79-17	14427-14428	8	_	
79-18	14429-14431	mm	_	
79-19	14431-14432	)	_	
79-20	14432-14433	.	_	

#Text=Using the default settings in CONN, images were resliced into isotropic 2mm voxels.
80-1	14434-14439	Using	_	
80-2	14440-14443	the	_	
80-3	14444-14451	default	_	
80-4	14452-14460	settings	_	
80-5	14461-14463	in	_	
80-6	14464-14468	CONN	_	
80-7	14468-14469	,	_	
80-8	14470-14476	images	_	
80-9	14477-14481	were	_	
80-10	14482-14490	resliced	_	
80-11	14491-14495	into	_	
80-12	14496-14505	isotropic	_	
80-13	14506-14509	2mm	_	
80-14	14510-14516	voxels	_	
80-15	14516-14517	.	_	

#Text=Anatomical volumes were segmented into grey matter, white matter, and cerebrospinal fluid (CSF) areas and the resulting masks were eroded to minimize partial volume effects.
81-1	14518-14528	Anatomical	_	
81-2	14529-14536	volumes	_	
81-3	14537-14541	were	_	
81-4	14542-14551	segmented	_	
81-5	14552-14556	into	_	
81-6	14557-14561	grey	_	
81-7	14562-14568	matter	_	
81-8	14568-14569	,	_	
81-9	14570-14575	white	_	
81-10	14576-14582	matter	_	
81-11	14582-14583	,	_	
81-12	14584-14587	and	_	
81-13	14588-14601	cerebrospinal	_	
81-14	14602-14607	fluid	_	
81-15	14608-14609	(	_	
81-16	14609-14612	CSF	_	
81-17	14612-14613	)	_	
81-18	14614-14619	areas	_	
81-19	14620-14623	and	_	
81-20	14624-14627	the	_	
81-21	14628-14637	resulting	_	
81-22	14638-14643	masks	_	
81-23	14644-14648	were	_	
81-24	14649-14655	eroded	_	
81-25	14656-14658	to	_	
81-26	14659-14667	minimize	_	
81-27	14668-14675	partial	_	
81-28	14676-14682	volume	_	
81-29	14683-14690	effects	_	
81-30	14690-14691	.	_	

#Text=At the individual level, the temporal timeseries of the participant-specific six rotation-translation motion parameters and the timeseries from within the white matter/CSF masks were used as temporal covariates, and removed from the blood oxygen level-dependent (BOLD) functional data using linear regression.
82-1	14692-14694	At	_	
82-2	14695-14698	the	_	
82-3	14699-14709	individual	_	
82-4	14710-14715	level	_	
82-5	14715-14716	,	_	
82-6	14717-14720	the	_	
82-7	14721-14729	temporal	_	
82-8	14730-14740	timeseries	_	
82-9	14741-14743	of	_	
82-10	14744-14747	the	_	
82-11	14748-14768	participant-specific	_	
82-12	14769-14772	six	_	
82-13	14773-14793	rotation-translation	_	
82-14	14794-14800	motion	_	
82-15	14801-14811	parameters	_	
82-16	14812-14815	and	_	
82-17	14816-14819	the	_	
82-18	14820-14830	timeseries	_	
82-19	14831-14835	from	_	
82-20	14836-14842	within	_	
82-21	14843-14846	the	_	
82-22	14847-14852	white	_	
82-23	14853-14859	matter	_	
82-24	14859-14860	/	_	
82-25	14860-14863	CSF	_	
82-26	14864-14869	masks	_	
82-27	14870-14874	were	_	
82-28	14875-14879	used	_	
82-29	14880-14882	as	_	
82-30	14883-14891	temporal	_	
82-31	14892-14902	covariates	_	
82-32	14902-14903	,	_	
82-33	14904-14907	and	_	
82-34	14908-14915	removed	_	
82-35	14916-14920	from	_	
82-36	14921-14924	the	_	
82-37	14925-14930	blood	_	
82-38	14931-14937	oxygen	_	
82-39	14938-14953	level-dependent	_	
82-40	14954-14955	(	_	
82-41	14955-14959	BOLD	_	
82-42	14959-14960	)	_	
82-43	14961-14971	functional	_	
82-44	14972-14976	data	_	
82-45	14977-14982	using	_	
82-46	14983-14989	linear	_	
82-47	14990-15000	regression	_	
82-48	15000-15001	.	_	

#Text=The resulting residual BOLD timeseries were band-pass filtered (0.008Hz < f < 0.15Hz).
83-1	15002-15005	The	_	
83-2	15006-15015	resulting	_	
83-3	15016-15024	residual	_	
83-4	15025-15029	BOLD	_	
83-5	15030-15040	timeseries	_	
83-6	15041-15045	were	_	
83-7	15046-15055	band-pass	_	
83-8	15056-15064	filtered	_	
83-9	15065-15066	(	_	
83-10	15066-15073	0.008Hz	_	
83-11	15074-15075	<	_	
83-12	15076-15077	f	_	
83-13	15078-15079	<	_	
83-14	15080-15086	0.15Hz	_	
83-15	15086-15087	)	_	
83-16	15087-15088	.	_	

#Text=Neuroimaging analysis
#Text=To our knowledge there is no reported sub-division of human GPe with concrete landmark definition and/or Talairach coordinate demarcation.
84-1	15089-15101	Neuroimaging	_	
84-2	15102-15110	analysis	_	
84-3	15111-15113	To	_	
84-4	15114-15117	our	_	
84-5	15118-15127	knowledge	_	
84-6	15128-15133	there	_	
84-7	15134-15136	is	_	
84-8	15137-15139	no	_	
84-9	15140-15148	reported	_	
84-10	15149-15161	sub-division	_	
84-11	15162-15164	of	_	
84-12	15165-15170	human	_	
84-13	15171-15174	GPe	_	
84-14	15175-15179	with	_	
84-15	15180-15188	concrete	_	
84-16	15189-15197	landmark	_	
84-17	15198-15208	definition	_	
84-18	15209-15212	and	_	
84-19	15212-15213	/	_	
84-20	15213-15215	or	_	
84-21	15216-15225	Talairach	_	
84-22	15226-15236	coordinate	_	
84-23	15237-15248	demarcation	_	
84-24	15248-15249	.	_	

#Text=Therefore, for these analyses, we used right and left GPe masks obtained from the Lead-DBS toolbox (http://www.lead-dbs.org/).
85-1	15250-15259	Therefore	_	
85-2	15259-15260	,	_	
85-3	15261-15264	for	_	
85-4	15265-15270	these	_	
85-5	15271-15279	analyses	_	
85-6	15279-15280	,	_	
85-7	15281-15283	we	_	
85-8	15284-15288	used	_	
85-9	15289-15294	right	_	
85-10	15295-15298	and	_	
85-11	15299-15303	left	_	
85-12	15304-15307	GPe	_	
85-13	15308-15313	masks	_	
85-14	15314-15322	obtained	_	
85-15	15323-15327	from	_	
85-16	15328-15331	the	_	
85-17	15332-15340	Lead-DBS	_	
85-18	15341-15348	toolbox	_	
85-19	15349-15350	(	_	
85-20	15350-15354	http	_	
85-21	15354-15355	:	_	
85-22	15355-15356	/	_	
85-23	15356-15357	/	_	
85-24	15357-15373	www.lead-dbs.org	_	
85-25	15373-15374	/	_	
85-26	15374-15375	)	_	
85-27	15375-15376	.	_	

#Text=These anatomical masks were generated using manual tracing of several structural MRIs and subsequent co-registration with histological studies, and have a combined volume of approximately 929 mm3.
86-1	15377-15382	These	_	
86-2	15383-15393	anatomical	_	
86-3	15394-15399	masks	_	
86-4	15400-15404	were	_	
86-5	15405-15414	generated	_	
86-6	15415-15420	using	_	
86-7	15421-15427	manual	_	
86-8	15428-15435	tracing	_	
86-9	15436-15438	of	_	
86-10	15439-15446	several	_	
86-11	15447-15457	structural	_	
86-12	15458-15462	MRIs	_	
86-13	15463-15466	and	_	
86-14	15467-15477	subsequent	_	
86-15	15478-15493	co-registration	_	
86-16	15494-15498	with	_	
86-17	15499-15511	histological	_	
86-18	15512-15519	studies	_	
86-19	15519-15520	,	_	
86-20	15521-15524	and	_	
86-21	15525-15529	have	_	
86-22	15530-15531	a	_	
86-23	15532-15540	combined	_	
86-24	15541-15547	volume	_	
86-25	15548-15550	of	_	
86-26	15551-15564	approximately	_	
86-27	15565-15568	929	_	
86-28	15569-15572	mm3	_	
86-29	15572-15573	.	_	

#Text=Seed-based correlations were calculated as Fisher-transformed bivariate correlation coefficients between the BOLD activity timeseries in the seed ROI and each other individual voxel BOLD.
87-1	15574-15584	Seed-based	_	
87-2	15585-15597	correlations	_	
87-3	15598-15602	were	_	
87-4	15603-15613	calculated	_	
87-5	15614-15616	as	_	
87-6	15617-15635	Fisher-transformed	_	
87-7	15636-15645	bivariate	_	
87-8	15646-15657	correlation	_	
87-9	15658-15670	coefficients	_	
87-10	15671-15678	between	_	
87-11	15679-15682	the	_	
87-12	15683-15687	BOLD	_	
87-13	15688-15696	activity	_	
87-14	15697-15707	timeseries	_	
87-15	15708-15710	in	_	
87-16	15711-15714	the	_	
87-17	15715-15719	seed	_	
87-18	15720-15723	ROI	_	
87-19	15724-15727	and	_	
87-20	15728-15732	each	_	
87-21	15733-15738	other	_	
87-22	15739-15749	individual	_	
87-23	15750-15755	voxel	_	
87-24	15756-15760	BOLD	_	
87-25	15760-15761	.	_	

#Text=CSF, grey matter, white matter signals and motion were included as covariates for this model at the single subject level.
88-1	15762-15765	CSF	_	
88-2	15765-15766	,	_	
88-3	15767-15771	grey	_	
88-4	15772-15778	matter	_	
88-5	15778-15779	,	_	
88-6	15780-15785	white	_	
88-7	15786-15792	matter	_	
88-8	15793-15800	signals	_	
88-9	15801-15804	and	_	
88-10	15805-15811	motion	_	
88-11	15812-15816	were	_	
88-12	15817-15825	included	_	
88-13	15826-15828	as	_	
88-14	15829-15839	covariates	_	
88-15	15840-15843	for	_	
88-16	15844-15848	this	_	
88-17	15849-15854	model	_	
88-18	15855-15857	at	_	
88-19	15858-15861	the	_	
88-20	15862-15868	single	_	
88-21	15869-15876	subject	_	
88-22	15877-15882	level	_	
88-23	15882-15883	.	_	

#Text=These correlations were calculated separately for the pre-infusion and post-infusion scans and for right and left GPe seeds.
89-1	15884-15889	These	_	
89-2	15890-15902	correlations	_	
89-3	15903-15907	were	_	
89-4	15908-15918	calculated	_	
89-5	15919-15929	separately	_	
89-6	15930-15933	for	_	
89-7	15934-15937	the	_	
89-8	15938-15950	pre-infusion	_	
89-9	15951-15954	and	_	
89-10	15955-15968	post-infusion	_	
89-11	15969-15974	scans	_	
89-12	15975-15978	and	_	
89-13	15979-15982	for	_	
89-14	15983-15988	right	_	
89-15	15989-15992	and	_	
89-16	15993-15997	left	_	
89-17	15998-16001	GPe	_	
89-18	16002-16007	seeds	_	
89-19	16007-16008	.	_	

#Text=For each of the pre- and post-infusion analyses, 150 time points (across 300 seconds) were used.
90-1	16009-16012	For	_	
90-2	16013-16017	each	_	
90-3	16018-16020	of	_	
90-4	16021-16024	the	_	
90-5	16025-16028	pre	_	
90-6	16028-16029	-	_	
90-7	16030-16033	and	_	
90-8	16034-16047	post-infusion	_	
90-9	16048-16056	analyses	_	
90-10	16056-16057	,	_	
90-11	16058-16061	150	_	
90-12	16062-16066	time	_	
90-13	16067-16073	points	_	
90-14	16074-16075	(	_	
90-15	16075-16081	across	_	
90-16	16082-16085	300	_	
90-17	16086-16093	seconds	_	
90-18	16093-16094	)	_	
90-19	16095-16099	were	_	
90-20	16100-16104	used	_	
90-21	16104-16105	.	_	

#Text=To examine group level effects, the resulting single-subject connectivity maps were used as input for second level analyses in a general linear model.
91-1	16106-16108	To	_	
91-2	16109-16116	examine	_	
91-3	16117-16122	group	_	
91-4	16123-16128	level	_	
91-5	16129-16136	effects	_	
91-6	16136-16137	,	_	
91-7	16138-16141	the	_	
91-8	16142-16151	resulting	_	
91-9	16152-16166	single-subject	_	
91-10	16167-16179	connectivity	_	
91-11	16180-16184	maps	_	
91-12	16185-16189	were	_	
91-13	16190-16194	used	_	
91-14	16195-16197	as	_	
91-15	16198-16203	input	_	
91-16	16204-16207	for	_	
91-17	16208-16214	second	_	
91-18	16215-16220	level	_	
91-19	16221-16229	analyses	_	
91-20	16230-16232	in	_	
91-21	16233-16234	a	_	
91-22	16235-16242	general	_	
91-23	16243-16249	linear	_	
91-24	16250-16255	model	_	
91-25	16255-16256	.	_	

#Text=We modeled the within-subject effect of timepoint (i.e., post- versus pre-alcohol infusion; see S1 File, S1 Fig and S1 Table for report of the main effects of alcohol administration) and between-subject effects of impulsivity (BIS-11, UPPS-P, and DDT) and recent drinking behaviors (number of drinks in the last 30 days, number of heavy drinking days).
92-1	16257-16259	We	_	
92-2	16260-16267	modeled	_	
92-3	16268-16271	the	_	
92-4	16272-16286	within-subject	_	
92-5	16287-16293	effect	_	
92-6	16294-16296	of	_	
92-7	16297-16306	timepoint	_	
92-8	16307-16308	(	_	
92-9	16308-16311	i.e	_	
92-10	16311-16312	.	_	
92-11	16312-16313	,	_	
92-12	16314-16318	post	_	
92-13	16318-16319	-	_	
92-14	16320-16326	versus	_	
92-15	16327-16338	pre-alcohol	_	
92-16	16339-16347	infusion	_	
92-17	16347-16348	;	_	
92-18	16349-16352	see	_	
92-19	16353-16355	S1	_	
92-20	16356-16360	File	_	
92-21	16360-16361	,	_	
92-22	16362-16364	S1	_	
92-23	16365-16368	Fig	_	
92-24	16369-16372	and	_	
92-25	16373-16375	S1	_	
92-26	16376-16381	Table	_	
92-27	16382-16385	for	_	
92-28	16386-16392	report	_	
92-29	16393-16395	of	_	
92-30	16396-16399	the	_	
92-31	16400-16404	main	_	
92-32	16405-16412	effects	_	
92-33	16413-16415	of	_	
92-34	16416-16423	alcohol	_	
92-35	16424-16438	administration	_	
92-36	16438-16439	)	_	
92-37	16440-16443	and	_	
92-38	16444-16459	between-subject	_	
92-39	16460-16467	effects	_	
92-40	16468-16470	of	_	
92-41	16471-16482	impulsivity	_	
92-42	16483-16484	(	_	
92-43	16484-16487	BIS	_	
92-44	16487-16488	-	_	
92-45	16488-16490	11	_	
92-46	16490-16491	,	_	
92-47	16492-16498	UPPS-P	_	
92-48	16498-16499	,	_	
92-49	16500-16503	and	_	
92-50	16504-16507	DDT	_	
92-51	16507-16508	)	_	
92-52	16509-16512	and	_	
92-53	16513-16519	recent	_	
92-54	16520-16528	drinking	_	
92-55	16529-16538	behaviors	_	
92-56	16539-16540	(	_	
92-57	16540-16546	number	_	
92-58	16547-16549	of	_	
92-59	16550-16556	drinks	_	
92-60	16557-16559	in	_	
92-61	16560-16563	the	_	
92-62	16564-16568	last	_	
92-63	16569-16571	30	_	
92-64	16572-16576	days	_	
92-65	16576-16577	,	_	
92-66	16578-16584	number	_	
92-67	16585-16587	of	_	
92-68	16588-16593	heavy	_	
92-69	16594-16602	drinking	_	
92-70	16603-16607	days	_	
92-71	16607-16608	)	_	
92-72	16608-16609	.	_	

#Text=S1 Table indicates clusters identified as showing significant changes from pre to post alcohol infusion, as well as associated statistics.
93-1	16610-16612	S1	_	
93-2	16613-16618	Table	_	
93-3	16619-16628	indicates	_	
93-4	16629-16637	clusters	_	
93-5	16638-16648	identified	_	
93-6	16649-16651	as	_	
93-7	16652-16659	showing	_	
93-8	16660-16671	significant	_	
93-9	16672-16679	changes	_	
93-10	16680-16684	from	_	
93-11	16685-16688	pre	_	
93-12	16689-16691	to	_	
93-13	16692-16696	post	_	
93-14	16697-16704	alcohol	_	
93-15	16705-16713	infusion	_	
93-16	16713-16714	,	_	
93-17	16715-16717	as	_	
93-18	16718-16722	well	_	
93-19	16723-16725	as	_	
93-20	16726-16736	associated	_	
93-21	16737-16747	statistics	_	
93-22	16747-16748	.	_	

#Text=For the seed-to-voxel analysis, reported clusters survived a height threshold of uncorrected p < 0.001 with a cluster level extent threshold of FDR-corrected p < 0.05.
94-1	16749-16752	For	_	
94-2	16753-16756	the	_	
94-3	16757-16770	seed-to-voxel	_	
94-4	16771-16779	analysis	_	
94-5	16779-16780	,	_	
94-6	16781-16789	reported	_	
94-7	16790-16798	clusters	_	
94-8	16799-16807	survived	_	
94-9	16808-16809	a	_	
94-10	16810-16816	height	_	
94-11	16817-16826	threshold	_	
94-12	16827-16829	of	_	
94-13	16830-16841	uncorrected	_	
94-14	16842-16843	p	_	
94-15	16844-16845	<	_	
94-16	16846-16851	0.001	_	
94-17	16852-16856	with	_	
94-18	16857-16858	a	_	
94-19	16859-16866	cluster	_	
94-20	16867-16872	level	_	
94-21	16873-16879	extent	_	
94-22	16880-16889	threshold	_	
94-23	16890-16892	of	_	
94-24	16893-16906	FDR-corrected	_	
94-25	16907-16908	p	_	
94-26	16909-16910	<	_	
94-27	16911-16915	0.05	_	
94-28	16915-16916	.	_	

#Text=In Figs 3–5, these clusters are shown overlaid on structural brain cutaways.
95-1	16917-16919	In	_	
95-2	16920-16924	Figs	_	
95-3	16925-16926	3	_	
95-4	16926-16927	–	_	
95-5	16927-16928	5	_	
95-6	16928-16929	,	_	
95-7	16930-16935	these	_	
95-8	16936-16944	clusters	_	
95-9	16945-16948	are	_	
95-10	16949-16954	shown	_	
95-11	16955-16963	overlaid	_	
95-12	16964-16966	on	_	
95-13	16967-16977	structural	_	
95-14	16978-16983	brain	_	
95-15	16984-16992	cutaways	_	
95-16	16992-16993	.	_	

#Text=Corresponding line plots are only for visual interpretation of these effects.
96-1	16994-17007	Corresponding	_	
96-2	17008-17012	line	_	
96-3	17013-17018	plots	_	
96-4	17019-17022	are	_	
96-5	17023-17027	only	_	
96-6	17028-17031	for	_	
96-7	17032-17038	visual	_	
96-8	17039-17053	interpretation	_	
96-9	17054-17056	of	_	
96-10	17057-17062	these	_	
96-11	17063-17070	effects	_	
96-12	17070-17071	.	_	

#Text=We also examined sex effects on alcohol-related changes in GPe connectivity at the whole brain level; there were no significant differences between males and females.
97-1	17072-17074	We	_	
97-2	17075-17079	also	_	
97-3	17080-17088	examined	_	
97-4	17089-17092	sex	_	
97-5	17093-17100	effects	_	
97-6	17101-17103	on	_	
97-7	17104-17119	alcohol-related	_	
97-8	17120-17127	changes	_	
97-9	17128-17130	in	_	
97-10	17131-17134	GPe	_	
97-11	17135-17147	connectivity	_	
97-12	17148-17150	at	_	
97-13	17151-17154	the	_	
97-14	17155-17160	whole	_	
97-15	17161-17166	brain	_	
97-16	17167-17172	level	_	
97-17	17172-17173	;	_	
97-18	17174-17179	there	_	
97-19	17180-17184	were	_	
97-20	17185-17187	no	_	
97-21	17188-17199	significant	_	
97-22	17200-17211	differences	_	
97-23	17212-17219	between	_	
97-24	17220-17225	males	_	
97-25	17226-17229	and	_	
97-26	17230-17237	females	_	
97-27	17237-17238	.	_	

#Text=In order to test our hypothesis that the interaction between recent drinking behaviors and impulsivity would contribute to alcohol-induced changes in GPe functional connectivity, we extracted ROI-to-voxel correlation values between the seeds and significant clusters and used those values to conduct multiple regression analysis in R/RStudio (version 3.4.2/1.1.383).
98-1	17239-17241	In	_	
98-2	17242-17247	order	_	
98-3	17248-17250	to	_	
98-4	17251-17255	test	_	
98-5	17256-17259	our	_	
98-6	17260-17270	hypothesis	_	
98-7	17271-17275	that	_	
98-8	17276-17279	the	_	
98-9	17280-17291	interaction	_	
98-10	17292-17299	between	_	
98-11	17300-17306	recent	_	
98-12	17307-17315	drinking	_	
98-13	17316-17325	behaviors	_	
98-14	17326-17329	and	_	
98-15	17330-17341	impulsivity	_	
98-16	17342-17347	would	_	
98-17	17348-17358	contribute	_	
98-18	17359-17361	to	_	
98-19	17362-17377	alcohol-induced	_	
98-20	17378-17385	changes	_	
98-21	17386-17388	in	_	
98-22	17389-17392	GPe	_	
98-23	17393-17403	functional	_	
98-24	17404-17416	connectivity	_	
98-25	17416-17417	,	_	
98-26	17418-17420	we	_	
98-27	17421-17430	extracted	_	
98-28	17431-17443	ROI-to-voxel	_	
98-29	17444-17455	correlation	_	
98-30	17456-17462	values	_	
98-31	17463-17470	between	_	
98-32	17471-17474	the	_	
98-33	17475-17480	seeds	_	
98-34	17481-17484	and	_	
98-35	17485-17496	significant	_	
98-36	17497-17505	clusters	_	
98-37	17506-17509	and	_	
98-38	17510-17514	used	_	
98-39	17515-17520	those	_	
98-40	17521-17527	values	_	
98-41	17528-17530	to	_	
98-42	17531-17538	conduct	_	
98-43	17539-17547	multiple	_	
98-44	17548-17558	regression	_	
98-45	17559-17567	analysis	_	
98-46	17568-17570	in	_	
98-47	17571-17572	R	_	
98-48	17572-17573	/	_	
98-49	17573-17580	RStudio	_	
98-50	17581-17582	(	_	
98-51	17582-17589	version	_	
98-52	17590-17595	3.4.2	_	
98-53	17595-17596	/	_	
98-54	17596-17603	1.1.383	_	
98-55	17603-17604	)	_	
98-56	17604-17605	.	_	

#Text=We modeled drinking history, impulsivity, and the interaction between the two as independent variables on the dependent variable of change in GPe connectivity.
99-1	17606-17608	We	_	
99-2	17609-17616	modeled	_	
99-3	17617-17625	drinking	_	
99-4	17626-17633	history	_	
99-5	17633-17634	,	_	
99-6	17635-17646	impulsivity	_	
99-7	17646-17647	,	_	
99-8	17648-17651	and	_	
99-9	17652-17655	the	_	
99-10	17656-17667	interaction	_	
99-11	17668-17675	between	_	
99-12	17676-17679	the	_	
99-13	17680-17683	two	_	
99-14	17684-17686	as	_	
99-15	17687-17698	independent	_	
99-16	17699-17708	variables	_	
99-17	17709-17711	on	_	
99-18	17712-17715	the	_	
99-19	17716-17725	dependent	_	
99-20	17726-17734	variable	_	
99-21	17735-17737	of	_	
99-22	17738-17744	change	_	
99-23	17745-17747	in	_	
99-24	17748-17751	GPe	_	
99-25	17752-17764	connectivity	_	
99-26	17764-17765	.	_	

#Text=We conducted these analyses only for significant clusters identified in the seed-to-voxel analysis, and only for the significant drinking and impulsivity measures.
100-1	17766-17768	We	_	
100-2	17769-17778	conducted	_	
100-3	17779-17784	these	_	
100-4	17785-17793	analyses	_	
100-5	17794-17798	only	_	
100-6	17799-17802	for	_	
100-7	17803-17814	significant	_	
100-8	17815-17823	clusters	_	
100-9	17824-17834	identified	_	
100-10	17835-17837	in	_	
100-11	17838-17841	the	_	
100-12	17842-17855	seed-to-voxel	_	
100-13	17856-17864	analysis	_	
100-14	17864-17865	,	_	
100-15	17866-17869	and	_	
100-16	17870-17874	only	_	
100-17	17875-17878	for	_	
100-18	17879-17882	the	_	
100-19	17883-17894	significant	_	
100-20	17895-17903	drinking	_	
100-21	17904-17907	and	_	
100-22	17908-17919	impulsivity	_	
100-23	17920-17928	measures	_	
100-24	17928-17929	.	_	

#Text=For the drinking measures identified in that seed-to-voxel analysis, models (for the specific significant cluster only) included the significant drinking variable as well as one of the two significant impulsivity variables; thus, 2 regressions per cluster were run.
101-1	17930-17933	For	_	
101-2	17934-17937	the	_	
101-3	17938-17946	drinking	_	
101-4	17947-17955	measures	_	
101-5	17956-17966	identified	_	
101-6	17967-17969	in	_	
101-7	17970-17974	that	_	
101-8	17975-17988	seed-to-voxel	_	
101-9	17989-17997	analysis	_	
101-10	17997-17998	,	_	
101-11	17999-18005	models	_	
101-12	18006-18007	(	_	
101-13	18007-18010	for	_	
101-14	18011-18014	the	_	
101-15	18015-18023	specific	_	
101-16	18024-18035	significant	_	
101-17	18036-18043	cluster	_	
101-18	18044-18048	only	_	
101-19	18048-18049	)	_	
101-20	18050-18058	included	_	
101-21	18059-18062	the	_	
101-22	18063-18074	significant	_	
101-23	18075-18083	drinking	_	
101-24	18084-18092	variable	_	
101-25	18093-18095	as	_	
101-26	18096-18100	well	_	
101-27	18101-18103	as	_	
101-28	18104-18107	one	_	
101-29	18108-18110	of	_	
101-30	18111-18114	the	_	
101-31	18115-18118	two	_	
101-32	18119-18130	significant	_	
101-33	18131-18142	impulsivity	_	
101-34	18143-18152	variables	_	
101-35	18152-18153	;	_	
101-36	18154-18158	thus	_	
101-37	18158-18159	,	_	
101-38	18160-18161	2	_	
101-39	18162-18173	regressions	_	
101-40	18174-18177	per	_	
101-41	18178-18185	cluster	_	
101-42	18186-18190	were	_	
101-43	18191-18194	run	_	
101-44	18194-18195	.	_	

#Text=Similarly, for significant impulsivity measures, 2 regressions per cluster were run (as there are two drinking variables).
102-1	18196-18205	Similarly	_	
102-2	18205-18206	,	_	
102-3	18207-18210	for	_	
102-4	18211-18222	significant	_	
102-5	18223-18234	impulsivity	_	
102-6	18235-18243	measures	_	
102-7	18243-18244	,	_	
102-8	18245-18246	2	_	
102-9	18247-18258	regressions	_	
102-10	18259-18262	per	_	
102-11	18263-18270	cluster	_	
102-12	18271-18275	were	_	
102-13	18276-18279	run	_	
102-14	18280-18281	(	_	
102-15	18281-18283	as	_	
102-16	18284-18289	there	_	
102-17	18290-18293	are	_	
102-18	18294-18297	two	_	
102-19	18298-18306	drinking	_	
102-20	18307-18316	variables	_	
102-21	18316-18317	)	_	
102-22	18317-18318	.	_	

#Text=This resulted in a total of 20 tests.
103-1	18319-18323	This	_	
103-2	18324-18332	resulted	_	
103-3	18333-18335	in	_	
103-4	18336-18337	a	_	
103-5	18338-18343	total	_	
103-6	18344-18346	of	_	
103-7	18347-18349	20	_	
103-8	18350-18355	tests	_	
103-9	18355-18356	.	_	

#Text=We then adjusted the omnibus test statistics to correct for multiple comparisons using FDR of < 0.05.
104-1	18357-18359	We	_	
104-2	18360-18364	then	_	
104-3	18365-18373	adjusted	_	
104-4	18374-18377	the	_	
104-5	18378-18385	omnibus	_	
104-6	18386-18390	test	_	
104-7	18391-18401	statistics	_	
104-8	18402-18404	to	_	
104-9	18405-18412	correct	_	
104-10	18413-18416	for	_	
104-11	18417-18425	multiple	_	
104-12	18426-18437	comparisons	_	
104-13	18438-18443	using	_	
104-14	18444-18447	FDR	_	
104-15	18448-18450	of	_	
104-16	18451-18452	<	_	
104-17	18453-18457	0.05	_	
104-18	18457-18458	.	_	

#Text=Of those regressions, only those with significant interaction effects are reported.
105-1	18459-18461	Of	_	
105-2	18462-18467	those	_	
105-3	18468-18479	regressions	_	
105-4	18479-18480	,	_	
105-5	18481-18485	only	_	
105-6	18486-18491	those	_	
105-7	18492-18496	with	_	
105-8	18497-18508	significant	_	
105-9	18509-18520	interaction	_	
105-10	18521-18528	effects	_	
105-11	18529-18532	are	_	
105-12	18533-18541	reported	_	
105-13	18541-18542	.	_	

#Text=Results
#Text=GPe connectivity and drinking behaviors
#Text=Neither the total number of drinks over 30 days nor the number of heavy drinking days were correlated with subjective effects of the alcohol infusion as measured by the DEQ.
106-1	18543-18550	Results	_	
106-2	18551-18554	GPe	_	
106-3	18555-18567	connectivity	_	
106-4	18568-18571	and	_	
106-5	18572-18580	drinking	_	
106-6	18581-18590	behaviors	_	
106-7	18591-18598	Neither	_	
106-8	18599-18602	the	_	
106-9	18603-18608	total	_	
106-10	18609-18615	number	_	
106-11	18616-18618	of	_	
106-12	18619-18625	drinks	_	
106-13	18626-18630	over	_	
106-14	18631-18633	30	_	
106-15	18634-18638	days	_	
106-16	18639-18642	nor	_	
106-17	18643-18646	the	_	
106-18	18647-18653	number	_	
106-19	18654-18656	of	_	
106-20	18657-18662	heavy	_	
106-21	18663-18671	drinking	_	
106-22	18672-18676	days	_	
106-23	18677-18681	were	_	
106-24	18682-18692	correlated	_	
106-25	18693-18697	with	_	
106-26	18698-18708	subjective	_	
106-27	18709-18716	effects	_	
106-28	18717-18719	of	_	
106-29	18720-18723	the	_	
106-30	18724-18731	alcohol	_	
106-31	18732-18740	infusion	_	
106-32	18741-18743	as	_	
106-33	18744-18752	measured	_	
106-34	18753-18755	by	_	
106-35	18756-18759	the	_	
106-36	18760-18763	DEQ	_	
106-37	18763-18764	.	_	

#Text=Table 2 shows the correlations between drinking and impulsivity measures.
107-1	18765-18770	Table	_	
107-2	18771-18772	2	_	
107-3	18773-18778	shows	_	
107-4	18779-18782	the	_	
107-5	18783-18795	correlations	_	
107-6	18796-18803	between	_	
107-7	18804-18812	drinking	_	
107-8	18813-18816	and	_	
107-9	18817-18828	impulsivity	_	
107-10	18829-18837	measures	_	
107-11	18837-18838	.	_	

#Text=Correlations between drinking and impulsivity measures.
108-1	18839-18851	Correlations	_	
108-2	18852-18859	between	_	
108-3	18860-18868	drinking	_	
108-4	18869-18872	and	_	
108-5	18873-18884	impulsivity	_	
108-6	18885-18893	measures	_	
108-7	18893-18894	.	_	

#Text=Measure\tDelay Discounting Rate (K)\tTLFB: Heavy Drinking Days\tTLFB: Drinks Per Thirty Days\tUPPS-P: Positive Urgency\tUPPS-P: Negative Urgency\tUPPS-P: Perseverance\tBIS: Attentional Impulsiveness\tBIS: Motor Impulsiveness\tBIS: Nonplanning Impulsiveness\t \tTLFB: Heavy Drinking Days\t-0.22\t-\t-\t-\t-\t-\t-\t-\t-\t \tTLFB: Drinks Per Thirty Days\t-0.33\t0.79 ***\t-\t-\t-\t-\t-\t-\t-\t \tUPPS-P: Positive Urgency\t0.07\t0.27\t0.30\t-\t-\t-\t-\t-\t-\t \tUPPS-P: Negative Urgency\t0.22\t0.30\t0.14\t0.48 *\t-\t-\t-\t-\t-\t \tUPPS-P: Perseverance\t0.06\t-0.28\t-0.22\t0.06\t0.46 *\t-\t-\t-\t-\t \tBIS: Attentional Impulsiveness\t0.11\t0.29\t0.15\t0.36\t0.42 *\t0.13\t-\t-\t-\t \tBIS: Motor Impulsiveness\t0.01\t0.05\t0.25\t0.38\t0.17\t0.36\t0.59 **\t-\t-\t \tBIS: Nonplanning Impulsiveness\t0.37\t-0.07\t-0.06\t0.18\t0.19\t0.59 **\t0.36\t0.64 ***\t-\t \tBIS: Total\t0.22\t0.09\t0.11\t0.36\t0.30\t0.46 *\t0.75 ***\t0.89 ***\t0.84 ***\t \t
#Text=Abbreviations as follow: BIS- Barratt Impulsiveness Scale; TLFB- Alcohol Timeline Followback.
109-1	18895-18902	Measure	_	
109-2	18903-18908	Delay	_	
109-3	18909-18920	Discounting	_	
109-4	18921-18925	Rate	_	
109-5	18926-18927	(	_	
109-6	18927-18928	K	_	
109-7	18928-18929	)	_	
109-8	18930-18934	TLFB	_	
109-9	18934-18935	:	_	
109-10	18936-18941	Heavy	_	
109-11	18942-18950	Drinking	_	
109-12	18951-18955	Days	_	
109-13	18956-18960	TLFB	_	
109-14	18960-18961	:	_	
109-15	18962-18968	Drinks	_	
109-16	18969-18972	Per	_	
109-17	18973-18979	Thirty	_	
109-18	18980-18984	Days	_	
109-19	18985-18991	UPPS-P	_	
109-20	18991-18992	:	_	
109-21	18993-19001	Positive	_	
109-22	19002-19009	Urgency	_	
109-23	19010-19016	UPPS-P	_	
109-24	19016-19017	:	_	
109-25	19018-19026	Negative	_	
109-26	19027-19034	Urgency	_	
109-27	19035-19041	UPPS-P	_	
109-28	19041-19042	:	_	
109-29	19043-19055	Perseverance	_	
109-30	19056-19059	BIS	_	
109-31	19059-19060	:	_	
109-32	19061-19072	Attentional	_	
109-33	19073-19086	Impulsiveness	_	
109-34	19087-19090	BIS	_	
109-35	19090-19091	:	_	
109-36	19092-19097	Motor	_	
109-37	19098-19111	Impulsiveness	_	
109-38	19112-19115	BIS	_	
109-39	19115-19116	:	_	
109-40	19117-19128	Nonplanning	_	
109-41	19129-19142	Impulsiveness	_	
109-42	19145-19149	TLFB	_	
109-43	19149-19150	:	_	
109-44	19151-19156	Heavy	_	
109-45	19157-19165	Drinking	_	
109-46	19166-19170	Days	_	
109-47	19171-19172	-	_	
109-48	19172-19176	0.22	_	
109-49	19177-19178	-	_	
109-50	19179-19180	-	_	
109-51	19181-19182	-	_	
109-52	19183-19184	-	_	
109-53	19185-19186	-	_	
109-54	19187-19188	-	_	
109-55	19189-19190	-	_	
109-56	19191-19192	-	_	
109-57	19195-19199	TLFB	_	
109-58	19199-19200	:	_	
109-59	19201-19207	Drinks	_	
109-60	19208-19211	Per	_	
109-61	19212-19218	Thirty	_	
109-62	19219-19223	Days	_	
109-63	19224-19225	-	_	
109-64	19225-19229	0.33	_	
109-65	19230-19234	0.79	_	
109-66	19235-19236	*	_	
109-67	19236-19237	*	_	
109-68	19237-19238	*	_	
109-69	19239-19240	-	_	
109-70	19241-19242	-	_	
109-71	19243-19244	-	_	
109-72	19245-19246	-	_	
109-73	19247-19248	-	_	
109-74	19249-19250	-	_	
109-75	19251-19252	-	_	
109-76	19255-19261	UPPS-P	_	
109-77	19261-19262	:	_	
109-78	19263-19271	Positive	_	
109-79	19272-19279	Urgency	_	
109-80	19280-19284	0.07	_	
109-81	19285-19289	0.27	_	
109-82	19290-19294	0.30	_	
109-83	19295-19296	-	_	
109-84	19297-19298	-	_	
109-85	19299-19300	-	_	
109-86	19301-19302	-	_	
109-87	19303-19304	-	_	
109-88	19305-19306	-	_	
109-89	19309-19315	UPPS-P	_	
109-90	19315-19316	:	_	
109-91	19317-19325	Negative	_	
109-92	19326-19333	Urgency	_	
109-93	19334-19338	0.22	_	
109-94	19339-19343	0.30	_	
109-95	19344-19348	0.14	_	
109-96	19349-19353	0.48	_	
109-97	19354-19355	*	_	
109-98	19356-19357	-	_	
109-99	19358-19359	-	_	
109-100	19360-19361	-	_	
109-101	19362-19363	-	_	
109-102	19364-19365	-	_	
109-103	19368-19374	UPPS-P	_	
109-104	19374-19375	:	_	
109-105	19376-19388	Perseverance	_	
109-106	19389-19393	0.06	_	
109-107	19394-19395	-	_	
109-108	19395-19399	0.28	_	
109-109	19400-19401	-	_	
109-110	19401-19405	0.22	_	
109-111	19406-19410	0.06	_	
109-112	19411-19415	0.46	_	
109-113	19416-19417	*	_	
109-114	19418-19419	-	_	
109-115	19420-19421	-	_	
109-116	19422-19423	-	_	
109-117	19424-19425	-	_	
109-118	19428-19431	BIS	_	
109-119	19431-19432	:	_	
109-120	19433-19444	Attentional	_	
109-121	19445-19458	Impulsiveness	_	
109-122	19459-19463	0.11	_	
109-123	19464-19468	0.29	_	
109-124	19469-19473	0.15	_	
109-125	19474-19478	0.36	_	
109-126	19479-19483	0.42	_	
109-127	19484-19485	*	_	
109-128	19486-19490	0.13	_	
109-129	19491-19492	-	_	
109-130	19493-19494	-	_	
109-131	19495-19496	-	_	
109-132	19499-19502	BIS	_	
109-133	19502-19503	:	_	
109-134	19504-19509	Motor	_	
109-135	19510-19523	Impulsiveness	_	
109-136	19524-19528	0.01	_	
109-137	19529-19533	0.05	_	
109-138	19534-19538	0.25	_	
109-139	19539-19543	0.38	_	
109-140	19544-19548	0.17	_	
109-141	19549-19553	0.36	_	
109-142	19554-19558	0.59	_	
109-143	19559-19560	*	_	
109-144	19560-19561	*	_	
109-145	19562-19563	-	_	
109-146	19564-19565	-	_	
109-147	19568-19571	BIS	_	
109-148	19571-19572	:	_	
109-149	19573-19584	Nonplanning	_	
109-150	19585-19598	Impulsiveness	_	
109-151	19599-19603	0.37	_	
109-152	19604-19605	-	_	
109-153	19605-19609	0.07	_	
109-154	19610-19611	-	_	
109-155	19611-19615	0.06	_	
109-156	19616-19620	0.18	_	
109-157	19621-19625	0.19	_	
109-158	19626-19630	0.59	_	
109-159	19631-19632	*	_	
109-160	19632-19633	*	_	
109-161	19634-19638	0.36	_	
109-162	19639-19643	0.64	_	
109-163	19644-19645	*	_	
109-164	19645-19646	*	_	
109-165	19646-19647	*	_	
109-166	19648-19649	-	_	
109-167	19652-19655	BIS	_	
109-168	19655-19656	:	_	
109-169	19657-19662	Total	_	
109-170	19663-19667	0.22	_	
109-171	19668-19672	0.09	_	
109-172	19673-19677	0.11	_	
109-173	19678-19682	0.36	_	
109-174	19683-19687	0.30	_	
109-175	19688-19692	0.46	_	
109-176	19693-19694	*	_	
109-177	19695-19699	0.75	_	
109-178	19700-19701	*	_	
109-179	19701-19702	*	_	
109-180	19702-19703	*	_	
109-181	19704-19708	0.89	_	
109-182	19709-19710	*	_	
109-183	19710-19711	*	_	
109-184	19711-19712	*	_	
109-185	19713-19717	0.84	_	
109-186	19718-19719	*	_	
109-187	19719-19720	*	_	
109-188	19720-19721	*	_	
109-189	19725-19738	Abbreviations	_	
109-190	19739-19741	as	_	
109-191	19742-19748	follow	_	
109-192	19748-19749	:	_	
109-193	19750-19753	BIS	_	
109-194	19753-19754	-	_	
109-195	19755-19762	Barratt	_	
109-196	19763-19776	Impulsiveness	_	
109-197	19777-19782	Scale	_	
109-198	19782-19783	;	_	
109-199	19784-19788	TLFB	_	
109-200	19788-19789	-	_	
109-201	19790-19797	Alcohol	_	
109-202	19798-19806	Timeline	_	
109-203	19807-19817	Followback	_	
109-204	19817-19818	.	_	

#Text=Significance as follows-
#Text=*: p < 0.05;
#Text=**: p < 0.01;
#Text=***: p < 0.001
#Text=Number of drinks in 30 days
#Text=The number of drinks consumed per 30 days prior to screening was significantly associated with alcohol-related changes in connectivity (Fig 2 and Table 3).
110-1	19819-19831	Significance	_	
110-2	19832-19834	as	_	
110-3	19835-19842	follows	_	
110-4	19842-19843	-	_	
110-5	19844-19845	*	_	
110-6	19845-19846	:	_	
110-7	19847-19848	p	_	
110-8	19849-19850	<	_	
110-9	19851-19855	0.05	_	
110-10	19855-19856	;	_	
110-11	19857-19858	*	_	
110-12	19858-19859	*	_	
110-13	19859-19860	:	_	
110-14	19861-19862	p	_	
110-15	19863-19864	<	_	
110-16	19865-19869	0.01	_	
110-17	19869-19870	;	_	
110-18	19871-19872	*	_	
110-19	19872-19873	*	_	
110-20	19873-19874	*	_	
110-21	19874-19875	:	_	
110-22	19876-19877	p	_	
110-23	19878-19879	<	_	
110-24	19880-19885	0.001	_	
110-25	19886-19892	Number	_	
110-26	19893-19895	of	_	
110-27	19896-19902	drinks	_	
110-28	19903-19905	in	_	
110-29	19906-19908	30	_	
110-30	19909-19913	days	_	
110-31	19914-19917	The	_	
110-32	19918-19924	number	_	
110-33	19925-19927	of	_	
110-34	19928-19934	drinks	_	
110-35	19935-19943	consumed	_	
110-36	19944-19947	per	_	
110-37	19948-19950	30	_	
110-38	19951-19955	days	_	
110-39	19956-19961	prior	_	
110-40	19962-19964	to	_	
110-41	19965-19974	screening	_	
110-42	19975-19978	was	_	
110-43	19979-19992	significantly	_	
110-44	19993-20003	associated	_	
110-45	20004-20008	with	_	
110-46	20009-20024	alcohol-related	_	
110-47	20025-20032	changes	_	
110-48	20033-20035	in	_	
110-49	20036-20048	connectivity	_	
110-50	20049-20050	(	_	
110-51	20050-20053	Fig	_	
110-52	20054-20055	2	_	
110-53	20056-20059	and	_	
110-54	20060-20065	Table	_	
110-55	20066-20067	3	_	
110-56	20067-20068	)	_	
110-57	20068-20069	.	_	

#Text=Drinks in past 30-days was negatively associated with alcohol-related changes in the connectivity between the left GPe and the left hippocampus /amygdala, left IFG extending into the anterior insula, and areas of the bilateral superior frontal / paracingulate cortices.
111-1	20070-20076	Drinks	_	
111-2	20077-20079	in	_	
111-3	20080-20084	past	_	
111-4	20085-20087	30	_	
111-5	20087-20088	-	_	
111-6	20088-20092	days	_	
111-7	20093-20096	was	_	
111-8	20097-20107	negatively	_	
111-9	20108-20118	associated	_	
111-10	20119-20123	with	_	
111-11	20124-20139	alcohol-related	_	
111-12	20140-20147	changes	_	
111-13	20148-20150	in	_	
111-14	20151-20154	the	_	
111-15	20155-20167	connectivity	_	
111-16	20168-20175	between	_	
111-17	20176-20179	the	_	
111-18	20180-20184	left	_	
111-19	20185-20188	GPe	_	
111-20	20189-20192	and	_	
111-21	20193-20196	the	_	
111-22	20197-20201	left	_	
111-23	20202-20213	hippocampus	_	
111-24	20214-20215	/	_	
111-25	20215-20223	amygdala	_	
111-26	20223-20224	,	_	
111-27	20225-20229	left	_	
111-28	20230-20233	IFG	_	
111-29	20234-20243	extending	_	
111-30	20244-20248	into	_	
111-31	20249-20252	the	_	
111-32	20253-20261	anterior	_	
111-33	20262-20268	insula	_	
111-34	20268-20269	,	_	
111-35	20270-20273	and	_	
111-36	20274-20279	areas	_	
111-37	20280-20282	of	_	
111-38	20283-20286	the	_	
111-39	20287-20296	bilateral	_	
111-40	20297-20305	superior	_	
111-41	20306-20313	frontal	_	
111-42	20314-20315	/	_	
111-43	20316-20329	paracingulate	_	
111-44	20330-20338	cortices	_	
111-45	20338-20339	.	_	

#Text=Moreover, the interaction between this drinking measure and negative urgency as measured by the UPPS-P significantly predicted left GPe-hippocampus/amygdala connectivity (F(3,21) = 4.694, omnibus FDR-p = 0.028, adjusted R2 = 0.316, interaction B = -0.023, interaction p = 0.008; Fig 3).
112-1	20340-20348	Moreover	_	
112-2	20348-20349	,	_	
112-3	20350-20353	the	_	
112-4	20354-20365	interaction	_	
112-5	20366-20373	between	_	
112-6	20374-20378	this	_	
112-7	20379-20387	drinking	_	
112-8	20388-20395	measure	_	
112-9	20396-20399	and	_	
112-10	20400-20408	negative	_	
112-11	20409-20416	urgency	_	
112-12	20417-20419	as	_	
112-13	20420-20428	measured	_	
112-14	20429-20431	by	_	
112-15	20432-20435	the	_	
112-16	20436-20442	UPPS-P	_	
112-17	20443-20456	significantly	_	
112-18	20457-20466	predicted	_	
112-19	20467-20471	left	_	
112-20	20472-20487	GPe-hippocampus	_	
112-21	20487-20488	/	_	
112-22	20488-20496	amygdala	_	
112-23	20497-20509	connectivity	_	
112-24	20510-20511	(	_	
112-25	20511-20512	F	_	
112-26	20512-20513	(	_	
112-27	20513-20517	3,21	_	
112-28	20517-20518	)	_	
112-29	20519-20520	=	_	
112-30	20521-20526	4.694	_	
112-31	20526-20527	,	_	
112-32	20528-20535	omnibus	_	
112-33	20536-20541	FDR-p	_	
112-34	20542-20543	=	_	
112-35	20544-20549	0.028	_	
112-36	20549-20550	,	_	
112-37	20551-20559	adjusted	_	
112-38	20560-20562	R2	_	
112-39	20563-20564	=	_	
112-40	20565-20570	0.316	_	
112-41	20570-20571	,	_	
112-42	20572-20583	interaction	_	
112-43	20584-20585	B	_	
112-44	20586-20587	=	_	
112-45	20588-20589	-	_	
112-46	20589-20594	0.023	_	
112-47	20594-20595	,	_	
112-48	20596-20607	interaction	_	
112-49	20608-20609	p	_	
112-50	20610-20611	=	_	
112-51	20612-20617	0.008	_	
112-52	20617-20618	;	_	
112-53	20619-20622	Fig	_	
112-54	20623-20624	3	_	
112-55	20624-20625	)	_	
112-56	20625-20626	.	_	

#Text=Drinks in past 30-days was also negatively associated with alcohol-induced change in connectivity between right GPe and bilateral putamen, Heschl’s gyrus, posterior insula, and central opercular cortices.
113-1	20627-20633	Drinks	_	
113-2	20634-20636	in	_	
113-3	20637-20641	past	_	
113-4	20642-20644	30	_	
113-5	20644-20645	-	_	
113-6	20645-20649	days	_	
113-7	20650-20653	was	_	
113-8	20654-20658	also	_	
113-9	20659-20669	negatively	_	
113-10	20670-20680	associated	_	
113-11	20681-20685	with	_	
113-12	20686-20701	alcohol-induced	_	
113-13	20702-20708	change	_	
113-14	20709-20711	in	_	
113-15	20712-20724	connectivity	_	
113-16	20725-20732	between	_	
113-17	20733-20738	right	_	
113-18	20739-20742	GPe	_	
113-19	20743-20746	and	_	
113-20	20747-20756	bilateral	_	
113-21	20757-20764	putamen	_	
113-22	20764-20765	,	_	
113-23	20766-20772	Heschl	_	
113-24	20772-20773	’	_	
113-25	20773-20774	s	_	
113-26	20775-20780	gyrus	_	
113-27	20780-20781	,	_	
113-28	20782-20791	posterior	_	
113-29	20792-20798	insula	_	
113-30	20798-20799	,	_	
113-31	20800-20803	and	_	
113-32	20804-20811	central	_	
113-33	20812-20821	opercular	_	
113-34	20822-20830	cortices	_	
113-35	20830-20831	.	_	

#Text=For each of these associations, the change was such that in individuals with more past 30 days drinking, alcohol decreased connectivity; in individuals with less drinking, alcohol increased connectivity.
114-1	20832-20835	For	_	
114-2	20836-20840	each	_	
114-3	20841-20843	of	_	
114-4	20844-20849	these	_	
114-5	20850-20862	associations	_	
114-6	20862-20863	,	_	
114-7	20864-20867	the	_	
114-8	20868-20874	change	_	
114-9	20875-20878	was	_	
114-10	20879-20883	such	_	
114-11	20884-20888	that	_	
114-12	20889-20891	in	_	
114-13	20892-20903	individuals	_	
114-14	20904-20908	with	_	
114-15	20909-20913	more	_	
114-16	20914-20918	past	_	
114-17	20919-20921	30	_	
114-18	20922-20926	days	_	
114-19	20927-20935	drinking	_	
114-20	20935-20936	,	_	
114-21	20937-20944	alcohol	_	
114-22	20945-20954	decreased	_	
114-23	20955-20967	connectivity	_	
114-24	20967-20968	;	_	
114-25	20969-20971	in	_	
114-26	20972-20983	individuals	_	
114-27	20984-20988	with	_	
114-28	20989-20993	less	_	
114-29	20994-21002	drinking	_	
114-30	21002-21003	,	_	
114-31	21004-21011	alcohol	_	
114-32	21012-21021	increased	_	
114-33	21022-21034	connectivity	_	
114-34	21034-21035	.	_	

#Text=Association between past 30 day drinking and alcohol induced changes in GPe connectivity.
115-1	21036-21047	Association	_	
115-2	21048-21055	between	_	
115-3	21056-21060	past	_	
115-4	21061-21063	30	_	
115-5	21064-21067	day	_	
115-6	21068-21076	drinking	_	
115-7	21077-21080	and	_	
115-8	21081-21088	alcohol	_	
115-9	21089-21096	induced	_	
115-10	21097-21104	changes	_	
115-11	21105-21107	in	_	
115-12	21108-21111	GPe	_	
115-13	21112-21124	connectivity	_	
115-14	21124-21125	.	_	

#Text=(As measured by the Alcohol Timeline Followback).
116-1	21126-21127	(	_	
116-2	21127-21129	As	_	
116-3	21130-21138	measured	_	
116-4	21139-21141	by	_	
116-5	21142-21145	the	_	
116-6	21146-21153	Alcohol	_	
116-7	21154-21162	Timeline	_	
116-8	21163-21173	Followback	_	
116-9	21173-21174	)	_	
116-10	21174-21175	.	_	

#Text=Scatter plots correspond to individual connectivity at baseline in teal (estimated BAC: 0.0) and after infusion in salmon (BAC: 0.08); linear fit lines are also displayed for each timepoint.
117-1	21176-21183	Scatter	_	
117-2	21184-21189	plots	_	
117-3	21190-21200	correspond	_	
117-4	21201-21203	to	_	
117-5	21204-21214	individual	_	
117-6	21215-21227	connectivity	_	
117-7	21228-21230	at	_	
117-8	21231-21239	baseline	_	
117-9	21240-21242	in	_	
117-10	21243-21247	teal	_	
117-11	21248-21249	(	_	
117-12	21249-21258	estimated	_	
117-13	21259-21262	BAC	_	
117-14	21262-21263	:	_	
117-15	21264-21267	0.0	_	
117-16	21267-21268	)	_	
117-17	21269-21272	and	_	
117-18	21273-21278	after	_	
117-19	21279-21287	infusion	_	
117-20	21288-21290	in	_	
117-21	21291-21297	salmon	_	
117-22	21298-21299	(	_	
117-23	21299-21302	BAC	_	
117-24	21302-21303	:	_	
117-25	21304-21308	0.08	_	
117-26	21308-21309	)	_	
117-27	21309-21310	;	_	
117-28	21311-21317	linear	_	
117-29	21318-21321	fit	_	
117-30	21322-21327	lines	_	
117-31	21328-21331	are	_	
117-32	21332-21336	also	_	
117-33	21337-21346	displayed	_	
117-34	21347-21350	for	_	
117-35	21351-21355	each	_	
117-36	21356-21365	timepoint	_	
117-37	21365-21366	.	_	

#Text=Connectivity coefficient is the r (correlation value) between the signal in the GPe seed and the coordinate indicated.
118-1	21367-21379	Connectivity	_	
118-2	21380-21391	coefficient	_	
118-3	21392-21394	is	_	
118-4	21395-21398	the	_	
118-5	21399-21400	r	_	
118-6	21401-21402	(	_	
118-7	21402-21413	correlation	_	
118-8	21414-21419	value	_	
118-9	21419-21420	)	_	
118-10	21421-21428	between	_	
118-11	21429-21432	the	_	
118-12	21433-21439	signal	_	
118-13	21440-21442	in	_	
118-14	21443-21446	the	_	
118-15	21447-21450	GPe	_	
118-16	21451-21455	seed	_	
118-17	21456-21459	and	_	
118-18	21460-21463	the	_	
118-19	21464-21474	coordinate	_	
118-20	21475-21484	indicated	_	
118-21	21484-21485	.	_	

#Text=Brain images represent whole effects of drinks in past 30 days on alcohol induced change in functional connectivity (post-infusion connectivity > pre-infusion connectivity).
119-1	21486-21491	Brain	_	
119-2	21492-21498	images	_	
119-3	21499-21508	represent	_	
119-4	21509-21514	whole	_	
119-5	21515-21522	effects	_	
119-6	21523-21525	of	_	
119-7	21526-21532	drinks	_	
119-8	21533-21535	in	_	
119-9	21536-21540	past	_	
119-10	21541-21543	30	_	
119-11	21544-21548	days	_	
119-12	21549-21551	on	_	
119-13	21552-21559	alcohol	_	
119-14	21560-21567	induced	_	
119-15	21568-21574	change	_	
119-16	21575-21577	in	_	
119-17	21578-21588	functional	_	
119-18	21589-21601	connectivity	_	
119-19	21602-21603	(	_	
119-20	21603-21616	post-infusion	_	
119-21	21617-21629	connectivity	_	
119-22	21630-21631	>	_	
119-23	21632-21644	pre-infusion	_	
119-24	21645-21657	connectivity	_	
119-25	21657-21658	)	_	
119-26	21658-21659	.	_	

#Text=Warm colors indicate intoxication related increases in connectivity; cool colors indicated intoxication related decreases in connectivity.
120-1	21660-21664	Warm	_	
120-2	21665-21671	colors	_	
120-3	21672-21680	indicate	_	
120-4	21681-21693	intoxication	_	
120-5	21694-21701	related	_	
120-6	21702-21711	increases	_	
120-7	21712-21714	in	_	
120-8	21715-21727	connectivity	_	
120-9	21727-21728	;	_	
120-10	21729-21733	cool	_	
120-11	21734-21740	colors	_	
120-12	21741-21750	indicated	_	
120-13	21751-21763	intoxication	_	
120-14	21764-21771	related	_	
120-15	21772-21781	decreases	_	
120-16	21782-21784	in	_	
120-17	21785-21797	connectivity	_	
120-18	21797-21798	.	_	

#Text=Images shown at p < 0.005.
121-1	21799-21805	Images	_	
121-2	21806-21811	shown	_	
121-3	21812-21814	at	_	
121-4	21815-21816	p	_	
121-5	21817-21818	<	_	
121-6	21819-21824	0.005	_	
121-7	21824-21825	.	_	

#Text=Clusters with significant interaction effects are reported in Fig 3.
122-1	21826-21834	Clusters	_	
122-2	21835-21839	with	_	
122-3	21840-21851	significant	_	
122-4	21852-21863	interaction	_	
122-5	21864-21871	effects	_	
122-6	21872-21875	are	_	
122-7	21876-21884	reported	_	
122-8	21885-21887	in	_	
122-9	21888-21891	Fig	_	
122-10	21892-21893	3	_	
122-11	21893-21894	.	_	

#Text=Reported clusters of connectivity with GPe area correspond to the following regions: A.i.
123-1	21895-21903	Reported	_	
123-2	21904-21912	clusters	_	
123-3	21913-21915	of	_	
123-4	21916-21928	connectivity	_	
123-5	21929-21933	with	_	
123-6	21934-21937	GPe	_	
123-7	21938-21942	area	_	
123-8	21943-21953	correspond	_	
123-9	21954-21956	to	_	
123-10	21957-21960	the	_	
123-11	21961-21970	following	_	
123-12	21971-21978	regions	_	
123-13	21978-21979	:	_	
123-14	21980-21983	A.i	_	
123-15	21983-21984	.	_	

#Text=—Superior Frontal Gyrus extending into dorsal anterior cingulate; A.ii.
124-1	21984-21985	—	_	
124-2	21985-21993	Superior	_	
124-3	21994-22001	Frontal	_	
124-4	22002-22007	Gyrus	_	
124-5	22008-22017	extending	_	
124-6	22018-22022	into	_	
124-7	22023-22029	dorsal	_	
124-8	22030-22038	anterior	_	
124-9	22039-22048	cingulate	_	
124-10	22048-22049	;	_	
124-11	22050-22054	A.ii	_	
124-12	22054-22055	.	_	

#Text=—Hippocampus/amygdala; B.i.
125-1	22055-22056	—	_	
125-2	22056-22067	Hippocampus	_	
125-3	22067-22068	/	_	
125-4	22068-22076	amygdala	_	
125-5	22076-22077	;	_	
125-6	22078-22081	B.i	_	
125-7	22081-22082	.	_	

#Text=—Heschl’s Gyrus extending into the insula/putamen; B.ii.
126-1	22082-22083	—	_	
126-2	22083-22089	Heschl	_	
126-3	22089-22090	’	_	
126-4	22090-22091	s	_	
126-5	22092-22097	Gyrus	_	
126-6	22098-22107	extending	_	
126-7	22108-22112	into	_	
126-8	22113-22116	the	_	
126-9	22117-22123	insula	_	
126-10	22123-22124	/	_	
126-11	22124-22131	putamen	_	
126-12	22131-22132	;	_	
126-13	22133-22137	B.ii	_	
126-14	22137-22138	.	_	

#Text=—Heschl’s Gyrus extending into the insula/putamen.
127-1	22138-22139	—	_	
127-2	22139-22145	Heschl	_	
127-3	22145-22146	’	_	
127-4	22146-22147	s	_	
127-5	22148-22153	Gyrus	_	
127-6	22154-22163	extending	_	
127-7	22164-22168	into	_	
127-8	22169-22172	the	_	
127-9	22173-22179	insula	_	
127-10	22179-22180	/	_	
127-11	22180-22187	putamen	_	
127-12	22187-22188	.	_	

#Text=Effect of alcohol induced changes in GPe connectivity on the association between drinking and impulsivity.
128-1	22189-22195	Effect	_	
128-2	22196-22198	of	_	
128-3	22199-22206	alcohol	_	
128-4	22207-22214	induced	_	
128-5	22215-22222	changes	_	
128-6	22223-22225	in	_	
128-7	22226-22229	GPe	_	
128-8	22230-22242	connectivity	_	
128-9	22243-22245	on	_	
128-10	22246-22249	the	_	
128-11	22250-22261	association	_	
128-12	22262-22269	between	_	
128-13	22270-22278	drinking	_	
128-14	22279-22282	and	_	
128-15	22283-22294	impulsivity	_	
128-16	22294-22295	.	_	

#Text=(As measured by the Alcohol Timeline Followback and UPPS-P, respectively).
129-1	22296-22297	(	_	
129-2	22297-22299	As	_	
129-3	22300-22308	measured	_	
129-4	22309-22311	by	_	
129-5	22312-22315	the	_	
129-6	22316-22323	Alcohol	_	
129-7	22324-22332	Timeline	_	
129-8	22333-22343	Followback	_	
129-9	22344-22347	and	_	
129-10	22348-22354	UPPS-P	_	
129-11	22354-22355	,	_	
129-12	22356-22368	respectively	_	
129-13	22368-22369	)	_	
129-14	22369-22370	.	_	

#Text=Cluster of Drinking Effect column: Brain images represent whole brain effects of drinks in past 30 days on alcohol induced change in functional connectivity (post-infusion connectivity > post-infusion connectivity).
130-1	22371-22378	Cluster	_	
130-2	22379-22381	of	_	
130-3	22382-22390	Drinking	_	
130-4	22391-22397	Effect	_	
130-5	22398-22404	column	_	
130-6	22404-22405	:	_	
130-7	22406-22411	Brain	_	
130-8	22412-22418	images	_	
130-9	22419-22428	represent	_	
130-10	22429-22434	whole	_	
130-11	22435-22440	brain	_	
130-12	22441-22448	effects	_	
130-13	22449-22451	of	_	
130-14	22452-22458	drinks	_	
130-15	22459-22461	in	_	
130-16	22462-22466	past	_	
130-17	22467-22469	30	_	
130-18	22470-22474	days	_	
130-19	22475-22477	on	_	
130-20	22478-22485	alcohol	_	
130-21	22486-22493	induced	_	
130-22	22494-22500	change	_	
130-23	22501-22503	in	_	
130-24	22504-22514	functional	_	
130-25	22515-22527	connectivity	_	
130-26	22528-22529	(	_	
130-27	22529-22542	post-infusion	_	
130-28	22543-22555	connectivity	_	
130-29	22556-22557	>	_	
130-30	22558-22571	post-infusion	_	
130-31	22572-22584	connectivity	_	
130-32	22584-22585	)	_	
130-33	22585-22586	.	_	

#Text=Warm colors indicate intoxication related increases in connectivity.
131-1	22587-22591	Warm	_	
131-2	22592-22598	colors	_	
131-3	22599-22607	indicate	_	
131-4	22608-22620	intoxication	_	
131-5	22621-22628	related	_	
131-6	22629-22638	increases	_	
131-7	22639-22641	in	_	
131-8	22642-22654	connectivity	_	
131-9	22654-22655	.	_	

#Text=Images shown at p < 0.005.
132-1	22656-22662	Images	_	
132-2	22663-22668	shown	_	
132-3	22669-22671	at	_	
132-4	22672-22673	p	_	
132-5	22674-22675	<	_	
132-6	22676-22681	0.005	_	
132-7	22681-22682	.	_	

#Text=Plots of Connectivity are scatter plots corresponding to individual connectivity at baseline in teal (estimated BAC: 0.0) and after infusion in salmon (BAC: 0.08); linear fit lines are also displayed for each timepoint.
133-1	22683-22688	Plots	_	
133-2	22689-22691	of	_	
133-3	22692-22704	Connectivity	_	
133-4	22705-22708	are	_	
133-5	22709-22716	scatter	_	
133-6	22717-22722	plots	_	
133-7	22723-22736	corresponding	_	
133-8	22737-22739	to	_	
133-9	22740-22750	individual	_	
133-10	22751-22763	connectivity	_	
133-11	22764-22766	at	_	
133-12	22767-22775	baseline	_	
133-13	22776-22778	in	_	
133-14	22779-22783	teal	_	
133-15	22784-22785	(	_	
133-16	22785-22794	estimated	_	
133-17	22795-22798	BAC	_	
133-18	22798-22799	:	_	
133-19	22800-22803	0.0	_	
133-20	22803-22804	)	_	
133-21	22805-22808	and	_	
133-22	22809-22814	after	_	
133-23	22815-22823	infusion	_	
133-24	22824-22826	in	_	
133-25	22827-22833	salmon	_	
133-26	22834-22835	(	_	
133-27	22835-22838	BAC	_	
133-28	22838-22839	:	_	
133-29	22840-22844	0.08	_	
133-30	22844-22845	)	_	
133-31	22845-22846	;	_	
133-32	22847-22853	linear	_	
133-33	22854-22857	fit	_	
133-34	22858-22863	lines	_	
133-35	22864-22867	are	_	
133-36	22868-22872	also	_	
133-37	22873-22882	displayed	_	
133-38	22883-22886	for	_	
133-39	22887-22891	each	_	
133-40	22892-22901	timepoint	_	
133-41	22901-22902	.	_	

#Text=The y-axis for both plots is the same; the x-axis reflects the number of drinks in the last 30 days (center plot) and the number of drinks in the last 30 days multiplied by impulsivity score on the UPPS Negative Urgency scale (right plot).
134-1	22903-22906	The	_	
134-2	22907-22913	y-axis	_	
134-3	22914-22917	for	_	
134-4	22918-22922	both	_	
134-5	22923-22928	plots	_	
134-6	22929-22931	is	_	
134-7	22932-22935	the	_	
134-8	22936-22940	same	_	
134-9	22940-22941	;	_	
134-10	22942-22945	the	_	
134-11	22946-22952	x-axis	_	
134-12	22953-22961	reflects	_	
134-13	22962-22965	the	_	
134-14	22966-22972	number	_	
134-15	22973-22975	of	_	
134-16	22976-22982	drinks	_	
134-17	22983-22985	in	_	
134-18	22986-22989	the	_	
134-19	22990-22994	last	_	
134-20	22995-22997	30	_	
134-21	22998-23002	days	_	
134-22	23003-23004	(	_	
134-23	23004-23010	center	_	
134-24	23011-23015	plot	_	
134-25	23015-23016	)	_	
134-26	23017-23020	and	_	
134-27	23021-23024	the	_	
134-28	23025-23031	number	_	
134-29	23032-23034	of	_	
134-30	23035-23041	drinks	_	
134-31	23042-23044	in	_	
134-32	23045-23048	the	_	
134-33	23049-23053	last	_	
134-34	23054-23056	30	_	
134-35	23057-23061	days	_	
134-36	23062-23072	multiplied	_	
134-37	23073-23075	by	_	
134-38	23076-23087	impulsivity	_	
134-39	23088-23093	score	_	
134-40	23094-23096	on	_	
134-41	23097-23100	the	_	
134-42	23101-23105	UPPS	_	
134-43	23106-23114	Negative	_	
134-44	23115-23122	Urgency	_	
134-45	23123-23128	scale	_	
134-46	23129-23130	(	_	
134-47	23130-23135	right	_	
134-48	23136-23140	plot	_	
134-49	23140-23141	)	_	
134-50	23141-23142	.	_	

#Text=Abbreviations as follows: L.
135-1	23143-23156	Abbreviations	_	
135-2	23157-23159	as	_	
135-3	23160-23167	follows	_	
135-4	23167-23168	:	_	
135-5	23169-23170	L	_	
135-6	23170-23171	.	_	

#Text=GPe- Left Globus Pallidus externus; Hipp.
136-1	23172-23175	GPe	_	
136-2	23175-23176	-	_	
136-3	23177-23181	Left	_	
136-4	23182-23188	Globus	_	
136-5	23189-23197	Pallidus	_	
136-6	23198-23206	externus	_	
136-7	23206-23207	;	_	
136-8	23208-23212	Hipp	_	
136-9	23212-23213	.	_	

#Text=/Amyg- Hippocampus/Amygdala cluster.
137-1	23213-23214	/	_	
137-2	23214-23218	Amyg	_	
137-3	23218-23219	-	_	
137-4	23220-23231	Hippocampus	_	
137-5	23231-23232	/	_	
137-6	23232-23240	Amygdala	_	
137-7	23241-23248	cluster	_	
137-8	23248-23249	.	_	

#Text=Associations between alcohol induced changes in GPe connectivity and drinking behaviors.
138-1	23250-23262	Associations	_	
138-2	23263-23270	between	_	
138-3	23271-23278	alcohol	_	
138-4	23279-23286	induced	_	
138-5	23287-23294	changes	_	
138-6	23295-23297	in	_	
138-7	23298-23301	GPe	_	
138-8	23302-23314	connectivity	_	
138-9	23315-23318	and	_	
138-10	23319-23327	drinking	_	
138-11	23328-23337	behaviors	_	
138-12	23337-23338	.	_	

#Text=DRINKING BEHAVIOR CORRELATIONS\t\tPeak\tCluster Size\tT\tp-FDR\tp-FWE\tAnatomical Labels\t \tx\ty\tz\t \tTimeline Followback\t\t\t\t\t\t\t\t\t \tRight GPe x 30 day drinking (Negative correlation)\t-42\t-16\t6\t100\t-6.04\t0.023\t0.014\tLeft Heschl’s Gyrus extending into the Insula, Central Operculum, Putamen\t \t42\t-20\t10\t83\t-4.96\t0.029\t0.036\tRight Heschl’s Gyrus into the Insula, Planum Temporale, Central/Parietal Operculum, Putamen\t \tRight GPe x 30 day drinking (Positive correlation)\t-12\t18\t-10\t98\t6.57\t0.008\t0.016\tLeft Subgenual Anterior Cingulate extending into the Accumbens\t \t6\t18\t-12\t75\t6.56\t0.015\t0.057\tRight Subgenual Anterior Cingulate extending into the Accumbens\t \tLeft GPe x 30 day drinking (Negative Correlation)\t-2\t50\t20\t142\t-6.01\t0.001\t0.001\tSuperior Frontal Gyrus extending into dorsal anterior cingulate\t \t-34\t28\t2\t72\t-6.01\t0.042\t0.062\tLeft Inferior Frontal Gyrus (pars triangularus) extending into Insula / Frontal Operculum\t \t-42\t-8\t-26\t66\t-6.14\t0.042\t0.089\tLeft Hippocampus / Amygdala\t \tRight GPe x Heavy drinking days (Negative Correlation)\t-36\t-22\t6\t147\t-6.08\t0.001\t0.001\tLeft Insula extending into Heschls Gyrus, Putamen, Pallidum, and Planum Temporale\t \t
#Text=The number of drinks consumed in the past 30 days was positively associated with alcohol-induced changes in connectivity between the right GPe and the bilateral subgenual cingulate extending into the basal ganglia.
139-1	23339-23347	DRINKING	_	
139-2	23348-23356	BEHAVIOR	_	
139-3	23357-23369	CORRELATIONS	_	
139-4	23371-23375	Peak	_	
139-5	23376-23383	Cluster	_	
139-6	23384-23388	Size	_	
139-7	23389-23390	T	_	
139-8	23391-23396	p-FDR	_	
139-9	23397-23402	p-FWE	_	
139-10	23403-23413	Anatomical	_	
139-11	23414-23420	Labels	_	
139-12	23423-23424	x	_	
139-13	23425-23426	y	_	
139-14	23427-23428	z	_	
139-15	23431-23439	Timeline	_	
139-16	23440-23450	Followback	_	
139-17	23461-23466	Right	_	
139-18	23467-23470	GPe	_	
139-19	23471-23472	x	_	
139-20	23473-23475	30	_	
139-21	23476-23479	day	_	
139-22	23480-23488	drinking	_	
139-23	23489-23490	(	_	
139-24	23490-23498	Negative	_	
139-25	23499-23510	correlation	_	
139-26	23510-23511	)	_	
139-27	23512-23513	-	_	
139-28	23513-23515	42	_	
139-29	23516-23517	-	_	
139-30	23517-23519	16	_	
139-31	23520-23521	6	_	
139-32	23522-23525	100	_	
139-33	23526-23527	-	_	
139-34	23527-23531	6.04	_	
139-35	23532-23537	0.023	_	
139-36	23538-23543	0.014	_	
139-37	23544-23548	Left	_	
139-38	23549-23555	Heschl	_	
139-39	23555-23556	’	_	
139-40	23556-23557	s	_	
139-41	23558-23563	Gyrus	_	
139-42	23564-23573	extending	_	
139-43	23574-23578	into	_	
139-44	23579-23582	the	_	
139-45	23583-23589	Insula	_	
139-46	23589-23590	,	_	
139-47	23591-23598	Central	_	
139-48	23599-23608	Operculum	_	
139-49	23608-23609	,	_	
139-50	23610-23617	Putamen	_	
139-51	23620-23622	42	_	
139-52	23623-23624	-	_	
139-53	23624-23626	20	_	
139-54	23627-23629	10	_	
139-55	23630-23632	83	_	
139-56	23633-23634	-	_	
139-57	23634-23638	4.96	_	
139-58	23639-23644	0.029	_	
139-59	23645-23650	0.036	_	
139-60	23651-23656	Right	_	
139-61	23657-23663	Heschl	_	
139-62	23663-23664	’	_	
139-63	23664-23665	s	_	
139-64	23666-23671	Gyrus	_	
139-65	23672-23676	into	_	
139-66	23677-23680	the	_	
139-67	23681-23687	Insula	_	
139-68	23687-23688	,	_	
139-69	23689-23695	Planum	_	
139-70	23696-23705	Temporale	_	
139-71	23705-23706	,	_	
139-72	23707-23714	Central	_	
139-73	23714-23715	/	_	
139-74	23715-23723	Parietal	_	
139-75	23724-23733	Operculum	_	
139-76	23733-23734	,	_	
139-77	23735-23742	Putamen	_	
139-78	23745-23750	Right	_	
139-79	23751-23754	GPe	_	
139-80	23755-23756	x	_	
139-81	23757-23759	30	_	
139-82	23760-23763	day	_	
139-83	23764-23772	drinking	_	
139-84	23773-23774	(	_	
139-85	23774-23782	Positive	_	
139-86	23783-23794	correlation	_	
139-87	23794-23795	)	_	
139-88	23796-23797	-	_	
139-89	23797-23799	12	_	
139-90	23800-23802	18	_	
139-91	23803-23804	-	_	
139-92	23804-23806	10	_	
139-93	23807-23809	98	_	
139-94	23810-23814	6.57	_	
139-95	23815-23820	0.008	_	
139-96	23821-23826	0.016	_	
139-97	23827-23831	Left	_	
139-98	23832-23841	Subgenual	_	
139-99	23842-23850	Anterior	_	
139-100	23851-23860	Cingulate	_	
139-101	23861-23870	extending	_	
139-102	23871-23875	into	_	
139-103	23876-23879	the	_	
139-104	23880-23889	Accumbens	_	
139-105	23892-23893	6	_	
139-106	23894-23896	18	_	
139-107	23897-23898	-	_	
139-108	23898-23900	12	_	
139-109	23901-23903	75	_	
139-110	23904-23908	6.56	_	
139-111	23909-23914	0.015	_	
139-112	23915-23920	0.057	_	
139-113	23921-23926	Right	_	
139-114	23927-23936	Subgenual	_	
139-115	23937-23945	Anterior	_	
139-116	23946-23955	Cingulate	_	
139-117	23956-23965	extending	_	
139-118	23966-23970	into	_	
139-119	23971-23974	the	_	
139-120	23975-23984	Accumbens	_	
139-121	23987-23991	Left	_	
139-122	23992-23995	GPe	_	
139-123	23996-23997	x	_	
139-124	23998-24000	30	_	
139-125	24001-24004	day	_	
139-126	24005-24013	drinking	_	
139-127	24014-24015	(	_	
139-128	24015-24023	Negative	_	
139-129	24024-24035	Correlation	_	
139-130	24035-24036	)	_	
139-131	24037-24038	-	_	
139-132	24038-24039	2	_	
139-133	24040-24042	50	_	
139-134	24043-24045	20	_	
139-135	24046-24049	142	_	
139-136	24050-24051	-	_	
139-137	24051-24055	6.01	_	
139-138	24056-24061	0.001	_	
139-139	24062-24067	0.001	_	
139-140	24068-24076	Superior	_	
139-141	24077-24084	Frontal	_	
139-142	24085-24090	Gyrus	_	
139-143	24091-24100	extending	_	
139-144	24101-24105	into	_	
139-145	24106-24112	dorsal	_	
139-146	24113-24121	anterior	_	
139-147	24122-24131	cingulate	_	
139-148	24134-24135	-	_	
139-149	24135-24137	34	_	
139-150	24138-24140	28	_	
139-151	24141-24142	2	_	
139-152	24143-24145	72	_	
139-153	24146-24147	-	_	
139-154	24147-24151	6.01	_	
139-155	24152-24157	0.042	_	
139-156	24158-24163	0.062	_	
139-157	24164-24168	Left	_	
139-158	24169-24177	Inferior	_	
139-159	24178-24185	Frontal	_	
139-160	24186-24191	Gyrus	_	
139-161	24192-24193	(	_	
139-162	24193-24197	pars	_	
139-163	24198-24210	triangularus	_	
139-164	24210-24211	)	_	
139-165	24212-24221	extending	_	
139-166	24222-24226	into	_	
139-167	24227-24233	Insula	_	
139-168	24234-24235	/	_	
139-169	24236-24243	Frontal	_	
139-170	24244-24253	Operculum	_	
139-171	24256-24257	-	_	
139-172	24257-24259	42	_	
139-173	24260-24261	-	_	
139-174	24261-24262	8	_	
139-175	24263-24264	-	_	
139-176	24264-24266	26	_	
139-177	24267-24269	66	_	
139-178	24270-24271	-	_	
139-179	24271-24275	6.14	_	
139-180	24276-24281	0.042	_	
139-181	24282-24287	0.089	_	
139-182	24288-24292	Left	_	
139-183	24293-24304	Hippocampus	_	
139-184	24305-24306	/	_	
139-185	24307-24315	Amygdala	_	
139-186	24318-24323	Right	_	
139-187	24324-24327	GPe	_	
139-188	24328-24329	x	_	
139-189	24330-24335	Heavy	_	
139-190	24336-24344	drinking	_	
139-191	24345-24349	days	_	
139-192	24350-24351	(	_	
139-193	24351-24359	Negative	_	
139-194	24360-24371	Correlation	_	
139-195	24371-24372	)	_	
139-196	24373-24374	-	_	
139-197	24374-24376	36	_	
139-198	24377-24378	-	_	
139-199	24378-24380	22	_	
139-200	24381-24382	6	_	
139-201	24383-24386	147	_	
139-202	24387-24388	-	_	
139-203	24388-24392	6.08	_	
139-204	24393-24398	0.001	_	
139-205	24399-24404	0.001	_	
139-206	24405-24409	Left	_	
139-207	24410-24416	Insula	_	
139-208	24417-24426	extending	_	
139-209	24427-24431	into	_	
139-210	24432-24439	Heschls	_	
139-211	24440-24445	Gyrus	_	
139-212	24445-24446	,	_	
139-213	24447-24454	Putamen	_	
139-214	24454-24455	,	_	
139-215	24456-24464	Pallidum	_	
139-216	24464-24465	,	_	
139-217	24466-24469	and	_	
139-218	24470-24476	Planum	_	
139-219	24477-24486	Temporale	_	
139-220	24490-24493	The	_	
139-221	24494-24500	number	_	
139-222	24501-24503	of	_	
139-223	24504-24510	drinks	_	
139-224	24511-24519	consumed	_	
139-225	24520-24522	in	_	
139-226	24523-24526	the	_	
139-227	24527-24531	past	_	
139-228	24532-24534	30	_	
139-229	24535-24539	days	_	
139-230	24540-24543	was	_	
139-231	24544-24554	positively	_	
139-232	24555-24565	associated	_	
139-233	24566-24570	with	_	
139-234	24571-24586	alcohol-induced	_	
139-235	24587-24594	changes	_	
139-236	24595-24597	in	_	
139-237	24598-24610	connectivity	_	
139-238	24611-24618	between	_	
139-239	24619-24622	the	_	
139-240	24623-24628	right	_	
139-241	24629-24632	GPe	_	
139-242	24633-24636	and	_	
139-243	24637-24640	the	_	
139-244	24641-24650	bilateral	_	
139-245	24651-24660	subgenual	_	
139-246	24661-24670	cingulate	_	
139-247	24671-24680	extending	_	
139-248	24681-24685	into	_	
139-249	24686-24689	the	_	
139-250	24690-24695	basal	_	
139-251	24696-24703	ganglia	_	
139-252	24703-24704	.	_	

#Text=The change was such that in individuals with more past 30 days drinking, alcohol increased connectivity; in individuals with less drinking, alcohol decreased connectivity.
140-1	24705-24708	The	_	
140-2	24709-24715	change	_	
140-3	24716-24719	was	_	
140-4	24720-24724	such	_	
140-5	24725-24729	that	_	
140-6	24730-24732	in	_	
140-7	24733-24744	individuals	_	
140-8	24745-24749	with	_	
140-9	24750-24754	more	_	
140-10	24755-24759	past	_	
140-11	24760-24762	30	_	
140-12	24763-24767	days	_	
140-13	24768-24776	drinking	_	
140-14	24776-24777	,	_	
140-15	24778-24785	alcohol	_	
140-16	24786-24795	increased	_	
140-17	24796-24808	connectivity	_	
140-18	24808-24809	;	_	
140-19	24810-24812	in	_	
140-20	24813-24824	individuals	_	
140-21	24825-24829	with	_	
140-22	24830-24834	less	_	
140-23	24835-24843	drinking	_	
140-24	24843-24844	,	_	
140-25	24845-24852	alcohol	_	
140-26	24853-24862	decreased	_	
140-27	24863-24875	connectivity	_	
140-28	24875-24876	.	_	

#Text=Total number of heavy drinking days
#Text=The total number of heavy drinking days was associated negatively with changes in right GPe connectivity with a left insula cluster extending into Heschl’s gyrus, putamen, pallidum and planum temporale, such that there were no drinking pattern related differences in connectivity at baseline; however, in individuals with fewer heavy drinking days but not those with more, alcohol infusion increased connectivity (Fig 4 and Table 4).
141-1	24877-24882	Total	_	
141-2	24883-24889	number	_	
141-3	24890-24892	of	_	
141-4	24893-24898	heavy	_	
141-5	24899-24907	drinking	_	
141-6	24908-24912	days	_	
141-7	24913-24916	The	_	
141-8	24917-24922	total	_	
141-9	24923-24929	number	_	
141-10	24930-24932	of	_	
141-11	24933-24938	heavy	_	
141-12	24939-24947	drinking	_	
141-13	24948-24952	days	_	
141-14	24953-24956	was	_	
141-15	24957-24967	associated	_	
141-16	24968-24978	negatively	_	
141-17	24979-24983	with	_	
141-18	24984-24991	changes	_	
141-19	24992-24994	in	_	
141-20	24995-25000	right	_	
141-21	25001-25004	GPe	_	
141-22	25005-25017	connectivity	_	
141-23	25018-25022	with	_	
141-24	25023-25024	a	_	
141-25	25025-25029	left	_	
141-26	25030-25036	insula	_	
141-27	25037-25044	cluster	_	
141-28	25045-25054	extending	_	
141-29	25055-25059	into	_	
141-30	25060-25066	Heschl	_	
141-31	25066-25067	’	_	
141-32	25067-25068	s	_	
141-33	25069-25074	gyrus	_	
141-34	25074-25075	,	_	
141-35	25076-25083	putamen	_	
141-36	25083-25084	,	_	
141-37	25085-25093	pallidum	_	
141-38	25094-25097	and	_	
141-39	25098-25104	planum	_	
141-40	25105-25114	temporale	_	
141-41	25114-25115	,	_	
141-42	25116-25120	such	_	
141-43	25121-25125	that	_	
141-44	25126-25131	there	_	
141-45	25132-25136	were	_	
141-46	25137-25139	no	_	
141-47	25140-25148	drinking	_	
141-48	25149-25156	pattern	_	
141-49	25157-25164	related	_	
141-50	25165-25176	differences	_	
141-51	25177-25179	in	_	
141-52	25180-25192	connectivity	_	
141-53	25193-25195	at	_	
141-54	25196-25204	baseline	_	
141-55	25204-25205	;	_	
141-56	25206-25213	however	_	
141-57	25213-25214	,	_	
141-58	25215-25217	in	_	
141-59	25218-25229	individuals	_	
141-60	25230-25234	with	_	
141-61	25235-25240	fewer	_	
141-62	25241-25246	heavy	_	
141-63	25247-25255	drinking	_	
141-64	25256-25260	days	_	
141-65	25261-25264	but	_	
141-66	25265-25268	not	_	
141-67	25269-25274	those	_	
141-68	25275-25279	with	_	
141-69	25280-25284	more	_	
141-70	25284-25285	,	_	
141-71	25286-25293	alcohol	_	
141-72	25294-25302	infusion	_	
141-73	25303-25312	increased	_	
141-74	25313-25325	connectivity	_	
141-75	25326-25327	(	_	
141-76	25327-25330	Fig	_	
141-77	25331-25332	4	_	
141-78	25333-25336	and	_	
141-79	25337-25342	Table	_	
141-80	25343-25344	4	_	
141-81	25344-25345	)	_	
141-82	25345-25346	.	_	

#Text=Association between heavy drinking days and alcohol induced changes in GPe connectivity.
142-1	25347-25358	Association	_	
142-2	25359-25366	between	_	
142-3	25367-25372	heavy	_	
142-4	25373-25381	drinking	_	
142-5	25382-25386	days	_	
142-6	25387-25390	and	_	
142-7	25391-25398	alcohol	_	
142-8	25399-25406	induced	_	
142-9	25407-25414	changes	_	
142-10	25415-25417	in	_	
142-11	25418-25421	GPe	_	
142-12	25422-25434	connectivity	_	
142-13	25434-25435	.	_	

#Text=(As measured by the Alcohol Timeline Followback).
143-1	25436-25437	(	_	
143-2	25437-25439	As	_	
143-3	25440-25448	measured	_	
143-4	25449-25451	by	_	
143-5	25452-25455	the	_	
143-6	25456-25463	Alcohol	_	
143-7	25464-25472	Timeline	_	
143-8	25473-25483	Followback	_	
143-9	25483-25484	)	_	
143-10	25484-25485	.	_	

#Text=Scatter plots correspond to individual connectivity at baseline in teal (estimated BAC: 0.0) and after infusion in salmon (BAC: 0.08); linear fit lines are also displayed for each timepoint.
144-1	25486-25493	Scatter	_	
144-2	25494-25499	plots	_	
144-3	25500-25510	correspond	_	
144-4	25511-25513	to	_	
144-5	25514-25524	individual	_	
144-6	25525-25537	connectivity	_	
144-7	25538-25540	at	_	
144-8	25541-25549	baseline	_	
144-9	25550-25552	in	_	
144-10	25553-25557	teal	_	
144-11	25558-25559	(	_	
144-12	25559-25568	estimated	_	
144-13	25569-25572	BAC	_	
144-14	25572-25573	:	_	
144-15	25574-25577	0.0	_	
144-16	25577-25578	)	_	
144-17	25579-25582	and	_	
144-18	25583-25588	after	_	
144-19	25589-25597	infusion	_	
144-20	25598-25600	in	_	
144-21	25601-25607	salmon	_	
144-22	25608-25609	(	_	
144-23	25609-25612	BAC	_	
144-24	25612-25613	:	_	
144-25	25614-25618	0.08	_	
144-26	25618-25619	)	_	
144-27	25619-25620	;	_	
144-28	25621-25627	linear	_	
144-29	25628-25631	fit	_	
144-30	25632-25637	lines	_	
144-31	25638-25641	are	_	
144-32	25642-25646	also	_	
144-33	25647-25656	displayed	_	
144-34	25657-25660	for	_	
144-35	25661-25665	each	_	
144-36	25666-25675	timepoint	_	
144-37	25675-25676	.	_	

#Text=Connectivity coefficient is the r (correlation value) between the signal in the right GPe seed and the coordinate indicated.
145-1	25677-25689	Connectivity	_	
145-2	25690-25701	coefficient	_	
145-3	25702-25704	is	_	
145-4	25705-25708	the	_	
145-5	25709-25710	r	_	
145-6	25711-25712	(	_	
145-7	25712-25723	correlation	_	
145-8	25724-25729	value	_	
145-9	25729-25730	)	_	
145-10	25731-25738	between	_	
145-11	25739-25742	the	_	
145-12	25743-25749	signal	_	
145-13	25750-25752	in	_	
145-14	25753-25756	the	_	
145-15	25757-25762	right	_	
145-16	25763-25766	GPe	_	
145-17	25767-25771	seed	_	
145-18	25772-25775	and	_	
145-19	25776-25779	the	_	
145-20	25780-25790	coordinate	_	
145-21	25791-25800	indicated	_	
145-22	25800-25801	.	_	

#Text=Brain images represent whole effects of drinks in past 30 days on alcohol induced change in functional connectivity (post-infusion connectivity > pre-infusion connectivity).
146-1	25802-25807	Brain	_	
146-2	25808-25814	images	_	
146-3	25815-25824	represent	_	
146-4	25825-25830	whole	_	
146-5	25831-25838	effects	_	
146-6	25839-25841	of	_	
146-7	25842-25848	drinks	_	
146-8	25849-25851	in	_	
146-9	25852-25856	past	_	
146-10	25857-25859	30	_	
146-11	25860-25864	days	_	
146-12	25865-25867	on	_	
146-13	25868-25875	alcohol	_	
146-14	25876-25883	induced	_	
146-15	25884-25890	change	_	
146-16	25891-25893	in	_	
146-17	25894-25904	functional	_	
146-18	25905-25917	connectivity	_	
146-19	25918-25919	(	_	
146-20	25919-25932	post-infusion	_	
146-21	25933-25945	connectivity	_	
146-22	25946-25947	>	_	
146-23	25948-25960	pre-infusion	_	
146-24	25961-25973	connectivity	_	
146-25	25973-25974	)	_	
146-26	25974-25975	.	_	

#Text=Warm colors indicate intoxication related increases in connectivity; cool colors indicated intoxication related decreases in connectivity.
147-1	25976-25980	Warm	_	
147-2	25981-25987	colors	_	
147-3	25988-25996	indicate	_	
147-4	25997-26009	intoxication	_	
147-5	26010-26017	related	_	
147-6	26018-26027	increases	_	
147-7	26028-26030	in	_	
147-8	26031-26043	connectivity	_	
147-9	26043-26044	;	_	
147-10	26045-26049	cool	_	
147-11	26050-26056	colors	_	
147-12	26057-26066	indicated	_	
147-13	26067-26079	intoxication	_	
147-14	26080-26087	related	_	
147-15	26088-26097	decreases	_	
147-16	26098-26100	in	_	
147-17	26101-26113	connectivity	_	
147-18	26113-26114	.	_	

#Text=Images shown at p < 0.005.
148-1	26115-26121	Images	_	
148-2	26122-26127	shown	_	
148-3	26128-26130	at	_	
148-4	26131-26132	p	_	
148-5	26133-26134	<	_	
148-6	26135-26140	0.005	_	
148-7	26140-26141	.	_	

#Text=Heavy Drinking Days as measured by the Alcohol Timeline Followback in the last 90 days.
149-1	26142-26147	Heavy	_	
149-2	26148-26156	Drinking	_	
149-3	26157-26161	Days	_	
149-4	26162-26164	as	_	
149-5	26165-26173	measured	_	
149-6	26174-26176	by	_	
149-7	26177-26180	the	_	
149-8	26181-26188	Alcohol	_	
149-9	26189-26197	Timeline	_	
149-10	26198-26208	Followback	_	
149-11	26209-26211	in	_	
149-12	26212-26215	the	_	
149-13	26216-26220	last	_	
149-14	26221-26223	90	_	
149-15	26224-26228	days	_	
149-16	26228-26229	.	_	

#Text=Abbreviations: R.GPe- Right Globus Pallidus Externus.
150-1	26230-26243	Abbreviations	_	
150-2	26243-26244	:	_	
150-3	26245-26250	R.GPe	_	
150-4	26250-26251	-	_	
150-5	26252-26257	Right	_	
150-6	26258-26264	Globus	_	
150-7	26265-26273	Pallidus	_	
150-8	26274-26282	Externus	_	
150-9	26282-26283	.	_	

#Text=Associations between alcohol induced changes in GPe connectivity and impulsivity measures.
151-1	26284-26296	Associations	_	
151-2	26297-26304	between	_	
151-3	26305-26312	alcohol	_	
151-4	26313-26320	induced	_	
151-5	26321-26328	changes	_	
151-6	26329-26331	in	_	
151-7	26332-26335	GPe	_	
151-8	26336-26348	connectivity	_	
151-9	26349-26352	and	_	
151-10	26353-26364	impulsivity	_	
151-11	26365-26373	measures	_	
151-12	26373-26374	.	_	

#Text=Peak\tCluster Size\tT\tp-FDR\tp-FWE\tAnatomical Labels\t \tx\ty\tz\t \tLeft GPe x UPPS -P Negative Urgency\t26\t-32\t52\t73\t6.12\t0.050\t0.060\tRight Postcentral Gyrus\t \tRight GPe x BIS Total\t0\t-24\t74\t96\t5.73\t0.021\t0.019\tPrecentral Gyrus (supplementary motor area)\t \t
#Text=Clusters represent positive correlations between alcohol induced changes in connectivity and impulsivity measures; BIS: Barrett Impulsivity Scale; UPPS-P: Impulsivity Scale
#Text=GPe connectivity and impulsivity
#Text=Measures of impulsivity (BIS-11, UPPS-P, DDT) were not correlated with subjective effects of alcohol infusion as measured by the DEQ.
152-1	26376-26380	Peak	_	
152-2	26381-26388	Cluster	_	
152-3	26389-26393	Size	_	
152-4	26394-26395	T	_	
152-5	26396-26401	p-FDR	_	
152-6	26402-26407	p-FWE	_	
152-7	26408-26418	Anatomical	_	
152-8	26419-26425	Labels	_	
152-9	26428-26429	x	_	
152-10	26430-26431	y	_	
152-11	26432-26433	z	_	
152-12	26436-26440	Left	_	
152-13	26441-26444	GPe	_	
152-14	26445-26446	x	_	
152-15	26447-26451	UPPS	_	
152-16	26452-26453	-	_	
152-17	26453-26454	P	_	
152-18	26455-26463	Negative	_	
152-19	26464-26471	Urgency	_	
152-20	26472-26474	26	_	
152-21	26475-26476	-	_	
152-22	26476-26478	32	_	
152-23	26479-26481	52	_	
152-24	26482-26484	73	_	
152-25	26485-26489	6.12	_	
152-26	26490-26495	0.050	_	
152-27	26496-26501	0.060	_	
152-28	26502-26507	Right	_	
152-29	26508-26519	Postcentral	_	
152-30	26520-26525	Gyrus	_	
152-31	26528-26533	Right	_	
152-32	26534-26537	GPe	_	
152-33	26538-26539	x	_	
152-34	26540-26543	BIS	_	
152-35	26544-26549	Total	_	
152-36	26550-26551	0	_	
152-37	26552-26553	-	_	
152-38	26553-26555	24	_	
152-39	26556-26558	74	_	
152-40	26559-26561	96	_	
152-41	26562-26566	5.73	_	
152-42	26567-26572	0.021	_	
152-43	26573-26578	0.019	_	
152-44	26579-26589	Precentral	_	
152-45	26590-26595	Gyrus	_	
152-46	26596-26597	(	_	
152-47	26597-26610	supplementary	_	
152-48	26611-26616	motor	_	
152-49	26617-26621	area	_	
152-50	26621-26622	)	_	
152-51	26626-26634	Clusters	_	
152-52	26635-26644	represent	_	
152-53	26645-26653	positive	_	
152-54	26654-26666	correlations	_	
152-55	26667-26674	between	_	
152-56	26675-26682	alcohol	_	
152-57	26683-26690	induced	_	
152-58	26691-26698	changes	_	
152-59	26699-26701	in	_	
152-60	26702-26714	connectivity	_	
152-61	26715-26718	and	_	
152-62	26719-26730	impulsivity	_	
152-63	26731-26739	measures	_	
152-64	26739-26740	;	_	
152-65	26741-26744	BIS	_	
152-66	26744-26745	:	_	
152-67	26746-26753	Barrett	_	
152-68	26754-26765	Impulsivity	_	
152-69	26766-26771	Scale	_	
152-70	26771-26772	;	_	
152-71	26773-26779	UPPS-P	_	
152-72	26779-26780	:	_	
152-73	26781-26792	Impulsivity	_	
152-74	26793-26798	Scale	_	
152-75	26799-26802	GPe	_	
152-76	26803-26815	connectivity	_	
152-77	26816-26819	and	_	
152-78	26820-26831	impulsivity	_	
152-79	26832-26840	Measures	_	
152-80	26841-26843	of	_	
152-81	26844-26855	impulsivity	_	
152-82	26856-26857	(	_	
152-83	26857-26860	BIS	_	
152-84	26860-26861	-	_	
152-85	26861-26863	11	_	
152-86	26863-26864	,	_	
152-87	26865-26871	UPPS-P	_	
152-88	26871-26872	,	_	
152-89	26873-26876	DDT	_	
152-90	26876-26877	)	_	
152-91	26878-26882	were	_	
152-92	26883-26886	not	_	
152-93	26887-26897	correlated	_	
152-94	26898-26902	with	_	
152-95	26903-26913	subjective	_	
152-96	26914-26921	effects	_	
152-97	26922-26924	of	_	
152-98	26925-26932	alcohol	_	
152-99	26933-26941	infusion	_	
152-100	26942-26944	as	_	
152-101	26945-26953	measured	_	
152-102	26954-26956	by	_	
152-103	26957-26960	the	_	
152-104	26961-26964	DEQ	_	
152-105	26964-26965	.	_	

#Text=Although we did examine both positive and negative associations, there were no significant negative associations between alcohol-induced GPe connectivity changes and impulsivity.
153-1	26966-26974	Although	_	
153-2	26975-26977	we	_	
153-3	26978-26981	did	_	
153-4	26982-26989	examine	_	
153-5	26990-26994	both	_	
153-6	26995-27003	positive	_	
153-7	27004-27007	and	_	
153-8	27008-27016	negative	_	
153-9	27017-27029	associations	_	
153-10	27029-27030	,	_	
153-11	27031-27036	there	_	
153-12	27037-27041	were	_	
153-13	27042-27044	no	_	
153-14	27045-27056	significant	_	
153-15	27057-27065	negative	_	
153-16	27066-27078	associations	_	
153-17	27079-27086	between	_	
153-18	27087-27102	alcohol-induced	_	
153-19	27103-27106	GPe	_	
153-20	27107-27119	connectivity	_	
153-21	27120-27127	changes	_	
153-22	27128-27131	and	_	
153-23	27132-27143	impulsivity	_	
153-24	27143-27144	.	_	

#Text=There were also no significant positive associations between alcohol-induced GPe connectivity changes and DDT.
154-1	27145-27150	There	_	
154-2	27151-27155	were	_	
154-3	27156-27160	also	_	
154-4	27161-27163	no	_	
154-5	27164-27175	significant	_	
154-6	27176-27184	positive	_	
154-7	27185-27197	associations	_	
154-8	27198-27205	between	_	
154-9	27206-27221	alcohol-induced	_	
154-10	27222-27225	GPe	_	
154-11	27226-27238	connectivity	_	
154-12	27239-27246	changes	_	
154-13	27247-27250	and	_	
154-14	27251-27254	DDT	_	
154-15	27254-27255	.	_	

#Text=Other findings reported below and in Table 4 and Fig 5.
155-1	27256-27261	Other	_	
155-2	27262-27270	findings	_	
155-3	27271-27279	reported	_	
155-4	27280-27285	below	_	
155-5	27286-27289	and	_	
155-6	27290-27292	in	_	
155-7	27293-27298	Table	_	
155-8	27299-27300	4	_	
155-9	27301-27304	and	_	
155-10	27305-27308	Fig	_	
155-11	27309-27310	5	_	
155-12	27310-27311	.	_	

#Text=Association between impulsivity measures and alcohol induced changes in GPe connectivity.
156-1	27312-27323	Association	_	
156-2	27324-27331	between	_	
156-3	27332-27343	impulsivity	_	
156-4	27344-27352	measures	_	
156-5	27353-27356	and	_	
156-6	27357-27364	alcohol	_	
156-7	27365-27372	induced	_	
156-8	27373-27380	changes	_	
156-9	27381-27383	in	_	
156-10	27384-27387	GPe	_	
156-11	27388-27400	connectivity	_	
156-12	27400-27401	.	_	

#Text=Scatter plots correspond to individual connectivity at baseline in teal (estimated BAC: 0.0) and after infusion in salmon (BAC: 0.08); linear fit lines are also displayed for each timepoint.
157-1	27402-27409	Scatter	_	
157-2	27410-27415	plots	_	
157-3	27416-27426	correspond	_	
157-4	27427-27429	to	_	
157-5	27430-27440	individual	_	
157-6	27441-27453	connectivity	_	
157-7	27454-27456	at	_	
157-8	27457-27465	baseline	_	
157-9	27466-27468	in	_	
157-10	27469-27473	teal	_	
157-11	27474-27475	(	_	
157-12	27475-27484	estimated	_	
157-13	27485-27488	BAC	_	
157-14	27488-27489	:	_	
157-15	27490-27493	0.0	_	
157-16	27493-27494	)	_	
157-17	27495-27498	and	_	
157-18	27499-27504	after	_	
157-19	27505-27513	infusion	_	
157-20	27514-27516	in	_	
157-21	27517-27523	salmon	_	
157-22	27524-27525	(	_	
157-23	27525-27528	BAC	_	
157-24	27528-27529	:	_	
157-25	27530-27534	0.08	_	
157-26	27534-27535	)	_	
157-27	27535-27536	;	_	
157-28	27537-27543	linear	_	
157-29	27544-27547	fit	_	
157-30	27548-27553	lines	_	
157-31	27554-27557	are	_	
157-32	27558-27562	also	_	
157-33	27563-27572	displayed	_	
157-34	27573-27576	for	_	
157-35	27577-27581	each	_	
157-36	27582-27591	timepoint	_	
157-37	27591-27592	.	_	

#Text=Connectivity coefficient is the r (correlation value) between the signal in the GPe seed and the coordinate indicated.
158-1	27593-27605	Connectivity	_	
158-2	27606-27617	coefficient	_	
158-3	27618-27620	is	_	
158-4	27621-27624	the	_	
158-5	27625-27626	r	_	
158-6	27627-27628	(	_	
158-7	27628-27639	correlation	_	
158-8	27640-27645	value	_	
158-9	27645-27646	)	_	
158-10	27647-27654	between	_	
158-11	27655-27658	the	_	
158-12	27659-27665	signal	_	
158-13	27666-27668	in	_	
158-14	27669-27672	the	_	
158-15	27673-27676	GPe	_	
158-16	27677-27681	seed	_	
158-17	27682-27685	and	_	
158-18	27686-27689	the	_	
158-19	27690-27700	coordinate	_	
158-20	27701-27710	indicated	_	
158-21	27710-27711	.	_	

#Text=Brain images represent whole brain effects of drinks in past 30 days on alcohol induced change in functional connectivity (post-infusion connectivity > pre-infusion connectivity).
159-1	27712-27717	Brain	_	
159-2	27718-27724	images	_	
159-3	27725-27734	represent	_	
159-4	27735-27740	whole	_	
159-5	27741-27746	brain	_	
159-6	27747-27754	effects	_	
159-7	27755-27757	of	_	
159-8	27758-27764	drinks	_	
159-9	27765-27767	in	_	
159-10	27768-27772	past	_	
159-11	27773-27775	30	_	
159-12	27776-27780	days	_	
159-13	27781-27783	on	_	
159-14	27784-27791	alcohol	_	
159-15	27792-27799	induced	_	
159-16	27800-27806	change	_	
159-17	27807-27809	in	_	
159-18	27810-27820	functional	_	
159-19	27821-27833	connectivity	_	
159-20	27834-27835	(	_	
159-21	27835-27848	post-infusion	_	
159-22	27849-27861	connectivity	_	
159-23	27862-27863	>	_	
159-24	27864-27876	pre-infusion	_	
159-25	27877-27889	connectivity	_	
159-26	27889-27890	)	_	
159-27	27890-27891	.	_	

#Text=Warm colors indicate intoxication related increases in connectivity.
160-1	27892-27896	Warm	_	
160-2	27897-27903	colors	_	
160-3	27904-27912	indicate	_	
160-4	27913-27925	intoxication	_	
160-5	27926-27933	related	_	
160-6	27934-27943	increases	_	
160-7	27944-27946	in	_	
160-8	27947-27959	connectivity	_	
160-9	27959-27960	.	_	

#Text=Images shown at p < 0.005.
161-1	27961-27967	Images	_	
161-2	27968-27973	shown	_	
161-3	27974-27976	at	_	
161-4	27977-27978	p	_	
161-5	27979-27980	<	_	
161-6	27981-27986	0.005	_	
161-7	27986-27987	.	_	

#Text=(left) Changes in connectivity plotted by total scores on the BIS (Barratt Impulsiveness Scale).
162-1	27988-27989	(	_	
162-2	27989-27993	left	_	
162-3	27993-27994	)	_	
162-4	27995-28002	Changes	_	
162-5	28003-28005	in	_	
162-6	28006-28018	connectivity	_	
162-7	28019-28026	plotted	_	
162-8	28027-28029	by	_	
162-9	28030-28035	total	_	
162-10	28036-28042	scores	_	
162-11	28043-28045	on	_	
162-12	28046-28049	the	_	
162-13	28050-28053	BIS	_	
162-14	28054-28055	(	_	
162-15	28055-28062	Barratt	_	
162-16	28063-28076	Impulsiveness	_	
162-17	28077-28082	Scale	_	
162-18	28082-28083	)	_	
162-19	28083-28084	.	_	

#Text=(right) Changes in connectivity plotted scores on the UPPS-P negative urgency subscale.
163-1	28085-28086	(	_	
163-2	28086-28091	right	_	
163-3	28091-28092	)	_	
163-4	28093-28100	Changes	_	
163-5	28101-28103	in	_	
163-6	28104-28116	connectivity	_	
163-7	28117-28124	plotted	_	
163-8	28125-28131	scores	_	
163-9	28132-28134	on	_	
163-10	28135-28138	the	_	
163-11	28139-28145	UPPS-P	_	
163-12	28146-28154	negative	_	
163-13	28155-28162	urgency	_	
163-14	28163-28171	subscale	_	
163-15	28171-28172	.	_	

#Text=Reported clusters of connectivity with GPe area correspond to the following regions: (left) Precentral gyrus / SMA (supplementary motor area).
164-1	28173-28181	Reported	_	
164-2	28182-28190	clusters	_	
164-3	28191-28193	of	_	
164-4	28194-28206	connectivity	_	
164-5	28207-28211	with	_	
164-6	28212-28215	GPe	_	
164-7	28216-28220	area	_	
164-8	28221-28231	correspond	_	
164-9	28232-28234	to	_	
164-10	28235-28238	the	_	
164-11	28239-28248	following	_	
164-12	28249-28256	regions	_	
164-13	28256-28257	:	_	
164-14	28258-28259	(	_	
164-15	28259-28263	left	_	
164-16	28263-28264	)	_	
164-17	28265-28275	Precentral	_	
164-18	28276-28281	gyrus	_	
164-19	28282-28283	/	_	
164-20	28284-28287	SMA	_	
164-21	28288-28289	(	_	
164-22	28289-28302	supplementary	_	
164-23	28303-28308	motor	_	
164-24	28309-28313	area	_	
164-25	28313-28314	)	_	
164-26	28314-28315	.	_	

#Text=Abbreviations: GPe- Globus Pallidus Externus; L.
165-1	28316-28329	Abbreviations	_	
165-2	28329-28330	:	_	
165-3	28331-28334	GPe	_	
165-4	28334-28335	-	_	
165-5	28336-28342	Globus	_	
165-6	28343-28351	Pallidus	_	
165-7	28352-28360	Externus	_	
165-8	28360-28361	;	_	
165-9	28362-28363	L	_	
165-10	28363-28364	.	_	

#Text=-Left; R.
166-1	28364-28365	-	_	
166-2	28365-28369	Left	_	
166-3	28369-28370	;	_	
166-4	28371-28372	R	_	
166-5	28372-28373	.	_	

#Text=-Right.
167-1	28373-28374	-	_	
167-2	28374-28379	Right	_	
167-3	28379-28380	.	_	

#Text=BIS-11 trait impulsivity
#Text=We found a significant positive association between BIS-11 total score and alcohol -induced connectivity change of right GPe with the precentral gyrus.
168-1	28381-28384	BIS	_	
168-2	28384-28385	-	_	
168-3	28385-28387	11	_	
168-4	28388-28393	trait	_	
168-5	28394-28405	impulsivity	_	
168-6	28406-28408	We	_	
168-7	28409-28414	found	_	
168-8	28415-28416	a	_	
168-9	28417-28428	significant	_	
168-10	28429-28437	positive	_	
168-11	28438-28449	association	_	
168-12	28450-28457	between	_	
168-13	28458-28461	BIS	_	
168-14	28461-28462	-	_	
168-15	28462-28464	11	_	
168-16	28465-28470	total	_	
168-17	28471-28476	score	_	
168-18	28477-28480	and	_	
168-19	28481-28488	alcohol	_	
168-20	28489-28490	-	_	
168-21	28490-28497	induced	_	
168-22	28498-28510	connectivity	_	
168-23	28511-28517	change	_	
168-24	28518-28520	of	_	
168-25	28521-28526	right	_	
168-26	28527-28530	GPe	_	
168-27	28531-28535	with	_	
168-28	28536-28539	the	_	
168-29	28540-28550	precentral	_	
168-30	28551-28556	gyrus	_	
168-31	28556-28557	.	_	

#Text=In other words, higher impulsivity score was associated with increased GPe functional connectivity while under the influence of alcohol; there was no association between impulsivity and connectivity with that cluster at baseline.
169-1	28558-28560	In	_	
169-2	28561-28566	other	_	
169-3	28567-28572	words	_	
169-4	28572-28573	,	_	
169-5	28574-28580	higher	_	
169-6	28581-28592	impulsivity	_	
169-7	28593-28598	score	_	
169-8	28599-28602	was	_	
169-9	28603-28613	associated	_	
169-10	28614-28618	with	_	
169-11	28619-28628	increased	_	
169-12	28629-28632	GPe	_	
169-13	28633-28643	functional	_	
169-14	28644-28656	connectivity	_	
169-15	28657-28662	while	_	
169-16	28663-28668	under	_	
169-17	28669-28672	the	_	
169-18	28673-28682	influence	_	
169-19	28683-28685	of	_	
169-20	28686-28693	alcohol	_	
169-21	28693-28694	;	_	
169-22	28695-28700	there	_	
169-23	28701-28704	was	_	
169-24	28705-28707	no	_	
169-25	28708-28719	association	_	
169-26	28720-28727	between	_	
169-27	28728-28739	impulsivity	_	
169-28	28740-28743	and	_	
169-29	28744-28756	connectivity	_	
169-30	28757-28761	with	_	
169-31	28762-28766	that	_	
169-32	28767-28774	cluster	_	
169-33	28775-28777	at	_	
169-34	28778-28786	baseline	_	
169-35	28786-28787	.	_	

#Text=Specific BIS sub-scores were not significantly related to change in connectivity.
170-1	28788-28796	Specific	_	
170-2	28797-28800	BIS	_	
170-3	28801-28811	sub-scores	_	
170-4	28812-28816	were	_	
170-5	28817-28820	not	_	
170-6	28821-28834	significantly	_	
170-7	28835-28842	related	_	
170-8	28843-28845	to	_	
170-9	28846-28852	change	_	
170-10	28853-28855	in	_	
170-11	28856-28868	connectivity	_	
170-12	28868-28869	.	_	

#Text=UPPS-P trait impulsivity
#Text=Tendency to display impulsive behaviors under strong negative emotions, as measured by the UPPS-P negative urgency score, was significantly positively associated with alcohol-induced connectivity changes between the left GPe and right postcentral gyri.
171-1	28870-28876	UPPS-P	_	
171-2	28877-28882	trait	_	
171-3	28883-28894	impulsivity	_	
171-4	28895-28903	Tendency	_	
171-5	28904-28906	to	_	
171-6	28907-28914	display	_	
171-7	28915-28924	impulsive	_	
171-8	28925-28934	behaviors	_	
171-9	28935-28940	under	_	
171-10	28941-28947	strong	_	
171-11	28948-28956	negative	_	
171-12	28957-28965	emotions	_	
171-13	28965-28966	,	_	
171-14	28967-28969	as	_	
171-15	28970-28978	measured	_	
171-16	28979-28981	by	_	
171-17	28982-28985	the	_	
171-18	28986-28992	UPPS-P	_	
171-19	28993-29001	negative	_	
171-20	29002-29009	urgency	_	
171-21	29010-29015	score	_	
171-22	29015-29016	,	_	
171-23	29017-29020	was	_	
171-24	29021-29034	significantly	_	
171-25	29035-29045	positively	_	
171-26	29046-29056	associated	_	
171-27	29057-29061	with	_	
171-28	29062-29077	alcohol-induced	_	
171-29	29078-29090	connectivity	_	
171-30	29091-29098	changes	_	
171-31	29099-29106	between	_	
171-32	29107-29110	the	_	
171-33	29111-29115	left	_	
171-34	29116-29119	GPe	_	
171-35	29120-29123	and	_	
171-36	29124-29129	right	_	
171-37	29130-29141	postcentral	_	
171-38	29142-29146	gyri	_	
171-39	29146-29147	.	_	

#Text=There was little association between impulsivity and connectivity under the influence of alcohol, but more impulsivity was associated with less connectivity at baseline.
172-1	29148-29153	There	_	
172-2	29154-29157	was	_	
172-3	29158-29164	little	_	
172-4	29165-29176	association	_	
172-5	29177-29184	between	_	
172-6	29185-29196	impulsivity	_	
172-7	29197-29200	and	_	
172-8	29201-29213	connectivity	_	
172-9	29214-29219	under	_	
172-10	29220-29223	the	_	
172-11	29224-29233	influence	_	
172-12	29234-29236	of	_	
172-13	29237-29244	alcohol	_	
172-14	29244-29245	,	_	
172-15	29246-29249	but	_	
172-16	29250-29254	more	_	
172-17	29255-29266	impulsivity	_	
172-18	29267-29270	was	_	
172-19	29271-29281	associated	_	
172-20	29282-29286	with	_	
172-21	29287-29291	less	_	
172-22	29292-29304	connectivity	_	
172-23	29305-29307	at	_	
172-24	29308-29316	baseline	_	
172-25	29316-29317	.	_	

#Text=Discussion
#Text=In this study, we examined the association between changes in GPe resting state connectivity following alcohol infusion with drinking history and impulsivity.
173-1	29318-29328	Discussion	_	
173-2	29329-29331	In	_	
173-3	29332-29336	this	_	
173-4	29337-29342	study	_	
173-5	29342-29343	,	_	
173-6	29344-29346	we	_	
173-7	29347-29355	examined	_	
173-8	29356-29359	the	_	
173-9	29360-29371	association	_	
173-10	29372-29379	between	_	
173-11	29380-29387	changes	_	
173-12	29388-29390	in	_	
173-13	29391-29394	GPe	_	
173-14	29395-29402	resting	_	
173-15	29403-29408	state	_	
173-16	29409-29421	connectivity	_	
173-17	29422-29431	following	_	
173-18	29432-29439	alcohol	_	
173-19	29440-29448	infusion	_	
173-20	29449-29453	with	_	
173-21	29454-29462	drinking	_	
173-22	29463-29470	history	_	
173-23	29471-29474	and	_	
173-24	29475-29486	impulsivity	_	
173-25	29486-29487	.	_	

#Text=Based on preclinical work finding alcohol alters neuronal firing in the GPe, and findings that the pathway is involved in response inhibition, we hypothesized that alcohol infusion would more greatly impact GPe functional connectivity in individuals with heavier drinking and more impulsivity.
174-1	29488-29493	Based	_	
174-2	29494-29496	on	_	
174-3	29497-29508	preclinical	_	
174-4	29509-29513	work	_	
174-5	29514-29521	finding	_	
174-6	29522-29529	alcohol	_	
174-7	29530-29536	alters	_	
174-8	29537-29545	neuronal	_	
174-9	29546-29552	firing	_	
174-10	29553-29555	in	_	
174-11	29556-29559	the	_	
174-12	29560-29563	GPe	_	
174-13	29563-29564	,	_	
174-14	29565-29568	and	_	
174-15	29569-29577	findings	_	
174-16	29578-29582	that	_	
174-17	29583-29586	the	_	
174-18	29587-29594	pathway	_	
174-19	29595-29597	is	_	
174-20	29598-29606	involved	_	
174-21	29607-29609	in	_	
174-22	29610-29618	response	_	
174-23	29619-29629	inhibition	_	
174-24	29629-29630	,	_	
174-25	29631-29633	we	_	
174-26	29634-29646	hypothesized	_	
174-27	29647-29651	that	_	
174-28	29652-29659	alcohol	_	
174-29	29660-29668	infusion	_	
174-30	29669-29674	would	_	
174-31	29675-29679	more	_	
174-32	29680-29687	greatly	_	
174-33	29688-29694	impact	_	
174-34	29695-29698	GPe	_	
174-35	29699-29709	functional	_	
174-36	29710-29722	connectivity	_	
174-37	29723-29725	in	_	
174-38	29726-29737	individuals	_	
174-39	29738-29742	with	_	
174-40	29743-29750	heavier	_	
174-41	29751-29759	drinking	_	
174-42	29760-29763	and	_	
174-43	29764-29768	more	_	
174-44	29769-29780	impulsivity	_	
174-45	29780-29781	.	_	

#Text=We also hypothesized that the interaction between recent drinking behaviors and impulsivity would contribute to alcohol-induced changes in GPe functional connectivity.
175-1	29782-29784	We	_	
175-2	29785-29789	also	_	
175-3	29790-29802	hypothesized	_	
175-4	29803-29807	that	_	
175-5	29808-29811	the	_	
175-6	29812-29823	interaction	_	
175-7	29824-29831	between	_	
175-8	29832-29838	recent	_	
175-9	29839-29847	drinking	_	
175-10	29848-29857	behaviors	_	
175-11	29858-29861	and	_	
175-12	29862-29873	impulsivity	_	
175-13	29874-29879	would	_	
175-14	29880-29890	contribute	_	
175-15	29891-29893	to	_	
175-16	29894-29909	alcohol-induced	_	
175-17	29910-29917	changes	_	
175-18	29918-29920	in	_	
175-19	29921-29924	GPe	_	
175-20	29925-29935	functional	_	
175-21	29936-29948	connectivity	_	
175-22	29948-29949	.	_	

#Text=We found reductions in connectivity between the GPe and some subregions of the brain following alcohol infusion in individuals with more drinking in the past 30 days and more heavy drinking days.
176-1	29950-29952	We	_	
176-2	29953-29958	found	_	
176-3	29959-29969	reductions	_	
176-4	29970-29972	in	_	
176-5	29973-29985	connectivity	_	
176-6	29986-29993	between	_	
176-7	29994-29997	the	_	
176-8	29998-30001	GPe	_	
176-9	30002-30005	and	_	
176-10	30006-30010	some	_	
176-11	30011-30021	subregions	_	
176-12	30022-30024	of	_	
176-13	30025-30028	the	_	
176-14	30029-30034	brain	_	
176-15	30035-30044	following	_	
176-16	30045-30052	alcohol	_	
176-17	30053-30061	infusion	_	
176-18	30062-30064	in	_	
176-19	30065-30076	individuals	_	
176-20	30077-30081	with	_	
176-21	30082-30086	more	_	
176-22	30087-30095	drinking	_	
176-23	30096-30098	in	_	
176-24	30099-30102	the	_	
176-25	30103-30107	past	_	
176-26	30108-30110	30	_	
176-27	30111-30115	days	_	
176-28	30116-30119	and	_	
176-29	30120-30124	more	_	
176-30	30125-30130	heavy	_	
176-31	30131-30139	drinking	_	
176-32	30140-30144	days	_	
176-33	30144-30145	.	_	

#Text=However, impulsivity was related to greater GPe connectivity while intoxicated.
177-1	30146-30153	However	_	
177-2	30153-30154	,	_	
177-3	30155-30166	impulsivity	_	
177-4	30167-30170	was	_	
177-5	30171-30178	related	_	
177-6	30179-30181	to	_	
177-7	30182-30189	greater	_	
177-8	30190-30193	GPe	_	
177-9	30194-30206	connectivity	_	
177-10	30207-30212	while	_	
177-11	30213-30224	intoxicated	_	
177-12	30224-30225	.	_	

#Text=Heavier recent drinking behaviors in combination with higher impulsivity were associated with greater alcohol-induced connectivity change between GPe and amygdala regions, but for most of our connectivity findings, the contribution of drinking and impulsivity were distinct.
178-1	30226-30233	Heavier	_	
178-2	30234-30240	recent	_	
178-3	30241-30249	drinking	_	
178-4	30250-30259	behaviors	_	
178-5	30260-30262	in	_	
178-6	30263-30274	combination	_	
178-7	30275-30279	with	_	
178-8	30280-30286	higher	_	
178-9	30287-30298	impulsivity	_	
178-10	30299-30303	were	_	
178-11	30304-30314	associated	_	
178-12	30315-30319	with	_	
178-13	30320-30327	greater	_	
178-14	30328-30343	alcohol-induced	_	
178-15	30344-30356	connectivity	_	
178-16	30357-30363	change	_	
178-17	30364-30371	between	_	
178-18	30372-30375	GPe	_	
178-19	30376-30379	and	_	
178-20	30380-30388	amygdala	_	
178-21	30389-30396	regions	_	
178-22	30396-30397	,	_	
178-23	30398-30401	but	_	
178-24	30402-30405	for	_	
178-25	30406-30410	most	_	
178-26	30411-30413	of	_	
178-27	30414-30417	our	_	
178-28	30418-30430	connectivity	_	
178-29	30431-30439	findings	_	
178-30	30439-30440	,	_	
178-31	30441-30444	the	_	
178-32	30445-30457	contribution	_	
178-33	30458-30460	of	_	
178-34	30461-30469	drinking	_	
178-35	30470-30473	and	_	
178-36	30474-30485	impulsivity	_	
178-37	30486-30490	were	_	
178-38	30491-30499	distinct	_	
178-39	30499-30500	.	_	

#Text=Together, our findings suggest that the relationship between GPe-related neuronal firing and alcohol-related impulsivity is more complicated than we previously anticipated.
179-1	30501-30509	Together	_	
179-2	30509-30510	,	_	
179-3	30511-30514	our	_	
179-4	30515-30523	findings	_	
179-5	30524-30531	suggest	_	
179-6	30532-30536	that	_	
179-7	30537-30540	the	_	
179-8	30541-30553	relationship	_	
179-9	30554-30561	between	_	
179-10	30562-30573	GPe-related	_	
179-11	30574-30582	neuronal	_	
179-12	30583-30589	firing	_	
179-13	30590-30593	and	_	
179-14	30594-30609	alcohol-related	_	
179-15	30610-30621	impulsivity	_	
179-16	30622-30624	is	_	
179-17	30625-30629	more	_	
179-18	30630-30641	complicated	_	
179-19	30642-30646	than	_	
179-20	30647-30649	we	_	
179-21	30650-30660	previously	_	
179-22	30661-30672	anticipated	_	
179-23	30672-30673	.	_	

#Text=As predicted, we found that heavier drinking individuals had pronounced changes in GPe connectivity with a frontal gyrus regions.
180-1	30674-30676	As	_	
180-2	30677-30686	predicted	_	
180-3	30686-30687	,	_	
180-4	30688-30690	we	_	
180-5	30691-30696	found	_	
180-6	30697-30701	that	_	
180-7	30702-30709	heavier	_	
180-8	30710-30718	drinking	_	
180-9	30719-30730	individuals	_	
180-10	30731-30734	had	_	
180-11	30735-30745	pronounced	_	
180-12	30746-30753	changes	_	
180-13	30754-30756	in	_	
180-14	30757-30760	GPe	_	
180-15	30761-30773	connectivity	_	
180-16	30774-30778	with	_	
180-17	30779-30780	a	_	
180-18	30781-30788	frontal	_	
180-19	30789-30794	gyrus	_	
180-20	30795-30802	regions	_	
180-21	30802-30803	.	_	

#Text=In these regions, individuals with patterns of heavy drinking had more coupling at baseline than individuals with lighter drinking patterns; in the binge infusion state, this association between heavy drinking history and GPe connectivity reversed.
181-1	30804-30806	In	_	
181-2	30807-30812	these	_	
181-3	30813-30820	regions	_	
181-4	30820-30821	,	_	
181-5	30822-30833	individuals	_	
181-6	30834-30838	with	_	
181-7	30839-30847	patterns	_	
181-8	30848-30850	of	_	
181-9	30851-30856	heavy	_	
181-10	30857-30865	drinking	_	
181-11	30866-30869	had	_	
181-12	30870-30874	more	_	
181-13	30875-30883	coupling	_	
181-14	30884-30886	at	_	
181-15	30887-30895	baseline	_	
181-16	30896-30900	than	_	
181-17	30901-30912	individuals	_	
181-18	30913-30917	with	_	
181-19	30918-30925	lighter	_	
181-20	30926-30934	drinking	_	
181-21	30935-30943	patterns	_	
181-22	30943-30944	;	_	
181-23	30945-30947	in	_	
181-24	30948-30951	the	_	
181-25	30952-30957	binge	_	
181-26	30958-30966	infusion	_	
181-27	30967-30972	state	_	
181-28	30972-30973	,	_	
181-29	30974-30978	this	_	
181-30	30979-30990	association	_	
181-31	30991-30998	between	_	
181-32	30999-31004	heavy	_	
181-33	31005-31013	drinking	_	
181-34	31014-31021	history	_	
181-35	31022-31025	and	_	
181-36	31026-31029	GPe	_	
181-37	31030-31042	connectivity	_	
181-38	31043-31051	reversed	_	
181-39	31051-31052	.	_	

#Text=The alcohol-induced reduction in GPe-frontal pathways in heavier drinkers, as opposed to increased coupling, may specifically reflect impairment of stop signaling.
182-1	31053-31056	The	_	
182-2	31057-31072	alcohol-induced	_	
182-3	31073-31082	reduction	_	
182-4	31083-31085	in	_	
182-5	31086-31097	GPe-frontal	_	
182-6	31098-31106	pathways	_	
182-7	31107-31109	in	_	
182-8	31110-31117	heavier	_	
182-9	31118-31126	drinkers	_	
182-10	31126-31127	,	_	
182-11	31128-31130	as	_	
182-12	31131-31138	opposed	_	
182-13	31139-31141	to	_	
182-14	31142-31151	increased	_	
182-15	31152-31160	coupling	_	
182-16	31160-31161	,	_	
182-17	31162-31165	may	_	
182-18	31166-31178	specifically	_	
182-19	31179-31186	reflect	_	
182-20	31187-31197	impairment	_	
182-21	31198-31200	of	_	
182-22	31201-31205	stop	_	
182-23	31206-31215	signaling	_	
182-24	31215-31216	.	_	

#Text=The inferior frontal gyrus (IFG) in particular has been demonstrated to control stop-signaling through the supplementary motor area, upstream from sub-cortical processes, possibly suggesting impaired behavioral inhibition or a shift towards reactive rather than proactive inhibition for individuals with more drinking.
183-1	31217-31220	The	_	
183-2	31221-31229	inferior	_	
183-3	31230-31237	frontal	_	
183-4	31238-31243	gyrus	_	
183-5	31244-31245	(	_	
183-6	31245-31248	IFG	_	
183-7	31248-31249	)	_	
183-8	31250-31252	in	_	
183-9	31253-31263	particular	_	
183-10	31264-31267	has	_	
183-11	31268-31272	been	_	
183-12	31273-31285	demonstrated	_	
183-13	31286-31288	to	_	
183-14	31289-31296	control	_	
183-15	31297-31311	stop-signaling	_	
183-16	31312-31319	through	_	
183-17	31320-31323	the	_	
183-18	31324-31337	supplementary	_	
183-19	31338-31343	motor	_	
183-20	31344-31348	area	_	
183-21	31348-31349	,	_	
183-22	31350-31358	upstream	_	
183-23	31359-31363	from	_	
183-24	31364-31376	sub-cortical	_	
183-25	31377-31386	processes	_	
183-26	31386-31387	,	_	
183-27	31388-31396	possibly	_	
183-28	31397-31407	suggesting	_	
183-29	31408-31416	impaired	_	
183-30	31417-31427	behavioral	_	
183-31	31428-31438	inhibition	_	
183-32	31439-31441	or	_	
183-33	31442-31443	a	_	
183-34	31444-31449	shift	_	
183-35	31450-31457	towards	_	
183-36	31458-31466	reactive	_	
183-37	31467-31473	rather	_	
183-38	31474-31478	than	_	
183-39	31479-31488	proactive	_	
183-40	31489-31499	inhibition	_	
183-41	31500-31503	for	_	
183-42	31504-31515	individuals	_	
183-43	31516-31520	with	_	
183-44	31521-31525	more	_	
183-45	31526-31534	drinking	_	
183-46	31534-31535	.	_	

#Text=This pattern may also reflect an alcohol sensitization effect in heavier drinkers, consistent with sensitization effects seen for other drugs of abuse, particularly in basal ganglia regions.
184-1	31536-31540	This	_	
184-2	31541-31548	pattern	_	
184-3	31549-31552	may	_	
184-4	31553-31557	also	_	
184-5	31558-31565	reflect	_	
184-6	31566-31568	an	_	
184-7	31569-31576	alcohol	_	
184-8	31577-31590	sensitization	_	
184-9	31591-31597	effect	_	
184-10	31598-31600	in	_	
184-11	31601-31608	heavier	_	
184-12	31609-31617	drinkers	_	
184-13	31617-31618	,	_	
184-14	31619-31629	consistent	_	
184-15	31630-31634	with	_	
184-16	31635-31648	sensitization	_	
184-17	31649-31656	effects	_	
184-18	31657-31661	seen	_	
184-19	31662-31665	for	_	
184-20	31666-31671	other	_	
184-21	31672-31677	drugs	_	
184-22	31678-31680	of	_	
184-23	31681-31686	abuse	_	
184-24	31686-31687	,	_	
184-25	31688-31700	particularly	_	
184-26	31701-31703	in	_	
184-27	31704-31709	basal	_	
184-28	31710-31717	ganglia	_	
184-29	31718-31725	regions	_	
184-30	31725-31726	.	_	

#Text=It is also notable that increased connectivity between the frontal gryus and the GPe at rest has also been seen in individuals with hepatic encephalopathy, a result of liver disease such as alcoholic cirrhosis.
185-1	31727-31729	It	_	
185-2	31730-31732	is	_	
185-3	31733-31737	also	_	
185-4	31738-31745	notable	_	
185-5	31746-31750	that	_	
185-6	31751-31760	increased	_	
185-7	31761-31773	connectivity	_	
185-8	31774-31781	between	_	
185-9	31782-31785	the	_	
185-10	31786-31793	frontal	_	
185-11	31794-31799	gryus	_	
185-12	31800-31803	and	_	
185-13	31804-31807	the	_	
185-14	31808-31811	GPe	_	
185-15	31812-31814	at	_	
185-16	31815-31819	rest	_	
185-17	31820-31823	has	_	
185-18	31824-31828	also	_	
185-19	31829-31833	been	_	
185-20	31834-31838	seen	_	
185-21	31839-31841	in	_	
185-22	31842-31853	individuals	_	
185-23	31854-31858	with	_	
185-24	31859-31866	hepatic	_	
185-25	31867-31881	encephalopathy	_	
185-26	31881-31882	,	_	
185-27	31883-31884	a	_	
185-28	31885-31891	result	_	
185-29	31892-31894	of	_	
185-30	31895-31900	liver	_	
185-31	31901-31908	disease	_	
185-32	31909-31913	such	_	
185-33	31914-31916	as	_	
185-34	31917-31926	alcoholic	_	
185-35	31927-31936	cirrhosis	_	
185-36	31936-31937	.	_	

#Text=Our new findings may suggest these previously observed baseline differences reflect a pre-disease vulnerability in heavier drinkers, or indeed that the effects of alcohol even at a non-problem level on the liver contributes to damage to this pathway.
186-1	31938-31941	Our	_	
186-2	31942-31945	new	_	
186-3	31946-31954	findings	_	
186-4	31955-31958	may	_	
186-5	31959-31966	suggest	_	
186-6	31967-31972	these	_	
186-7	31973-31983	previously	_	
186-8	31984-31992	observed	_	
186-9	31993-32001	baseline	_	
186-10	32002-32013	differences	_	
186-11	32014-32021	reflect	_	
186-12	32022-32023	a	_	
186-13	32024-32035	pre-disease	_	
186-14	32036-32049	vulnerability	_	
186-15	32050-32052	in	_	
186-16	32053-32060	heavier	_	
186-17	32061-32069	drinkers	_	
186-18	32069-32070	,	_	
186-19	32071-32073	or	_	
186-20	32074-32080	indeed	_	
186-21	32081-32085	that	_	
186-22	32086-32089	the	_	
186-23	32090-32097	effects	_	
186-24	32098-32100	of	_	
186-25	32101-32108	alcohol	_	
186-26	32109-32113	even	_	
186-27	32114-32116	at	_	
186-28	32117-32118	a	_	
186-29	32119-32130	non-problem	_	
186-30	32131-32136	level	_	
186-31	32137-32139	on	_	
186-32	32140-32143	the	_	
186-33	32144-32149	liver	_	
186-34	32150-32161	contributes	_	
186-35	32162-32164	to	_	
186-36	32165-32171	damage	_	
186-37	32172-32174	to	_	
186-38	32175-32179	this	_	
186-39	32180-32187	pathway	_	
186-40	32187-32188	.	_	

#Text=We also found that heavier drinking individuals had less change caused by alcohol infusion in connectivity between the GPe and dorsal ACC, superior frontal gyrus, and insula regions.
187-1	32189-32191	We	_	
187-2	32192-32196	also	_	
187-3	32197-32202	found	_	
187-4	32203-32207	that	_	
187-5	32208-32215	heavier	_	
187-6	32216-32224	drinking	_	
187-7	32225-32236	individuals	_	
187-8	32237-32240	had	_	
187-9	32241-32245	less	_	
187-10	32246-32252	change	_	
187-11	32253-32259	caused	_	
187-12	32260-32262	by	_	
187-13	32263-32270	alcohol	_	
187-14	32271-32279	infusion	_	
187-15	32280-32282	in	_	
187-16	32283-32295	connectivity	_	
187-17	32296-32303	between	_	
187-18	32304-32307	the	_	
187-19	32308-32311	GPe	_	
187-20	32312-32315	and	_	
187-21	32316-32322	dorsal	_	
187-22	32323-32326	ACC	_	
187-23	32326-32327	,	_	
187-24	32328-32336	superior	_	
187-25	32337-32344	frontal	_	
187-26	32345-32350	gyrus	_	
187-27	32350-32351	,	_	
187-28	32352-32355	and	_	
187-29	32356-32362	insula	_	
187-30	32363-32370	regions	_	
187-31	32370-32371	.	_	

#Text=In fact, while alcohol decreased GPe connectivity with these regions in individuals with more recent drinking, the effect was reverse for those with less drinking.
188-1	32372-32374	In	_	
188-2	32375-32379	fact	_	
188-3	32379-32380	,	_	
188-4	32381-32386	while	_	
188-5	32387-32394	alcohol	_	
188-6	32395-32404	decreased	_	
188-7	32405-32408	GPe	_	
188-8	32409-32421	connectivity	_	
188-9	32422-32426	with	_	
188-10	32427-32432	these	_	
188-11	32433-32440	regions	_	
188-12	32441-32443	in	_	
188-13	32444-32455	individuals	_	
188-14	32456-32460	with	_	
188-15	32461-32465	more	_	
188-16	32466-32472	recent	_	
188-17	32473-32481	drinking	_	
188-18	32481-32482	,	_	
188-19	32483-32486	the	_	
188-20	32487-32493	effect	_	
188-21	32494-32497	was	_	
188-22	32498-32505	reverse	_	
188-23	32506-32509	for	_	
188-24	32510-32515	those	_	
188-25	32516-32520	with	_	
188-26	32521-32525	less	_	
188-27	32526-32534	drinking	_	
188-28	32534-32535	.	_	

#Text=These regions are thought to play a role in signaling unsuccessful stopping, particularly in cases where errors are less common.
189-1	32536-32541	These	_	
189-2	32542-32549	regions	_	
189-3	32550-32553	are	_	
189-4	32554-32561	thought	_	
189-5	32562-32564	to	_	
189-6	32565-32569	play	_	
189-7	32570-32571	a	_	
189-8	32572-32576	role	_	
189-9	32577-32579	in	_	
189-10	32580-32589	signaling	_	
189-11	32590-32602	unsuccessful	_	
189-12	32603-32611	stopping	_	
189-13	32611-32612	,	_	
189-14	32613-32625	particularly	_	
189-15	32626-32628	in	_	
189-16	32629-32634	cases	_	
189-17	32635-32640	where	_	
189-18	32641-32647	errors	_	
189-19	32648-32651	are	_	
189-20	32652-32656	less	_	
189-21	32657-32663	common	_	
189-22	32663-32664	.	_	

#Text=Intoxication-related changes in connectivity between this region and the GPe in individuals with less recent drinking may reflect novelty of failures in stop-signaling.
190-1	32665-32685	Intoxication-related	_	
190-2	32686-32693	changes	_	
190-3	32694-32696	in	_	
190-4	32697-32709	connectivity	_	
190-5	32710-32717	between	_	
190-6	32718-32722	this	_	
190-7	32723-32729	region	_	
190-8	32730-32733	and	_	
190-9	32734-32737	the	_	
190-10	32738-32741	GPe	_	
190-11	32742-32744	in	_	
190-12	32745-32756	individuals	_	
190-13	32757-32761	with	_	
190-14	32762-32766	less	_	
190-15	32767-32773	recent	_	
190-16	32774-32782	drinking	_	
190-17	32783-32786	may	_	
190-18	32787-32794	reflect	_	
190-19	32795-32802	novelty	_	
190-20	32803-32805	of	_	
190-21	32806-32814	failures	_	
190-22	32815-32817	in	_	
190-23	32818-32832	stop-signaling	_	
190-24	32832-32833	.	_	

#Text=Individuals who drink more may expect failures of stop-signaling during intoxication, as opposed to those with infrequent drinking.
191-1	32834-32845	Individuals	_	
191-2	32846-32849	who	_	
191-3	32850-32855	drink	_	
191-4	32856-32860	more	_	
191-5	32861-32864	may	_	
191-6	32865-32871	expect	_	
191-7	32872-32880	failures	_	
191-8	32881-32883	of	_	
191-9	32884-32898	stop-signaling	_	
191-10	32899-32905	during	_	
191-11	32906-32918	intoxication	_	
191-12	32918-32919	,	_	
191-13	32920-32922	as	_	
191-14	32923-32930	opposed	_	
191-15	32931-32933	to	_	
191-16	32934-32939	those	_	
191-17	32940-32944	with	_	
191-18	32945-32955	infrequent	_	
191-19	32956-32964	drinking	_	
191-20	32964-32965	.	_	

#Text=A lack of baseline association between recent drinks and error feedback in the right insula is consistent with lack of differences in expectation of low-frequency errors at baseline.
192-1	32966-32967	A	_	
192-2	32968-32972	lack	_	
192-3	32973-32975	of	_	
192-4	32976-32984	baseline	_	
192-5	32985-32996	association	_	
192-6	32997-33004	between	_	
192-7	33005-33011	recent	_	
192-8	33012-33018	drinks	_	
192-9	33019-33022	and	_	
192-10	33023-33028	error	_	
192-11	33029-33037	feedback	_	
192-12	33038-33040	in	_	
192-13	33041-33044	the	_	
192-14	33045-33050	right	_	
192-15	33051-33057	insula	_	
192-16	33058-33060	is	_	
192-17	33061-33071	consistent	_	
192-18	33072-33076	with	_	
192-19	33077-33081	lack	_	
192-20	33082-33084	of	_	
192-21	33085-33096	differences	_	
192-22	33097-33099	in	_	
192-23	33100-33111	expectation	_	
192-24	33112-33114	of	_	
192-25	33115-33128	low-frequency	_	
192-26	33129-33135	errors	_	
192-27	33136-33138	at	_	
192-28	33139-33147	baseline	_	
192-29	33147-33148	.	_	

#Text=Alternatively, during intoxication, less stop-signaling could correspond to less failures, leading to a reduced need for error signaling.
193-1	33149-33162	Alternatively	_	
193-2	33162-33163	,	_	
193-3	33164-33170	during	_	
193-4	33171-33183	intoxication	_	
193-5	33183-33184	,	_	
193-6	33185-33189	less	_	
193-7	33190-33204	stop-signaling	_	
193-8	33205-33210	could	_	
193-9	33211-33221	correspond	_	
193-10	33222-33224	to	_	
193-11	33225-33229	less	_	
193-12	33230-33238	failures	_	
193-13	33238-33239	,	_	
193-14	33240-33247	leading	_	
193-15	33248-33250	to	_	
193-16	33251-33252	a	_	
193-17	33253-33260	reduced	_	
193-18	33261-33265	need	_	
193-19	33266-33269	for	_	
193-20	33270-33275	error	_	
193-21	33276-33285	signaling	_	
193-22	33285-33286	.	_	

#Text=However, there may be other explanations; the insula in particular is a heterogeneous structure involved in a variety of functions.
194-1	33287-33294	However	_	
194-2	33294-33295	,	_	
194-3	33296-33301	there	_	
194-4	33302-33305	may	_	
194-5	33306-33308	be	_	
194-6	33309-33314	other	_	
194-7	33315-33327	explanations	_	
194-8	33327-33328	;	_	
194-9	33329-33332	the	_	
194-10	33333-33339	insula	_	
194-11	33340-33342	in	_	
194-12	33343-33353	particular	_	
194-13	33354-33356	is	_	
194-14	33357-33358	a	_	
194-15	33359-33372	heterogeneous	_	
194-16	33373-33382	structure	_	
194-17	33383-33391	involved	_	
194-18	33392-33394	in	_	
194-19	33395-33396	a	_	
194-20	33397-33404	variety	_	
194-21	33405-33407	of	_	
194-22	33408-33417	functions	_	
194-23	33417-33418	.	_	

#Text=For example, Feng and colleagues suggest reductions in spontaneous activity in this posterior insula structure reflect input of emotional state feedback during fear memory consolidation.
195-1	33419-33422	For	_	
195-2	33423-33430	example	_	
195-3	33430-33431	,	_	
195-4	33432-33436	Feng	_	
195-5	33437-33440	and	_	
195-6	33441-33451	colleagues	_	
195-7	33452-33459	suggest	_	
195-8	33460-33470	reductions	_	
195-9	33471-33473	in	_	
195-10	33474-33485	spontaneous	_	
195-11	33486-33494	activity	_	
195-12	33495-33497	in	_	
195-13	33498-33502	this	_	
195-14	33503-33512	posterior	_	
195-15	33513-33519	insula	_	
195-16	33520-33529	structure	_	
195-17	33530-33537	reflect	_	
195-18	33538-33543	input	_	
195-19	33544-33546	of	_	
195-20	33547-33556	emotional	_	
195-21	33557-33562	state	_	
195-22	33563-33571	feedback	_	
195-23	33572-33578	during	_	
195-24	33579-33583	fear	_	
195-25	33584-33590	memory	_	
195-26	33591-33604	consolidation	_	
195-27	33604-33605	.	_	

#Text=From that perspective, one might interpret our results to mean that in individuals with less recent drinking, alcohol decreases the integration of emotional state feedback into behavior.
196-1	33606-33610	From	_	
196-2	33611-33615	that	_	
196-3	33616-33627	perspective	_	
196-4	33627-33628	,	_	
196-5	33629-33632	one	_	
196-6	33633-33638	might	_	
196-7	33639-33648	interpret	_	
196-8	33649-33652	our	_	
196-9	33653-33660	results	_	
196-10	33661-33663	to	_	
196-11	33664-33668	mean	_	
196-12	33669-33673	that	_	
196-13	33674-33676	in	_	
196-14	33677-33688	individuals	_	
196-15	33689-33693	with	_	
196-16	33694-33698	less	_	
196-17	33699-33705	recent	_	
196-18	33706-33714	drinking	_	
196-19	33714-33715	,	_	
196-20	33716-33723	alcohol	_	
196-21	33724-33733	decreases	_	
196-22	33734-33737	the	_	
196-23	33738-33749	integration	_	
196-24	33750-33752	of	_	
196-25	33753-33762	emotional	_	
196-26	33763-33768	state	_	
196-27	33769-33777	feedback	_	
196-28	33778-33782	into	_	
196-29	33783-33791	behavior	_	
196-30	33791-33792	.	_	

#Text=On the other hand, we found that alcohol increased subgenual ACC-GPe connectivity in individuals with more recent drinking.
197-1	33793-33795	On	_	
197-2	33796-33799	the	_	
197-3	33800-33805	other	_	
197-4	33806-33810	hand	_	
197-5	33810-33811	,	_	
197-6	33812-33814	we	_	
197-7	33815-33820	found	_	
197-8	33821-33825	that	_	
197-9	33826-33833	alcohol	_	
197-10	33834-33843	increased	_	
197-11	33844-33853	subgenual	_	
197-12	33854-33861	ACC-GPe	_	
197-13	33862-33874	connectivity	_	
197-14	33875-33877	in	_	
197-15	33878-33889	individuals	_	
197-16	33890-33894	with	_	
197-17	33895-33899	more	_	
197-18	33900-33906	recent	_	
197-19	33907-33915	drinking	_	
197-20	33915-33916	.	_	

#Text=This pathway may be involved in reward-driven overrides of the stop-signal.
198-1	33917-33921	This	_	
198-2	33922-33929	pathway	_	
198-3	33930-33933	may	_	
198-4	33934-33936	be	_	
198-5	33937-33945	involved	_	
198-6	33946-33948	in	_	
198-7	33949-33962	reward-driven	_	
198-8	33963-33972	overrides	_	
198-9	33973-33975	of	_	
198-10	33976-33979	the	_	
198-11	33980-33991	stop-signal	_	
198-12	33991-33992	.	_	

#Text=Greater coupling of ACC-GPe at baseline may lead to a greater tendency to override the stop-signal in face of drinking; this would likely be more pronounced in individuals with positive experiences with alcohol, such as light social drinking, or from the rewarding nature of novelty.
199-1	33993-34000	Greater	_	
199-2	34001-34009	coupling	_	
199-3	34010-34012	of	_	
199-4	34013-34020	ACC-GPe	_	
199-5	34021-34023	at	_	
199-6	34024-34032	baseline	_	
199-7	34033-34036	may	_	
199-8	34037-34041	lead	_	
199-9	34042-34044	to	_	
199-10	34045-34046	a	_	
199-11	34047-34054	greater	_	
199-12	34055-34063	tendency	_	
199-13	34064-34066	to	_	
199-14	34067-34075	override	_	
199-15	34076-34079	the	_	
199-16	34080-34091	stop-signal	_	
199-17	34092-34094	in	_	
199-18	34095-34099	face	_	
199-19	34100-34102	of	_	
199-20	34103-34111	drinking	_	
199-21	34111-34112	;	_	
199-22	34113-34117	this	_	
199-23	34118-34123	would	_	
199-24	34124-34130	likely	_	
199-25	34131-34133	be	_	
199-26	34134-34138	more	_	
199-27	34139-34149	pronounced	_	
199-28	34150-34152	in	_	
199-29	34153-34164	individuals	_	
199-30	34165-34169	with	_	
199-31	34170-34178	positive	_	
199-32	34179-34190	experiences	_	
199-33	34191-34195	with	_	
199-34	34196-34203	alcohol	_	
199-35	34203-34204	,	_	
199-36	34205-34209	such	_	
199-37	34210-34212	as	_	
199-38	34213-34218	light	_	
199-39	34219-34225	social	_	
199-40	34226-34234	drinking	_	
199-41	34234-34235	,	_	
199-42	34236-34238	or	_	
199-43	34239-34243	from	_	
199-44	34244-34247	the	_	
199-45	34248-34257	rewarding	_	
199-46	34258-34264	nature	_	
199-47	34265-34267	of	_	
199-48	34268-34275	novelty	_	
199-49	34275-34276	.	_	

#Text=However, this override would be less necessary when the impulse control pathways are working sub-optimally and sending less stop-signals, such as during intoxication.
200-1	34277-34284	However	_	
200-2	34284-34285	,	_	
200-3	34286-34290	this	_	
200-4	34291-34299	override	_	
200-5	34300-34305	would	_	
200-6	34306-34308	be	_	
200-7	34309-34313	less	_	
200-8	34314-34323	necessary	_	
200-9	34324-34328	when	_	
200-10	34329-34332	the	_	
200-11	34333-34340	impulse	_	
200-12	34341-34348	control	_	
200-13	34349-34357	pathways	_	
200-14	34358-34361	are	_	
200-15	34362-34369	working	_	
200-16	34370-34383	sub-optimally	_	
200-17	34384-34387	and	_	
200-18	34388-34395	sending	_	
200-19	34396-34400	less	_	
200-20	34401-34413	stop-signals	_	
200-21	34413-34414	,	_	
200-22	34415-34419	such	_	
200-23	34420-34422	as	_	
200-24	34423-34429	during	_	
200-25	34430-34442	intoxication	_	
200-26	34442-34443	.	_	

#Text=Alcohol intoxication may also serve to reduce inhibition via increased connectivity to this override; our results may suggest alcohol has a reward heightening effect in individuals with more recent drinking but a dampening effect in lighter drinkers.
201-1	34444-34451	Alcohol	_	
201-2	34452-34464	intoxication	_	
201-3	34465-34468	may	_	
201-4	34469-34473	also	_	
201-5	34474-34479	serve	_	
201-6	34480-34482	to	_	
201-7	34483-34489	reduce	_	
201-8	34490-34500	inhibition	_	
201-9	34501-34504	via	_	
201-10	34505-34514	increased	_	
201-11	34515-34527	connectivity	_	
201-12	34528-34530	to	_	
201-13	34531-34535	this	_	
201-14	34536-34544	override	_	
201-15	34544-34545	;	_	
201-16	34546-34549	our	_	
201-17	34550-34557	results	_	
201-18	34558-34561	may	_	
201-19	34562-34569	suggest	_	
201-20	34570-34577	alcohol	_	
201-21	34578-34581	has	_	
201-22	34582-34583	a	_	
201-23	34584-34590	reward	_	
201-24	34591-34602	heightening	_	
201-25	34603-34609	effect	_	
201-26	34610-34612	in	_	
201-27	34613-34624	individuals	_	
201-28	34625-34629	with	_	
201-29	34630-34634	more	_	
201-30	34635-34641	recent	_	
201-31	34642-34650	drinking	_	
201-32	34651-34654	but	_	
201-33	34655-34656	a	_	
201-34	34657-34666	dampening	_	
201-35	34667-34673	effect	_	
201-36	34674-34676	in	_	
201-37	34677-34684	lighter	_	
201-38	34685-34693	drinkers	_	
201-39	34693-34694	.	_	

#Text=This fronto-striatal circuit has also been described as subserving development of cognitive and motor behavioral plans; an alternative explanation for our findings, then, given baseline decoupling in individuals with more recent drinking, could be a general deficit in action planning.
202-1	34695-34699	This	_	
202-2	34700-34715	fronto-striatal	_	
202-3	34716-34723	circuit	_	
202-4	34724-34727	has	_	
202-5	34728-34732	also	_	
202-6	34733-34737	been	_	
202-7	34738-34747	described	_	
202-8	34748-34750	as	_	
202-9	34751-34761	subserving	_	
202-10	34762-34773	development	_	
202-11	34774-34776	of	_	
202-12	34777-34786	cognitive	_	
202-13	34787-34790	and	_	
202-14	34791-34796	motor	_	
202-15	34797-34807	behavioral	_	
202-16	34808-34813	plans	_	
202-17	34813-34814	;	_	
202-18	34815-34817	an	_	
202-19	34818-34829	alternative	_	
202-20	34830-34841	explanation	_	
202-21	34842-34845	for	_	
202-22	34846-34849	our	_	
202-23	34850-34858	findings	_	
202-24	34858-34859	,	_	
202-25	34860-34864	then	_	
202-26	34864-34865	,	_	
202-27	34866-34871	given	_	
202-28	34872-34880	baseline	_	
202-29	34881-34891	decoupling	_	
202-30	34892-34894	in	_	
202-31	34895-34906	individuals	_	
202-32	34907-34911	with	_	
202-33	34912-34916	more	_	
202-34	34917-34923	recent	_	
202-35	34924-34932	drinking	_	
202-36	34932-34933	,	_	
202-37	34934-34939	could	_	
202-38	34940-34942	be	_	
202-39	34943-34944	a	_	
202-40	34945-34952	general	_	
202-41	34953-34960	deficit	_	
202-42	34961-34963	in	_	
202-43	34964-34970	action	_	
202-44	34971-34979	planning	_	
202-45	34979-34980	.	_	

#Text=However, it is difficult to determine if lower baseline GPe connectivity is caused by heavy drinking or if it is a vulnerability factor that leads to heavy drinking.
203-1	34981-34988	However	_	
203-2	34988-34989	,	_	
203-3	34990-34992	it	_	
203-4	34993-34995	is	_	
203-5	34996-35005	difficult	_	
203-6	35006-35008	to	_	
203-7	35009-35018	determine	_	
203-8	35019-35021	if	_	
203-9	35022-35027	lower	_	
203-10	35028-35036	baseline	_	
203-11	35037-35040	GPe	_	
203-12	35041-35053	connectivity	_	
203-13	35054-35056	is	_	
203-14	35057-35063	caused	_	
203-15	35064-35066	by	_	
203-16	35067-35072	heavy	_	
203-17	35073-35081	drinking	_	
203-18	35082-35084	or	_	
203-19	35085-35087	if	_	
203-20	35088-35090	it	_	
203-21	35091-35093	is	_	
203-22	35094-35095	a	_	
203-23	35096-35109	vulnerability	_	
203-24	35110-35116	factor	_	
203-25	35117-35121	that	_	
203-26	35122-35127	leads	_	
203-27	35128-35130	to	_	
203-28	35131-35136	heavy	_	
203-29	35137-35145	drinking	_	
203-30	35145-35146	.	_	

#Text=It may be that individuals with lower GPe-ACC connectivity are more vulnerable to engaging in heavy drinking episodes.
204-1	35147-35149	It	_	
204-2	35150-35153	may	_	
204-3	35154-35156	be	_	
204-4	35157-35161	that	_	
204-5	35162-35173	individuals	_	
204-6	35174-35178	with	_	
204-7	35179-35184	lower	_	
204-8	35185-35192	GPe-ACC	_	
204-9	35193-35205	connectivity	_	
204-10	35206-35209	are	_	
204-11	35210-35214	more	_	
204-12	35215-35225	vulnerable	_	
204-13	35226-35228	to	_	
204-14	35229-35237	engaging	_	
204-15	35238-35240	in	_	
204-16	35241-35246	heavy	_	
204-17	35247-35255	drinking	_	
204-18	35256-35264	episodes	_	
204-19	35264-35265	.	_	

#Text=Another possibility is that drinking, even at a social level, has lasting effects on resting thresholds of GPe connectivity; for example, some work has shown that alcohol leads to hyperactive IFG response during stop-signaling.
205-1	35266-35273	Another	_	
205-2	35274-35285	possibility	_	
205-3	35286-35288	is	_	
205-4	35289-35293	that	_	
205-5	35294-35302	drinking	_	
205-6	35302-35303	,	_	
205-7	35304-35308	even	_	
205-8	35309-35311	at	_	
205-9	35312-35313	a	_	
205-10	35314-35320	social	_	
205-11	35321-35326	level	_	
205-12	35326-35327	,	_	
205-13	35328-35331	has	_	
205-14	35332-35339	lasting	_	
205-15	35340-35347	effects	_	
205-16	35348-35350	on	_	
205-17	35351-35358	resting	_	
205-18	35359-35369	thresholds	_	
205-19	35370-35372	of	_	
205-20	35373-35376	GPe	_	
205-21	35377-35389	connectivity	_	
205-22	35389-35390	;	_	
205-23	35391-35394	for	_	
205-24	35395-35402	example	_	
205-25	35402-35403	,	_	
205-26	35404-35408	some	_	
205-27	35409-35413	work	_	
205-28	35414-35417	has	_	
205-29	35418-35423	shown	_	
205-30	35424-35428	that	_	
205-31	35429-35436	alcohol	_	
205-32	35437-35442	leads	_	
205-33	35443-35445	to	_	
205-34	35446-35457	hyperactive	_	
205-35	35458-35461	IFG	_	
205-36	35462-35470	response	_	
205-37	35471-35477	during	_	
205-38	35478-35492	stop-signaling	_	
205-39	35492-35493	.	_	

#Text=Future work should use longitudinal approaches to investigate risk factors and consequences of heavy and binge drinking across the lifespan.
206-1	35494-35500	Future	_	
206-2	35501-35505	work	_	
206-3	35506-35512	should	_	
206-4	35513-35516	use	_	
206-5	35517-35529	longitudinal	_	
206-6	35530-35540	approaches	_	
206-7	35541-35543	to	_	
206-8	35544-35555	investigate	_	
206-9	35556-35560	risk	_	
206-10	35561-35568	factors	_	
206-11	35569-35572	and	_	
206-12	35573-35585	consequences	_	
206-13	35586-35588	of	_	
206-14	35589-35594	heavy	_	
206-15	35595-35598	and	_	
206-16	35599-35604	binge	_	
206-17	35605-35613	drinking	_	
206-18	35614-35620	across	_	
206-19	35621-35624	the	_	
206-20	35625-35633	lifespan	_	
206-21	35633-35634	.	_	

#Text=We also found that heavier drinking individuals had greater decoupling caused by alcohol infusion in connectivity between the GPe and amygdala/hippocampus regions.
207-1	35635-35637	We	_	
207-2	35638-35642	also	_	
207-3	35643-35648	found	_	
207-4	35649-35653	that	_	
207-5	35654-35661	heavier	_	
207-6	35662-35670	drinking	_	
207-7	35671-35682	individuals	_	
207-8	35683-35686	had	_	
207-9	35687-35694	greater	_	
207-10	35695-35705	decoupling	_	
207-11	35706-35712	caused	_	
207-12	35713-35715	by	_	
207-13	35716-35723	alcohol	_	
207-14	35724-35732	infusion	_	
207-15	35733-35735	in	_	
207-16	35736-35748	connectivity	_	
207-17	35749-35756	between	_	
207-18	35757-35760	the	_	
207-19	35761-35764	GPe	_	
207-20	35765-35768	and	_	
207-21	35769-35777	amygdala	_	
207-22	35777-35778	/	_	
207-23	35778-35789	hippocampus	_	
207-24	35790-35797	regions	_	
207-25	35797-35798	.	_	

#Text=The amygdala modulates striatum activity during reward learning and instrumental choice through direct connections within the limbic stream.
208-1	35799-35802	The	_	
208-2	35803-35811	amygdala	_	
208-3	35812-35821	modulates	_	
208-4	35822-35830	striatum	_	
208-5	35831-35839	activity	_	
208-6	35840-35846	during	_	
208-7	35847-35853	reward	_	
208-8	35854-35862	learning	_	
208-9	35863-35866	and	_	
208-10	35867-35879	instrumental	_	
208-11	35880-35886	choice	_	
208-12	35887-35894	through	_	
208-13	35895-35901	direct	_	
208-14	35902-35913	connections	_	
208-15	35914-35920	within	_	
208-16	35921-35924	the	_	
208-17	35925-35931	limbic	_	
208-18	35932-35938	stream	_	
208-19	35938-35939	.	_	

#Text=Moreover, connectivity between the amygdala and basal ganglia is associated with greater stress-induced cortisol response dependent on the availability of mineralocorticoid receptors.
209-1	35940-35948	Moreover	_	
209-2	35948-35949	,	_	
209-3	35950-35962	connectivity	_	
209-4	35963-35970	between	_	
209-5	35971-35974	the	_	
209-6	35975-35983	amygdala	_	
209-7	35984-35987	and	_	
209-8	35988-35993	basal	_	
209-9	35994-36001	ganglia	_	
209-10	36002-36004	is	_	
209-11	36005-36015	associated	_	
209-12	36016-36020	with	_	
209-13	36021-36028	greater	_	
209-14	36029-36043	stress-induced	_	
209-15	36044-36052	cortisol	_	
209-16	36053-36061	response	_	
209-17	36062-36071	dependent	_	
209-18	36072-36074	on	_	
209-19	36075-36078	the	_	
209-20	36079-36091	availability	_	
209-21	36092-36094	of	_	
209-22	36095-36112	mineralocorticoid	_	
209-23	36113-36122	receptors	_	
209-24	36122-36123	.	_	

#Text=Decoupling of the amygdala and GPe signaling during intoxication in heavier drinkers, particularly those with a tendency to act impulsively during negative emotions, may reflect drinking to reduce stress rather than drinking as a reward.
210-1	36124-36134	Decoupling	_	
210-2	36135-36137	of	_	
210-3	36138-36141	the	_	
210-4	36142-36150	amygdala	_	
210-5	36151-36154	and	_	
210-6	36155-36158	GPe	_	
210-7	36159-36168	signaling	_	
210-8	36169-36175	during	_	
210-9	36176-36188	intoxication	_	
210-10	36189-36191	in	_	
210-11	36192-36199	heavier	_	
210-12	36200-36208	drinkers	_	
210-13	36208-36209	,	_	
210-14	36210-36222	particularly	_	
210-15	36223-36228	those	_	
210-16	36229-36233	with	_	
210-17	36234-36235	a	_	
210-18	36236-36244	tendency	_	
210-19	36245-36247	to	_	
210-20	36248-36251	act	_	
210-21	36252-36263	impulsively	_	
210-22	36264-36270	during	_	
210-23	36271-36279	negative	_	
210-24	36280-36288	emotions	_	
210-25	36288-36289	,	_	
210-26	36290-36293	may	_	
210-27	36294-36301	reflect	_	
210-28	36302-36310	drinking	_	
210-29	36311-36313	to	_	
210-30	36314-36320	reduce	_	
210-31	36321-36327	stress	_	
210-32	36328-36334	rather	_	
210-33	36335-36339	than	_	
210-34	36340-36348	drinking	_	
210-35	36349-36351	as	_	
210-36	36352-36353	a	_	
210-37	36354-36360	reward	_	
210-38	36360-36361	.	_	

#Text=This “drinking to reduce negative affect” is a key feature in addiction, and may mean that individuals with this pattern of response are particularly vulnerable to developing alcohol use disorder.
211-1	36362-36366	This	_	
211-2	36367-36368	“	_	
211-3	36368-36376	drinking	_	
211-4	36377-36379	to	_	
211-5	36380-36386	reduce	_	
211-6	36387-36395	negative	_	
211-7	36396-36402	affect	_	
211-8	36402-36403	”	_	
211-9	36404-36406	is	_	
211-10	36407-36408	a	_	
211-11	36409-36412	key	_	
211-12	36413-36420	feature	_	
211-13	36421-36423	in	_	
211-14	36424-36433	addiction	_	
211-15	36433-36434	,	_	
211-16	36435-36438	and	_	
211-17	36439-36442	may	_	
211-18	36443-36447	mean	_	
211-19	36448-36452	that	_	
211-20	36453-36464	individuals	_	
211-21	36465-36469	with	_	
211-22	36470-36474	this	_	
211-23	36475-36482	pattern	_	
211-24	36483-36485	of	_	
211-25	36486-36494	response	_	
211-26	36495-36498	are	_	
211-27	36499-36511	particularly	_	
211-28	36512-36522	vulnerable	_	
211-29	36523-36525	to	_	
211-30	36526-36536	developing	_	
211-31	36537-36544	alcohol	_	
211-32	36545-36548	use	_	
211-33	36549-36557	disorder	_	
211-34	36557-36558	.	_	

#Text=In fact, chronic alcohol consumption leads to increased mineralocorticoid receptor pathway activity, suggesting that by drinking to reduce stress, these individuals may be making themselves more vulnerable to stress in the future.
212-1	36559-36561	In	_	
212-2	36562-36566	fact	_	
212-3	36566-36567	,	_	
212-4	36568-36575	chronic	_	
212-5	36576-36583	alcohol	_	
212-6	36584-36595	consumption	_	
212-7	36596-36601	leads	_	
212-8	36602-36604	to	_	
212-9	36605-36614	increased	_	
212-10	36615-36632	mineralocorticoid	_	
212-11	36633-36641	receptor	_	
212-12	36642-36649	pathway	_	
212-13	36650-36658	activity	_	
212-14	36658-36659	,	_	
212-15	36660-36670	suggesting	_	
212-16	36671-36675	that	_	
212-17	36676-36678	by	_	
212-18	36679-36687	drinking	_	
212-19	36688-36690	to	_	
212-20	36691-36697	reduce	_	
212-21	36698-36704	stress	_	
212-22	36704-36705	,	_	
212-23	36706-36711	these	_	
212-24	36712-36723	individuals	_	
212-25	36724-36727	may	_	
212-26	36728-36730	be	_	
212-27	36731-36737	making	_	
212-28	36738-36748	themselves	_	
212-29	36749-36753	more	_	
212-30	36754-36764	vulnerable	_	
212-31	36765-36767	to	_	
212-32	36768-36774	stress	_	
212-33	36775-36777	in	_	
212-34	36778-36781	the	_	
212-35	36782-36788	future	_	
212-36	36788-36789	.	_	

#Text=Impulsivity across measures was associated with greater change in GPe connectivity following alcohol infusion.
213-1	36790-36801	Impulsivity	_	
213-2	36802-36808	across	_	
213-3	36809-36817	measures	_	
213-4	36818-36821	was	_	
213-5	36822-36832	associated	_	
213-6	36833-36837	with	_	
213-7	36838-36845	greater	_	
213-8	36846-36852	change	_	
213-9	36853-36855	in	_	
213-10	36856-36859	GPe	_	
213-11	36860-36872	connectivity	_	
213-12	36873-36882	following	_	
213-13	36883-36890	alcohol	_	
213-14	36891-36899	infusion	_	
213-15	36899-36900	.	_	

#Text=For clusters in the postcentral and precentral gyrus, individuals low on impulsivity had no differences in connectivity with the GPe as a result of alcohol.
214-1	36901-36904	For	_	
214-2	36905-36913	clusters	_	
214-3	36914-36916	in	_	
214-4	36917-36920	the	_	
214-5	36921-36932	postcentral	_	
214-6	36933-36936	and	_	
214-7	36937-36947	precentral	_	
214-8	36948-36953	gyrus	_	
214-9	36953-36954	,	_	
214-10	36955-36966	individuals	_	
214-11	36967-36970	low	_	
214-12	36971-36973	on	_	
214-13	36974-36985	impulsivity	_	
214-14	36986-36989	had	_	
214-15	36990-36992	no	_	
214-16	36993-37004	differences	_	
214-17	37005-37007	in	_	
214-18	37008-37020	connectivity	_	
214-19	37021-37025	with	_	
214-20	37026-37029	the	_	
214-21	37030-37033	GPe	_	
214-22	37034-37036	as	_	
214-23	37037-37038	a	_	
214-24	37039-37045	result	_	
214-25	37046-37048	of	_	
214-26	37049-37056	alcohol	_	
214-27	37056-37057	.	_	

#Text=For the precentral/supplementary motor area(SMA) cluster, across the continuum of impulsive traits, there were no baseline differences in GPe connectivity, but after alcohol infusion, impulsivity was related to increased connectivity of these areas to the GPe.
215-1	37058-37061	For	_	
215-2	37062-37065	the	_	
215-3	37066-37076	precentral	_	
215-4	37076-37077	/	_	
215-5	37077-37090	supplementary	_	
215-6	37091-37096	motor	_	
215-7	37097-37101	area	_	
215-8	37101-37102	(	_	
215-9	37102-37105	SMA	_	
215-10	37105-37106	)	_	
215-11	37107-37114	cluster	_	
215-12	37114-37115	,	_	
215-13	37116-37122	across	_	
215-14	37123-37126	the	_	
215-15	37127-37136	continuum	_	
215-16	37137-37139	of	_	
215-17	37140-37149	impulsive	_	
215-18	37150-37156	traits	_	
215-19	37156-37157	,	_	
215-20	37158-37163	there	_	
215-21	37164-37168	were	_	
215-22	37169-37171	no	_	
215-23	37172-37180	baseline	_	
215-24	37181-37192	differences	_	
215-25	37193-37195	in	_	
215-26	37196-37199	GPe	_	
215-27	37200-37212	connectivity	_	
215-28	37212-37213	,	_	
215-29	37214-37217	but	_	
215-30	37218-37223	after	_	
215-31	37224-37231	alcohol	_	
215-32	37232-37240	infusion	_	
215-33	37240-37241	,	_	
215-34	37242-37253	impulsivity	_	
215-35	37254-37257	was	_	
215-36	37258-37265	related	_	
215-37	37266-37268	to	_	
215-38	37269-37278	increased	_	
215-39	37279-37291	connectivity	_	
215-40	37292-37294	of	_	
215-41	37295-37300	these	_	
215-42	37301-37306	areas	_	
215-43	37307-37309	to	_	
215-44	37310-37313	the	_	
215-45	37314-37317	GPe	_	
215-46	37317-37318	.	_	

#Text=Previous work has shown that increased SMA-dorsal striatum structural connectivity was associated with more motor impulsivity, such that these results may suggest that individuals with trait impulsivity have an alcohol-related vulnerability to greater behavioral impulsivity.
216-1	37319-37327	Previous	_	
216-2	37328-37332	work	_	
216-3	37333-37336	has	_	
216-4	37337-37342	shown	_	
216-5	37343-37347	that	_	
216-6	37348-37357	increased	_	
216-7	37358-37368	SMA-dorsal	_	
216-8	37369-37377	striatum	_	
216-9	37378-37388	structural	_	
216-10	37389-37401	connectivity	_	
216-11	37402-37405	was	_	
216-12	37406-37416	associated	_	
216-13	37417-37421	with	_	
216-14	37422-37426	more	_	
216-15	37427-37432	motor	_	
216-16	37433-37444	impulsivity	_	
216-17	37444-37445	,	_	
216-18	37446-37450	such	_	
216-19	37451-37455	that	_	
216-20	37456-37461	these	_	
216-21	37462-37469	results	_	
216-22	37470-37473	may	_	
216-23	37474-37481	suggest	_	
216-24	37482-37486	that	_	
216-25	37487-37498	individuals	_	
216-26	37499-37503	with	_	
216-27	37504-37509	trait	_	
216-28	37510-37521	impulsivity	_	
216-29	37522-37526	have	_	
216-30	37527-37529	an	_	
216-31	37530-37545	alcohol-related	_	
216-32	37546-37559	vulnerability	_	
216-33	37560-37562	to	_	
216-34	37563-37570	greater	_	
216-35	37571-37581	behavioral	_	
216-36	37582-37593	impulsivity	_	
216-37	37593-37594	.	_	

#Text=Alternatively, SMA engagement is associated with reactive inhibition and is thought to influence inhibition through a hyperdirect rather than indirect pathway.
217-1	37595-37608	Alternatively	_	
217-2	37608-37609	,	_	
217-3	37610-37613	SMA	_	
217-4	37614-37624	engagement	_	
217-5	37625-37627	is	_	
217-6	37628-37638	associated	_	
217-7	37639-37643	with	_	
217-8	37644-37652	reactive	_	
217-9	37653-37663	inhibition	_	
217-10	37664-37667	and	_	
217-11	37668-37670	is	_	
217-12	37671-37678	thought	_	
217-13	37679-37681	to	_	
217-14	37682-37691	influence	_	
217-15	37692-37702	inhibition	_	
217-16	37703-37710	through	_	
217-17	37711-37712	a	_	
217-18	37713-37724	hyperdirect	_	
217-19	37725-37731	rather	_	
217-20	37732-37736	than	_	
217-21	37737-37745	indirect	_	
217-22	37746-37753	pathway	_	
217-23	37753-37754	.	_	

#Text=However, the highest instance of successful inhibition is when the hyperdirect and indirect pathways work in conjunction, meaning impulsive individuals with disproportional recruitment of the hyperdirect pathway, as seen here may still have impaired inhibition.
218-1	37755-37762	However	_	
218-2	37762-37763	,	_	
218-3	37764-37767	the	_	
218-4	37768-37775	highest	_	
218-5	37776-37784	instance	_	
218-6	37785-37787	of	_	
218-7	37788-37798	successful	_	
218-8	37799-37809	inhibition	_	
218-9	37810-37812	is	_	
218-10	37813-37817	when	_	
218-11	37818-37821	the	_	
218-12	37822-37833	hyperdirect	_	
218-13	37834-37837	and	_	
218-14	37838-37846	indirect	_	
218-15	37847-37855	pathways	_	
218-16	37856-37860	work	_	
218-17	37861-37863	in	_	
218-18	37864-37875	conjunction	_	
218-19	37875-37876	,	_	
218-20	37877-37884	meaning	_	
218-21	37885-37894	impulsive	_	
218-22	37895-37906	individuals	_	
218-23	37907-37911	with	_	
218-24	37912-37927	disproportional	_	
218-25	37928-37939	recruitment	_	
218-26	37940-37942	of	_	
218-27	37943-37946	the	_	
218-28	37947-37958	hyperdirect	_	
218-29	37959-37966	pathway	_	
218-30	37966-37967	,	_	
218-31	37968-37970	as	_	
218-32	37971-37975	seen	_	
218-33	37976-37980	here	_	
218-34	37981-37984	may	_	
218-35	37985-37990	still	_	
218-36	37991-37995	have	_	
218-37	37996-38004	impaired	_	
218-38	38005-38015	inhibition	_	
218-39	38015-38016	.	_	

#Text=On the other hand, in the postcentral cluster, negative urgency was associated with hypoconnectivity to the GPe at baseline, but not when intoxicated.
219-1	38017-38019	On	_	
219-2	38020-38023	the	_	
219-3	38024-38029	other	_	
219-4	38030-38034	hand	_	
219-5	38034-38035	,	_	
219-6	38036-38038	in	_	
219-7	38039-38042	the	_	
219-8	38043-38054	postcentral	_	
219-9	38055-38062	cluster	_	
219-10	38062-38063	,	_	
219-11	38064-38072	negative	_	
219-12	38073-38080	urgency	_	
219-13	38081-38084	was	_	
219-14	38085-38095	associated	_	
219-15	38096-38100	with	_	
219-16	38101-38117	hypoconnectivity	_	
219-17	38118-38120	to	_	
219-18	38121-38124	the	_	
219-19	38125-38128	GPe	_	
219-20	38129-38131	at	_	
219-21	38132-38140	baseline	_	
219-22	38140-38141	,	_	
219-23	38142-38145	but	_	
219-24	38146-38149	not	_	
219-25	38150-38154	when	_	
219-26	38155-38166	intoxicated	_	
219-27	38166-38167	.	_	

#Text=The postcentral gyrus is part of a motor cortical network activated during “go” signalling; it may be that individuals higher in impulsivity have a lower threshold for such a signal, reflected in the lower baseline value.
220-1	38168-38171	The	_	
220-2	38172-38183	postcentral	_	
220-3	38184-38189	gyrus	_	
220-4	38190-38192	is	_	
220-5	38193-38197	part	_	
220-6	38198-38200	of	_	
220-7	38201-38202	a	_	
220-8	38203-38208	motor	_	
220-9	38209-38217	cortical	_	
220-10	38218-38225	network	_	
220-11	38226-38235	activated	_	
220-12	38236-38242	during	_	
220-13	38243-38244	“	_	
220-14	38244-38246	go	_	
220-15	38246-38247	”	_	
220-16	38248-38258	signalling	_	
220-17	38258-38259	;	_	
220-18	38260-38262	it	_	
220-19	38263-38266	may	_	
220-20	38267-38269	be	_	
220-21	38270-38274	that	_	
220-22	38275-38286	individuals	_	
220-23	38287-38293	higher	_	
220-24	38294-38296	in	_	
220-25	38297-38308	impulsivity	_	
220-26	38309-38313	have	_	
220-27	38314-38315	a	_	
220-28	38316-38321	lower	_	
220-29	38322-38331	threshold	_	
220-30	38332-38335	for	_	
220-31	38336-38340	such	_	
220-32	38341-38342	a	_	
220-33	38343-38349	signal	_	
220-34	38349-38350	,	_	
220-35	38351-38360	reflected	_	
220-36	38361-38363	in	_	
220-37	38364-38367	the	_	
220-38	38368-38373	lower	_	
220-39	38374-38382	baseline	_	
220-40	38383-38388	value	_	
220-41	38388-38389	.	_	

#Text=If so, intoxication may compound the risk for impuslive behavior in these individuals.
221-1	38390-38392	If	_	
221-2	38393-38395	so	_	
221-3	38395-38396	,	_	
221-4	38397-38409	intoxication	_	
221-5	38410-38413	may	_	
221-6	38414-38422	compound	_	
221-7	38423-38426	the	_	
221-8	38427-38431	risk	_	
221-9	38432-38435	for	_	
221-10	38436-38445	impuslive	_	
221-11	38446-38454	behavior	_	
221-12	38455-38457	in	_	
221-13	38458-38463	these	_	
221-14	38464-38475	individuals	_	
221-15	38475-38476	.	_	

#Text=An alternative explanation is that individuals with higher negative urgency tend to engage in internal rumination more; the previous literature illustrates that decreases in activation in the postcentral gyrus at rest are more pronounced in interospective, eyes-closed conditions.
222-1	38477-38479	An	_	
222-2	38480-38491	alternative	_	
222-3	38492-38503	explanation	_	
222-4	38504-38506	is	_	
222-5	38507-38511	that	_	
222-6	38512-38523	individuals	_	
222-7	38524-38528	with	_	
222-8	38529-38535	higher	_	
222-9	38536-38544	negative	_	
222-10	38545-38552	urgency	_	
222-11	38553-38557	tend	_	
222-12	38558-38560	to	_	
222-13	38561-38567	engage	_	
222-14	38568-38570	in	_	
222-15	38571-38579	internal	_	
222-16	38580-38590	rumination	_	
222-17	38591-38595	more	_	
222-18	38595-38596	;	_	
222-19	38597-38600	the	_	
222-20	38601-38609	previous	_	
222-21	38610-38620	literature	_	
222-22	38621-38632	illustrates	_	
222-23	38633-38637	that	_	
222-24	38638-38647	decreases	_	
222-25	38648-38650	in	_	
222-26	38651-38661	activation	_	
222-27	38662-38664	in	_	
222-28	38665-38668	the	_	
222-29	38669-38680	postcentral	_	
222-30	38681-38686	gyrus	_	
222-31	38687-38689	at	_	
222-32	38690-38694	rest	_	
222-33	38695-38698	are	_	
222-34	38699-38703	more	_	
222-35	38704-38714	pronounced	_	
222-36	38715-38717	in	_	
222-37	38718-38732	interospective	_	
222-38	38732-38733	,	_	
222-39	38734-38745	eyes-closed	_	
222-40	38746-38756	conditions	_	
222-41	38756-38757	.	_	

#Text=Alcohol may then serve to normalize this self-focused dwelling on internal feelings in individuals higher in negative urgency.
223-1	38758-38765	Alcohol	_	
223-2	38766-38769	may	_	
223-3	38770-38774	then	_	
223-4	38775-38780	serve	_	
223-5	38781-38783	to	_	
223-6	38784-38793	normalize	_	
223-7	38794-38798	this	_	
223-8	38799-38811	self-focused	_	
223-9	38812-38820	dwelling	_	
223-10	38821-38823	on	_	
223-11	38824-38832	internal	_	
223-12	38833-38841	feelings	_	
223-13	38842-38844	in	_	
223-14	38845-38856	individuals	_	
223-15	38857-38863	higher	_	
223-16	38864-38866	in	_	
223-17	38867-38875	negative	_	
223-18	38876-38883	urgency	_	
223-19	38883-38884	.	_	

#Text=Limitations
#Text=Because we did not have a placebo infusion condition, we cannot rule out that pre- to post-infusion changes were not due to dynamic fluctuations within resting states.
224-1	38885-38896	Limitations	_	
224-2	38897-38904	Because	_	
224-3	38905-38907	we	_	
224-4	38908-38911	did	_	
224-5	38912-38915	not	_	
224-6	38916-38920	have	_	
224-7	38921-38922	a	_	
224-8	38923-38930	placebo	_	
224-9	38931-38939	infusion	_	
224-10	38940-38949	condition	_	
224-11	38949-38950	,	_	
224-12	38951-38953	we	_	
224-13	38954-38960	cannot	_	
224-14	38961-38965	rule	_	
224-15	38966-38969	out	_	
224-16	38970-38974	that	_	
224-17	38975-38978	pre	_	
224-18	38978-38979	-	_	
224-19	38980-38982	to	_	
224-20	38983-38996	post-infusion	_	
224-21	38997-39004	changes	_	
224-22	39005-39009	were	_	
224-23	39010-39013	not	_	
224-24	39014-39017	due	_	
224-25	39018-39020	to	_	
224-26	39021-39028	dynamic	_	
224-27	39029-39041	fluctuations	_	
224-28	39042-39048	within	_	
224-29	39049-39056	resting	_	
224-30	39057-39063	states	_	
224-31	39063-39064	.	_	

#Text=However, we do not believe this is the case.
225-1	39065-39072	However	_	
225-2	39072-39073	,	_	
225-3	39074-39076	we	_	
225-4	39077-39079	do	_	
225-5	39080-39083	not	_	
225-6	39084-39091	believe	_	
225-7	39092-39096	this	_	
225-8	39097-39099	is	_	
225-9	39100-39103	the	_	
225-10	39104-39108	case	_	
225-11	39108-39109	.	_	

#Text=A previous study using an alcohol infusion paradigm with a full, double-blind crossover design found alcohol effects on resting-state connectivity compared to placebo.
226-1	39110-39111	A	_	
226-2	39112-39120	previous	_	
226-3	39121-39126	study	_	
226-4	39127-39132	using	_	
226-5	39133-39135	an	_	
226-6	39136-39143	alcohol	_	
226-7	39144-39152	infusion	_	
226-8	39153-39161	paradigm	_	
226-9	39162-39166	with	_	
226-10	39167-39168	a	_	
226-11	39169-39173	full	_	
226-12	39173-39174	,	_	
226-13	39175-39187	double-blind	_	
226-14	39188-39197	crossover	_	
226-15	39198-39204	design	_	
226-16	39205-39210	found	_	
226-17	39211-39218	alcohol	_	
226-18	39219-39226	effects	_	
226-19	39227-39229	on	_	
226-20	39230-39243	resting-state	_	
226-21	39244-39256	connectivity	_	
226-22	39257-39265	compared	_	
226-23	39266-39268	to	_	
226-24	39269-39276	placebo	_	
226-25	39276-39277	.	_	

#Text=Although that study examined network level connectivity changes rather than seed-based changes in subcortical regions as reported here, the fact that acute alcohol intoxication impacts connectivity during resting state has already been established.
227-1	39278-39286	Although	_	
227-2	39287-39291	that	_	
227-3	39292-39297	study	_	
227-4	39298-39306	examined	_	
227-5	39307-39314	network	_	
227-6	39315-39320	level	_	
227-7	39321-39333	connectivity	_	
227-8	39334-39341	changes	_	
227-9	39342-39348	rather	_	
227-10	39349-39353	than	_	
227-11	39354-39364	seed-based	_	
227-12	39365-39372	changes	_	
227-13	39373-39375	in	_	
227-14	39376-39387	subcortical	_	
227-15	39388-39395	regions	_	
227-16	39396-39398	as	_	
227-17	39399-39407	reported	_	
227-18	39408-39412	here	_	
227-19	39412-39413	,	_	
227-20	39414-39417	the	_	
227-21	39418-39422	fact	_	
227-22	39423-39427	that	_	
227-23	39428-39433	acute	_	
227-24	39434-39441	alcohol	_	
227-25	39442-39454	intoxication	_	
227-26	39455-39462	impacts	_	
227-27	39463-39475	connectivity	_	
227-28	39476-39482	during	_	
227-29	39483-39490	resting	_	
227-30	39491-39496	state	_	
227-31	39497-39500	has	_	
227-32	39501-39508	already	_	
227-33	39509-39513	been	_	
227-34	39514-39525	established	_	
227-35	39525-39526	.	_	

#Text=Moreover, this study is based on animal literature that found alcohol-induced changes in this pathway that are dose-dependent.
228-1	39527-39535	Moreover	_	
228-2	39535-39536	,	_	
228-3	39537-39541	this	_	
228-4	39542-39547	study	_	
228-5	39548-39550	is	_	
228-6	39551-39556	based	_	
228-7	39557-39559	on	_	
228-8	39560-39566	animal	_	
228-9	39567-39577	literature	_	
228-10	39578-39582	that	_	
228-11	39583-39588	found	_	
228-12	39589-39604	alcohol-induced	_	
228-13	39605-39612	changes	_	
228-14	39613-39615	in	_	
228-15	39616-39620	this	_	
228-16	39621-39628	pathway	_	
228-17	39629-39633	that	_	
228-18	39634-39637	are	_	
228-19	39638-39652	dose-dependent	_	
228-20	39652-39653	.	_	

#Text=Our measures of impulsivity and drinking were primarily retrospective and obtained via self-report.
229-1	39654-39657	Our	_	
229-2	39658-39666	measures	_	
229-3	39667-39669	of	_	
229-4	39670-39681	impulsivity	_	
229-5	39682-39685	and	_	
229-6	39686-39694	drinking	_	
229-7	39695-39699	were	_	
229-8	39700-39709	primarily	_	
229-9	39710-39723	retrospective	_	
229-10	39724-39727	and	_	
229-11	39728-39736	obtained	_	
229-12	39737-39740	via	_	
229-13	39741-39752	self-report	_	
229-14	39752-39753	.	_	

#Text=Although we have designed our analysis to provide insight on the relationship between impulsivity, drinking, and alcohol-related changes in brain connectivity, we cannot comment on the directionality or causality of these relationships.
230-1	39754-39762	Although	_	
230-2	39763-39765	we	_	
230-3	39766-39770	have	_	
230-4	39771-39779	designed	_	
230-5	39780-39783	our	_	
230-6	39784-39792	analysis	_	
230-7	39793-39795	to	_	
230-8	39796-39803	provide	_	
230-9	39804-39811	insight	_	
230-10	39812-39814	on	_	
230-11	39815-39818	the	_	
230-12	39819-39831	relationship	_	
230-13	39832-39839	between	_	
230-14	39840-39851	impulsivity	_	
230-15	39851-39852	,	_	
230-16	39853-39861	drinking	_	
230-17	39861-39862	,	_	
230-18	39863-39866	and	_	
230-19	39867-39882	alcohol-related	_	
230-20	39883-39890	changes	_	
230-21	39891-39893	in	_	
230-22	39894-39899	brain	_	
230-23	39900-39912	connectivity	_	
230-24	39912-39913	,	_	
230-25	39914-39916	we	_	
230-26	39917-39923	cannot	_	
230-27	39924-39931	comment	_	
230-28	39932-39934	on	_	
230-29	39935-39938	the	_	
230-30	39939-39953	directionality	_	
230-31	39954-39956	or	_	
230-32	39957-39966	causality	_	
230-33	39967-39969	of	_	
230-34	39970-39975	these	_	
230-35	39976-39989	relationships	_	
230-36	39989-39990	.	_	

#Text=Nonetheless, we did find evidence that connectivity during our laboratory “binge drinking” state was influenced by previous drinking and impulsive traits.
231-1	39991-40002	Nonetheless	_	
231-2	40002-40003	,	_	
231-3	40004-40006	we	_	
231-4	40007-40010	did	_	
231-5	40011-40015	find	_	
231-6	40016-40024	evidence	_	
231-7	40025-40029	that	_	
231-8	40030-40042	connectivity	_	
231-9	40043-40049	during	_	
231-10	40050-40053	our	_	
231-11	40054-40064	laboratory	_	
231-12	40065-40066	“	_	
231-13	40066-40071	binge	_	
231-14	40072-40080	drinking	_	
231-15	40080-40081	”	_	
231-16	40082-40087	state	_	
231-17	40088-40091	was	_	
231-18	40092-40102	influenced	_	
231-19	40103-40105	by	_	
231-20	40106-40114	previous	_	
231-21	40115-40123	drinking	_	
231-22	40124-40127	and	_	
231-23	40128-40137	impulsive	_	
231-24	40138-40144	traits	_	
231-25	40144-40145	.	_	

#Text=Future studies should take a prospective approach that could speak directly to the neural mechanisms leading to problem drinking behaviors, as well as measuring within-subject changes in choice impulsivity during acute intoxication.
232-1	40146-40152	Future	_	
232-2	40153-40160	studies	_	
232-3	40161-40167	should	_	
232-4	40168-40172	take	_	
232-5	40173-40174	a	_	
232-6	40175-40186	prospective	_	
232-7	40187-40195	approach	_	
232-8	40196-40200	that	_	
232-9	40201-40206	could	_	
232-10	40207-40212	speak	_	
232-11	40213-40221	directly	_	
232-12	40222-40224	to	_	
232-13	40225-40228	the	_	
232-14	40229-40235	neural	_	
232-15	40236-40246	mechanisms	_	
232-16	40247-40254	leading	_	
232-17	40255-40257	to	_	
232-18	40258-40265	problem	_	
232-19	40266-40274	drinking	_	
232-20	40275-40284	behaviors	_	
232-21	40284-40285	,	_	
232-22	40286-40288	as	_	
232-23	40289-40293	well	_	
232-24	40294-40296	as	_	
232-25	40297-40306	measuring	_	
232-26	40307-40321	within-subject	_	
232-27	40322-40329	changes	_	
232-28	40330-40332	in	_	
232-29	40333-40339	choice	_	
232-30	40340-40351	impulsivity	_	
232-31	40352-40358	during	_	
232-32	40359-40364	acute	_	
232-33	40365-40377	intoxication	_	
232-34	40377-40378	.	_	

#Text=Another limitation to our inferences about baseline impulsivity and drinking measures is that our participants were light social drinkers with a limited range of alcohol use and an absence of AUD.
233-1	40379-40386	Another	_	
233-2	40387-40397	limitation	_	
233-3	40398-40400	to	_	
233-4	40401-40404	our	_	
233-5	40405-40415	inferences	_	
233-6	40416-40421	about	_	
233-7	40422-40430	baseline	_	
233-8	40431-40442	impulsivity	_	
233-9	40443-40446	and	_	
233-10	40447-40455	drinking	_	
233-11	40456-40464	measures	_	
233-12	40465-40467	is	_	
233-13	40468-40472	that	_	
233-14	40473-40476	our	_	
233-15	40477-40489	participants	_	
233-16	40490-40494	were	_	
233-17	40495-40500	light	_	
233-18	40501-40507	social	_	
233-19	40508-40516	drinkers	_	
233-20	40517-40521	with	_	
233-21	40522-40523	a	_	
233-22	40524-40531	limited	_	
233-23	40532-40537	range	_	
233-24	40538-40540	of	_	
233-25	40541-40548	alcohol	_	
233-26	40549-40552	use	_	
233-27	40553-40556	and	_	
233-28	40557-40559	an	_	
233-29	40560-40567	absence	_	
233-30	40568-40570	of	_	
233-31	40571-40574	AUD	_	
233-32	40574-40575	.	_	

#Text=This may explain why impulsivity and drinking measures were not significantly correlated in our sample, despite their clear link in the literature (e.g.,).
234-1	40576-40580	This	_	
234-2	40581-40584	may	_	
234-3	40585-40592	explain	_	
234-4	40593-40596	why	_	
234-5	40597-40608	impulsivity	_	
234-6	40609-40612	and	_	
234-7	40613-40621	drinking	_	
234-8	40622-40630	measures	_	
234-9	40631-40635	were	_	
234-10	40636-40639	not	_	
234-11	40640-40653	significantly	_	
234-12	40654-40664	correlated	_	
234-13	40665-40667	in	_	
234-14	40668-40671	our	_	
234-15	40672-40678	sample	_	
234-16	40678-40679	,	_	
234-17	40680-40687	despite	_	
234-18	40688-40693	their	_	
234-19	40694-40699	clear	_	
234-20	40700-40704	link	_	
234-21	40705-40707	in	_	
234-22	40708-40711	the	_	
234-23	40712-40722	literature	_	
234-24	40723-40724	(	_	
234-25	40724-40727	e.g	_	
234-26	40727-40728	.	_	
234-27	40728-40729	,	_	
234-28	40729-40730	)	_	
234-29	40730-40731	.	_	

#Text=Overall, our findings are most applicable to non-AUD binge drinking groups, such as adolescents and emerging adults, rather than in chronic heavy binge drinkers with AUD.
235-1	40732-40739	Overall	_	
235-2	40739-40740	,	_	
235-3	40741-40744	our	_	
235-4	40745-40753	findings	_	
235-5	40754-40757	are	_	
235-6	40758-40762	most	_	
235-7	40763-40773	applicable	_	
235-8	40774-40776	to	_	
235-9	40777-40784	non-AUD	_	
235-10	40785-40790	binge	_	
235-11	40791-40799	drinking	_	
235-12	40800-40806	groups	_	
235-13	40806-40807	,	_	
235-14	40808-40812	such	_	
235-15	40813-40815	as	_	
235-16	40816-40827	adolescents	_	
235-17	40828-40831	and	_	
235-18	40832-40840	emerging	_	
235-19	40841-40847	adults	_	
235-20	40847-40848	,	_	
235-21	40849-40855	rather	_	
235-22	40856-40860	than	_	
235-23	40861-40863	in	_	
235-24	40864-40871	chronic	_	
235-25	40872-40877	heavy	_	
235-26	40878-40883	binge	_	
235-27	40884-40892	drinkers	_	
235-28	40893-40897	with	_	
235-29	40898-40901	AUD	_	
235-30	40901-40902	.	_	

#Text=The small sample size of this study (n = 25) allowed us to test our specific hypotheses but may limit our ability to rule out the involvement of GPe connectivity to areas that were not found to be significant in this study.
236-1	40903-40906	The	_	
236-2	40907-40912	small	_	
236-3	40913-40919	sample	_	
236-4	40920-40924	size	_	
236-5	40925-40927	of	_	
236-6	40928-40932	this	_	
236-7	40933-40938	study	_	
236-8	40939-40940	(	_	
236-9	40940-40941	n	_	
236-10	40942-40943	=	_	
236-11	40944-40946	25	_	
236-12	40946-40947	)	_	
236-13	40948-40955	allowed	_	
236-14	40956-40958	us	_	
236-15	40959-40961	to	_	
236-16	40962-40966	test	_	
236-17	40967-40970	our	_	
236-18	40971-40979	specific	_	
236-19	40980-40990	hypotheses	_	
236-20	40991-40994	but	_	
236-21	40995-40998	may	_	
236-22	40999-41004	limit	_	
236-23	41005-41008	our	_	
236-24	41009-41016	ability	_	
236-25	41017-41019	to	_	
236-26	41020-41024	rule	_	
236-27	41025-41028	out	_	
236-28	41029-41032	the	_	
236-29	41033-41044	involvement	_	
236-30	41045-41047	of	_	
236-31	41048-41051	GPe	_	
236-32	41052-41064	connectivity	_	
236-33	41065-41067	to	_	
236-34	41068-41073	areas	_	
236-35	41074-41078	that	_	
236-36	41079-41083	were	_	
236-37	41084-41087	not	_	
236-38	41088-41093	found	_	
236-39	41094-41096	to	_	
236-40	41097-41099	be	_	
236-41	41100-41111	significant	_	
236-42	41112-41114	in	_	
236-43	41115-41119	this	_	
236-44	41120-41125	study	_	
236-45	41125-41126	.	_	

#Text=We limited our investigation to the connectivity of the hypothesized region of interest (GPe) and did not investigate other potential pathways of behavior control.
237-1	41127-41129	We	_	
237-2	41130-41137	limited	_	
237-3	41138-41141	our	_	
237-4	41142-41155	investigation	_	
237-5	41156-41158	to	_	
237-6	41159-41162	the	_	
237-7	41163-41175	connectivity	_	
237-8	41176-41178	of	_	
237-9	41179-41182	the	_	
237-10	41183-41195	hypothesized	_	
237-11	41196-41202	region	_	
237-12	41203-41205	of	_	
237-13	41206-41214	interest	_	
237-14	41215-41216	(	_	
237-15	41216-41219	GPe	_	
237-16	41219-41220	)	_	
237-17	41221-41224	and	_	
237-18	41225-41228	did	_	
237-19	41229-41232	not	_	
237-20	41233-41244	investigate	_	
237-21	41245-41250	other	_	
237-22	41251-41260	potential	_	
237-23	41261-41269	pathways	_	
237-24	41270-41272	of	_	
237-25	41273-41281	behavior	_	
237-26	41282-41289	control	_	
237-27	41289-41290	.	_	

#Text=Importantly, we do not assert that GPe pathways are the only mechanisms of control influenced by acute or chronic alcohol consumption or related to impulsivity.
238-1	41291-41302	Importantly	_	
238-2	41302-41303	,	_	
238-3	41304-41306	we	_	
238-4	41307-41309	do	_	
238-5	41310-41313	not	_	
238-6	41314-41320	assert	_	
238-7	41321-41325	that	_	
238-8	41326-41329	GPe	_	
238-9	41330-41338	pathways	_	
238-10	41339-41342	are	_	
238-11	41343-41346	the	_	
238-12	41347-41351	only	_	
238-13	41352-41362	mechanisms	_	
238-14	41363-41365	of	_	
238-15	41366-41373	control	_	
238-16	41374-41384	influenced	_	
238-17	41385-41387	by	_	
238-18	41388-41393	acute	_	
238-19	41394-41396	or	_	
238-20	41397-41404	chronic	_	
238-21	41405-41412	alcohol	_	
238-22	41413-41424	consumption	_	
238-23	41425-41427	or	_	
238-24	41428-41435	related	_	
238-25	41436-41438	to	_	
238-26	41439-41450	impulsivity	_	
238-27	41450-41451	.	_	

#Text=In fact, increased connectivity in behavioral control circuits suggests that alternative mechanisms or alternative recruitment of pathways are involved in failures of inhibition.
239-1	41452-41454	In	_	
239-2	41455-41459	fact	_	
239-3	41459-41460	,	_	
239-4	41461-41470	increased	_	
239-5	41471-41483	connectivity	_	
239-6	41484-41486	in	_	
239-7	41487-41497	behavioral	_	
239-8	41498-41505	control	_	
239-9	41506-41514	circuits	_	
239-10	41515-41523	suggests	_	
239-11	41524-41528	that	_	
239-12	41529-41540	alternative	_	
239-13	41541-41551	mechanisms	_	
239-14	41552-41554	or	_	
239-15	41555-41566	alternative	_	
239-16	41567-41578	recruitment	_	
239-17	41579-41581	of	_	
239-18	41582-41590	pathways	_	
239-19	41591-41594	are	_	
239-20	41595-41603	involved	_	
239-21	41604-41606	in	_	
239-22	41607-41615	failures	_	
239-23	41616-41618	of	_	
239-24	41619-41629	inhibition	_	
239-25	41629-41630	.	_	

#Text=Although outside the scope of the current study, future work should investigate those pathways during acute alcohol intoxication in a larger sample, and during specific stop-signaling tasks.
240-1	41631-41639	Although	_	
240-2	41640-41647	outside	_	
240-3	41648-41651	the	_	
240-4	41652-41657	scope	_	
240-5	41658-41660	of	_	
240-6	41661-41664	the	_	
240-7	41665-41672	current	_	
240-8	41673-41678	study	_	
240-9	41678-41679	,	_	
240-10	41680-41686	future	_	
240-11	41687-41691	work	_	
240-12	41692-41698	should	_	
240-13	41699-41710	investigate	_	
240-14	41711-41716	those	_	
240-15	41717-41725	pathways	_	
240-16	41726-41732	during	_	
240-17	41733-41738	acute	_	
240-18	41739-41746	alcohol	_	
240-19	41747-41759	intoxication	_	
240-20	41760-41762	in	_	
240-21	41763-41764	a	_	
240-22	41765-41771	larger	_	
240-23	41772-41778	sample	_	
240-24	41778-41779	,	_	
240-25	41780-41783	and	_	
240-26	41784-41790	during	_	
240-27	41791-41799	specific	_	
240-28	41800-41814	stop-signaling	_	
240-29	41815-41820	tasks	_	
240-30	41820-41821	.	_	

#Text=Because we do not have behavioral data on response inhibition in the alcohol intoxication state, there are other potential explanations for our findings.
241-1	41822-41829	Because	_	
241-2	41830-41832	we	_	
241-3	41833-41835	do	_	
241-4	41836-41839	not	_	
241-5	41840-41844	have	_	
241-6	41845-41855	behavioral	_	
241-7	41856-41860	data	_	
241-8	41861-41863	on	_	
241-9	41864-41872	response	_	
241-10	41873-41883	inhibition	_	
241-11	41884-41886	in	_	
241-12	41887-41890	the	_	
241-13	41891-41898	alcohol	_	
241-14	41899-41911	intoxication	_	
241-15	41912-41917	state	_	
241-16	41917-41918	,	_	
241-17	41919-41924	there	_	
241-18	41925-41928	are	_	
241-19	41929-41934	other	_	
241-20	41935-41944	potential	_	
241-21	41945-41957	explanations	_	
241-22	41958-41961	for	_	
241-23	41962-41965	our	_	
241-24	41966-41974	findings	_	
241-25	41974-41975	.	_	

#Text=First, given that our study looked at resting-state connectivity differences, rather than actual differences in stop-signaling, it is possible that observed changes are not directly related to behavioral control.
242-1	41976-41981	First	_	
242-2	41981-41982	,	_	
242-3	41983-41988	given	_	
242-4	41989-41993	that	_	
242-5	41994-41997	our	_	
242-6	41998-42003	study	_	
242-7	42004-42010	looked	_	
242-8	42011-42013	at	_	
242-9	42014-42027	resting-state	_	
242-10	42028-42040	connectivity	_	
242-11	42041-42052	differences	_	
242-12	42052-42053	,	_	
242-13	42054-42060	rather	_	
242-14	42061-42065	than	_	
242-15	42066-42072	actual	_	
242-16	42073-42084	differences	_	
242-17	42085-42087	in	_	
242-18	42088-42102	stop-signaling	_	
242-19	42102-42103	,	_	
242-20	42104-42106	it	_	
242-21	42107-42109	is	_	
242-22	42110-42118	possible	_	
242-23	42119-42123	that	_	
242-24	42124-42132	observed	_	
242-25	42133-42140	changes	_	
242-26	42141-42144	are	_	
242-27	42145-42148	not	_	
242-28	42149-42157	directly	_	
242-29	42158-42165	related	_	
242-30	42166-42168	to	_	
242-31	42169-42179	behavioral	_	
242-32	42180-42187	control	_	
242-33	42187-42188	.	_	

#Text=Abnormal frontostriatal connectivity has also been implicated in anhedonia and psychomotor retardation, mental time-keeping, cognitive load during working memory, set-shifting, and long-term reward learning.
243-1	42189-42197	Abnormal	_	
243-2	42198-42212	frontostriatal	_	
243-3	42213-42225	connectivity	_	
243-4	42226-42229	has	_	
243-5	42230-42234	also	_	
243-6	42235-42239	been	_	
243-7	42240-42250	implicated	_	
243-8	42251-42253	in	_	
243-9	42254-42263	anhedonia	_	
243-10	42264-42267	and	_	
243-11	42268-42279	psychomotor	_	
243-12	42280-42291	retardation	_	
243-13	42291-42292	,	_	
243-14	42293-42299	mental	_	
243-15	42300-42312	time-keeping	_	
243-16	42312-42313	,	_	
243-17	42314-42323	cognitive	_	
243-18	42324-42328	load	_	
243-19	42329-42335	during	_	
243-20	42336-42343	working	_	
243-21	42344-42350	memory	_	
243-22	42350-42351	,	_	
243-23	42352-42364	set-shifting	_	
243-24	42364-42365	,	_	
243-25	42366-42369	and	_	
243-26	42370-42379	long-term	_	
243-27	42380-42386	reward	_	
243-28	42387-42395	learning	_	
243-29	42395-42396	.	_	

#Text=Changes in connectivity could also be driven by alcohol-related changes in neurotransmitter availability across the whole brain that may or may not translate directly to functional change; dopamine has been shown to modulate both resting and set-shifting based functional connectivity.
244-1	42397-42404	Changes	_	
244-2	42405-42407	in	_	
244-3	42408-42420	connectivity	_	
244-4	42421-42426	could	_	
244-5	42427-42431	also	_	
244-6	42432-42434	be	_	
244-7	42435-42441	driven	_	
244-8	42442-42444	by	_	
244-9	42445-42460	alcohol-related	_	
244-10	42461-42468	changes	_	
244-11	42469-42471	in	_	
244-12	42472-42488	neurotransmitter	_	
244-13	42489-42501	availability	_	
244-14	42502-42508	across	_	
244-15	42509-42512	the	_	
244-16	42513-42518	whole	_	
244-17	42519-42524	brain	_	
244-18	42525-42529	that	_	
244-19	42530-42533	may	_	
244-20	42534-42536	or	_	
244-21	42537-42540	may	_	
244-22	42541-42544	not	_	
244-23	42545-42554	translate	_	
244-24	42555-42563	directly	_	
244-25	42564-42566	to	_	
244-26	42567-42577	functional	_	
244-27	42578-42584	change	_	
244-28	42584-42585	;	_	
244-29	42586-42594	dopamine	_	
244-30	42595-42598	has	_	
244-31	42599-42603	been	_	
244-32	42604-42609	shown	_	
244-33	42610-42612	to	_	
244-34	42613-42621	modulate	_	
244-35	42622-42626	both	_	
244-36	42627-42634	resting	_	
244-37	42635-42638	and	_	
244-38	42639-42651	set-shifting	_	
244-39	42652-42657	based	_	
244-40	42658-42668	functional	_	
244-41	42669-42681	connectivity	_	
244-42	42681-42682	.	_	

#Text=Conclusion
#Text=Here we translated preclinical research to investigate how alcohol-induced GPe connectivity disruptions explain impulsive behaviors and drinking patterns in social drinkers.
245-1	42683-42693	Conclusion	_	
245-2	42694-42698	Here	_	
245-3	42699-42701	we	_	
245-4	42702-42712	translated	_	
245-5	42713-42724	preclinical	_	
245-6	42725-42733	research	_	
245-7	42734-42736	to	_	
245-8	42737-42748	investigate	_	
245-9	42749-42752	how	_	
245-10	42753-42768	alcohol-induced	_	
245-11	42769-42772	GPe	_	
245-12	42773-42785	connectivity	_	
245-13	42786-42797	disruptions	_	
245-14	42798-42805	explain	_	
245-15	42806-42815	impulsive	_	
245-16	42816-42825	behaviors	_	
245-17	42826-42829	and	_	
245-18	42830-42838	drinking	_	
245-19	42839-42847	patterns	_	
245-20	42848-42850	in	_	
245-21	42851-42857	social	_	
245-22	42858-42866	drinkers	_	
245-23	42866-42867	.	_	

#Text=We found that impulsivity and alcohol use are associated at rest with impairment of GPe circuits implicated in typical stop-signaling processing.
246-1	42868-42870	We	_	
246-2	42871-42876	found	_	
246-3	42877-42881	that	_	
246-4	42882-42893	impulsivity	_	
246-5	42894-42897	and	_	
246-6	42898-42905	alcohol	_	
246-7	42906-42909	use	_	
246-8	42910-42913	are	_	
246-9	42914-42924	associated	_	
246-10	42925-42927	at	_	
246-11	42928-42932	rest	_	
246-12	42933-42937	with	_	
246-13	42938-42948	impairment	_	
246-14	42949-42951	of	_	
246-15	42952-42955	GPe	_	
246-16	42956-42964	circuits	_	
246-17	42965-42975	implicated	_	
246-18	42976-42978	in	_	
246-19	42979-42986	typical	_	
246-20	42987-43001	stop-signaling	_	
246-21	43002-43012	processing	_	
246-22	43012-43013	.	_	

#Text=To our knowledge, this is the first demonstration of an association between impulsivity, drinking measures, and GPe connectivity changes under clamped alcohol exposure in humans.
247-1	43014-43016	To	_	
247-2	43017-43020	our	_	
247-3	43021-43030	knowledge	_	
247-4	43030-43031	,	_	
247-5	43032-43036	this	_	
247-6	43037-43039	is	_	
247-7	43040-43043	the	_	
247-8	43044-43049	first	_	
247-9	43050-43063	demonstration	_	
247-10	43064-43066	of	_	
247-11	43067-43069	an	_	
247-12	43070-43081	association	_	
247-13	43082-43089	between	_	
247-14	43090-43101	impulsivity	_	
247-15	43101-43102	,	_	
247-16	43103-43111	drinking	_	
247-17	43112-43120	measures	_	
247-18	43120-43121	,	_	
247-19	43122-43125	and	_	
247-20	43126-43129	GPe	_	
247-21	43130-43142	connectivity	_	
247-22	43143-43150	changes	_	
247-23	43151-43156	under	_	
247-24	43157-43164	clamped	_	
247-25	43165-43172	alcohol	_	
247-26	43173-43181	exposure	_	
247-27	43182-43184	in	_	
247-28	43185-43191	humans	_	
247-29	43191-43192	.	_	

#Text=These findings suggest that individuals with impulsive traits and past drinking are particularly vulnerable to the control impairments of alcohol intoxication.
248-1	43193-43198	These	_	
248-2	43199-43207	findings	_	
248-3	43208-43215	suggest	_	
248-4	43216-43220	that	_	
248-5	43221-43232	individuals	_	
248-6	43233-43237	with	_	
248-7	43238-43247	impulsive	_	
248-8	43248-43254	traits	_	
248-9	43255-43258	and	_	
248-10	43259-43263	past	_	
248-11	43264-43272	drinking	_	
248-12	43273-43276	are	_	
248-13	43277-43289	particularly	_	
248-14	43290-43300	vulnerable	_	
248-15	43301-43303	to	_	
248-16	43304-43307	the	_	
248-17	43308-43315	control	_	
248-18	43316-43327	impairments	_	
248-19	43328-43330	of	_	
248-20	43331-43338	alcohol	_	
248-21	43339-43351	intoxication	_	
248-22	43351-43352	.	_	

#Text=Moreover, they have important implications with regard to identifying those most at risk for drinking-related consequences; they suggest a mechanism for how alcohol leads to impulsive behaviors, including excessive drinking.
249-1	43353-43361	Moreover	_	
249-2	43361-43362	,	_	
249-3	43363-43367	they	_	
249-4	43368-43372	have	_	
249-5	43373-43382	important	_	
249-6	43383-43395	implications	_	
249-7	43396-43400	with	_	
249-8	43401-43407	regard	_	
249-9	43408-43410	to	_	
249-10	43411-43422	identifying	_	
249-11	43423-43428	those	_	
249-12	43429-43433	most	_	
249-13	43434-43436	at	_	
249-14	43437-43441	risk	_	
249-15	43442-43445	for	_	
249-16	43446-43462	drinking-related	_	
249-17	43463-43475	consequences	_	
249-18	43475-43476	;	_	
249-19	43477-43481	they	_	
249-20	43482-43489	suggest	_	
249-21	43490-43491	a	_	
249-22	43492-43501	mechanism	_	
249-23	43502-43505	for	_	
249-24	43506-43509	how	_	
249-25	43510-43517	alcohol	_	
249-26	43518-43523	leads	_	
249-27	43524-43526	to	_	
249-28	43527-43536	impulsive	_	
249-29	43537-43546	behaviors	_	
249-30	43546-43547	,	_	
249-31	43548-43557	including	_	
249-32	43558-43567	excessive	_	
249-33	43568-43576	drinking	_	
249-34	43576-43577	.	_	

#Text=Finally, the neuronal connectivity changes induced by alcohol may represent a target for interventions that would mitigate the impact of binge drinking or AUD by reducing impulsivity.
250-1	43578-43585	Finally	_	
250-2	43585-43586	,	_	
250-3	43587-43590	the	_	
250-4	43591-43599	neuronal	_	
250-5	43600-43612	connectivity	_	
250-6	43613-43620	changes	_	
250-7	43621-43628	induced	_	
250-8	43629-43631	by	_	
250-9	43632-43639	alcohol	_	
250-10	43640-43643	may	_	
250-11	43644-43653	represent	_	
250-12	43654-43655	a	_	
250-13	43656-43662	target	_	
250-14	43663-43666	for	_	
250-15	43667-43680	interventions	_	
250-16	43681-43685	that	_	
250-17	43686-43691	would	_	
250-18	43692-43700	mitigate	_	
250-19	43701-43704	the	_	
250-20	43705-43711	impact	_	
250-21	43712-43714	of	_	
250-22	43715-43720	binge	_	
250-23	43721-43729	drinking	_	
250-24	43730-43732	or	_	
250-25	43733-43736	AUD	_	
250-26	43737-43739	by	_	
250-27	43740-43748	reducing	_	
250-28	43749-43760	impulsivity	_	
250-29	43760-43761	.	_	

#Text=Although additional work, including longitudinal studies, are needed before these findings can be useful in a clinical setting, this study achieves the important first step of translating preclinical models of binge drinking to the human brain and behavior.
251-1	43762-43770	Although	_	
251-2	43771-43781	additional	_	
251-3	43782-43786	work	_	
251-4	43786-43787	,	_	
251-5	43788-43797	including	_	
251-6	43798-43810	longitudinal	_	
251-7	43811-43818	studies	_	
251-8	43818-43819	,	_	
251-9	43820-43823	are	_	
251-10	43824-43830	needed	_	
251-11	43831-43837	before	_	
251-12	43838-43843	these	_	
251-13	43844-43852	findings	_	
251-14	43853-43856	can	_	
251-15	43857-43859	be	_	
251-16	43860-43866	useful	_	
251-17	43867-43869	in	_	
251-18	43870-43871	a	_	
251-19	43872-43880	clinical	_	
251-20	43881-43888	setting	_	
251-21	43888-43889	,	_	
251-22	43890-43894	this	_	
251-23	43895-43900	study	_	
251-24	43901-43909	achieves	_	
251-25	43910-43913	the	_	
251-26	43914-43923	important	_	
251-27	43924-43929	first	_	
251-28	43930-43934	step	_	
251-29	43935-43937	of	_	
251-30	43938-43949	translating	_	
251-31	43950-43961	preclinical	_	
251-32	43962-43968	models	_	
251-33	43969-43971	of	_	
251-34	43972-43977	binge	_	
251-35	43978-43986	drinking	_	
251-36	43987-43989	to	_	
251-37	43990-43993	the	_	
251-38	43994-43999	human	_	
251-39	44000-44005	brain	_	
251-40	44006-44009	and	_	
251-41	44010-44018	behavior	_	
251-42	44018-44019	.	_	

#Text=Supporting information
#Text=References
#Text=Binge drinking: Health impact, prevalence, correlates and interventions
#Text=WHO WHO.
252-1	44020-44030	Supporting	_	
252-2	44031-44042	information	_	
252-3	44043-44053	References	_	
252-4	44054-44059	Binge	_	
252-5	44060-44068	drinking	_	
252-6	44068-44069	:	_	
252-7	44070-44076	Health	_	
252-8	44077-44083	impact	_	
252-9	44083-44084	,	_	
252-10	44085-44095	prevalence	_	
252-11	44095-44096	,	_	
252-12	44097-44107	correlates	_	
252-13	44108-44111	and	_	
252-14	44112-44125	interventions	_	
252-15	44126-44129	WHO	_	
252-16	44130-44133	WHO	_	
252-17	44133-44134	.	_	

#Text=Global status report on alcohol and health, 2014: World Health Organization; 2014.
253-1	44135-44141	Global	_	
253-2	44142-44148	status	_	
253-3	44149-44155	report	_	
253-4	44156-44158	on	_	
253-5	44159-44166	alcohol	_	
253-6	44167-44170	and	_	
253-7	44171-44177	health	_	
253-8	44177-44178	,	_	
253-9	44179-44183	2014	_	
253-10	44183-44184	:	_	
253-11	44185-44190	World	_	
253-12	44191-44197	Health	_	
253-13	44198-44210	Organization	_	
253-14	44210-44211	;	_	
253-15	44212-44216	2014	_	
253-16	44216-44217	.	_	

#Text=Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
#Text=Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in US adults
#Text=Impulsivity, frontal lobes and risk for addiction
#Text=Fractionating impulsivity: neuropsychiatric implications
#Text=Cognitive processes in alcohol binges: a review and research agenda
#Text=Vulnerability for alcohol use disorder and rate of alcohol consumption
#Text=Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents
#Text=Alcohol-induced impairment of inhibitory control is linked to attenuated brain responses in right fronto-temporal cortex
#Text=The connectome of the basal ganglia
#Text=Effective connectivity reveals important roles for both the hyperdirect (fronto-subthalamic) and the indirect (fronto-striatal-pallidal) fronto-basal ganglia pathways during response inhibition
#Text=Competing basal ganglia pathways determine the difference between stopping and deciding not to go
#Text=Cortical areas involved in behavioral expression of external pallidum dysfunctions: a PET imaging study in non-human primates
#Text=Canceling actions involves a race between basal ganglia pathways
#Text=A Pause-then-Cancel model of stopping: evidence from basal ganglia neurophysiology
#Text=Ethanol-sensitive pacemaker neurons in the mouse external globus pallidus
#Text=Alcohol affects neuronal substrates of response inhibition but not of perceptual processing of stimuli signalling a stop response
#Text=
#Text=Reliability of a timeline method: assessing normal drinkers’ reports of recent drinking and a comparative evaluation across several populations
#Text=
#Text=Measures of impulsivity in cigarette smokers and non-smokers
#Text=Delay or probability discounting in a model of impulsive behavior: effect of alcohol
#Text=Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients
#Text=A genetic determinant of the striatal dopamine response to alcohol in men
#Text=Plawecki M, DeCarlo R, Ramchandani V, O’Connor S, editors.
254-1	44218-44225	Alcohol	_	
254-2	44225-44226	,	_	
254-3	44227-44234	adipose	_	
254-4	44235-44241	tissue	_	
254-5	44242-44245	and	_	
254-6	44246-44251	liver	_	
254-7	44252-44259	disease	_	
254-8	44259-44260	:	_	
254-9	44261-44272	mechanistic	_	
254-10	44273-44278	links	_	
254-11	44279-44282	and	_	
254-12	44283-44291	clinical	_	
254-13	44292-44306	considerations	_	
254-14	44307-44319	Relationship	_	
254-15	44320-44322	of	_	
254-16	44323-44330	alcohol	_	
254-17	44331-44342	consumption	_	
254-18	44343-44345	to	_	
254-19	44346-44355	all-cause	_	
254-20	44355-44356	,	_	
254-21	44357-44371	cardiovascular	_	
254-22	44371-44372	,	_	
254-23	44373-44376	and	_	
254-24	44377-44391	cancer-related	_	
254-25	44392-44401	mortality	_	
254-26	44402-44404	in	_	
254-27	44405-44407	US	_	
254-28	44408-44414	adults	_	
254-29	44415-44426	Impulsivity	_	
254-30	44426-44427	,	_	
254-31	44428-44435	frontal	_	
254-32	44436-44441	lobes	_	
254-33	44442-44445	and	_	
254-34	44446-44450	risk	_	
254-35	44451-44454	for	_	
254-36	44455-44464	addiction	_	
254-37	44465-44478	Fractionating	_	
254-38	44479-44490	impulsivity	_	
254-39	44490-44491	:	_	
254-40	44492-44508	neuropsychiatric	_	
254-41	44509-44521	implications	_	
254-42	44522-44531	Cognitive	_	
254-43	44532-44541	processes	_	
254-44	44542-44544	in	_	
254-45	44545-44552	alcohol	_	
254-46	44553-44559	binges	_	
254-47	44559-44560	:	_	
254-48	44561-44562	a	_	
254-49	44563-44569	review	_	
254-50	44570-44573	and	_	
254-51	44574-44582	research	_	
254-52	44583-44589	agenda	_	
254-53	44590-44603	Vulnerability	_	
254-54	44604-44607	for	_	
254-55	44608-44615	alcohol	_	
254-56	44616-44619	use	_	
254-57	44620-44628	disorder	_	
254-58	44629-44632	and	_	
254-59	44633-44637	rate	_	
254-60	44638-44640	of	_	
254-61	44641-44648	alcohol	_	
254-62	44649-44660	consumption	_	
254-63	44661-44668	Blunted	_	
254-64	44669-44676	ventral	_	
254-65	44677-44685	striatal	_	
254-66	44686-44695	responses	_	
254-67	44696-44698	to	_	
254-68	44699-44710	anticipated	_	
254-69	44711-44718	rewards	_	
254-70	44719-44729	foreshadow	_	
254-71	44730-44741	problematic	_	
254-72	44742-44746	drug	_	
254-73	44747-44750	use	_	
254-74	44751-44753	in	_	
254-75	44754-44769	novelty-seeking	_	
254-76	44770-44781	adolescents	_	
254-77	44782-44797	Alcohol-induced	_	
254-78	44798-44808	impairment	_	
254-79	44809-44811	of	_	
254-80	44812-44822	inhibitory	_	
254-81	44823-44830	control	_	
254-82	44831-44833	is	_	
254-83	44834-44840	linked	_	
254-84	44841-44843	to	_	
254-85	44844-44854	attenuated	_	
254-86	44855-44860	brain	_	
254-87	44861-44870	responses	_	
254-88	44871-44873	in	_	
254-89	44874-44879	right	_	
254-90	44880-44895	fronto-temporal	_	
254-91	44896-44902	cortex	_	
254-92	44903-44906	The	_	
254-93	44907-44917	connectome	_	
254-94	44918-44920	of	_	
254-95	44921-44924	the	_	
254-96	44925-44930	basal	_	
254-97	44931-44938	ganglia	_	
254-98	44939-44948	Effective	_	
254-99	44949-44961	connectivity	_	
254-100	44962-44969	reveals	_	
254-101	44970-44979	important	_	
254-102	44980-44985	roles	_	
254-103	44986-44989	for	_	
254-104	44990-44994	both	_	
254-105	44995-44998	the	_	
254-106	44999-45010	hyperdirect	_	
254-107	45011-45012	(	_	
254-108	45012-45030	fronto-subthalamic	_	
254-109	45030-45031	)	_	
254-110	45032-45035	and	_	
254-111	45036-45039	the	_	
254-112	45040-45048	indirect	_	
254-113	45049-45050	(	_	
254-114	45050-45074	fronto-striatal-pallidal	_	
254-115	45074-45075	)	_	
254-116	45076-45088	fronto-basal	_	
254-117	45089-45096	ganglia	_	
254-118	45097-45105	pathways	_	
254-119	45106-45112	during	_	
254-120	45113-45121	response	_	
254-121	45122-45132	inhibition	_	
254-122	45133-45142	Competing	_	
254-123	45143-45148	basal	_	
254-124	45149-45156	ganglia	_	
254-125	45157-45165	pathways	_	
254-126	45166-45175	determine	_	
254-127	45176-45179	the	_	
254-128	45180-45190	difference	_	
254-129	45191-45198	between	_	
254-130	45199-45207	stopping	_	
254-131	45208-45211	and	_	
254-132	45212-45220	deciding	_	
254-133	45221-45224	not	_	
254-134	45225-45227	to	_	
254-135	45228-45230	go	_	
254-136	45231-45239	Cortical	_	
254-137	45240-45245	areas	_	
254-138	45246-45254	involved	_	
254-139	45255-45257	in	_	
254-140	45258-45268	behavioral	_	
254-141	45269-45279	expression	_	
254-142	45280-45282	of	_	
254-143	45283-45291	external	_	
254-144	45292-45300	pallidum	_	
254-145	45301-45313	dysfunctions	_	
254-146	45313-45314	:	_	
254-147	45315-45316	a	_	
254-148	45317-45320	PET	_	
254-149	45321-45328	imaging	_	
254-150	45329-45334	study	_	
254-151	45335-45337	in	_	
254-152	45338-45347	non-human	_	
254-153	45348-45356	primates	_	
254-154	45357-45366	Canceling	_	
254-155	45367-45374	actions	_	
254-156	45375-45383	involves	_	
254-157	45384-45385	a	_	
254-158	45386-45390	race	_	
254-159	45391-45398	between	_	
254-160	45399-45404	basal	_	
254-161	45405-45412	ganglia	_	
254-162	45413-45421	pathways	_	
254-163	45422-45423	A	_	
254-164	45424-45441	Pause-then-Cancel	_	
254-165	45442-45447	model	_	
254-166	45448-45450	of	_	
254-167	45451-45459	stopping	_	
254-168	45459-45460	:	_	
254-169	45461-45469	evidence	_	
254-170	45470-45474	from	_	
254-171	45475-45480	basal	_	
254-172	45481-45488	ganglia	_	
254-173	45489-45504	neurophysiology	_	
254-174	45505-45522	Ethanol-sensitive	_	
254-175	45523-45532	pacemaker	_	
254-176	45533-45540	neurons	_	
254-177	45541-45543	in	_	
254-178	45544-45547	the	_	
254-179	45548-45553	mouse	_	
254-180	45554-45562	external	_	
254-181	45563-45569	globus	_	
254-182	45570-45578	pallidus	_	
254-183	45579-45586	Alcohol	_	
254-184	45587-45594	affects	_	
254-185	45595-45603	neuronal	_	
254-186	45604-45614	substrates	_	
254-187	45615-45617	of	_	
254-188	45618-45626	response	_	
254-189	45627-45637	inhibition	_	
254-190	45638-45641	but	_	
254-191	45642-45645	not	_	
254-192	45646-45648	of	_	
254-193	45649-45659	perceptual	_	
254-194	45660-45670	processing	_	
254-195	45671-45673	of	_	
254-196	45674-45681	stimuli	_	
254-197	45682-45692	signalling	_	
254-198	45693-45694	a	_	
254-199	45695-45699	stop	_	
254-200	45700-45708	response	_	
254-201	45710-45721	Reliability	_	
254-202	45722-45724	of	_	
254-203	45725-45726	a	_	
254-204	45727-45735	timeline	_	
254-205	45736-45742	method	_	
254-206	45742-45743	:	_	
254-207	45744-45753	assessing	_	
254-208	45754-45760	normal	_	
254-209	45761-45769	drinkers	_	
254-210	45769-45770	’	_	
254-211	45771-45778	reports	_	
254-212	45779-45781	of	_	
254-213	45782-45788	recent	_	
254-214	45789-45797	drinking	_	
254-215	45798-45801	and	_	
254-216	45802-45803	a	_	
254-217	45804-45815	comparative	_	
254-218	45816-45826	evaluation	_	
254-219	45827-45833	across	_	
254-220	45834-45841	several	_	
254-221	45842-45853	populations	_	
254-222	45855-45863	Measures	_	
254-223	45864-45866	of	_	
254-224	45867-45878	impulsivity	_	
254-225	45879-45881	in	_	
254-226	45882-45891	cigarette	_	
254-227	45892-45899	smokers	_	
254-228	45900-45903	and	_	
254-229	45904-45915	non-smokers	_	
254-230	45916-45921	Delay	_	
254-231	45922-45924	or	_	
254-232	45925-45936	probability	_	
254-233	45937-45948	discounting	_	
254-234	45949-45951	in	_	
254-235	45952-45953	a	_	
254-236	45954-45959	model	_	
254-237	45960-45962	of	_	
254-238	45963-45972	impulsive	_	
254-239	45973-45981	behavior	_	
254-240	45981-45982	:	_	
254-241	45983-45989	effect	_	
254-242	45990-45992	of	_	
254-243	45993-46000	alcohol	_	
254-244	46001-46011	Modulation	_	
254-245	46012-46014	of	_	
254-246	46015-46020	brain	_	
254-247	46021-46029	response	_	
254-248	46030-46032	to	_	
254-249	46033-46042	emotional	_	
254-250	46043-46049	images	_	
254-251	46050-46052	by	_	
254-252	46053-46060	alcohol	_	
254-253	46061-46065	cues	_	
254-254	46066-46068	in	_	
254-255	46069-46086	alcohol-dependent	_	
254-256	46087-46095	patients	_	
254-257	46096-46097	A	_	
254-258	46098-46105	genetic	_	
254-259	46106-46117	determinant	_	
254-260	46118-46120	of	_	
254-261	46121-46124	the	_	
254-262	46125-46133	striatal	_	
254-263	46134-46142	dopamine	_	
254-264	46143-46151	response	_	
254-265	46152-46154	to	_	
254-266	46155-46162	alcohol	_	
254-267	46163-46165	in	_	
254-268	46166-46169	men	_	
254-269	46170-46178	Plawecki	_	
254-270	46179-46180	M	_	
254-271	46180-46181	,	_	
254-272	46182-46189	DeCarlo	_	
254-273	46190-46191	R	_	
254-274	46191-46192	,	_	
254-275	46193-46204	Ramchandani	_	
254-276	46205-46206	V	_	
254-277	46206-46207	,	_	
254-278	46208-46209	O	_	
254-279	46209-46210	’	_	
254-280	46210-46216	Connor	_	
254-281	46217-46218	S	_	
254-282	46218-46219	,	_	
254-283	46220-46227	editors	_	
254-284	46227-46228	.	_	

#Text=Estimation of ethanol infusion profile to produce specified BrAC time course using physiologically-based pharmacokinetic (PBPK) models.
255-1	46229-46239	Estimation	_	
255-2	46240-46242	of	_	
255-3	46243-46250	ethanol	_	
255-4	46251-46259	infusion	_	
255-5	46260-46267	profile	_	
255-6	46268-46270	to	_	
255-7	46271-46278	produce	_	
255-8	46279-46288	specified	_	
255-9	46289-46293	BrAC	_	
255-10	46294-46298	time	_	
255-11	46299-46305	course	_	
255-12	46306-46311	using	_	
255-13	46312-46333	physiologically-based	_	
255-14	46334-46349	pharmacokinetic	_	
255-15	46350-46351	(	_	
255-16	46351-46355	PBPK	_	
255-17	46355-46356	)	_	
255-18	46357-46363	models	_	
255-19	46363-46364	.	_	

#Text=The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2004: IEEE.
256-1	46365-46368	The	_	
256-2	46369-46373	26th	_	
256-3	46374-46380	Annual	_	
256-4	46381-46394	International	_	
256-5	46395-46405	Conference	_	
256-6	46406-46408	of	_	
256-7	46409-46412	the	_	
256-8	46413-46417	IEEE	_	
256-9	46418-46429	Engineering	_	
256-10	46430-46432	in	_	
256-11	46433-46441	Medicine	_	
256-12	46442-46445	and	_	
256-13	46446-46453	Biology	_	
256-14	46454-46461	Society	_	
256-15	46461-46462	;	_	
256-16	46463-46467	2004	_	
256-17	46467-46468	:	_	
256-18	46469-46473	IEEE	_	
256-19	46473-46474	.	_	

#Text=A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping
#Text=PBPK modeling as a basis for achieving a steady BrAC of 60 +/- 5 mg% within ten minutes
#Text=A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping
#Text=Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol
#Text=The drug effects questionnaire: psychometric support across three drug types
#Text=Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks
#Text=BOLD fractional contribution to resting-state functional connectivity above 0.1 Hz
#Text=Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity
#Text=Dorsal and ventral streams: the distinct role of striatal subregions in the acquisition and performance of goal-directed actions
#Text=Functional Connectivity Delineates Distinct Roles of the Inferior Frontal Cortex and Presupplementary Motor Area in Stop Signal Inhibition
#Text=A fronto–striato–subthalamic–pallidal network for goal-directed and habitual inhibition
#Text=THE NEURAL BASIS OF DRUG CRAVING—AN INCENTIVE-SENSITIZATION THEORY OF ADDICTION
#Text=Locomotor sensitization to ethanol impairs NMDA receptor-dependent synaptic plasticity in the nucleus accumbens and increases ethanol self-administration
#Text=Altered effective connectivity network of the basal ganglia in low-grade hepatic encephalopathy: a resting-state fMRI study with Granger causality analysis
#Text=Probability effects in the stop-signal paradigm: the insula and the significance of failed inhibition
#Text=Dorsal Anterior Cingulate Cortex: A Bottom-Up View
#Text=Altered resting-state brain activity at functional MRI during automatic memory consolidation of fear conditioning
#Text=Ramping ensemble activity in dorsal anterior cingulate neurons during persistent commitment to a decision
#Text=Medial Prefrontal and Subcortical Mechanisms Underlying the Acquisition of Motor and Cognitive Action Sequences in Humans
#Text=Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum
#Text=Neurobiology of addiction: a neurocircuitry analysis
#Text=A relationship between the aldosterone–mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans
#Text=Dissociable frontostriatal white matter connectivity underlies reward and motor impulsivity
#Text=Functional significance of the cortico–subthalamo–pallidal ‘hyperdirect’ pathway
#Text=Functional networks for cognitive control in a stop signal task: independent component analysis
#Text=Eyes open and eyes closed as rest conditions: impact on brain activation patterns
#Text=Effects of morphine and alcohol on functional brain connectivity during "resting state": A placebo-controlled crossover study in healthy young men
#Text=Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls
#Text=Resting-state connectivity biomarkers define neurophysiological subtypes of depression
#Text=Functional neural circuits for mental timekeeping
#Text=Altered frontostriatal coupling in pre-manifest Huntington’s disease: effects of increasing cognitive load
#Text=Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task
#Text=Baseline Frontostriatal-Limbic Connectivity Predicts Reward-Based Memory Formation
#Text=L-Dopa Modulates Functional Connectivity in Striatal Cognitive and Motor Networks: A Double-Blind Placebo-Controlled Study
#Text=10.1371/journal.pone.0224906.r001
#Text=Decision Letter 0
#Text=Pattij
#Text=Tommy
#Text=This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
#Text= 10 Jan 2020 
#Text=PONE-D-19-29169
#Text=Alcohol Effects on Globus Pallidus Connectivity: Role of Impulsivity and Binge Drinking
#Text=PLOS ONE
#Text=Dear Dr.
257-1	46475-46476	A	_	
257-2	46477-46498	physiologically-based	_	
257-3	46499-46514	pharmacokinetic	_	
257-4	46515-46516	(	_	
257-5	46516-46520	PBPK	_	
257-6	46520-46521	)	_	
257-7	46522-46527	model	_	
257-8	46528-46531	for	_	
257-9	46532-46539	alcohol	_	
257-10	46540-46551	facilitates	_	
257-11	46552-46557	rapid	_	
257-12	46558-46562	BrAC	_	
257-13	46563-46571	clamping	_	
257-14	46572-46576	PBPK	_	
257-15	46577-46585	modeling	_	
257-16	46586-46588	as	_	
257-17	46589-46590	a	_	
257-18	46591-46596	basis	_	
257-19	46597-46600	for	_	
257-20	46601-46610	achieving	_	
257-21	46611-46612	a	_	
257-22	46613-46619	steady	_	
257-23	46620-46624	BrAC	_	
257-24	46625-46627	of	_	
257-25	46628-46630	60	_	
257-26	46631-46632	+	_	
257-27	46632-46633	/	_	
257-28	46633-46634	-	_	
257-29	46635-46636	5	_	
257-30	46637-46639	mg	_	
257-31	46639-46640	%	_	
257-32	46641-46647	within	_	
257-33	46648-46651	ten	_	
257-34	46652-46659	minutes	_	
257-35	46660-46661	A	_	
257-36	46662-46683	physiologically-based	_	
257-37	46684-46699	pharmacokinetic	_	
257-38	46700-46701	(	_	
257-39	46701-46705	PBPK	_	
257-40	46705-46706	)	_	
257-41	46707-46712	model	_	
257-42	46713-46716	for	_	
257-43	46717-46724	alcohol	_	
257-44	46725-46736	facilitates	_	
257-45	46737-46742	rapid	_	
257-46	46743-46747	BrAC	_	
257-47	46748-46756	clamping	_	
257-48	46757-46760	Why	_	
257-49	46761-46763	we	_	
257-50	46764-46768	like	_	
257-51	46769-46771	to	_	
257-52	46772-46777	drink	_	
257-53	46777-46778	:	_	
257-54	46779-46780	a	_	
257-55	46781-46791	functional	_	
257-56	46792-46800	magnetic	_	
257-57	46801-46810	resonance	_	
257-58	46811-46818	imaging	_	
257-59	46819-46824	study	_	
257-60	46825-46827	of	_	
257-61	46828-46831	the	_	
257-62	46832-46841	rewarding	_	
257-63	46842-46845	and	_	
257-64	46846-46856	anxiolytic	_	
257-65	46857-46864	effects	_	
257-66	46865-46867	of	_	
257-67	46868-46875	alcohol	_	
257-68	46876-46879	The	_	
257-69	46880-46884	drug	_	
257-70	46885-46892	effects	_	
257-71	46893-46906	questionnaire	_	
257-72	46906-46907	:	_	
257-73	46908-46920	psychometric	_	
257-74	46921-46928	support	_	
257-75	46929-46935	across	_	
257-76	46936-46941	three	_	
257-77	46942-46946	drug	_	
257-78	46947-46952	types	_	
257-79	46953-46957	Conn	_	
257-80	46957-46958	:	_	
257-81	46959-46960	a	_	
257-82	46961-46971	functional	_	
257-83	46972-46984	connectivity	_	
257-84	46985-46992	toolbox	_	
257-85	46993-46996	for	_	
257-86	46997-47007	correlated	_	
257-87	47008-47011	and	_	
257-88	47012-47026	anticorrelated	_	
257-89	47027-47032	brain	_	
257-90	47033-47041	networks	_	
257-91	47042-47046	BOLD	_	
257-92	47047-47057	fractional	_	
257-93	47058-47070	contribution	_	
257-94	47071-47073	to	_	
257-95	47074-47087	resting-state	_	
257-96	47088-47098	functional	_	
257-97	47099-47111	connectivity	_	
257-98	47112-47117	above	_	
257-99	47118-47121	0.1	_	
257-100	47122-47124	Hz	_	
257-101	47125-47131	Toward	_	
257-102	47132-47140	defining	_	
257-103	47141-47145	deep	_	
257-104	47146-47151	brain	_	
257-105	47152-47163	stimulation	_	
257-106	47164-47171	targets	_	
257-107	47172-47174	in	_	
257-108	47175-47178	MNI	_	
257-109	47179-47184	space	_	
257-110	47184-47185	:	_	
257-111	47186-47187	A	_	
257-112	47188-47199	subcortical	_	
257-113	47200-47205	atlas	_	
257-114	47206-47211	based	_	
257-115	47212-47214	on	_	
257-116	47215-47225	multimodal	_	
257-117	47226-47229	MRI	_	
257-118	47229-47230	,	_	
257-119	47231-47240	histology	_	
257-120	47241-47244	and	_	
257-121	47245-47255	structural	_	
257-122	47256-47268	connectivity	_	
257-123	47269-47275	Dorsal	_	
257-124	47276-47279	and	_	
257-125	47280-47287	ventral	_	
257-126	47288-47295	streams	_	
257-127	47295-47296	:	_	
257-128	47297-47300	the	_	
257-129	47301-47309	distinct	_	
257-130	47310-47314	role	_	
257-131	47315-47317	of	_	
257-132	47318-47326	striatal	_	
257-133	47327-47337	subregions	_	
257-134	47338-47340	in	_	
257-135	47341-47344	the	_	
257-136	47345-47356	acquisition	_	
257-137	47357-47360	and	_	
257-138	47361-47372	performance	_	
257-139	47373-47375	of	_	
257-140	47376-47389	goal-directed	_	
257-141	47390-47397	actions	_	
257-142	47398-47408	Functional	_	
257-143	47409-47421	Connectivity	_	
257-144	47422-47432	Delineates	_	
257-145	47433-47441	Distinct	_	
257-146	47442-47447	Roles	_	
257-147	47448-47450	of	_	
257-148	47451-47454	the	_	
257-149	47455-47463	Inferior	_	
257-150	47464-47471	Frontal	_	
257-151	47472-47478	Cortex	_	
257-152	47479-47482	and	_	
257-153	47483-47499	Presupplementary	_	
257-154	47500-47505	Motor	_	
257-155	47506-47510	Area	_	
257-156	47511-47513	in	_	
257-157	47514-47518	Stop	_	
257-158	47519-47525	Signal	_	
257-159	47526-47536	Inhibition	_	
257-160	47537-47538	A	_	
257-161	47539-47574	fronto–striato–subthalamic–pallidal	_	
257-162	47575-47582	network	_	
257-163	47583-47586	for	_	
257-164	47587-47600	goal-directed	_	
257-165	47601-47604	and	_	
257-166	47605-47613	habitual	_	
257-167	47614-47624	inhibition	_	
257-168	47625-47628	THE	_	
257-169	47629-47635	NEURAL	_	
257-170	47636-47641	BASIS	_	
257-171	47642-47644	OF	_	
257-172	47645-47649	DRUG	_	
257-173	47650-47660	CRAVING—AN	_	
257-174	47661-47684	INCENTIVE-SENSITIZATION	_	
257-175	47685-47691	THEORY	_	
257-176	47692-47694	OF	_	
257-177	47695-47704	ADDICTION	_	
257-178	47705-47714	Locomotor	_	
257-179	47715-47728	sensitization	_	
257-180	47729-47731	to	_	
257-181	47732-47739	ethanol	_	
257-182	47740-47747	impairs	_	
257-183	47748-47752	NMDA	_	
257-184	47753-47771	receptor-dependent	_	
257-185	47772-47780	synaptic	_	
257-186	47781-47791	plasticity	_	
257-187	47792-47794	in	_	
257-188	47795-47798	the	_	
257-189	47799-47806	nucleus	_	
257-190	47807-47816	accumbens	_	
257-191	47817-47820	and	_	
257-192	47821-47830	increases	_	
257-193	47831-47838	ethanol	_	
257-194	47839-47858	self-administration	_	
257-195	47859-47866	Altered	_	
257-196	47867-47876	effective	_	
257-197	47877-47889	connectivity	_	
257-198	47890-47897	network	_	
257-199	47898-47900	of	_	
257-200	47901-47904	the	_	
257-201	47905-47910	basal	_	
257-202	47911-47918	ganglia	_	
257-203	47919-47921	in	_	
257-204	47922-47931	low-grade	_	
257-205	47932-47939	hepatic	_	
257-206	47940-47954	encephalopathy	_	
257-207	47954-47955	:	_	
257-208	47956-47957	a	_	
257-209	47958-47971	resting-state	_	
257-210	47972-47976	fMRI	_	
257-211	47977-47982	study	_	
257-212	47983-47987	with	_	
257-213	47988-47995	Granger	_	
257-214	47996-48005	causality	_	
257-215	48006-48014	analysis	_	
257-216	48015-48026	Probability	_	
257-217	48027-48034	effects	_	
257-218	48035-48037	in	_	
257-219	48038-48041	the	_	
257-220	48042-48053	stop-signal	_	
257-221	48054-48062	paradigm	_	
257-222	48062-48063	:	_	
257-223	48064-48067	the	_	
257-224	48068-48074	insula	_	
257-225	48075-48078	and	_	
257-226	48079-48082	the	_	
257-227	48083-48095	significance	_	
257-228	48096-48098	of	_	
257-229	48099-48105	failed	_	
257-230	48106-48116	inhibition	_	
257-231	48117-48123	Dorsal	_	
257-232	48124-48132	Anterior	_	
257-233	48133-48142	Cingulate	_	
257-234	48143-48149	Cortex	_	
257-235	48149-48150	:	_	
257-236	48151-48152	A	_	
257-237	48153-48162	Bottom-Up	_	
257-238	48163-48167	View	_	
257-239	48168-48175	Altered	_	
257-240	48176-48189	resting-state	_	
257-241	48190-48195	brain	_	
257-242	48196-48204	activity	_	
257-243	48205-48207	at	_	
257-244	48208-48218	functional	_	
257-245	48219-48222	MRI	_	
257-246	48223-48229	during	_	
257-247	48230-48239	automatic	_	
257-248	48240-48246	memory	_	
257-249	48247-48260	consolidation	_	
257-250	48261-48263	of	_	
257-251	48264-48268	fear	_	
257-252	48269-48281	conditioning	_	
257-253	48282-48289	Ramping	_	
257-254	48290-48298	ensemble	_	
257-255	48299-48307	activity	_	
257-256	48308-48310	in	_	
257-257	48311-48317	dorsal	_	
257-258	48318-48326	anterior	_	
257-259	48327-48336	cingulate	_	
257-260	48337-48344	neurons	_	
257-261	48345-48351	during	_	
257-262	48352-48362	persistent	_	
257-263	48363-48373	commitment	_	
257-264	48374-48376	to	_	
257-265	48377-48378	a	_	
257-266	48379-48387	decision	_	
257-267	48388-48394	Medial	_	
257-268	48395-48405	Prefrontal	_	
257-269	48406-48409	and	_	
257-270	48410-48421	Subcortical	_	
257-271	48422-48432	Mechanisms	_	
257-272	48433-48443	Underlying	_	
257-273	48444-48447	the	_	
257-274	48448-48459	Acquisition	_	
257-275	48460-48462	of	_	
257-276	48463-48468	Motor	_	
257-277	48469-48472	and	_	
257-278	48473-48482	Cognitive	_	
257-279	48483-48489	Action	_	
257-280	48490-48499	Sequences	_	
257-281	48500-48502	in	_	
257-282	48503-48509	Humans	_	
257-283	48510-48518	Blocking	_	
257-284	48519-48522	the	_	
257-285	48523-48540	mineralocorticoid	_	
257-286	48541-48549	receptor	_	
257-287	48550-48552	in	_	
257-288	48553-48559	humans	_	
257-289	48560-48568	prevents	_	
257-290	48569-48572	the	_	
257-291	48573-48587	stress-induced	_	
257-292	48588-48599	enhancement	_	
257-293	48600-48602	of	_	
257-294	48603-48615	centromedial	_	
257-295	48616-48624	amygdala	_	
257-296	48625-48637	connectivity	_	
257-297	48638-48642	with	_	
257-298	48643-48646	the	_	
257-299	48647-48653	dorsal	_	
257-300	48654-48662	striatum	_	
257-301	48663-48675	Neurobiology	_	
257-302	48676-48678	of	_	
257-303	48679-48688	addiction	_	
257-304	48688-48689	:	_	
257-305	48690-48691	a	_	
257-306	48692-48706	neurocircuitry	_	
257-307	48707-48715	analysis	_	
257-308	48716-48717	A	_	
257-309	48718-48730	relationship	_	
257-310	48731-48738	between	_	
257-311	48739-48742	the	_	
257-312	48743-48772	aldosterone–mineralocorticoid	_	
257-313	48773-48781	receptor	_	
257-314	48782-48789	pathway	_	
257-315	48790-48793	and	_	
257-316	48794-48801	alcohol	_	
257-317	48802-48810	drinking	_	
257-318	48810-48811	:	_	
257-319	48812-48823	preliminary	_	
257-320	48824-48837	translational	_	
257-321	48838-48846	findings	_	
257-322	48847-48853	across	_	
257-323	48854-48858	rats	_	
257-324	48858-48859	,	_	
257-325	48860-48867	monkeys	_	
257-326	48868-48871	and	_	
257-327	48872-48878	humans	_	
257-328	48879-48890	Dissociable	_	
257-329	48891-48905	frontostriatal	_	
257-330	48906-48911	white	_	
257-331	48912-48918	matter	_	
257-332	48919-48931	connectivity	_	
257-333	48932-48941	underlies	_	
257-334	48942-48948	reward	_	
257-335	48949-48952	and	_	
257-336	48953-48958	motor	_	
257-337	48959-48970	impulsivity	_	
257-338	48971-48981	Functional	_	
257-339	48982-48994	significance	_	
257-340	48995-48997	of	_	
257-341	48998-49001	the	_	
257-342	49002-49029	cortico–subthalamo–pallidal	_	
257-343	49030-49031	‘	_	
257-344	49031-49042	hyperdirect	_	
257-345	49042-49043	’	_	
257-346	49044-49051	pathway	_	
257-347	49052-49062	Functional	_	
257-348	49063-49071	networks	_	
257-349	49072-49075	for	_	
257-350	49076-49085	cognitive	_	
257-351	49086-49093	control	_	
257-352	49094-49096	in	_	
257-353	49097-49098	a	_	
257-354	49099-49103	stop	_	
257-355	49104-49110	signal	_	
257-356	49111-49115	task	_	
257-357	49115-49116	:	_	
257-358	49117-49128	independent	_	
257-359	49129-49138	component	_	
257-360	49139-49147	analysis	_	
257-361	49148-49152	Eyes	_	
257-362	49153-49157	open	_	
257-363	49158-49161	and	_	
257-364	49162-49166	eyes	_	
257-365	49167-49173	closed	_	
257-366	49174-49176	as	_	
257-367	49177-49181	rest	_	
257-368	49182-49192	conditions	_	
257-369	49192-49193	:	_	
257-370	49194-49200	impact	_	
257-371	49201-49203	on	_	
257-372	49204-49209	brain	_	
257-373	49210-49220	activation	_	
257-374	49221-49229	patterns	_	
257-375	49230-49237	Effects	_	
257-376	49238-49240	of	_	
257-377	49241-49249	morphine	_	
257-378	49250-49253	and	_	
257-379	49254-49261	alcohol	_	
257-380	49262-49264	on	_	
257-381	49265-49275	functional	_	
257-382	49276-49281	brain	_	
257-383	49282-49294	connectivity	_	
257-384	49295-49301	during	_	
257-385	49302-49303	"	_	
257-386	49303-49310	resting	_	
257-387	49311-49316	state	_	
257-388	49316-49317	"	_	
257-389	49317-49318	:	_	
257-390	49319-49320	A	_	
257-391	49321-49339	placebo-controlled	_	
257-392	49340-49349	crossover	_	
257-393	49350-49355	study	_	
257-394	49356-49358	in	_	
257-395	49359-49366	healthy	_	
257-396	49367-49372	young	_	
257-397	49373-49376	men	_	
257-398	49377-49382	Delay	_	
257-399	49383-49394	discounting	_	
257-400	49395-49397	of	_	
257-401	49398-49403	money	_	
257-402	49404-49407	and	_	
257-403	49408-49415	alcohol	_	
257-404	49416-49418	in	_	
257-405	49419-49427	actively	_	
257-406	49428-49433	using	_	
257-407	49434-49444	alcoholics	_	
257-408	49444-49445	,	_	
257-409	49446-49455	currently	_	
257-410	49456-49465	abstinent	_	
257-411	49466-49476	alcoholics	_	
257-412	49476-49477	,	_	
257-413	49478-49481	and	_	
257-414	49482-49490	controls	_	
257-415	49491-49504	Resting-state	_	
257-416	49505-49517	connectivity	_	
257-417	49518-49528	biomarkers	_	
257-418	49529-49535	define	_	
257-419	49536-49554	neurophysiological	_	
257-420	49555-49563	subtypes	_	
257-421	49564-49566	of	_	
257-422	49567-49577	depression	_	
257-423	49578-49588	Functional	_	
257-424	49589-49595	neural	_	
257-425	49596-49604	circuits	_	
257-426	49605-49608	for	_	
257-427	49609-49615	mental	_	
257-428	49616-49627	timekeeping	_	
257-429	49628-49635	Altered	_	
257-430	49636-49650	frontostriatal	_	
257-431	49651-49659	coupling	_	
257-432	49660-49662	in	_	
257-433	49663-49675	pre-manifest	_	
257-434	49676-49686	Huntington	_	
257-435	49686-49687	’	_	
257-436	49687-49688	s	_	
257-437	49689-49696	disease	_	
257-438	49696-49697	:	_	
257-439	49698-49705	effects	_	
257-440	49706-49708	of	_	
257-441	49709-49719	increasing	_	
257-442	49720-49729	cognitive	_	
257-443	49730-49734	load	_	
257-444	49735-49743	Dopamine	_	
257-445	49744-49753	depletion	_	
257-446	49754-49761	impairs	_	
257-447	49762-49776	frontostriatal	_	
257-448	49777-49787	functional	_	
257-449	49788-49800	connectivity	_	
257-450	49801-49807	during	_	
257-451	49808-49809	a	_	
257-452	49810-49822	set-shifting	_	
257-453	49823-49827	task	_	
257-454	49828-49836	Baseline	_	
257-455	49837-49858	Frontostriatal-Limbic	_	
257-456	49859-49871	Connectivity	_	
257-457	49872-49880	Predicts	_	
257-458	49881-49893	Reward-Based	_	
257-459	49894-49900	Memory	_	
257-460	49901-49910	Formation	_	
257-461	49911-49917	L-Dopa	_	
257-462	49918-49927	Modulates	_	
257-463	49928-49938	Functional	_	
257-464	49939-49951	Connectivity	_	
257-465	49952-49954	in	_	
257-466	49955-49963	Striatal	_	
257-467	49964-49973	Cognitive	_	
257-468	49974-49977	and	_	
257-469	49978-49983	Motor	_	
257-470	49984-49992	Networks	_	
257-471	49992-49993	:	_	
257-472	49994-49995	A	_	
257-473	49996-50008	Double-Blind	_	
257-474	50009-50027	Placebo-Controlled	_	
257-475	50028-50033	Study	_	
257-476	50034-50041	10.1371	_	
257-477	50041-50042	/	_	
257-478	50042-50054	journal.pone	_	
257-479	50054-50062	.0224906	_	
257-480	50062-50063	.	_	
257-481	50063-50067	r001	_	
257-482	50068-50076	Decision	_	
257-483	50077-50083	Letter	_	
257-484	50084-50085	0	_	
257-485	50086-50092	Pattij	_	
257-486	50093-50098	Tommy	_	
257-487	50099-50103	This	_	
257-488	50104-50106	is	_	
257-489	50107-50109	an	_	
257-490	50110-50114	open	_	
257-491	50115-50121	access	_	
257-492	50122-50129	article	_	
257-493	50130-50141	distributed	_	
257-494	50142-50147	under	_	
257-495	50148-50151	the	_	
257-496	50152-50157	terms	_	
257-497	50158-50160	of	_	
257-498	50161-50164	the	_	
257-499	50165-50173	Creative	_	
257-500	50174-50181	Commons	_	
257-501	50182-50193	Attribution	_	
257-502	50194-50201	License	_	
257-503	50201-50202	,	_	
257-504	50203-50208	which	_	
257-505	50209-50216	permits	_	
257-506	50217-50229	unrestricted	_	
257-507	50230-50233	use	_	
257-508	50233-50234	,	_	
257-509	50235-50247	distribution	_	
257-510	50247-50248	,	_	
257-511	50249-50252	and	_	
257-512	50253-50265	reproduction	_	
257-513	50266-50268	in	_	
257-514	50269-50272	any	_	
257-515	50273-50279	medium	_	
257-516	50279-50280	,	_	
257-517	50281-50289	provided	_	
257-518	50290-50293	the	_	
257-519	50294-50302	original	_	
257-520	50303-50309	author	_	
257-521	50310-50313	and	_	
257-522	50314-50320	source	_	
257-523	50321-50324	are	_	
257-524	50325-50333	credited	_	
257-525	50333-50334	.	_	
257-526	50336-50338	10	_	
257-527	50339-50342	Jan	_	
257-528	50343-50347	2020	_	
257-529	50349-50355	PONE-D	_	
257-530	50355-50356	-	_	
257-531	50356-50358	19	_	
257-532	50358-50359	-	_	
257-533	50359-50364	29169	_	
257-534	50365-50372	Alcohol	_	
257-535	50373-50380	Effects	_	
257-536	50381-50383	on	_	
257-537	50384-50390	Globus	_	
257-538	50391-50399	Pallidus	_	
257-539	50400-50412	Connectivity	_	
257-540	50412-50413	:	_	
257-541	50413-50414	 	_	
257-542	50414-50418	Role	_	
257-543	50419-50421	of	_	
257-544	50422-50433	Impulsivity	_	
257-545	50434-50437	and	_	
257-546	50438-50443	Binge	_	
257-547	50444-50452	Drinking	_	
257-548	50453-50457	PLOS	_	
257-549	50458-50461	ONE	_	
257-550	50462-50466	Dear	_	
257-551	50467-50469	Dr	_	
257-552	50469-50470	.	_	

#Text=Momenan,
#Text=Thank you for submitting your manuscript to PLOS ONE.
258-1	50471-50478	Momenan	_	
258-2	50478-50479	,	_	
258-3	50480-50485	Thank	_	
258-4	50486-50489	you	_	
258-5	50490-50493	for	_	
258-6	50494-50504	submitting	_	
258-7	50505-50509	your	_	
258-8	50510-50520	manuscript	_	
258-9	50521-50523	to	_	
258-10	50524-50528	PLOS	_	
258-11	50529-50532	ONE	_	
258-12	50532-50533	.	_	

#Text=After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands.
259-1	50534-50539	After	_	
259-2	50540-50547	careful	_	
259-3	50548-50561	consideration	_	
259-4	50561-50562	,	_	
259-5	50563-50565	we	_	
259-6	50566-50570	feel	_	
259-7	50571-50575	that	_	
259-8	50576-50578	it	_	
259-9	50579-50582	has	_	
259-10	50583-50588	merit	_	
259-11	50589-50592	but	_	
259-12	50593-50597	does	_	
259-13	50598-50601	not	_	
259-14	50602-50607	fully	_	
259-15	50608-50612	meet	_	
259-16	50613-50617	PLOS	_	
259-17	50618-50621	ONE	_	
259-18	50621-50622	’	_	
259-19	50622-50623	s	_	
259-20	50624-50635	publication	_	
259-21	50636-50644	criteria	_	
259-22	50645-50647	as	_	
259-23	50648-50650	it	_	
259-24	50651-50660	currently	_	
259-25	50661-50667	stands	_	
259-26	50667-50668	.	_	

#Text=Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process.
260-1	50669-50678	Therefore	_	
260-2	50678-50679	,	_	
260-3	50680-50682	we	_	
260-4	50683-50689	invite	_	
260-5	50690-50693	you	_	
260-6	50694-50696	to	_	
260-7	50697-50703	submit	_	
260-8	50704-50705	a	_	
260-9	50706-50713	revised	_	
260-10	50714-50721	version	_	
260-11	50722-50724	of	_	
260-12	50725-50728	the	_	
260-13	50729-50739	manuscript	_	
260-14	50740-50744	that	_	
260-15	50745-50754	addresses	_	
260-16	50755-50758	all	_	
260-17	50759-50762	the	_	
260-18	50763-50769	points	_	
260-19	50770-50776	raised	_	
260-20	50777-50783	during	_	
260-21	50784-50787	the	_	
260-22	50788-50794	review	_	
260-23	50795-50802	process	_	
260-24	50802-50803	.	_	

#Text=In particular, regarding the statistical analyses and presentation of the data: 1) present effect sizes in the results section and include analyses on gender effects as suggested by reviewer 1 and 2) use more conservative cluster-forming thresholds and be more specific and complete in the description of the employed analyses as suggested by reviewer 2.
261-1	50804-50806	In	_	
261-2	50807-50817	particular	_	
261-3	50817-50818	,	_	
261-4	50819-50828	regarding	_	
261-5	50829-50832	the	_	
261-6	50833-50844	statistical	_	
261-7	50845-50853	analyses	_	
261-8	50854-50857	and	_	
261-9	50858-50870	presentation	_	
261-10	50871-50873	of	_	
261-11	50874-50877	the	_	
261-12	50878-50882	data	_	
261-13	50882-50883	:	_	
261-14	50884-50885	1	_	
261-15	50885-50886	)	_	
261-16	50886-50887	 	_	
261-17	50887-50894	present	_	
261-18	50895-50901	effect	_	
261-19	50902-50907	sizes	_	
261-20	50908-50910	in	_	
261-21	50911-50914	the	_	
261-22	50915-50922	results	_	
261-23	50923-50930	section	_	
261-24	50931-50934	and	_	
261-25	50935-50942	include	_	
261-26	50943-50951	analyses	_	
261-27	50952-50954	on	_	
261-28	50955-50961	gender	_	
261-29	50962-50969	effects	_	
261-30	50970-50972	as	_	
261-31	50973-50982	suggested	_	
261-32	50983-50985	by	_	
261-33	50986-50994	reviewer	_	
261-34	50995-50996	1	_	
261-35	50997-51000	and	_	
261-36	51001-51002	2	_	
261-37	51002-51003	)	_	
261-38	51004-51007	use	_	
261-39	51008-51012	more	_	
261-40	51013-51025	conservative	_	
261-41	51026-51041	cluster-forming	_	
261-42	51041-51042	 	_	
261-43	51042-51052	thresholds	_	
261-44	51053-51056	and	_	
261-45	51057-51059	be	_	
261-46	51060-51064	more	_	
261-47	51065-51073	specific	_	
261-48	51074-51077	and	_	
261-49	51078-51086	complete	_	
261-50	51087-51089	in	_	
261-51	51090-51093	the	_	
261-52	51094-51105	description	_	
261-53	51106-51108	of	_	
261-54	51109-51112	the	_	
261-55	51113-51121	employed	_	
261-56	51122-51130	analyses	_	
261-57	51131-51133	as	_	
261-58	51134-51143	suggested	_	
261-59	51144-51146	by	_	
261-60	51147-51155	reviewer	_	
261-61	51156-51157	2	_	
261-62	51157-51158	.	_	

#Text=In addition, the GPe as region of interest should be more clearly motivated as suggested by reviewer 1, and the discrepancy between the discussion of behavioural data and the absence thereof in the results section should be addressed.
262-1	51159-51161	In	_	
262-2	51162-51170	addition	_	
262-3	51170-51171	,	_	
262-4	51172-51175	the	_	
262-5	51176-51179	GPe	_	
262-6	51180-51182	as	_	
262-7	51183-51189	region	_	
262-8	51190-51192	of	_	
262-9	51193-51201	interest	_	
262-10	51202-51208	should	_	
262-11	51209-51211	be	_	
262-12	51212-51216	more	_	
262-13	51217-51224	clearly	_	
262-14	51225-51234	motivated	_	
262-15	51235-51237	as	_	
262-16	51238-51247	suggested	_	
262-17	51248-51250	by	_	
262-18	51251-51259	reviewer	_	
262-19	51260-51261	1	_	
262-20	51261-51262	,	_	
262-21	51263-51266	and	_	
262-22	51267-51270	the	_	
262-23	51271-51282	discrepancy	_	
262-24	51283-51290	between	_	
262-25	51291-51294	the	_	
262-26	51295-51305	discussion	_	
262-27	51306-51308	of	_	
262-28	51309-51320	behavioural	_	
262-29	51321-51325	data	_	
262-30	51326-51329	and	_	
262-31	51330-51333	the	_	
262-32	51334-51341	absence	_	
262-33	51342-51349	thereof	_	
262-34	51350-51352	in	_	
262-35	51353-51356	the	_	
262-36	51357-51364	results	_	
262-37	51365-51372	section	_	
262-38	51373-51379	should	_	
262-39	51380-51382	be	_	
262-40	51383-51392	addressed	_	
262-41	51392-51393	.	_	

#Text=We would appreciate receiving your revised manuscript by Feb 24 2020 11:59PM.
263-1	51394-51396	We	_	
263-2	51397-51402	would	_	
263-3	51403-51413	appreciate	_	
263-4	51414-51423	receiving	_	
263-5	51424-51428	your	_	
263-6	51429-51436	revised	_	
263-7	51437-51447	manuscript	_	
263-8	51448-51450	by	_	
263-9	51451-51454	Feb	_	
263-10	51455-51457	24	_	
263-11	51458-51462	2020	_	
263-12	51463-51465	11	_	
263-13	51465-51466	:	_	
263-14	51466-51470	59PM	_	
263-15	51470-51471	.	_	

#Text=When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
264-1	51472-51476	When	_	
264-2	51477-51480	you	_	
264-3	51481-51484	are	_	
264-4	51485-51490	ready	_	
264-5	51491-51493	to	_	
264-6	51494-51500	submit	_	
264-7	51501-51505	your	_	
264-8	51506-51514	revision	_	
264-9	51514-51515	,	_	
264-10	51516-51519	log	_	
264-11	51520-51522	on	_	
264-12	51523-51525	to	_	
264-13	51526-51531	https	_	
264-14	51531-51532	:	_	
264-15	51532-51533	/	_	
264-16	51533-51534	/	_	
264-17	51534-51558	www.editorialmanager.com	_	
264-18	51558-51559	/	_	
264-19	51559-51563	pone	_	
264-20	51563-51564	/	_	
264-21	51565-51568	and	_	
264-22	51569-51575	select	_	
264-23	51576-51579	the	_	
264-24	51580-51581	'	_	
264-25	51581-51592	Submissions	_	
264-26	51593-51600	Needing	_	
264-27	51601-51609	Revision	_	
264-28	51609-51610	'	_	
264-29	51611-51617	folder	_	
264-30	51618-51620	to	_	
264-31	51621-51627	locate	_	
264-32	51628-51632	your	_	
264-33	51633-51643	manuscript	_	
264-34	51644-51648	file	_	
264-35	51648-51649	.	_	

#Text=If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.
265-1	51650-51652	If	_	
265-2	51653-51656	you	_	
265-3	51657-51662	would	_	
265-4	51663-51667	like	_	
265-5	51668-51670	to	_	
265-6	51671-51675	make	_	
265-7	51676-51683	changes	_	
265-8	51684-51686	to	_	
265-9	51687-51691	your	_	
265-10	51692-51701	financial	_	
265-11	51702-51712	disclosure	_	
265-12	51712-51713	,	_	
265-13	51714-51720	please	_	
265-14	51721-51728	include	_	
265-15	51729-51733	your	_	
265-16	51734-51741	updated	_	
265-17	51742-51751	statement	_	
265-18	51752-51754	in	_	
265-19	51755-51759	your	_	
265-20	51760-51765	cover	_	
265-21	51766-51772	letter	_	
265-22	51772-51773	.	_	

#Text=To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future.
266-1	51774-51776	To	_	
266-2	51777-51784	enhance	_	
266-3	51785-51788	the	_	
266-4	51789-51804	reproducibility	_	
266-5	51805-51807	of	_	
266-6	51808-51812	your	_	
266-7	51813-51820	results	_	
266-8	51820-51821	,	_	
266-9	51822-51824	we	_	
266-10	51825-51834	recommend	_	
266-11	51835-51839	that	_	
266-12	51840-51842	if	_	
266-13	51843-51853	applicable	_	
266-14	51854-51857	you	_	
266-15	51858-51865	deposit	_	
266-16	51866-51870	your	_	
266-17	51871-51881	laboratory	_	
266-18	51882-51891	protocols	_	
266-19	51892-51894	in	_	
266-20	51895-51907	protocols.io	_	
266-21	51907-51908	,	_	
266-22	51909-51914	where	_	
266-23	51915-51916	a	_	
266-24	51917-51925	protocol	_	
266-25	51926-51929	can	_	
266-26	51930-51932	be	_	
266-27	51933-51941	assigned	_	
266-28	51942-51945	its	_	
266-29	51946-51949	own	_	
266-30	51950-51960	identifier	_	
266-31	51961-51962	(	_	
266-32	51962-51965	DOI	_	
266-33	51965-51966	)	_	
266-34	51967-51971	such	_	
266-35	51972-51976	that	_	
266-36	51977-51979	it	_	
266-37	51980-51983	can	_	
266-38	51984-51986	be	_	
266-39	51987-51992	cited	_	
266-40	51993-52006	independently	_	
266-41	52007-52009	in	_	
266-42	52010-52013	the	_	
266-43	52014-52020	future	_	
266-44	52020-52021	.	_	

#Text=For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols
#Text=Please include the following items when submitting your revised manuscript:
#Text=A rebuttal letter that responds to each point raised by the academic editor and reviewer(s).
267-1	52022-52025	For	_	
267-2	52026-52038	instructions	_	
267-3	52039-52042	see	_	
267-4	52042-52043	:	_	
267-5	52044-52048	http	_	
267-6	52048-52049	:	_	
267-7	52049-52050	/	_	
267-8	52050-52051	/	_	
267-9	52051-52068	journals.plos.org	_	
267-10	52068-52069	/	_	
267-11	52069-52076	plosone	_	
267-12	52076-52077	/	_	
267-13	52077-52078	s	_	
267-14	52078-52079	/	_	
267-15	52079-52100	submission-guidelines	_	
267-16	52100-52101	#	_	
267-17	52101-52125	loc-laboratory-protocols	_	
267-18	52126-52132	Please	_	
267-19	52133-52140	include	_	
267-20	52141-52144	the	_	
267-21	52145-52154	following	_	
267-22	52155-52160	items	_	
267-23	52161-52165	when	_	
267-24	52166-52176	submitting	_	
267-25	52177-52181	your	_	
267-26	52182-52189	revised	_	
267-27	52190-52200	manuscript	_	
267-28	52200-52201	:	_	
267-29	52202-52203	A	_	
267-30	52204-52212	rebuttal	_	
267-31	52213-52219	letter	_	
267-32	52220-52224	that	_	
267-33	52225-52233	responds	_	
267-34	52234-52236	to	_	
267-35	52237-52241	each	_	
267-36	52242-52247	point	_	
267-37	52248-52254	raised	_	
267-38	52255-52257	by	_	
267-39	52258-52261	the	_	
267-40	52262-52270	academic	_	
267-41	52271-52277	editor	_	
267-42	52278-52281	and	_	
267-43	52282-52290	reviewer	_	
267-44	52290-52291	(	_	
267-45	52291-52292	s	_	
267-46	52292-52293	)	_	
267-47	52293-52294	.	_	

#Text=This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
268-1	52295-52299	This	_	
268-2	52300-52306	letter	_	
268-3	52307-52313	should	_	
268-4	52314-52316	be	_	
268-5	52317-52325	uploaded	_	
268-6	52326-52328	as	_	
268-7	52329-52337	separate	_	
268-8	52338-52342	file	_	
268-9	52343-52346	and	_	
268-10	52347-52354	labeled	_	
268-11	52355-52356	'	_	
268-12	52356-52364	Response	_	
268-13	52365-52367	to	_	
268-14	52368-52377	Reviewers	_	
268-15	52377-52378	'	_	
268-16	52378-52379	.	_	

#Text=A marked-up copy of your manuscript that highlights changes made to the original version.
269-1	52380-52381	A	_	
269-2	52382-52391	marked-up	_	
269-3	52392-52396	copy	_	
269-4	52397-52399	of	_	
269-5	52400-52404	your	_	
269-6	52405-52415	manuscript	_	
269-7	52416-52420	that	_	
269-8	52421-52431	highlights	_	
269-9	52432-52439	changes	_	
269-10	52440-52444	made	_	
269-11	52445-52447	to	_	
269-12	52448-52451	the	_	
269-13	52452-52460	original	_	
269-14	52461-52468	version	_	
269-15	52468-52469	.	_	

#Text=This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
270-1	52470-52474	This	_	
270-2	52475-52479	file	_	
270-3	52480-52486	should	_	
270-4	52487-52489	be	_	
270-5	52490-52498	uploaded	_	
270-6	52499-52501	as	_	
270-7	52502-52510	separate	_	
270-8	52511-52515	file	_	
270-9	52516-52519	and	_	
270-10	52520-52527	labeled	_	
270-11	52528-52529	'	_	
270-12	52529-52536	Revised	_	
270-13	52537-52547	Manuscript	_	
270-14	52548-52552	with	_	
270-15	52553-52558	Track	_	
270-16	52559-52566	Changes	_	
270-17	52566-52567	'	_	
270-18	52567-52568	.	_	

#Text=An unmarked version of your revised paper without tracked changes.
271-1	52569-52571	An	_	
271-2	52572-52580	unmarked	_	
271-3	52581-52588	version	_	
271-4	52589-52591	of	_	
271-5	52592-52596	your	_	
271-6	52597-52604	revised	_	
271-7	52605-52610	paper	_	
271-8	52611-52618	without	_	
271-9	52619-52626	tracked	_	
271-10	52627-52634	changes	_	
271-11	52634-52635	.	_	

#Text=This file should be uploaded as separate file and labeled 'Manuscript'.
272-1	52636-52640	This	_	
272-2	52641-52645	file	_	
272-3	52646-52652	should	_	
272-4	52653-52655	be	_	
272-5	52656-52664	uploaded	_	
272-6	52665-52667	as	_	
272-7	52668-52676	separate	_	
272-8	52677-52681	file	_	
272-9	52682-52685	and	_	
272-10	52686-52693	labeled	_	
272-11	52694-52695	'	_	
272-12	52695-52705	Manuscript	_	
272-13	52705-52706	'	_	
272-14	52706-52707	.	_	

#Text=Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available.
273-1	52708-52714	Please	_	
273-2	52715-52719	note	_	
273-3	52720-52725	while	_	
273-4	52726-52733	forming	_	
273-5	52734-52738	your	_	
273-6	52739-52747	response	_	
273-7	52747-52748	,	_	
273-8	52749-52751	if	_	
273-9	52752-52756	your	_	
273-10	52757-52764	article	_	
273-11	52765-52767	is	_	
273-12	52768-52776	accepted	_	
273-13	52776-52777	,	_	
273-14	52778-52781	you	_	
273-15	52782-52785	may	_	
273-16	52786-52790	have	_	
273-17	52791-52794	the	_	
273-18	52795-52806	opportunity	_	
273-19	52807-52809	to	_	
273-20	52810-52814	make	_	
273-21	52815-52818	the	_	
273-22	52819-52823	peer	_	
273-23	52824-52830	review	_	
273-24	52831-52838	history	_	
273-25	52839-52847	publicly	_	
273-26	52848-52857	available	_	
273-27	52857-52858	.	_	

#Text=The record will include editor decision letters (with reviews) and your responses to reviewer comments.
274-1	52859-52862	The	_	
274-2	52863-52869	record	_	
274-3	52870-52874	will	_	
274-4	52875-52882	include	_	
274-5	52883-52889	editor	_	
274-6	52890-52898	decision	_	
274-7	52899-52906	letters	_	
274-8	52907-52908	(	_	
274-9	52908-52912	with	_	
274-10	52913-52920	reviews	_	
274-11	52920-52921	)	_	
274-12	52922-52925	and	_	
274-13	52926-52930	your	_	
274-14	52931-52940	responses	_	
274-15	52941-52943	to	_	
274-16	52944-52952	reviewer	_	
274-17	52953-52961	comments	_	
274-18	52961-52962	.	_	

#Text=If eligible, we will contact you to opt in or out.
275-1	52963-52965	If	_	
275-2	52966-52974	eligible	_	
275-3	52974-52975	,	_	
275-4	52976-52978	we	_	
275-5	52979-52983	will	_	
275-6	52984-52991	contact	_	
275-7	52992-52995	you	_	
275-8	52996-52998	to	_	
275-9	52999-53002	opt	_	
275-10	53003-53005	in	_	
275-11	53006-53008	or	_	
275-12	53009-53012	out	_	
275-13	53012-53013	.	_	

#Text=We look forward to receiving your revised manuscript.
276-1	53014-53016	We	_	
276-2	53017-53021	look	_	
276-3	53022-53029	forward	_	
276-4	53030-53032	to	_	
276-5	53033-53042	receiving	_	
276-6	53043-53047	your	_	
276-7	53048-53055	revised	_	
276-8	53056-53066	manuscript	_	
276-9	53066-53067	.	_	

#Text=Kind regards,
#Text=Tommy Pattij, Ph.D.
277-1	53068-53072	Kind	_	
277-2	53073-53080	regards	_	
277-3	53080-53081	,	_	
277-4	53082-53087	Tommy	_	
277-5	53088-53094	Pattij	_	
277-6	53094-53095	,	_	
277-7	53096-53100	Ph.D	_	
277-8	53100-53101	.	_	

#Text=Academic Editor
#Text=PLOS ONE
#Text=Journal Requirements:
#Text=When submitting your revision, we need you to address these additional requirements.
#Text=1.
278-1	53102-53110	Academic	_	
278-2	53111-53117	Editor	_	
278-3	53118-53122	PLOS	_	
278-4	53123-53126	ONE	_	
278-5	53127-53134	Journal	_	
278-6	53135-53147	Requirements	_	
278-7	53147-53148	:	_	
278-8	53149-53153	When	_	
278-9	53154-53164	submitting	_	
278-10	53165-53169	your	_	
278-11	53170-53178	revision	_	
278-12	53178-53179	,	_	
278-13	53180-53182	we	_	
278-14	53183-53187	need	_	
278-15	53188-53191	you	_	
278-16	53192-53194	to	_	
278-17	53195-53202	address	_	
278-18	53203-53208	these	_	
278-19	53209-53219	additional	_	
278-20	53220-53232	requirements	_	
278-21	53232-53233	.	_	
278-22	53234-53235	1	_	
278-23	53235-53236	.	_	

#Text=Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.
279-1	53237-53243	Please	_	
279-2	53244-53250	ensure	_	
279-3	53251-53255	that	_	
279-4	53256-53260	your	_	
279-5	53261-53271	manuscript	_	
279-6	53272-53277	meets	_	
279-7	53278-53282	PLOS	_	
279-8	53283-53288	ONE's	_	
279-9	53289-53294	style	_	
279-10	53295-53307	requirements	_	
279-11	53307-53308	,	_	
279-12	53309-53318	including	_	
279-13	53319-53324	those	_	
279-14	53325-53328	for	_	
279-15	53329-53333	file	_	
279-16	53334-53340	naming	_	
279-17	53340-53341	.	_	

#Text=The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?
280-1	53342-53345	The	_	
280-2	53346-53350	PLOS	_	
280-3	53351-53354	ONE	_	
280-4	53355-53360	style	_	
280-5	53361-53370	templates	_	
280-6	53371-53374	can	_	
280-7	53375-53377	be	_	
280-8	53378-53383	found	_	
280-9	53384-53386	at	_	
280-10	53387-53391	http	_	
280-11	53391-53392	:	_	
280-12	53392-53393	/	_	
280-13	53393-53394	/	_	
280-14	53394-53415	www.journals.plos.org	_	
280-15	53415-53416	/	_	
280-16	53416-53423	plosone	_	
280-17	53423-53424	/	_	
280-18	53424-53425	s	_	
280-19	53425-53426	/	_	
280-20	53426-53430	file	_	
280-21	53430-53431	?	_	

#Text=id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?
281-1	53431-53433	id	_	
281-2	53433-53434	=	_	
281-3	53434-53438	wjVg	_	
281-4	53438-53439	/	_	
281-5	53439-53478	PLOSOne_formatting_sample_main_body.pdf	_	
281-6	53479-53482	and	_	
281-7	53483-53487	http	_	
281-8	53487-53488	:	_	
281-9	53488-53489	/	_	
281-10	53489-53490	/	_	
281-11	53490-53511	www.journals.plos.org	_	
281-12	53511-53512	/	_	
281-13	53512-53519	plosone	_	
281-14	53519-53520	/	_	
281-15	53520-53521	s	_	
281-16	53521-53522	/	_	
281-17	53522-53526	file	_	
281-18	53526-53527	?	_	

#Text=id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf
#Text=2.
282-1	53527-53529	id	_	
282-2	53529-53530	=	_	
282-3	53530-53534	ba62	_	
282-4	53534-53535	/	_	
282-5	53535-53591	PLOSOne_formatting_sample_title_authors_affiliations.pdf	_	
282-6	53592-53593	2	_	
282-7	53593-53594	.	_	

#Text=Our internal editors have looked over your manuscript and determined that it may be within the scope of our Neuroscience of Reward and Decision Making Call for Papers.
283-1	53595-53598	Our	_	
283-2	53599-53607	internal	_	
283-3	53608-53615	editors	_	
283-4	53616-53620	have	_	
283-5	53621-53627	looked	_	
283-6	53628-53632	over	_	
283-7	53633-53637	your	_	
283-8	53638-53648	manuscript	_	
283-9	53649-53652	and	_	
283-10	53653-53663	determined	_	
283-11	53664-53668	that	_	
283-12	53669-53671	it	_	
283-13	53672-53675	may	_	
283-14	53676-53678	be	_	
283-15	53679-53685	within	_	
283-16	53686-53689	the	_	
283-17	53690-53695	scope	_	
283-18	53696-53698	of	_	
283-19	53699-53702	our	_	
283-20	53703-53715	Neuroscience	_	
283-21	53716-53718	of	_	
283-22	53719-53725	Reward	_	
283-23	53726-53729	and	_	
283-24	53730-53738	Decision	_	
283-25	53739-53745	Making	_	
283-26	53746-53750	Call	_	
283-27	53751-53754	for	_	
283-28	53755-53761	Papers	_	
283-29	53761-53762	.	_	

#Text=This collection of papers is headed by a team of Guest Editors for PLOS ONE: Stephanie Groman, Satoshi Ikemoto, Jane Taylor and Robert Whelan.
284-1	53763-53767	This	_	
284-2	53768-53778	collection	_	
284-3	53779-53781	of	_	
284-4	53782-53788	papers	_	
284-5	53789-53791	is	_	
284-6	53792-53798	headed	_	
284-7	53799-53801	by	_	
284-8	53802-53803	a	_	
284-9	53804-53808	team	_	
284-10	53809-53811	of	_	
284-11	53812-53817	Guest	_	
284-12	53818-53825	Editors	_	
284-13	53826-53829	for	_	
284-14	53830-53834	PLOS	_	
284-15	53835-53838	ONE	_	
284-16	53838-53839	:	_	
284-17	53840-53849	Stephanie	_	
284-18	53850-53856	Groman	_	
284-19	53856-53857	,	_	
284-20	53858-53865	Satoshi	_	
284-21	53866-53873	Ikemoto	_	
284-22	53873-53874	,	_	
284-23	53875-53879	Jane	_	
284-24	53880-53886	Taylor	_	
284-25	53887-53890	and	_	
284-26	53891-53897	Robert	_	
284-27	53898-53904	Whelan	_	
284-28	53904-53905	.	_	

#Text=With this Collection we hope to bring together researchers working on a wide range of disciplines, from animal subjects research, computational approaches and patient-centered research.
285-1	53906-53910	With	_	
285-2	53911-53915	this	_	
285-3	53916-53926	Collection	_	
285-4	53927-53929	we	_	
285-5	53930-53934	hope	_	
285-6	53935-53937	to	_	
285-7	53938-53943	bring	_	
285-8	53944-53952	together	_	
285-9	53953-53964	researchers	_	
285-10	53965-53972	working	_	
285-11	53973-53975	on	_	
285-12	53976-53977	a	_	
285-13	53978-53982	wide	_	
285-14	53983-53988	range	_	
285-15	53989-53991	of	_	
285-16	53992-54003	disciplines	_	
285-17	54003-54004	,	_	
285-18	54005-54009	from	_	
285-19	54010-54016	animal	_	
285-20	54017-54025	subjects	_	
285-21	54026-54034	research	_	
285-22	54034-54035	,	_	
285-23	54036-54049	computational	_	
285-24	54050-54060	approaches	_	
285-25	54061-54064	and	_	
285-26	54065-54081	patient-centered	_	
285-27	54082-54090	research	_	
285-28	54090-54091	.	_	

#Text=Additional information can be found on our announcement page: https://collections.plos.org/s/reward-and-decision-making.
286-1	54092-54102	Additional	_	
286-2	54103-54114	information	_	
286-3	54115-54118	can	_	
286-4	54119-54121	be	_	
286-5	54122-54127	found	_	
286-6	54128-54130	on	_	
286-7	54131-54134	our	_	
286-8	54135-54147	announcement	_	
286-9	54148-54152	page	_	
286-10	54152-54153	:	_	
286-11	54154-54159	https	_	
286-12	54159-54160	:	_	
286-13	54160-54161	/	_	
286-14	54161-54162	/	_	
286-15	54162-54182	collections.plos.org	_	
286-16	54182-54183	/	_	
286-17	54183-54184	s	_	
286-18	54184-54185	/	_	
286-19	54185-54211	reward-and-decision-making	_	
286-20	54211-54212	.	_	

#Text=If you would like your manuscript to be considered for this collection, please let us know in your cover letter and we will ensure that your paper is treated as if you were responding to this call.
287-1	54213-54215	If	_	
287-2	54216-54219	you	_	
287-3	54220-54225	would	_	
287-4	54226-54230	like	_	
287-5	54231-54235	your	_	
287-6	54236-54246	manuscript	_	
287-7	54247-54249	to	_	
287-8	54250-54252	be	_	
287-9	54253-54263	considered	_	
287-10	54264-54267	for	_	
287-11	54268-54272	this	_	
287-12	54273-54283	collection	_	
287-13	54283-54284	,	_	
287-14	54285-54291	please	_	
287-15	54292-54295	let	_	
287-16	54296-54298	us	_	
287-17	54299-54303	know	_	
287-18	54304-54306	in	_	
287-19	54307-54311	your	_	
287-20	54312-54317	cover	_	
287-21	54318-54324	letter	_	
287-22	54325-54328	and	_	
287-23	54329-54331	we	_	
287-24	54332-54336	will	_	
287-25	54337-54343	ensure	_	
287-26	54344-54348	that	_	
287-27	54349-54353	your	_	
287-28	54354-54359	paper	_	
287-29	54360-54362	is	_	
287-30	54363-54370	treated	_	
287-31	54371-54373	as	_	
287-32	54374-54376	if	_	
287-33	54377-54380	you	_	
287-34	54381-54385	were	_	
287-35	54386-54396	responding	_	
287-36	54397-54399	to	_	
287-37	54400-54404	this	_	
287-38	54405-54409	call	_	
287-39	54409-54410	.	_	

#Text=Agreeing to be part of the call-for-papers will not affect the date your manuscript is published.
288-1	54411-54419	Agreeing	_	
288-2	54420-54422	to	_	
288-3	54423-54425	be	_	
288-4	54426-54430	part	_	
288-5	54431-54433	of	_	
288-6	54434-54437	the	_	
288-7	54438-54453	call-for-papers	_	
288-8	54454-54458	will	_	
288-9	54459-54462	not	_	
288-10	54463-54469	affect	_	
288-11	54470-54473	the	_	
288-12	54474-54478	date	_	
288-13	54479-54483	your	_	
288-14	54484-54494	manuscript	_	
288-15	54495-54497	is	_	
288-16	54498-54507	published	_	
288-17	54507-54508	.	_	

#Text=If you would prefer to remove your manuscript from collection consideration, please specify this in the cover letter.
#Text=3.
289-1	54509-54511	If	_	
289-2	54512-54515	you	_	
289-3	54516-54521	would	_	
289-4	54522-54528	prefer	_	
289-5	54529-54531	to	_	
289-6	54532-54538	remove	_	
289-7	54539-54543	your	_	
289-8	54544-54554	manuscript	_	
289-9	54555-54559	from	_	
289-10	54560-54570	collection	_	
289-11	54571-54584	consideration	_	
289-12	54584-54585	,	_	
289-13	54586-54592	please	_	
289-14	54593-54600	specify	_	
289-15	54601-54605	this	_	
289-16	54606-54608	in	_	
289-17	54609-54612	the	_	
289-18	54613-54618	cover	_	
289-19	54619-54625	letter	_	
289-20	54625-54626	.	_	
289-21	54627-54628	3	_	
289-22	54628-54629	.	_	

#Text=Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly.
290-1	54630-54636	Please	_	
290-2	54637-54644	include	_	
290-3	54645-54653	captions	_	
290-4	54654-54657	for	_	
290-5	54658-54662	your	_	
290-6	54663-54673	Supporting	_	
290-7	54674-54685	Information	_	
290-8	54686-54691	files	_	
290-9	54692-54694	at	_	
290-10	54695-54698	the	_	
290-11	54699-54702	end	_	
290-12	54703-54705	of	_	
290-13	54706-54710	your	_	
290-14	54711-54721	manuscript	_	
290-15	54721-54722	,	_	
290-16	54723-54726	and	_	
290-17	54727-54733	update	_	
290-18	54734-54737	any	_	
290-19	54738-54745	in-text	_	
290-20	54746-54755	citations	_	
290-21	54756-54758	to	_	
290-22	54759-54764	match	_	
290-23	54765-54776	accordingly	_	
290-24	54776-54777	.	_	

#Text=Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.
291-1	54778-54784	Please	_	
291-2	54785-54788	see	_	
291-3	54789-54792	our	_	
291-4	54793-54803	Supporting	_	
291-5	54804-54815	Information	_	
291-6	54816-54826	guidelines	_	
291-7	54827-54830	for	_	
291-8	54831-54835	more	_	
291-9	54836-54847	information	_	
291-10	54847-54848	:	_	
291-11	54849-54853	http	_	
291-12	54853-54854	:	_	
291-13	54854-54855	/	_	
291-14	54855-54856	/	_	
291-15	54856-54873	journals.plos.org	_	
291-16	54873-54874	/	_	
291-17	54874-54881	plosone	_	
291-18	54881-54882	/	_	
291-19	54882-54883	s	_	
291-20	54883-54884	/	_	
291-21	54884-54906	supporting-information	_	
291-22	54906-54907	.	_	

#Text=Additional Editor Comments (if provided):
#Text=[Note: HTML markup is below.
292-1	54908-54918	Additional	_	
292-2	54919-54925	Editor	_	
292-3	54926-54934	Comments	_	
292-4	54935-54936	(	_	
292-5	54936-54938	if	_	
292-6	54939-54947	provided	_	
292-7	54947-54948	)	_	
292-8	54948-54949	:	_	
292-9	54950-54951	[	_	
292-10	54951-54955	Note	_	
292-11	54955-54956	:	_	
292-12	54957-54961	HTML	_	
292-13	54962-54968	markup	_	
292-14	54969-54971	is	_	
292-15	54972-54977	below	_	
292-16	54977-54978	.	_	

#Text=Please do not edit.]
293-1	54979-54985	Please	_	
293-2	54986-54988	do	_	
293-3	54989-54992	not	_	
293-4	54993-54997	edit	_	
293-5	54997-54998	.	_	
293-6	54998-54999	]	_	

#Text=Reviewers' comments:
#Text=Reviewer's Responses to Questions
#Text=Comments to the Author
#Text=1.
294-1	55000-55009	Reviewers	_	
294-2	55009-55010	'	_	
294-3	55011-55019	comments	_	
294-4	55019-55020	:	_	
294-5	55021-55031	Reviewer's	_	
294-6	55032-55041	Responses	_	
294-7	55042-55044	to	_	
294-8	55045-55054	Questions	_	
294-9	55055-55063	Comments	_	
294-10	55064-55066	to	_	
294-11	55067-55070	the	_	
294-12	55071-55077	Author	_	
294-13	55078-55079	1	_	
294-14	55079-55080	.	_	

#Text=Is the manuscript technically sound, and do the data support the conclusions?
295-1	55081-55083	Is	_	
295-2	55084-55087	the	_	
295-3	55088-55098	manuscript	_	
295-4	55099-55110	technically	_	
295-5	55111-55116	sound	_	
295-6	55116-55117	,	_	
295-7	55118-55121	and	_	
295-8	55122-55124	do	_	
295-9	55125-55128	the	_	
295-10	55129-55133	data	_	
295-11	55134-55141	support	_	
295-12	55142-55145	the	_	
295-13	55146-55157	conclusions	_	
295-14	55157-55158	?	_	

#Text=The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions.
296-1	55159-55162	The	_	
296-2	55163-55173	manuscript	_	
296-3	55174-55178	must	_	
296-4	55179-55187	describe	_	
296-5	55188-55189	a	_	
296-6	55190-55201	technically	_	
296-7	55202-55207	sound	_	
296-8	55208-55213	piece	_	
296-9	55214-55216	of	_	
296-10	55217-55227	scientific	_	
296-11	55228-55236	research	_	
296-12	55237-55241	with	_	
296-13	55242-55246	data	_	
296-14	55247-55251	that	_	
296-15	55252-55260	supports	_	
296-16	55261-55264	the	_	
296-17	55265-55276	conclusions	_	
296-18	55276-55277	.	_	

#Text=Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes.
297-1	55278-55289	Experiments	_	
297-2	55290-55294	must	_	
297-3	55295-55299	have	_	
297-4	55300-55304	been	_	
297-5	55305-55314	conducted	_	
297-6	55315-55325	rigorously	_	
297-7	55325-55326	,	_	
297-8	55327-55331	with	_	
297-9	55332-55343	appropriate	_	
297-10	55344-55352	controls	_	
297-11	55352-55353	,	_	
297-12	55354-55365	replication	_	
297-13	55365-55366	,	_	
297-14	55367-55370	and	_	
297-15	55371-55377	sample	_	
297-16	55378-55383	sizes	_	
297-17	55383-55384	.	_	

#Text=The conclusions must be drawn appropriately based on the data presented.
298-1	55385-55388	The	_	
298-2	55389-55400	conclusions	_	
298-3	55401-55405	must	_	
298-4	55406-55408	be	_	
298-5	55409-55414	drawn	_	
298-6	55415-55428	appropriately	_	
298-7	55429-55434	based	_	
298-8	55435-55437	on	_	
298-9	55438-55441	the	_	
298-10	55442-55446	data	_	
298-11	55447-55456	presented	_	
298-12	55456-55457	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: Yes
#Text=**********
#Text=2.
299-1	55459-55467	Reviewer	_	
299-2	55468-55470	#1	_	
299-3	55470-55471	:	_	
299-4	55472-55475	Yes	_	
299-5	55476-55484	Reviewer	_	
299-6	55485-55487	#2	_	
299-7	55487-55488	:	_	
299-8	55489-55492	Yes	_	
299-9	55493-55494	*	_	
299-10	55494-55495	*	_	
299-11	55495-55496	*	_	
299-12	55496-55497	*	_	
299-13	55497-55498	*	_	
299-14	55498-55499	*	_	
299-15	55499-55500	*	_	
299-16	55500-55501	*	_	
299-17	55501-55502	*	_	
299-18	55502-55503	*	_	
299-19	55504-55505	2	_	
299-20	55505-55506	.	_	

#Text=Has the statistical analysis been performed appropriately and rigorously?
300-1	55507-55510	Has	_	
300-2	55511-55514	the	_	
300-3	55515-55526	statistical	_	
300-4	55527-55535	analysis	_	
300-5	55536-55540	been	_	
300-6	55541-55550	performed	_	
300-7	55551-55564	appropriately	_	
300-8	55565-55568	and	_	
300-9	55569-55579	rigorously	_	
300-10	55579-55580	?	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: I Don't Know
#Text=**********
#Text=3.
301-1	55582-55590	Reviewer	_	
301-2	55591-55593	#1	_	
301-3	55593-55594	:	_	
301-4	55595-55598	Yes	_	
301-5	55599-55607	Reviewer	_	
301-6	55608-55610	#2	_	
301-7	55610-55611	:	_	
301-8	55612-55613	I	_	
301-9	55614-55619	Don't	_	
301-10	55620-55624	Know	_	
301-11	55625-55626	*	_	
301-12	55626-55627	*	_	
301-13	55627-55628	*	_	
301-14	55628-55629	*	_	
301-15	55629-55630	*	_	
301-16	55630-55631	*	_	
301-17	55631-55632	*	_	
301-18	55632-55633	*	_	
301-19	55633-55634	*	_	
301-20	55634-55635	*	_	
301-21	55636-55637	3	_	
301-22	55637-55638	.	_	

#Text=Have the authors made all data underlying the findings in their manuscript fully available?
302-1	55639-55643	Have	_	
302-2	55644-55647	the	_	
302-3	55648-55655	authors	_	
302-4	55656-55660	made	_	
302-5	55661-55664	all	_	
302-6	55665-55669	data	_	
302-7	55670-55680	underlying	_	
302-8	55681-55684	the	_	
302-9	55685-55693	findings	_	
302-10	55694-55696	in	_	
302-11	55697-55702	their	_	
302-12	55703-55713	manuscript	_	
302-13	55714-55719	fully	_	
302-14	55720-55729	available	_	
302-15	55729-55730	?	_	

#Text=The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file).
303-1	55731-55734	The	_	
303-2	55735-55739	PLOS	_	
303-3	55740-55744	Data	_	
303-4	55745-55751	policy	_	
303-5	55752-55760	requires	_	
303-6	55761-55768	authors	_	
303-7	55769-55771	to	_	
303-8	55772-55776	make	_	
303-9	55777-55780	all	_	
303-10	55781-55785	data	_	
303-11	55786-55796	underlying	_	
303-12	55797-55800	the	_	
303-13	55801-55809	findings	_	
303-14	55810-55819	described	_	
303-15	55820-55822	in	_	
303-16	55823-55828	their	_	
303-17	55829-55839	manuscript	_	
303-18	55840-55845	fully	_	
303-19	55846-55855	available	_	
303-20	55856-55863	without	_	
303-21	55864-55875	restriction	_	
303-22	55875-55876	,	_	
303-23	55877-55881	with	_	
303-24	55882-55886	rare	_	
303-25	55887-55896	exception	_	
303-26	55897-55898	(	_	
303-27	55898-55904	please	_	
303-28	55905-55910	refer	_	
303-29	55911-55913	to	_	
303-30	55914-55917	the	_	
303-31	55918-55922	Data	_	
303-32	55923-55935	Availability	_	
303-33	55936-55945	Statement	_	
303-34	55946-55948	in	_	
303-35	55949-55952	the	_	
303-36	55953-55963	manuscript	_	
303-37	55964-55967	PDF	_	
303-38	55968-55972	file	_	
303-39	55972-55973	)	_	
303-40	55973-55974	.	_	

#Text=The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository.
304-1	55975-55978	The	_	
304-2	55979-55983	data	_	
304-3	55984-55990	should	_	
304-4	55991-55993	be	_	
304-5	55994-56002	provided	_	
304-6	56003-56005	as	_	
304-7	56006-56010	part	_	
304-8	56011-56013	of	_	
304-9	56014-56017	the	_	
304-10	56018-56028	manuscript	_	
304-11	56029-56031	or	_	
304-12	56032-56035	its	_	
304-13	56036-56046	supporting	_	
304-14	56047-56058	information	_	
304-15	56058-56059	,	_	
304-16	56060-56062	or	_	
304-17	56063-56072	deposited	_	
304-18	56073-56075	to	_	
304-19	56076-56077	a	_	
304-20	56078-56084	public	_	
304-21	56085-56095	repository	_	
304-22	56095-56096	.	_	

#Text=For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available.
305-1	56097-56100	For	_	
305-2	56101-56108	example	_	
305-3	56108-56109	,	_	
305-4	56110-56112	in	_	
305-5	56113-56121	addition	_	
305-6	56122-56124	to	_	
305-7	56125-56132	summary	_	
305-8	56133-56143	statistics	_	
305-9	56143-56144	,	_	
305-10	56145-56148	the	_	
305-11	56149-56153	data	_	
305-12	56154-56160	points	_	
305-13	56161-56167	behind	_	
305-14	56168-56173	means	_	
305-15	56173-56174	,	_	
305-16	56175-56182	medians	_	
305-17	56183-56186	and	_	
305-18	56187-56195	variance	_	
305-19	56196-56204	measures	_	
305-20	56205-56211	should	_	
305-21	56212-56214	be	_	
305-22	56215-56224	available	_	
305-23	56224-56225	.	_	

#Text=If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.
306-1	56226-56228	If	_	
306-2	56229-56234	there	_	
306-3	56235-56238	are	_	
306-4	56239-56251	restrictions	_	
306-5	56252-56254	on	_	
306-6	56255-56263	publicly	_	
306-7	56264-56271	sharing	_	
306-8	56272-56280	data—e.g	_	
306-9	56280-56281	.	_	
306-10	56282-56293	participant	_	
306-11	56294-56301	privacy	_	
306-12	56302-56304	or	_	
306-13	56305-56308	use	_	
306-14	56309-56311	of	_	
306-15	56312-56316	data	_	
306-16	56317-56321	from	_	
306-17	56322-56323	a	_	
306-18	56324-56329	third	_	
306-19	56330-56341	party—those	_	
306-20	56342-56346	must	_	
306-21	56347-56349	be	_	
306-22	56350-56359	specified	_	
306-23	56359-56360	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: No
#Text=**********
#Text=4.
307-1	56361-56369	Reviewer	_	
307-2	56370-56372	#1	_	
307-3	56372-56373	:	_	
307-4	56374-56377	Yes	_	
307-5	56378-56386	Reviewer	_	
307-6	56387-56389	#2	_	
307-7	56389-56390	:	_	
307-8	56391-56393	No	_	
307-9	56394-56395	*	_	
307-10	56395-56396	*	_	
307-11	56396-56397	*	_	
307-12	56397-56398	*	_	
307-13	56398-56399	*	_	
307-14	56399-56400	*	_	
307-15	56400-56401	*	_	
307-16	56401-56402	*	_	
307-17	56402-56403	*	_	
307-18	56403-56404	*	_	
307-19	56405-56406	4	_	
307-20	56406-56407	.	_	

#Text=Is the manuscript presented in an intelligible fashion and written in standard English?
308-1	56408-56410	Is	_	
308-2	56411-56414	the	_	
308-3	56415-56425	manuscript	_	
308-4	56426-56435	presented	_	
308-5	56436-56438	in	_	
308-6	56439-56441	an	_	
308-7	56442-56454	intelligible	_	
308-8	56455-56462	fashion	_	
308-9	56463-56466	and	_	
308-10	56467-56474	written	_	
308-11	56475-56477	in	_	
308-12	56478-56486	standard	_	
308-13	56487-56494	English	_	
308-14	56494-56495	?	_	

#Text=PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous.
309-1	56496-56500	PLOS	_	
309-2	56501-56504	ONE	_	
309-3	56505-56509	does	_	
309-4	56510-56513	not	_	
309-5	56514-56522	copyedit	_	
309-6	56523-56531	accepted	_	
309-7	56532-56543	manuscripts	_	
309-8	56543-56544	,	_	
309-9	56545-56547	so	_	
309-10	56548-56551	the	_	
309-11	56552-56560	language	_	
309-12	56561-56563	in	_	
309-13	56564-56573	submitted	_	
309-14	56574-56582	articles	_	
309-15	56583-56587	must	_	
309-16	56588-56590	be	_	
309-17	56591-56596	clear	_	
309-18	56596-56597	,	_	
309-19	56598-56605	correct	_	
309-20	56605-56606	,	_	
309-21	56607-56610	and	_	
309-22	56611-56622	unambiguous	_	
309-23	56622-56623	.	_	

#Text=Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
310-1	56624-56627	Any	_	
310-2	56628-56641	typographical	_	
310-3	56642-56644	or	_	
310-4	56645-56656	grammatical	_	
310-5	56657-56663	errors	_	
310-6	56664-56670	should	_	
310-7	56671-56673	be	_	
310-8	56674-56683	corrected	_	
310-9	56684-56686	at	_	
310-10	56687-56695	revision	_	
310-11	56695-56696	,	_	
310-12	56697-56699	so	_	
310-13	56700-56706	please	_	
310-14	56707-56711	note	_	
310-15	56712-56715	any	_	
310-16	56716-56724	specific	_	
310-17	56725-56731	errors	_	
310-18	56732-56736	here	_	
310-19	56736-56737	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: Yes
#Text=**********
#Text=5.
311-1	56738-56746	Reviewer	_	
311-2	56747-56749	#1	_	
311-3	56749-56750	:	_	
311-4	56751-56754	Yes	_	
311-5	56755-56763	Reviewer	_	
311-6	56764-56766	#2	_	
311-7	56766-56767	:	_	
311-8	56768-56771	Yes	_	
311-9	56772-56773	*	_	
311-10	56773-56774	*	_	
311-11	56774-56775	*	_	
311-12	56775-56776	*	_	
311-13	56776-56777	*	_	
311-14	56777-56778	*	_	
311-15	56778-56779	*	_	
311-16	56779-56780	*	_	
311-17	56780-56781	*	_	
311-18	56781-56782	*	_	
311-19	56783-56784	5	_	
311-20	56784-56785	.	_	

#Text=Review Comments to the Author
#Text=Please use the space provided to explain your answers to the questions above.
312-1	56786-56792	Review	_	
312-2	56793-56801	Comments	_	
312-3	56802-56804	to	_	
312-4	56805-56808	the	_	
312-5	56809-56815	Author	_	
312-6	56816-56822	Please	_	
312-7	56823-56826	use	_	
312-8	56827-56830	the	_	
312-9	56831-56836	space	_	
312-10	56837-56845	provided	_	
312-11	56846-56848	to	_	
312-12	56849-56856	explain	_	
312-13	56857-56861	your	_	
312-14	56862-56869	answers	_	
312-15	56870-56872	to	_	
312-16	56873-56876	the	_	
312-17	56877-56886	questions	_	
312-18	56887-56892	above	_	
312-19	56892-56893	.	_	

#Text=You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics.
313-1	56894-56897	You	_	
313-2	56898-56901	may	_	
313-3	56902-56906	also	_	
313-4	56907-56914	include	_	
313-5	56915-56925	additional	_	
313-6	56926-56934	comments	_	
313-7	56935-56938	for	_	
313-8	56939-56942	the	_	
313-9	56943-56949	author	_	
313-10	56949-56950	,	_	
313-11	56951-56960	including	_	
313-12	56961-56969	concerns	_	
313-13	56970-56975	about	_	
313-14	56976-56980	dual	_	
313-15	56981-56992	publication	_	
313-16	56992-56993	,	_	
313-17	56994-57002	research	_	
313-18	57003-57009	ethics	_	
313-19	57009-57010	,	_	
313-20	57011-57013	or	_	
313-21	57014-57025	publication	_	
313-22	57026-57032	ethics	_	
313-23	57032-57033	.	_	

#Text=(Please upload your review as an attachment if it exceeds 20,000 characters)
#Text=Reviewer #1: This is an interesting and relevant study that focus on the harm caused by binge drinking in young men and women.
314-1	57034-57035	(	_	
314-2	57035-57041	Please	_	
314-3	57042-57048	upload	_	
314-4	57049-57053	your	_	
314-5	57054-57060	review	_	
314-6	57061-57063	as	_	
314-7	57064-57066	an	_	
314-8	57067-57077	attachment	_	
314-9	57078-57080	if	_	
314-10	57081-57083	it	_	
314-11	57084-57091	exceeds	_	
314-12	57092-57098	20,000	_	
314-13	57099-57109	characters	_	
314-14	57109-57110	)	_	
314-15	57111-57119	Reviewer	_	
314-16	57120-57122	#1	_	
314-17	57122-57123	:	_	
314-18	57124-57128	This	_	
314-19	57129-57131	is	_	
314-20	57132-57134	an	_	
314-21	57135-57146	interesting	_	
314-22	57147-57150	and	_	
314-23	57151-57159	relevant	_	
314-24	57160-57165	study	_	
314-25	57166-57170	that	_	
314-26	57171-57176	focus	_	
314-27	57177-57179	on	_	
314-28	57180-57183	the	_	
314-29	57184-57188	harm	_	
314-30	57189-57195	caused	_	
314-31	57196-57198	by	_	
314-32	57199-57204	binge	_	
314-33	57205-57213	drinking	_	
314-34	57214-57216	in	_	
314-35	57217-57222	young	_	
314-36	57223-57226	men	_	
314-37	57227-57230	and	_	
314-38	57231-57236	women	_	
314-39	57236-57237	.	_	

#Text=To better understand the neural mechanisms leading to risky and disinhibited intoxication-related behaviors the authors tested twenty-five healthy volunteers who underwent intravenous alcohol infusion to achieve a blood alcohol level of 0.08 g/dl.
315-1	57238-57240	To	_	
315-2	57241-57247	better	_	
315-3	57248-57258	understand	_	
315-4	57259-57262	the	_	
315-5	57263-57269	neural	_	
315-6	57270-57280	mechanisms	_	
315-7	57281-57288	leading	_	
315-8	57289-57291	to	_	
315-9	57292-57297	risky	_	
315-10	57298-57301	and	_	
315-11	57302-57314	disinhibited	_	
315-12	57315-57335	intoxication-related	_	
315-13	57336-57345	behaviors	_	
315-14	57346-57349	the	_	
315-15	57350-57357	authors	_	
315-16	57358-57364	tested	_	
315-17	57365-57376	twenty-five	_	
315-18	57377-57384	healthy	_	
315-19	57385-57395	volunteers	_	
315-20	57396-57399	who	_	
315-21	57400-57409	underwent	_	
315-22	57410-57421	intravenous	_	
315-23	57422-57429	alcohol	_	
315-24	57430-57438	infusion	_	
315-25	57439-57441	to	_	
315-26	57442-57449	achieve	_	
315-27	57450-57451	a	_	
315-28	57452-57457	blood	_	
315-29	57458-57465	alcohol	_	
315-30	57466-57471	level	_	
315-31	57472-57474	of	_	
315-32	57475-57479	0.08	_	
315-33	57480-57481	g	_	
315-34	57481-57482	/	_	
315-35	57482-57484	dl	_	
315-36	57484-57485	.	_	

#Text=A resting state functional magnetic resonance imaging scan was collected prior to the infusion and at binge-level exposure.
316-1	57486-57487	A	_	
316-2	57488-57495	resting	_	
316-3	57496-57501	state	_	
316-4	57502-57512	functional	_	
316-5	57513-57521	magnetic	_	
316-6	57522-57531	resonance	_	
316-7	57532-57539	imaging	_	
316-8	57540-57544	scan	_	
316-9	57545-57548	was	_	
316-10	57549-57558	collected	_	
316-11	57559-57564	prior	_	
316-12	57565-57567	to	_	
316-13	57568-57571	the	_	
316-14	57572-57580	infusion	_	
316-15	57581-57584	and	_	
316-16	57585-57587	at	_	
316-17	57588-57599	binge-level	_	
316-18	57600-57608	exposure	_	
316-19	57608-57609	.	_	

#Text=The authors were in particular interested in assessing alcohol-induced changes in globus pallidus externus (GPe) connectivity in relation to drinking behaviors and impulsivity traits.
317-1	57610-57613	The	_	
317-2	57614-57621	authors	_	
317-3	57622-57626	were	_	
317-4	57627-57629	in	_	
317-5	57630-57640	particular	_	
317-6	57641-57651	interested	_	
317-7	57652-57654	in	_	
317-8	57655-57664	assessing	_	
317-9	57665-57680	alcohol-induced	_	
317-10	57681-57688	changes	_	
317-11	57689-57691	in	_	
317-12	57692-57698	globus	_	
317-13	57699-57707	pallidus	_	
317-14	57708-57716	externus	_	
317-15	57717-57718	(	_	
317-16	57718-57721	GPe	_	
317-17	57721-57722	)	_	
317-18	57723-57735	connectivity	_	
317-19	57736-57738	in	_	
317-20	57739-57747	relation	_	
317-21	57748-57750	to	_	
317-22	57751-57759	drinking	_	
317-23	57760-57769	behaviors	_	
317-24	57770-57773	and	_	
317-25	57774-57785	impulsivity	_	
317-26	57786-57792	traits	_	
317-27	57792-57793	.	_	

#Text=The authors found that subjects with greater number of drinks in the recent past had greater alcohol-induced deficits in the connectivity of GPe particularly to the striatum; impulsivity was related to greater GPe connectivity while intoxicated.
318-1	57794-57797	The	_	
318-2	57798-57805	authors	_	
318-3	57806-57811	found	_	
318-4	57812-57816	that	_	
318-5	57817-57825	subjects	_	
318-6	57826-57830	with	_	
318-7	57831-57838	greater	_	
318-8	57839-57845	number	_	
318-9	57846-57848	of	_	
318-10	57849-57855	drinks	_	
318-11	57856-57858	in	_	
318-12	57859-57862	the	_	
318-13	57863-57869	recent	_	
318-14	57870-57874	past	_	
318-15	57875-57878	had	_	
318-16	57879-57886	greater	_	
318-17	57887-57902	alcohol-induced	_	
318-18	57903-57911	deficits	_	
318-19	57912-57914	in	_	
318-20	57915-57918	the	_	
318-21	57919-57931	connectivity	_	
318-22	57932-57934	of	_	
318-23	57935-57938	GPe	_	
318-24	57939-57951	particularly	_	
318-25	57952-57954	to	_	
318-26	57955-57958	the	_	
318-27	57959-57967	striatum	_	
318-28	57967-57968	;	_	
318-29	57969-57980	impulsivity	_	
318-30	57981-57984	was	_	
318-31	57985-57992	related	_	
318-32	57993-57995	to	_	
318-33	57996-58003	greater	_	
318-34	58004-58007	GPe	_	
318-35	58008-58020	connectivity	_	
318-36	58021-58026	while	_	
318-37	58027-58038	intoxicated	_	
318-38	58038-58039	.	_	

#Text=Overall this is a well written paper.
319-1	58040-58047	Overall	_	
319-2	58048-58052	this	_	
319-3	58053-58055	is	_	
319-4	58056-58057	a	_	
319-5	58058-58062	well	_	
319-6	58063-58070	written	_	
319-7	58071-58076	paper	_	
319-8	58076-58077	.	_	

#Text=However, I have some concerns, which are listed below:
#Text=One of the main problems of this study is the relatively small sample size for the number of analyses performed.
320-1	58078-58085	However	_	
320-2	58085-58086	,	_	
320-3	58087-58088	I	_	
320-4	58089-58093	have	_	
320-5	58094-58098	some	_	
320-6	58099-58107	concerns	_	
320-7	58107-58108	,	_	
320-8	58109-58114	which	_	
320-9	58115-58118	are	_	
320-10	58119-58125	listed	_	
320-11	58126-58131	below	_	
320-12	58131-58132	:	_	
320-13	58133-58136	One	_	
320-14	58137-58139	of	_	
320-15	58140-58143	the	_	
320-16	58144-58148	main	_	
320-17	58149-58157	problems	_	
320-18	58158-58160	of	_	
320-19	58161-58165	this	_	
320-20	58166-58171	study	_	
320-21	58172-58174	is	_	
320-22	58175-58178	the	_	
320-23	58179-58189	relatively	_	
320-24	58190-58195	small	_	
320-25	58196-58202	sample	_	
320-26	58203-58207	size	_	
320-27	58208-58211	for	_	
320-28	58212-58215	the	_	
320-29	58216-58222	number	_	
320-30	58223-58225	of	_	
320-31	58226-58234	analyses	_	
320-32	58235-58244	performed	_	
320-33	58244-58245	.	_	

#Text=The authors may provide effect sizes for their significant results.
321-1	58246-58249	The	_	
321-2	58250-58257	authors	_	
321-3	58258-58261	may	_	
321-4	58262-58269	provide	_	
321-5	58270-58276	effect	_	
321-6	58277-58282	sizes	_	
321-7	58283-58286	for	_	
321-8	58287-58292	their	_	
321-9	58293-58304	significant	_	
321-10	58305-58312	results	_	
321-11	58312-58313	.	_	

#Text=Sex effects were not explored although half of the participants were women.
322-1	58314-58317	Sex	_	
322-2	58318-58325	effects	_	
322-3	58326-58330	were	_	
322-4	58331-58334	not	_	
322-5	58335-58343	explored	_	
322-6	58344-58352	although	_	
322-7	58353-58357	half	_	
322-8	58358-58360	of	_	
322-9	58361-58364	the	_	
322-10	58365-58377	participants	_	
322-11	58378-58382	were	_	
322-12	58383-58388	women	_	
322-13	58388-58389	.	_	

#Text=The menstrual cycle can have an influence on the metabolization of alcohol and although it was recorded in the study, it is not noted if it was controlled for or considered in the data analyses.
323-1	58390-58393	The	_	
323-2	58394-58403	menstrual	_	
323-3	58404-58409	cycle	_	
323-4	58410-58413	can	_	
323-5	58414-58418	have	_	
323-6	58419-58421	an	_	
323-7	58422-58431	influence	_	
323-8	58432-58434	on	_	
323-9	58435-58438	the	_	
323-10	58439-58453	metabolization	_	
323-11	58454-58456	of	_	
323-12	58457-58464	alcohol	_	
323-13	58465-58468	and	_	
323-14	58469-58477	although	_	
323-15	58478-58480	it	_	
323-16	58481-58484	was	_	
323-17	58485-58493	recorded	_	
323-18	58494-58496	in	_	
323-19	58497-58500	the	_	
323-20	58501-58506	study	_	
323-21	58506-58507	,	_	
323-22	58508-58510	it	_	
323-23	58511-58513	is	_	
323-24	58514-58517	not	_	
323-25	58518-58523	noted	_	
323-26	58524-58526	if	_	
323-27	58527-58529	it	_	
323-28	58530-58533	was	_	
323-29	58534-58544	controlled	_	
323-30	58545-58548	for	_	
323-31	58549-58551	or	_	
323-32	58552-58562	considered	_	
323-33	58563-58565	in	_	
323-34	58566-58569	the	_	
323-35	58570-58574	data	_	
323-36	58575-58583	analyses	_	
323-37	58583-58584	.	_	

#Text=The targeted blood alcohol level of 0.08 g/dl may have different effects on neurofunctional connectivity in men and women depending on individual alcohol tolerance levels.
324-1	58585-58588	The	_	
324-2	58589-58597	targeted	_	
324-3	58598-58603	blood	_	
324-4	58604-58611	alcohol	_	
324-5	58612-58617	level	_	
324-6	58618-58620	of	_	
324-7	58621-58625	0.08	_	
324-8	58626-58627	g	_	
324-9	58627-58628	/	_	
324-10	58628-58630	dl	_	
324-11	58631-58634	may	_	
324-12	58635-58639	have	_	
324-13	58640-58649	different	_	
324-14	58650-58657	effects	_	
324-15	58658-58660	on	_	
324-16	58661-58676	neurofunctional	_	
324-17	58677-58689	connectivity	_	
324-18	58690-58692	in	_	
324-19	58693-58696	men	_	
324-20	58697-58700	and	_	
324-21	58701-58706	women	_	
324-22	58707-58716	depending	_	
324-23	58717-58719	on	_	
324-24	58720-58730	individual	_	
324-25	58731-58738	alcohol	_	
324-26	58739-58748	tolerance	_	
324-27	58749-58755	levels	_	
324-28	58755-58756	.	_	

#Text=Nicotine consumption should also be used as a co-variate.
325-1	58757-58765	Nicotine	_	
325-2	58766-58777	consumption	_	
325-3	58778-58784	should	_	
325-4	58785-58789	also	_	
325-5	58790-58792	be	_	
325-6	58793-58797	used	_	
325-7	58798-58800	as	_	
325-8	58801-58802	a	_	
325-9	58803-58813	co-variate	_	
325-10	58813-58814	.	_	

#Text=The methods are well described; however, it is not clear why the authors focused on the globus pallidus externus (GPe) and did not use other seed regions involved in inhibitory control as well.
326-1	58815-58818	The	_	
326-2	58819-58826	methods	_	
326-3	58827-58830	are	_	
326-4	58831-58835	well	_	
326-5	58836-58845	described	_	
326-6	58845-58846	;	_	
326-7	58847-58854	however	_	
326-8	58854-58855	,	_	
326-9	58856-58858	it	_	
326-10	58859-58861	is	_	
326-11	58862-58865	not	_	
326-12	58866-58871	clear	_	
326-13	58872-58875	why	_	
326-14	58876-58879	the	_	
326-15	58880-58887	authors	_	
326-16	58888-58895	focused	_	
326-17	58896-58898	on	_	
326-18	58899-58902	the	_	
326-19	58903-58909	globus	_	
326-20	58910-58918	pallidus	_	
326-21	58919-58927	externus	_	
326-22	58928-58929	(	_	
326-23	58929-58932	GPe	_	
326-24	58932-58933	)	_	
326-25	58934-58937	and	_	
326-26	58938-58941	did	_	
326-27	58942-58945	not	_	
326-28	58946-58949	use	_	
326-29	58950-58955	other	_	
326-30	58956-58960	seed	_	
326-31	58961-58968	regions	_	
326-32	58969-58977	involved	_	
326-33	58978-58980	in	_	
326-34	58981-58991	inhibitory	_	
326-35	58992-58999	control	_	
326-36	59000-59002	as	_	
326-37	59003-59007	well	_	
326-38	59007-59008	.	_	

#Text=No behavioral performance data are presented, yet the authors extensively discuss the stop-signal task along the lines of “reduced behavioral inhibition” or “reactive rather than proactive inhibition for individuals with more drinking.”
327-1	59009-59011	No	_	
327-2	59012-59022	behavioral	_	
327-3	59023-59034	performance	_	
327-4	59035-59039	data	_	
327-5	59040-59043	are	_	
327-6	59044-59053	presented	_	
327-7	59053-59054	,	_	
327-8	59055-59058	yet	_	
327-9	59059-59062	the	_	
327-10	59063-59070	authors	_	
327-11	59071-59082	extensively	_	
327-12	59083-59090	discuss	_	
327-13	59091-59094	the	_	
327-14	59095-59106	stop-signal	_	
327-15	59107-59111	task	_	
327-16	59112-59117	along	_	
327-17	59118-59121	the	_	
327-18	59122-59127	lines	_	
327-19	59128-59130	of	_	
327-20	59131-59132	“	_	
327-21	59132-59139	reduced	_	
327-22	59140-59150	behavioral	_	
327-23	59151-59161	inhibition	_	
327-24	59161-59162	”	_	
327-25	59163-59165	or	_	
327-26	59166-59167	“	_	
327-27	59167-59175	reactive	_	
327-28	59176-59182	rather	_	
327-29	59183-59187	than	_	
327-30	59188-59197	proactive	_	
327-31	59198-59208	inhibition	_	
327-32	59209-59212	for	_	
327-33	59213-59224	individuals	_	
327-34	59225-59229	with	_	
327-35	59230-59234	more	_	
327-36	59235-59243	drinking	_	
327-37	59243-59244	.	_	
327-38	59244-59245	”	_	

#Text=Either the discussion needs to be reformulated or performance data should be added to the analyses.
328-1	59246-59252	Either	_	
328-2	59253-59256	the	_	
328-3	59257-59267	discussion	_	
328-4	59268-59273	needs	_	
328-5	59274-59276	to	_	
328-6	59277-59279	be	_	
328-7	59280-59292	reformulated	_	
328-8	59293-59295	or	_	
328-9	59296-59307	performance	_	
328-10	59308-59312	data	_	
328-11	59313-59319	should	_	
328-12	59320-59322	be	_	
328-13	59323-59328	added	_	
328-14	59329-59331	to	_	
328-15	59332-59335	the	_	
328-16	59336-59344	analyses	_	
328-17	59344-59345	.	_	

#Text=The list of limitations of the study is long including not having a placebo group and a small sample size.
329-1	59346-59349	The	_	
329-2	59350-59354	list	_	
329-3	59355-59357	of	_	
329-4	59358-59369	limitations	_	
329-5	59370-59372	of	_	
329-6	59373-59376	the	_	
329-7	59377-59382	study	_	
329-8	59383-59385	is	_	
329-9	59386-59390	long	_	
329-10	59391-59400	including	_	
329-11	59401-59404	not	_	
329-12	59405-59411	having	_	
329-13	59412-59413	a	_	
329-14	59414-59421	placebo	_	
329-15	59422-59427	group	_	
329-16	59428-59431	and	_	
329-17	59432-59433	a	_	
329-18	59434-59439	small	_	
329-19	59440-59446	sample	_	
329-20	59447-59451	size	_	
329-21	59451-59452	.	_	

#Text=However, because of the complexity of the results, the introduction and discussion would profit from a model that can integrate the different connectivity results and also provide a rationale for focusing on the GPe as seed region for the analyses.
330-1	59453-59460	However	_	
330-2	59460-59461	,	_	
330-3	59462-59469	because	_	
330-4	59470-59472	of	_	
330-5	59473-59476	the	_	
330-6	59477-59487	complexity	_	
330-7	59488-59490	of	_	
330-8	59491-59494	the	_	
330-9	59495-59502	results	_	
330-10	59502-59503	,	_	
330-11	59504-59507	the	_	
330-12	59508-59520	introduction	_	
330-13	59521-59524	and	_	
330-14	59525-59535	discussion	_	
330-15	59536-59541	would	_	
330-16	59542-59548	profit	_	
330-17	59549-59553	from	_	
330-18	59554-59555	a	_	
330-19	59556-59561	model	_	
330-20	59562-59566	that	_	
330-21	59567-59570	can	_	
330-22	59571-59580	integrate	_	
330-23	59581-59584	the	_	
330-24	59585-59594	different	_	
330-25	59595-59607	connectivity	_	
330-26	59608-59615	results	_	
330-27	59616-59619	and	_	
330-28	59620-59624	also	_	
330-29	59625-59632	provide	_	
330-30	59633-59634	a	_	
330-31	59635-59644	rationale	_	
330-32	59645-59648	for	_	
330-33	59649-59657	focusing	_	
330-34	59658-59660	on	_	
330-35	59661-59664	the	_	
330-36	59665-59668	GPe	_	
330-37	59669-59671	as	_	
330-38	59672-59676	seed	_	
330-39	59677-59683	region	_	
330-40	59684-59687	for	_	
330-41	59688-59691	the	_	
330-42	59692-59700	analyses	_	
330-43	59700-59701	.	_	

#Text=Reviewer #2: “Alcohol effects on globus pallidus connectivity: role of impulsivity and binge drinking” by Dr.
331-1	59702-59710	Reviewer	_	
331-2	59711-59713	#2	_	
331-3	59713-59714	:	_	
331-4	59715-59716	“	_	
331-5	59716-59723	Alcohol	_	
331-6	59724-59731	effects	_	
331-7	59732-59734	on	_	
331-8	59735-59741	globus	_	
331-9	59742-59750	pallidus	_	
331-10	59751-59763	connectivity	_	
331-11	59763-59764	:	_	
331-12	59765-59769	role	_	
331-13	59770-59772	of	_	
331-14	59773-59784	impulsivity	_	
331-15	59785-59788	and	_	
331-16	59789-59794	binge	_	
331-17	59795-59803	drinking	_	
331-18	59803-59804	”	_	
331-19	59805-59807	by	_	
331-20	59808-59810	Dr	_	
331-21	59810-59811	.	_	

#Text=Fede and colleagues describes (clamped) alcohol-induced alterations in resting-state connectivity of the globus pallidus externus (GPe) with other regions, and how that relates to recent drinking history and impulsivity traits/behavior.
332-1	59812-59816	Fede	_	
332-2	59817-59820	and	_	
332-3	59821-59831	colleagues	_	
332-4	59832-59841	describes	_	
332-5	59842-59843	(	_	
332-6	59843-59850	clamped	_	
332-7	59850-59851	)	_	
332-8	59852-59867	alcohol-induced	_	
332-9	59868-59879	alterations	_	
332-10	59880-59882	in	_	
332-11	59883-59896	resting-state	_	
332-12	59897-59909	connectivity	_	
332-13	59910-59912	of	_	
332-14	59913-59916	the	_	
332-15	59917-59923	globus	_	
332-16	59924-59932	pallidus	_	
332-17	59933-59941	externus	_	
332-18	59942-59943	(	_	
332-19	59943-59946	GPe	_	
332-20	59946-59947	)	_	
332-21	59948-59952	with	_	
332-22	59953-59958	other	_	
332-23	59959-59966	regions	_	
332-24	59966-59967	,	_	
332-25	59968-59971	and	_	
332-26	59972-59975	how	_	
332-27	59976-59980	that	_	
332-28	59981-59988	relates	_	
332-29	59989-59991	to	_	
332-30	59992-59998	recent	_	
332-31	59999-60007	drinking	_	
332-32	60008-60015	history	_	
332-33	60016-60019	and	_	
332-34	60020-60031	impulsivity	_	
332-35	60032-60038	traits	_	
332-36	60038-60039	/	_	
332-37	60039-60047	behavior	_	
332-38	60047-60048	.	_	

#Text=This well-written manuscript is interesting and timely.
333-1	60049-60053	This	_	
333-2	60054-60066	well-written	_	
333-3	60067-60077	manuscript	_	
333-4	60078-60080	is	_	
333-5	60081-60092	interesting	_	
333-6	60093-60096	and	_	
333-7	60097-60103	timely	_	
333-8	60103-60104	.	_	

#Text=The most major critique relates to the cluster-forming threshold chosen.
334-1	60105-60108	The	_	
334-2	60109-60113	most	_	
334-3	60114-60119	major	_	
334-4	60120-60128	critique	_	
334-5	60129-60136	relates	_	
334-6	60137-60139	to	_	
334-7	60140-60143	the	_	
334-8	60144-60159	cluster-forming	_	
334-9	60160-60169	threshold	_	
334-10	60170-60176	chosen	_	
334-11	60176-60177	.	_	

#Text=A few points could be clarified with greater detail, elaborated below.
335-1	60178-60179	A	_	
335-2	60180-60183	few	_	
335-3	60184-60190	points	_	
335-4	60191-60196	could	_	
335-5	60197-60199	be	_	
335-6	60200-60209	clarified	_	
335-7	60210-60214	with	_	
335-8	60215-60222	greater	_	
335-9	60223-60229	detail	_	
335-10	60229-60230	,	_	
335-11	60231-60241	elaborated	_	
335-12	60242-60247	below	_	
335-13	60247-60248	.	_	

#Text=Major
#Text=Line 215: A cluster-forming threshold of p<.005, pFDR<.05 is rather liberal (Eklund et al. 2016), with cluster-forming thresholds of p<.001 producing much more acceptable false-positive rates.
336-1	60249-60254	Major	_	
336-2	60255-60259	Line	_	
336-3	60260-60263	215	_	
336-4	60263-60264	:	_	
336-5	60265-60266	A	_	
336-6	60267-60282	cluster-forming	_	
336-7	60283-60292	threshold	_	
336-8	60293-60295	of	_	
336-9	60296-60297	p	_	
336-10	60297-60298	<	_	
336-11	60298-60302	.005	_	
336-12	60302-60303	,	_	
336-13	60304-60308	pFDR	_	
336-14	60308-60309	<	_	
336-15	60309-60312	.05	_	
336-16	60313-60315	is	_	
336-17	60316-60322	rather	_	
336-18	60323-60330	liberal	_	
336-19	60331-60332	(	_	
336-20	60332-60338	Eklund	_	
336-21	60339-60341	et	_	
336-22	60342-60344	al	_	
336-23	60344-60345	.	_	
336-24	60346-60350	2016	_	
336-25	60350-60351	)	_	
336-26	60351-60352	,	_	
336-27	60353-60357	with	_	
336-28	60358-60373	cluster-forming	_	
336-29	60374-60384	thresholds	_	
336-30	60385-60387	of	_	
336-31	60388-60389	p	_	
336-32	60389-60390	<	_	
336-33	60390-60394	.001	_	
336-34	60395-60404	producing	_	
336-35	60405-60409	much	_	
336-36	60410-60414	more	_	
336-37	60415-60425	acceptable	_	
336-38	60426-60440	false-positive	_	
336-39	60441-60446	rates	_	
336-40	60446-60447	.	_	

#Text=Unless there is a rationale for using a more liberal threshold with these connectivity data, the p<.001 threshold should be followed.
337-1	60448-60454	Unless	_	
337-2	60455-60460	there	_	
337-3	60461-60463	is	_	
337-4	60464-60465	a	_	
337-5	60466-60475	rationale	_	
337-6	60476-60479	for	_	
337-7	60480-60485	using	_	
337-8	60486-60487	a	_	
337-9	60488-60492	more	_	
337-10	60493-60500	liberal	_	
337-11	60501-60510	threshold	_	
337-12	60511-60515	with	_	
337-13	60516-60521	these	_	
337-14	60522-60534	connectivity	_	
337-15	60535-60539	data	_	
337-16	60539-60540	,	_	
337-17	60541-60544	the	_	
337-18	60545-60546	p	_	
337-19	60546-60547	<	_	
337-20	60547-60551	.001	_	
337-21	60552-60561	threshold	_	
337-22	60562-60568	should	_	
337-23	60569-60571	be	_	
337-24	60572-60580	followed	_	
337-25	60580-60581	.	_	

#Text=Lines 220-231: If I follow, the authors performed paired t-tests (pre, post) with no regressors, then paired-t tests with impulsivity and drinking regressors.
338-1	60582-60587	Lines	_	
338-2	60588-60591	220	_	
338-3	60591-60592	-	_	
338-4	60592-60595	231	_	
338-5	60595-60596	:	_	
338-6	60597-60599	If	_	
338-7	60600-60601	I	_	
338-8	60602-60608	follow	_	
338-9	60608-60609	,	_	
338-10	60610-60613	the	_	
338-11	60614-60621	authors	_	
338-12	60622-60631	performed	_	
338-13	60632-60638	paired	_	
338-14	60639-60646	t-tests	_	
338-15	60647-60648	(	_	
338-16	60648-60651	pre	_	
338-17	60651-60652	,	_	
338-18	60653-60657	post	_	
338-19	60657-60658	)	_	
338-20	60659-60663	with	_	
338-21	60664-60666	no	_	
338-22	60667-60677	regressors	_	
338-23	60677-60678	,	_	
338-24	60679-60683	then	_	
338-25	60684-60692	paired-t	_	
338-26	60693-60698	tests	_	
338-27	60699-60703	with	_	
338-28	60704-60715	impulsivity	_	
338-29	60716-60719	and	_	
338-30	60720-60728	drinking	_	
338-31	60729-60739	regressors	_	
338-32	60739-60740	.	_	

#Text=These clusters’ beta weights were then extracted and used as the outcome of a linear model conducted in R(?)
339-1	60741-60746	These	_	
339-2	60747-60755	clusters	_	
339-3	60755-60756	’	_	
339-4	60757-60761	beta	_	
339-5	60762-60769	weights	_	
339-6	60770-60774	were	_	
339-7	60775-60779	then	_	
339-8	60780-60789	extracted	_	
339-9	60790-60793	and	_	
339-10	60794-60798	used	_	
339-11	60799-60801	as	_	
339-12	60802-60805	the	_	
339-13	60806-60813	outcome	_	
339-14	60814-60816	of	_	
339-15	60817-60818	a	_	
339-16	60819-60825	linear	_	
339-17	60826-60831	model	_	
339-18	60832-60841	conducted	_	
339-19	60842-60844	in	_	
339-20	60845-60846	R	_	
339-21	60846-60847	(	_	
339-22	60847-60848	?	_	
339-23	60848-60849	)	_	

#Text=Please clarify.
340-1	60850-60856	Please	_	
340-2	60857-60864	clarify	_	
340-3	60864-60865	.	_	

#Text=Be very explicit about exactly how the analyses were performed, with a helpful step-by-step description in more depth.
341-1	60866-60868	Be	_	
341-2	60869-60873	very	_	
341-3	60874-60882	explicit	_	
341-4	60883-60888	about	_	
341-5	60889-60896	exactly	_	
341-6	60897-60900	how	_	
341-7	60901-60904	the	_	
341-8	60905-60913	analyses	_	
341-9	60914-60918	were	_	
341-10	60919-60928	performed	_	
341-11	60928-60929	,	_	
341-12	60930-60934	with	_	
341-13	60935-60936	a	_	
341-14	60937-60944	helpful	_	
341-15	60945-60957	step-by-step	_	
341-16	60958-60969	description	_	
341-17	60970-60972	in	_	
341-18	60973-60977	more	_	
341-19	60978-60983	depth	_	
341-20	60983-60984	.	_	

#Text=This section was a bit hard to follow.
342-1	60985-60989	This	_	
342-2	60990-60997	section	_	
342-3	60998-61001	was	_	
342-4	61002-61003	a	_	
342-5	61004-61007	bit	_	
342-6	61008-61012	hard	_	
342-7	61013-61015	to	_	
342-8	61016-61022	follow	_	
342-9	61022-61023	.	_	

#Text=Line 343: “As predicted, we found that heavier drinking individuals had more pronounced changes in GPe connectivity with the basal ganglia, OFC, and mPFC regions.
343-1	61024-61028	Line	_	
343-2	61029-61032	343	_	
343-3	61032-61033	:	_	
343-4	61034-61035	“	_	
343-5	61035-61037	As	_	
343-6	61038-61047	predicted	_	
343-7	61047-61048	,	_	
343-8	61049-61051	we	_	
343-9	61052-61057	found	_	
343-10	61058-61062	that	_	
343-11	61063-61070	heavier	_	
343-12	61071-61079	drinking	_	
343-13	61080-61091	individuals	_	
343-14	61092-61095	had	_	
343-15	61096-61100	more	_	
343-16	61101-61111	pronounced	_	
343-17	61112-61119	changes	_	
343-18	61120-61122	in	_	
343-19	61123-61126	GPe	_	
343-20	61127-61139	connectivity	_	
343-21	61140-61144	with	_	
343-22	61145-61148	the	_	
343-23	61149-61154	basal	_	
343-24	61155-61162	ganglia	_	
343-25	61162-61163	,	_	
343-26	61164-61167	OFC	_	
343-27	61167-61168	,	_	
343-28	61169-61172	and	_	
343-29	61173-61177	mPFC	_	
343-30	61178-61185	regions	_	
343-31	61185-61186	.	_	

#Text=In these regions, individuals with patterns of heavy drinking had less coupling at baseline than individuals with lighter drinking patterns;” Figure 2 (upper right) appears to illustrate the heaviest drinkers with more coupling at baseline (r= ~.25) relative to the lightest drinkers (r= ~0) in the R.GPe-L insula/putamen, with the lighter drinkers showing the largest alcohol-induced change in connectivity.
344-1	61187-61189	In	_	
344-2	61190-61195	these	_	
344-3	61196-61203	regions	_	
344-4	61203-61204	,	_	
344-5	61205-61216	individuals	_	
344-6	61217-61221	with	_	
344-7	61222-61230	patterns	_	
344-8	61231-61233	of	_	
344-9	61234-61239	heavy	_	
344-10	61240-61248	drinking	_	
344-11	61249-61252	had	_	
344-12	61253-61257	less	_	
344-13	61258-61266	coupling	_	
344-14	61267-61269	at	_	
344-15	61270-61278	baseline	_	
344-16	61279-61283	than	_	
344-17	61284-61295	individuals	_	
344-18	61296-61300	with	_	
344-19	61301-61308	lighter	_	
344-20	61309-61317	drinking	_	
344-21	61318-61326	patterns	_	
344-22	61326-61327	;	_	
344-23	61327-61328	”	_	
344-24	61329-61335	Figure	_	
344-25	61336-61337	2	_	
344-26	61338-61339	(	_	
344-27	61339-61344	upper	_	
344-28	61345-61350	right	_	
344-29	61350-61351	)	_	
344-30	61352-61359	appears	_	
344-31	61360-61362	to	_	
344-32	61363-61373	illustrate	_	
344-33	61374-61377	the	_	
344-34	61378-61386	heaviest	_	
344-35	61387-61395	drinkers	_	
344-36	61396-61400	with	_	
344-37	61401-61405	more	_	
344-38	61406-61414	coupling	_	
344-39	61415-61417	at	_	
344-40	61418-61426	baseline	_	
344-41	61427-61428	(	_	
344-42	61428-61429	r	_	
344-43	61429-61430	=	_	
344-44	61431-61432	~	_	
344-45	61432-61435	.25	_	
344-46	61435-61436	)	_	
344-47	61437-61445	relative	_	
344-48	61446-61448	to	_	
344-49	61449-61452	the	_	
344-50	61453-61461	lightest	_	
344-51	61462-61470	drinkers	_	
344-52	61471-61472	(	_	
344-53	61472-61473	r	_	
344-54	61473-61474	=	_	
344-55	61475-61476	~	_	
344-56	61476-61477	0	_	
344-57	61477-61478	)	_	
344-58	61479-61481	in	_	
344-59	61482-61485	the	_	
344-60	61486-61493	R.GPe-L	_	
344-61	61494-61500	insula	_	
344-62	61500-61501	/	_	
344-63	61501-61508	putamen	_	
344-64	61508-61509	,	_	
344-65	61510-61514	with	_	
344-66	61515-61518	the	_	
344-67	61519-61526	lighter	_	
344-68	61527-61535	drinkers	_	
344-69	61536-61543	showing	_	
344-70	61544-61547	the	_	
344-71	61548-61555	largest	_	
344-72	61556-61571	alcohol-induced	_	
344-73	61572-61578	change	_	
344-74	61579-61581	in	_	
344-75	61582-61594	connectivity	_	
344-76	61594-61595	.	_	

#Text=Please clarify
#Text=Minor
#Text=Line 56: “This is largely due to organ damage caused by chronic drinking, intoxication-related car accidents and domestic violence, and the development of alcohol use disorder (AUD) [3, 4].”
345-1	61596-61602	Please	_	
345-2	61603-61610	clarify	_	
345-3	61611-61616	Minor	_	
345-4	61617-61621	Line	_	
345-5	61622-61624	56	_	
345-6	61624-61625	:	_	
345-7	61626-61627	“	_	
345-8	61627-61631	This	_	
345-9	61632-61634	is	_	
345-10	61635-61642	largely	_	
345-11	61643-61646	due	_	
345-12	61647-61649	to	_	
345-13	61650-61655	organ	_	
345-14	61656-61662	damage	_	
345-15	61663-61669	caused	_	
345-16	61670-61672	by	_	
345-17	61673-61680	chronic	_	
345-18	61681-61689	drinking	_	
345-19	61689-61690	,	_	
345-20	61691-61711	intoxication-related	_	
345-21	61712-61715	car	_	
345-22	61716-61725	accidents	_	
345-23	61726-61729	and	_	
345-24	61730-61738	domestic	_	
345-25	61739-61747	violence	_	
345-26	61747-61748	,	_	
345-27	61749-61752	and	_	
345-28	61753-61756	the	_	
345-29	61757-61768	development	_	
345-30	61769-61771	of	_	
345-31	61772-61779	alcohol	_	
345-32	61780-61783	use	_	
345-33	61784-61792	disorder	_	
345-34	61793-61794	(	_	
345-35	61794-61797	AUD	_	
345-36	61797-61798	)	_	
345-37	61799-61800	[	_	
345-38	61800-61801	3	_	
345-39	61801-61802	,	_	
345-40	61803-61804	4	_	
345-41	61804-61805	]	_	
345-42	61805-61806	.	_	
345-43	61806-61807	”	_	

#Text=AUD is antecedent to the vast majority of the ills described here; please clarify this relationship.
346-1	61808-61811	AUD	_	
346-2	61812-61814	is	_	
346-3	61815-61825	antecedent	_	
346-4	61826-61828	to	_	
346-5	61829-61832	the	_	
346-6	61833-61837	vast	_	
346-7	61838-61846	majority	_	
346-8	61847-61849	of	_	
346-9	61850-61853	the	_	
346-10	61854-61858	ills	_	
346-11	61859-61868	described	_	
346-12	61869-61873	here	_	
346-13	61873-61874	;	_	
346-14	61875-61881	please	_	
346-15	61882-61889	clarify	_	
346-16	61890-61894	this	_	
346-17	61895-61907	relationship	_	
346-18	61907-61908	.	_	

#Text=Table 1: Though it is specified in-text, it would be helpful to discriminate the two TLFB measures; either in the table Notes or within the table, e.g., “Drinks in last Thirty Days”.
347-1	61909-61914	Table	_	
347-2	61915-61916	1	_	
347-3	61916-61917	:	_	
347-4	61918-61924	Though	_	
347-5	61925-61927	it	_	
347-6	61928-61930	is	_	
347-7	61931-61940	specified	_	
347-8	61941-61948	in-text	_	
347-9	61948-61949	,	_	
347-10	61950-61952	it	_	
347-11	61953-61958	would	_	
347-12	61959-61961	be	_	
347-13	61962-61969	helpful	_	
347-14	61970-61972	to	_	
347-15	61973-61985	discriminate	_	
347-16	61986-61989	the	_	
347-17	61990-61993	two	_	
347-18	61994-61998	TLFB	_	
347-19	61999-62007	measures	_	
347-20	62007-62008	;	_	
347-21	62009-62015	either	_	
347-22	62016-62018	in	_	
347-23	62019-62022	the	_	
347-24	62023-62028	table	_	
347-25	62029-62034	Notes	_	
347-26	62035-62037	or	_	
347-27	62038-62044	within	_	
347-28	62045-62048	the	_	
347-29	62049-62054	table	_	
347-30	62054-62055	,	_	
347-31	62056-62059	e.g	_	
347-32	62059-62060	.	_	
347-33	62060-62061	,	_	
347-34	62062-62063	“	_	
347-35	62063-62069	Drinks	_	
347-36	62070-62072	in	_	
347-37	62073-62077	last	_	
347-38	62078-62084	Thirty	_	
347-39	62085-62089	Days	_	
347-40	62089-62090	”	_	
347-41	62090-62091	.	_	

#Text=Line 133: What monetary amounts were used for the DDT?
348-1	62092-62096	Line	_	
348-2	62097-62100	133	_	
348-3	62100-62101	:	_	
348-4	62102-62106	What	_	
348-5	62107-62115	monetary	_	
348-6	62116-62123	amounts	_	
348-7	62124-62128	were	_	
348-8	62129-62133	used	_	
348-9	62134-62137	for	_	
348-10	62138-62141	the	_	
348-11	62142-62145	DDT	_	
348-12	62145-62146	?	_	

#Text=Supplementary Figure 1A: Perhaps I misunderstand, but the way this is presented it appears to show a (group mean?)
349-1	62147-62160	Supplementary	_	
349-2	62161-62167	Figure	_	
349-3	62168-62170	1A	_	
349-4	62170-62171	:	_	
349-5	62172-62179	Perhaps	_	
349-6	62180-62181	I	_	
349-7	62182-62195	misunderstand	_	
349-8	62195-62196	,	_	
349-9	62197-62200	but	_	
349-10	62201-62204	the	_	
349-11	62205-62208	way	_	
349-12	62209-62213	this	_	
349-13	62214-62216	is	_	
349-14	62217-62226	presented	_	
349-15	62227-62229	it	_	
349-16	62230-62237	appears	_	
349-17	62238-62240	to	_	
349-18	62241-62245	show	_	
349-19	62246-62247	a	_	
349-20	62248-62249	(	_	
349-21	62249-62254	group	_	
349-22	62255-62259	mean	_	
349-23	62259-62260	?	_	
349-24	62260-62261	)	_	

#Text=time series from the right GPe OFF and ON alcohol.
350-1	62262-62266	time	_	
350-2	62267-62273	series	_	
350-3	62274-62278	from	_	
350-4	62279-62282	the	_	
350-5	62283-62288	right	_	
350-6	62289-62292	GPe	_	
350-7	62293-62296	OFF	_	
350-8	62297-62300	and	_	
350-9	62301-62303	ON	_	
350-10	62304-62311	alcohol	_	
350-11	62311-62312	.	_	

#Text=If so, then the stereotyped pattern from the (pre) condition resting scan is replicated in a (post) resting scan 25 min later, albeit with a small timeshift.
351-1	62313-62315	If	_	
351-2	62316-62318	so	_	
351-3	62318-62319	,	_	
351-4	62320-62324	then	_	
351-5	62325-62328	the	_	
351-6	62329-62340	stereotyped	_	
351-7	62341-62348	pattern	_	
351-8	62349-62353	from	_	
351-9	62354-62357	the	_	
351-10	62358-62359	(	_	
351-11	62359-62362	pre	_	
351-12	62362-62363	)	_	
351-13	62364-62373	condition	_	
351-14	62374-62381	resting	_	
351-15	62382-62386	scan	_	
351-16	62387-62389	is	_	
351-17	62390-62400	replicated	_	
351-18	62401-62403	in	_	
351-19	62404-62405	a	_	
351-20	62406-62407	(	_	
351-21	62407-62411	post	_	
351-22	62411-62412	)	_	
351-23	62413-62420	resting	_	
351-24	62421-62425	scan	_	
351-25	62426-62428	25	_	
351-26	62429-62432	min	_	
351-27	62433-62438	later	_	
351-28	62438-62439	,	_	
351-29	62440-62446	albeit	_	
351-30	62447-62451	with	_	
351-31	62452-62453	a	_	
351-32	62454-62459	small	_	
351-33	62460-62469	timeshift	_	
351-34	62469-62470	.	_	

#Text=It seems impossible that a resting scan would produce a stereotyped/replicated pattern as illustrated; i.e.
352-1	62471-62473	It	_	
352-2	62474-62479	seems	_	
352-3	62480-62490	impossible	_	
352-4	62491-62495	that	_	
352-5	62496-62497	a	_	
352-6	62498-62505	resting	_	
352-7	62506-62510	scan	_	
352-8	62511-62516	would	_	
352-9	62517-62524	produce	_	
352-10	62525-62526	a	_	
352-11	62527-62538	stereotyped	_	
352-12	62538-62539	/	_	
352-13	62539-62549	replicated	_	
352-14	62550-62557	pattern	_	
352-15	62558-62560	as	_	
352-16	62561-62572	illustrated	_	
352-17	62572-62573	;	_	
352-18	62574-62577	i.e	_	
352-19	62577-62578	.	_	

#Text=I would expect that the group mean resting BOLD signal would look like noise.
353-1	62579-62580	I	_	
353-2	62581-62586	would	_	
353-3	62587-62593	expect	_	
353-4	62594-62598	that	_	
353-5	62599-62602	the	_	
353-6	62603-62608	group	_	
353-7	62609-62613	mean	_	
353-8	62614-62621	resting	_	
353-9	62622-62626	BOLD	_	
353-10	62627-62633	signal	_	
353-11	62634-62639	would	_	
353-12	62640-62644	look	_	
353-13	62645-62649	like	_	
353-14	62650-62655	noise	_	
353-15	62655-62656	.	_	

#Text=Please explain what this figure is showing.
354-1	62657-62663	Please	_	
354-2	62664-62671	explain	_	
354-3	62672-62676	what	_	
354-4	62677-62681	this	_	
354-5	62682-62688	figure	_	
354-6	62689-62691	is	_	
354-7	62692-62699	showing	_	
354-8	62699-62700	.	_	

#Text=Interestingly, alcohol-increased connectivity was mostly ipsilateral for left GPe, but mostly contralateral for right GPe.
355-1	62701-62714	Interestingly	_	
355-2	62714-62715	,	_	
355-3	62716-62733	alcohol-increased	_	
355-4	62734-62746	connectivity	_	
355-5	62747-62750	was	_	
355-6	62751-62757	mostly	_	
355-7	62758-62769	ipsilateral	_	
355-8	62770-62773	for	_	
355-9	62774-62778	left	_	
355-10	62779-62782	GPe	_	
355-11	62782-62783	,	_	
355-12	62784-62787	but	_	
355-13	62788-62794	mostly	_	
355-14	62795-62808	contralateral	_	
355-15	62809-62812	for	_	
355-16	62813-62818	right	_	
355-17	62819-62822	GPe	_	
355-18	62822-62823	.	_	

#Text=What do the authors make of this?
356-1	62824-62828	What	_	
356-2	62829-62831	do	_	
356-3	62832-62835	the	_	
356-4	62836-62843	authors	_	
356-5	62844-62848	make	_	
356-6	62849-62851	of	_	
356-7	62852-62856	this	_	
356-8	62856-62857	?	_	

#Text=Line 239: “The number of drinks consumed per 30 days prior to screening had a significant effect on alcohol-related change in connectivity.”
357-1	62858-62862	Line	_	
357-2	62863-62866	239	_	
357-3	62866-62867	:	_	
357-4	62868-62869	“	_	
357-5	62869-62872	The	_	
357-6	62873-62879	number	_	
357-7	62880-62882	of	_	
357-8	62883-62889	drinks	_	
357-9	62890-62898	consumed	_	
357-10	62899-62902	per	_	
357-11	62903-62905	30	_	
357-12	62906-62910	days	_	
357-13	62911-62916	prior	_	
357-14	62917-62919	to	_	
357-15	62920-62929	screening	_	
357-16	62930-62933	had	_	
357-17	62934-62935	a	_	
357-18	62936-62947	significant	_	
357-19	62948-62954	effect	_	
357-20	62955-62957	on	_	
357-21	62958-62973	alcohol-related	_	
357-22	62974-62980	change	_	
357-23	62981-62983	in	_	
357-24	62984-62996	connectivity	_	
357-25	62996-62997	.	_	
357-26	62997-62998	”	_	

#Text=Please reword to reflect “association”; the current wording implies directionality and causation.
358-1	62999-63005	Please	_	
358-2	63006-63012	reword	_	
358-3	63013-63015	to	_	
358-4	63016-63023	reflect	_	
358-5	63024-63025	“	_	
358-6	63025-63036	association	_	
358-7	63036-63037	”	_	
358-8	63037-63038	;	_	
358-9	63039-63042	the	_	
358-10	63043-63050	current	_	
358-11	63051-63058	wording	_	
358-12	63059-63066	implies	_	
358-13	63067-63081	directionality	_	
358-14	63082-63085	and	_	
358-15	63086-63095	causation	_	
358-16	63095-63096	.	_	

#Text=Figure 2 legend: “B.i.
359-1	63097-63103	Figure	_	
359-2	63104-63105	2	_	
359-3	63106-63112	legend	_	
359-4	63112-63113	:	_	
359-5	63114-63115	“	_	
359-6	63115-63118	B.i	_	
359-7	63118-63119	.	_	

#Text=Heschl’s Gyrus…” appears to be labeled “ii.” on the figure diagram.
360-1	63120-63126	Heschl	_	
360-2	63126-63127	’	_	
360-3	63127-63128	s	_	
360-4	63129-63134	Gyrus	_	
360-5	63134-63135	…	_	
360-6	63135-63136	”	_	
360-7	63137-63144	appears	_	
360-8	63145-63147	to	_	
360-9	63148-63150	be	_	
360-10	63151-63158	labeled	_	
360-11	63159-63160	“	_	
360-12	63160-63162	ii	_	
360-13	63162-63163	.	_	
360-14	63163-63164	”	_	
360-15	63165-63167	on	_	
360-16	63168-63171	the	_	
360-17	63172-63178	figure	_	
360-18	63179-63186	diagram	_	
360-19	63186-63187	.	_	

#Text=Figure 3 legend: “Reported clusters clusters of connectivity with GPe area correspond to the following regions: i. – Orbitofrontal cortex extending into subgenual anterior cingulate; ii. – Angular/supramarginal gyrus; iii.
361-1	63188-63194	Figure	_	
361-2	63195-63196	3	_	
361-3	63197-63203	legend	_	
361-4	63203-63204	:	_	
361-5	63205-63206	“	_	
361-6	63206-63214	Reported	_	
361-7	63215-63223	clusters	_	
361-8	63224-63232	clusters	_	
361-9	63233-63235	of	_	
361-10	63236-63248	connectivity	_	
361-11	63249-63253	with	_	
361-12	63254-63257	GPe	_	
361-13	63258-63262	area	_	
361-14	63263-63273	correspond	_	
361-15	63274-63276	to	_	
361-16	63277-63280	the	_	
361-17	63281-63290	following	_	
361-18	63291-63298	regions	_	
361-19	63298-63299	:	_	
361-20	63300-63301	i	_	
361-21	63301-63302	.	_	
361-22	63303-63304	–	_	
361-23	63305-63318	Orbitofrontal	_	
361-24	63319-63325	cortex	_	
361-25	63326-63335	extending	_	
361-26	63336-63340	into	_	
361-27	63341-63350	subgenual	_	
361-28	63351-63359	anterior	_	
361-29	63360-63369	cingulate	_	
361-30	63369-63370	;	_	
361-31	63371-63373	ii	_	
361-32	63373-63374	.	_	
361-33	63375-63376	–	_	
361-34	63377-63384	Angular	_	
361-35	63384-63385	/	_	
361-36	63385-63398	supramarginal	_	
361-37	63399-63404	gyrus	_	
361-38	63404-63405	;	_	
361-39	63406-63409	iii	_	
361-40	63409-63410	.	_	

#Text=Frontal pole.”
362-1	63411-63418	Frontal	_	
362-2	63419-63423	pole	_	
362-3	63423-63424	.	_	
362-4	63424-63425	”	_	

#Text=It seems that “GPe area” should be described as “left GPe”.
363-1	63426-63428	It	_	
363-2	63429-63434	seems	_	
363-3	63435-63439	that	_	
363-4	63440-63441	“	_	
363-5	63441-63444	GPe	_	
363-6	63445-63449	area	_	
363-7	63449-63450	”	_	
363-8	63451-63457	should	_	
363-9	63458-63460	be	_	
363-10	63461-63470	described	_	
363-11	63471-63473	as	_	
363-12	63474-63475	“	_	
363-13	63475-63479	left	_	
363-14	63480-63483	GPe	_	
363-15	63483-63484	”	_	
363-16	63484-63485	.	_	

#Text=No mention is made of “iv”, “v”, or “vi”.
364-1	63486-63488	No	_	
364-2	63489-63496	mention	_	
364-3	63497-63499	is	_	
364-4	63500-63504	made	_	
364-5	63505-63507	of	_	
364-6	63508-63509	“	_	
364-7	63509-63511	iv	_	
364-8	63511-63512	”	_	
364-9	63512-63513	,	_	
364-10	63514-63515	“	_	
364-11	63515-63516	v	_	
364-12	63516-63517	”	_	
364-13	63517-63518	,	_	
364-14	63519-63521	or	_	
364-15	63522-63523	“	_	
364-16	63523-63525	vi	_	
364-17	63525-63526	”	_	
364-18	63526-63527	.	_	

#Text=Figure 5: “Diagram of Drinking/Impulsivity Mediation column” is not present in the attached figures.
365-1	63528-63534	Figure	_	
365-2	63535-63536	5	_	
365-3	63536-63537	:	_	
365-4	63538-63539	“	_	
365-5	63539-63546	Diagram	_	
365-6	63547-63549	of	_	
365-7	63550-63558	Drinking	_	
365-8	63558-63559	/	_	
365-9	63559-63570	Impulsivity	_	
365-10	63571-63580	Mediation	_	
365-11	63581-63587	column	_	
365-12	63587-63588	”	_	
365-13	63589-63591	is	_	
365-14	63592-63595	not	_	
365-15	63596-63603	present	_	
365-16	63604-63606	in	_	
365-17	63607-63610	the	_	
365-18	63611-63619	attached	_	
365-19	63620-63627	figures	_	
365-20	63627-63628	.	_	

#Text=Only 3 columns are displayed in Fig 5.
#Text=**********
#Text=6.
366-1	63629-63633	Only	_	
366-2	63634-63635	3	_	
366-3	63636-63643	columns	_	
366-4	63644-63647	are	_	
366-5	63648-63657	displayed	_	
366-6	63658-63660	in	_	
366-7	63661-63664	Fig	_	
366-8	63665-63666	5	_	
366-9	63666-63667	.	_	
366-10	63668-63669	*	_	
366-11	63669-63670	*	_	
366-12	63670-63671	*	_	
366-13	63671-63672	*	_	
366-14	63672-63673	*	_	
366-15	63673-63674	*	_	
366-16	63674-63675	*	_	
366-17	63675-63676	*	_	
366-18	63676-63677	*	_	
366-19	63677-63678	*	_	
366-20	63679-63680	6	_	
366-21	63680-63681	.	_	

#Text=PLOS authors have the option to publish the peer review history of their article (what does this mean?).
367-1	63682-63686	PLOS	_	
367-2	63687-63694	authors	_	
367-3	63695-63699	have	_	
367-4	63700-63703	the	_	
367-5	63704-63710	option	_	
367-6	63711-63713	to	_	
367-7	63714-63721	publish	_	
367-8	63722-63725	the	_	
367-9	63726-63730	peer	_	
367-10	63731-63737	review	_	
367-11	63738-63745	history	_	
367-12	63746-63748	of	_	
367-13	63749-63754	their	_	
367-14	63755-63762	article	_	
367-15	63763-63764	(	_	
367-16	63764-63768	what	_	
367-17	63769-63773	does	_	
367-18	63774-63778	this	_	
367-19	63779-63783	mean	_	
367-20	63783-63784	?	_	
367-21	63784-63785	)	_	
367-22	63785-63786	.	_	

#Text=If published, this will include your full peer review and any attached files.
368-1	63787-63789	If	_	
368-2	63790-63799	published	_	
368-3	63799-63800	,	_	
368-4	63801-63805	this	_	
368-5	63806-63810	will	_	
368-6	63811-63818	include	_	
368-7	63819-63823	your	_	
368-8	63824-63828	full	_	
368-9	63829-63833	peer	_	
368-10	63834-63840	review	_	
368-11	63841-63844	and	_	
368-12	63845-63848	any	_	
368-13	63849-63857	attached	_	
368-14	63858-63863	files	_	
368-15	63863-63864	.	_	

#Text=If you choose “no”, your identity will remain anonymous but your review may still be made public.
369-1	63865-63867	If	_	
369-2	63868-63871	you	_	
369-3	63872-63878	choose	_	
369-4	63879-63880	“	_	
369-5	63880-63882	no	_	
369-6	63882-63883	”	_	
369-7	63883-63884	,	_	
369-8	63885-63889	your	_	
369-9	63890-63898	identity	_	
369-10	63899-63903	will	_	
369-11	63904-63910	remain	_	
369-12	63911-63920	anonymous	_	
369-13	63921-63924	but	_	
369-14	63925-63929	your	_	
369-15	63930-63936	review	_	
369-16	63937-63940	may	_	
369-17	63941-63946	still	_	
369-18	63947-63949	be	_	
369-19	63950-63954	made	_	
369-20	63955-63961	public	_	
369-21	63961-63962	.	_	

#Text=Do you want your identity to be public for this peer review?
370-1	63963-63965	Do	_	
370-2	63966-63969	you	_	
370-3	63970-63974	want	_	
370-4	63975-63979	your	_	
370-5	63980-63988	identity	_	
370-6	63989-63991	to	_	
370-7	63992-63994	be	_	
370-8	63995-64001	public	_	
370-9	64002-64005	for	_	
370-10	64006-64010	this	_	
370-11	64011-64015	peer	_	
370-12	64016-64022	review	_	
370-13	64022-64023	?	_	

#Text=For information about this choice, including consent withdrawal, please see our Privacy Policy.
371-1	64024-64027	For	_	
371-2	64028-64039	information	_	
371-3	64040-64045	about	_	
371-4	64046-64050	this	_	
371-5	64051-64057	choice	_	
371-6	64057-64058	,	_	
371-7	64059-64068	including	_	
371-8	64069-64076	consent	_	
371-9	64077-64087	withdrawal	_	
371-10	64087-64088	,	_	
371-11	64089-64095	please	_	
371-12	64096-64099	see	_	
371-13	64100-64103	our	_	
371-14	64104-64111	Privacy	_	
371-15	64112-64118	Policy	_	
371-16	64118-64119	.	_	

#Text=Reviewer #1: No
#Text=Reviewer #2: No
#Text=[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site.
372-1	64120-64128	Reviewer	_	
372-2	64129-64131	#1	_	
372-3	64131-64132	:	_	
372-4	64133-64135	No	_	
372-5	64136-64144	Reviewer	_	
372-6	64145-64147	#2	_	
372-7	64147-64148	:	_	
372-8	64149-64151	No	_	
372-9	64152-64153	[	_	
372-10	64153-64157	NOTE	_	
372-11	64157-64158	:	_	
372-12	64159-64161	If	_	
372-13	64162-64170	reviewer	_	
372-14	64171-64179	comments	_	
372-15	64180-64184	were	_	
372-16	64185-64194	submitted	_	
372-17	64195-64197	as	_	
372-18	64198-64200	an	_	
372-19	64201-64211	attachment	_	
372-20	64212-64216	file	_	
372-21	64216-64217	,	_	
372-22	64218-64222	they	_	
372-23	64223-64227	will	_	
372-24	64228-64230	be	_	
372-25	64231-64239	attached	_	
372-26	64240-64242	to	_	
372-27	64243-64247	this	_	
372-28	64248-64253	email	_	
372-29	64254-64257	and	_	
372-30	64258-64268	accessible	_	
372-31	64269-64272	via	_	
372-32	64273-64276	the	_	
372-33	64277-64287	submission	_	
372-34	64288-64292	site	_	
372-35	64292-64293	.	_	

#Text=Please log into your account, locate the manuscript record, and check for the action link "View Attachments".
373-1	64294-64300	Please	_	
373-2	64301-64304	log	_	
373-3	64305-64309	into	_	
373-4	64310-64314	your	_	
373-5	64315-64322	account	_	
373-6	64322-64323	,	_	
373-7	64324-64330	locate	_	
373-8	64331-64334	the	_	
373-9	64335-64345	manuscript	_	
373-10	64346-64352	record	_	
373-11	64352-64353	,	_	
373-12	64354-64357	and	_	
373-13	64358-64363	check	_	
373-14	64364-64367	for	_	
373-15	64368-64371	the	_	
373-16	64372-64378	action	_	
373-17	64379-64383	link	_	
373-18	64384-64385	"	_	
373-19	64385-64389	View	_	
373-20	64390-64401	Attachments	_	
373-21	64401-64402	"	_	
373-22	64402-64403	.	_	

#Text=If this link does not appear, there are no attachment files to be viewed.]
374-1	64404-64406	If	_	
374-2	64407-64411	this	_	
374-3	64412-64416	link	_	
374-4	64417-64421	does	_	
374-5	64422-64425	not	_	
374-6	64426-64432	appear	_	
374-7	64432-64433	,	_	
374-8	64434-64439	there	_	
374-9	64440-64443	are	_	
374-10	64444-64446	no	_	
374-11	64447-64457	attachment	_	
374-12	64458-64463	files	_	
374-13	64464-64466	to	_	
374-14	64467-64469	be	_	
374-15	64470-64476	viewed	_	
374-16	64476-64477	.	_	
374-17	64477-64478	]	_	

#Text=While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/.
375-1	64479-64484	While	_	
375-2	64485-64493	revising	_	
375-3	64494-64498	your	_	
375-4	64499-64509	submission	_	
375-5	64509-64510	,	_	
375-6	64511-64517	please	_	
375-7	64518-64524	upload	_	
375-8	64525-64529	your	_	
375-9	64530-64536	figure	_	
375-10	64537-64542	files	_	
375-11	64543-64545	to	_	
375-12	64546-64549	the	_	
375-13	64550-64559	Preflight	_	
375-14	64560-64568	Analysis	_	
375-15	64569-64572	and	_	
375-16	64573-64583	Conversion	_	
375-17	64584-64590	Engine	_	
375-18	64591-64592	(	_	
375-19	64592-64596	PACE	_	
375-20	64596-64597	)	_	
375-21	64598-64605	digital	_	
375-22	64606-64616	diagnostic	_	
375-23	64617-64621	tool	_	
375-24	64621-64622	,	_	
375-25	64623-64628	https	_	
375-26	64628-64629	:	_	
375-27	64629-64630	/	_	
375-28	64630-64631	/	_	
375-29	64631-64637	pacev2	_	
375-30	64637-64638	.	_	
375-31	64638-64655	apexcovantage.com	_	
375-32	64655-64656	/	_	
375-33	64656-64657	.	_	

#Text=PACE helps ensure that figures meet PLOS requirements.
376-1	64658-64662	PACE	_	
376-2	64663-64668	helps	_	
376-3	64669-64675	ensure	_	
376-4	64676-64680	that	_	
376-5	64681-64688	figures	_	
376-6	64689-64693	meet	_	
376-7	64694-64698	PLOS	_	
376-8	64699-64711	requirements	_	
376-9	64711-64712	.	_	

#Text=To use PACE, you must first register as a user.
377-1	64713-64715	To	_	
377-2	64716-64719	use	_	
377-3	64720-64724	PACE	_	
377-4	64724-64725	,	_	
377-5	64726-64729	you	_	
377-6	64730-64734	must	_	
377-7	64735-64740	first	_	
377-8	64741-64749	register	_	
377-9	64750-64752	as	_	
377-10	64753-64754	a	_	
377-11	64755-64759	user	_	
377-12	64759-64760	.	_	

#Text=Registration is free.
378-1	64761-64773	Registration	_	
378-2	64774-64776	is	_	
378-3	64777-64781	free	_	
378-4	64781-64782	.	_	

#Text=Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool.
379-1	64783-64787	Then	_	
379-2	64787-64788	,	_	
379-3	64789-64794	login	_	
379-4	64795-64798	and	_	
379-5	64799-64807	navigate	_	
379-6	64808-64810	to	_	
379-7	64811-64814	the	_	
379-8	64815-64821	UPLOAD	_	
379-9	64822-64825	tab	_	
379-10	64825-64826	,	_	
379-11	64827-64832	where	_	
379-12	64833-64836	you	_	
379-13	64837-64841	will	_	
379-14	64842-64846	find	_	
379-15	64847-64855	detailed	_	
379-16	64856-64868	instructions	_	
379-17	64869-64871	on	_	
379-18	64872-64875	how	_	
379-19	64876-64878	to	_	
379-20	64879-64882	use	_	
379-21	64883-64886	the	_	
379-22	64887-64891	tool	_	
379-23	64891-64892	.	_	

#Text=If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.
380-1	64893-64895	If	_	
380-2	64896-64899	you	_	
380-3	64900-64909	encounter	_	
380-4	64910-64913	any	_	
380-5	64914-64920	issues	_	
380-6	64921-64923	or	_	
380-7	64924-64928	have	_	
380-8	64929-64932	any	_	
380-9	64933-64942	questions	_	
380-10	64943-64947	when	_	
380-11	64948-64953	using	_	
380-12	64954-64958	PACE	_	
380-13	64958-64959	,	_	
380-14	64960-64966	please	_	
380-15	64967-64972	email	_	
380-16	64973-64975	us	_	
380-17	64976-64978	at	_	
380-18	64979-64986	figures	_	
380-19	64986-64987	@	_	
380-20	64987-64995	plos.org	_	
380-21	64995-64996	.	_	

#Text=Please note that Supporting Information files do not need this step.
#Text=10.1371/journal.pone.0224906.r002
#Text=Author response to Decision Letter 0
#Text= 4 Feb 2020 
#Text=Reviewer #1: 
#Text=1) One of the main problems of this study is the relatively small sample size for the number of analyses performed.
381-1	64997-65003	Please	_	
381-2	65004-65008	note	_	
381-3	65009-65013	that	_	
381-4	65014-65024	Supporting	_	
381-5	65025-65036	Information	_	
381-6	65037-65042	files	_	
381-7	65043-65045	do	_	
381-8	65046-65049	not	_	
381-9	65050-65054	need	_	
381-10	65055-65059	this	_	
381-11	65060-65064	step	_	
381-12	65064-65065	.	_	
381-13	65066-65073	10.1371	_	
381-14	65073-65074	/	_	
381-15	65074-65086	journal.pone	_	
381-16	65086-65094	.0224906	_	
381-17	65094-65095	.	_	
381-18	65095-65099	r002	_	
381-19	65100-65106	Author	_	
381-20	65107-65115	response	_	
381-21	65116-65118	to	_	
381-22	65119-65127	Decision	_	
381-23	65128-65134	Letter	_	
381-24	65135-65136	0	_	
381-25	65138-65139	4	_	
381-26	65140-65143	Feb	_	
381-27	65144-65148	2020	_	
381-28	65150-65158	Reviewer	_	
381-29	65159-65161	#1	_	
381-30	65161-65162	:	_	
381-31	65164-65165	1	_	
381-32	65165-65166	)	_	
381-33	65167-65170	One	_	
381-34	65171-65173	of	_	
381-35	65174-65177	the	_	
381-36	65178-65182	main	_	
381-37	65183-65191	problems	_	
381-38	65192-65194	of	_	
381-39	65195-65199	this	_	
381-40	65200-65205	study	_	
381-41	65206-65208	is	_	
381-42	65209-65212	the	_	
381-43	65213-65223	relatively	_	
381-44	65224-65229	small	_	
381-45	65230-65236	sample	_	
381-46	65237-65241	size	_	
381-47	65242-65245	for	_	
381-48	65246-65249	the	_	
381-49	65250-65256	number	_	
381-50	65257-65259	of	_	
381-51	65260-65268	analyses	_	
381-52	65269-65278	performed	_	
381-53	65278-65279	.	_	

#Text=The authors may provide effect sizes for their significant results.
382-1	65280-65283	The	_	
382-2	65284-65291	authors	_	
382-3	65292-65295	may	_	
382-4	65296-65303	provide	_	
382-5	65304-65310	effect	_	
382-6	65311-65316	sizes	_	
382-7	65317-65320	for	_	
382-8	65321-65326	their	_	
382-9	65327-65338	significant	_	
382-10	65339-65346	results	_	
382-11	65346-65347	.	_	

#Text=Response: We have added T-values to Tables 3 & 4 and report adjusted R2 for the regression analysis.
#Text=2) Sex effects were not explored although half of the participants were women.
383-1	65348-65356	Response	_	
383-2	65356-65357	:	_	
383-3	65358-65360	We	_	
383-4	65361-65365	have	_	
383-5	65366-65371	added	_	
383-6	65372-65380	T-values	_	
383-7	65381-65383	to	_	
383-8	65384-65390	Tables	_	
383-9	65391-65392	3	_	
383-10	65393-65394	&	_	
383-11	65395-65396	4	_	
383-12	65397-65400	and	_	
383-13	65401-65407	report	_	
383-14	65408-65416	adjusted	_	
383-15	65417-65419	R2	_	
383-16	65420-65423	for	_	
383-17	65424-65427	the	_	
383-18	65428-65438	regression	_	
383-19	65439-65447	analysis	_	
383-20	65447-65448	.	_	
383-21	65449-65450	2	_	
383-22	65450-65451	)	_	
383-23	65452-65455	Sex	_	
383-24	65456-65463	effects	_	
383-25	65464-65468	were	_	
383-26	65469-65472	not	_	
383-27	65473-65481	explored	_	
383-28	65482-65490	although	_	
383-29	65491-65495	half	_	
383-30	65496-65498	of	_	
383-31	65499-65502	the	_	
383-32	65503-65515	participants	_	
383-33	65516-65520	were	_	
383-34	65521-65526	women	_	
383-35	65526-65527	.	_	

#Text=The menstrual cycle can have an influence on the metabolization of alcohol and although it was recorded in the study, it is not noted if it was controlled for or considered in the data analyses.
384-1	65528-65531	The	_	
384-2	65532-65541	menstrual	_	
384-3	65542-65547	cycle	_	
384-4	65548-65551	can	_	
384-5	65552-65556	have	_	
384-6	65557-65559	an	_	
384-7	65560-65569	influence	_	
384-8	65570-65572	on	_	
384-9	65573-65576	the	_	
384-10	65577-65591	metabolization	_	
384-11	65592-65594	of	_	
384-12	65595-65602	alcohol	_	
384-13	65603-65606	and	_	
384-14	65607-65615	although	_	
384-15	65616-65618	it	_	
384-16	65619-65622	was	_	
384-17	65623-65631	recorded	_	
384-18	65632-65634	in	_	
384-19	65635-65638	the	_	
384-20	65639-65644	study	_	
384-21	65644-65645	,	_	
384-22	65646-65648	it	_	
384-23	65649-65651	is	_	
384-24	65652-65655	not	_	
384-25	65656-65661	noted	_	
384-26	65662-65664	if	_	
384-27	65665-65667	it	_	
384-28	65668-65671	was	_	
384-29	65672-65682	controlled	_	
384-30	65683-65686	for	_	
384-31	65687-65689	or	_	
384-32	65690-65700	considered	_	
384-33	65701-65703	in	_	
384-34	65704-65707	the	_	
384-35	65708-65712	data	_	
384-36	65713-65721	analyses	_	
384-37	65721-65722	.	_	

#Text=The targeted blood alcohol level of 0.08 g/dl may have different effects on neurofunctional connectivity in men and women depending on individual alcohol tolerance levels.
385-1	65723-65726	The	_	
385-2	65727-65735	targeted	_	
385-3	65736-65741	blood	_	
385-4	65742-65749	alcohol	_	
385-5	65750-65755	level	_	
385-6	65756-65758	of	_	
385-7	65759-65763	0.08	_	
385-8	65764-65765	g	_	
385-9	65765-65766	/	_	
385-10	65766-65768	dl	_	
385-11	65769-65772	may	_	
385-12	65773-65777	have	_	
385-13	65778-65787	different	_	
385-14	65788-65795	effects	_	
385-15	65796-65798	on	_	
385-16	65799-65814	neurofunctional	_	
385-17	65815-65827	connectivity	_	
385-18	65828-65830	in	_	
385-19	65831-65834	men	_	
385-20	65835-65838	and	_	
385-21	65839-65844	women	_	
385-22	65845-65854	depending	_	
385-23	65855-65857	on	_	
385-24	65858-65868	individual	_	
385-25	65869-65876	alcohol	_	
385-26	65877-65886	tolerance	_	
385-27	65887-65893	levels	_	
385-28	65893-65894	.	_	

#Text=Response: We ran a supplementary analysis to address this concern and noted the lack of sex effects in the manuscript as follows (page 10): “We also examined sex effects on alcohol-related changes in GPe connectivity at the whole brain level; there were no significant differences between males and females.”
#Text=3) Nicotine consumption should also be used as a co-variate.
386-1	65895-65903	Response	_	
386-2	65903-65904	:	_	
386-3	65905-65907	We	_	
386-4	65908-65911	ran	_	
386-5	65912-65913	a	_	
386-6	65914-65927	supplementary	_	
386-7	65928-65936	analysis	_	
386-8	65937-65939	to	_	
386-9	65940-65947	address	_	
386-10	65948-65952	this	_	
386-11	65953-65960	concern	_	
386-12	65961-65964	and	_	
386-13	65965-65970	noted	_	
386-14	65971-65974	the	_	
386-15	65975-65979	lack	_	
386-16	65980-65982	of	_	
386-17	65983-65986	sex	_	
386-18	65987-65994	effects	_	
386-19	65995-65997	in	_	
386-20	65998-66001	the	_	
386-21	66002-66012	manuscript	_	
386-22	66013-66015	as	_	
386-23	66016-66023	follows	_	
386-24	66024-66025	(	_	
386-25	66025-66029	page	_	
386-26	66030-66032	10	_	
386-27	66032-66033	)	_	
386-28	66033-66034	:	_	
386-29	66035-66036	“	_	
386-30	66036-66038	We	_	
386-31	66039-66043	also	_	
386-32	66044-66052	examined	_	
386-33	66053-66056	sex	_	
386-34	66057-66064	effects	_	
386-35	66065-66067	on	_	
386-36	66068-66083	alcohol-related	_	
386-37	66084-66091	changes	_	
386-38	66092-66094	in	_	
386-39	66095-66098	GPe	_	
386-40	66099-66111	connectivity	_	
386-41	66112-66114	at	_	
386-42	66115-66118	the	_	
386-43	66119-66124	whole	_	
386-44	66125-66130	brain	_	
386-45	66131-66136	level	_	
386-46	66136-66137	;	_	
386-47	66138-66143	there	_	
386-48	66144-66148	were	_	
386-49	66149-66151	no	_	
386-50	66152-66163	significant	_	
386-51	66164-66175	differences	_	
386-52	66176-66183	between	_	
386-53	66184-66189	males	_	
386-54	66190-66193	and	_	
386-55	66194-66201	females	_	
386-56	66201-66202	.	_	
386-57	66202-66203	”	_	
386-58	66204-66205	3	_	
386-59	66205-66206	)	_	
386-60	66207-66215	Nicotine	_	
386-61	66216-66227	consumption	_	
386-62	66228-66234	should	_	
386-63	66235-66239	also	_	
386-64	66240-66242	be	_	
386-65	66243-66247	used	_	
386-66	66248-66250	as	_	
386-67	66251-66252	a	_	
386-68	66253-66263	co-variate	_	
386-69	66263-66264	.	_	

#Text=Response: There was only one participant in our study who reported smoking (as indicated in Table 1).
387-1	66266-66274	Response	_	
387-2	66274-66275	:	_	
387-3	66276-66281	There	_	
387-4	66282-66285	was	_	
387-5	66286-66290	only	_	
387-6	66291-66294	one	_	
387-7	66295-66306	participant	_	
387-8	66307-66309	in	_	
387-9	66310-66313	our	_	
387-10	66314-66319	study	_	
387-11	66320-66323	who	_	
387-12	66324-66332	reported	_	
387-13	66333-66340	smoking	_	
387-14	66341-66342	(	_	
387-15	66342-66344	as	_	
387-16	66345-66354	indicated	_	
387-17	66355-66357	in	_	
387-18	66358-66363	Table	_	
387-19	66364-66365	1	_	
387-20	66365-66366	)	_	
387-21	66366-66367	.	_	

#Text=Therefore, we cannot covary nicotine consumption, but we do not expect it influences our results.
#Text=4) The methods are well described; however, it is not clear why the authors focused on the globus pallidus externus (GPe) and did not use other seed regions involved in inhibitory control as well.
388-1	66368-66377	Therefore	_	
388-2	66377-66378	,	_	
388-3	66379-66381	we	_	
388-4	66382-66388	cannot	_	
388-5	66389-66395	covary	_	
388-6	66396-66404	nicotine	_	
388-7	66405-66416	consumption	_	
388-8	66416-66417	,	_	
388-9	66418-66421	but	_	
388-10	66422-66424	we	_	
388-11	66425-66427	do	_	
388-12	66428-66431	not	_	
388-13	66432-66438	expect	_	
388-14	66439-66441	it	_	
388-15	66442-66452	influences	_	
388-16	66453-66456	our	_	
388-17	66457-66464	results	_	
388-18	66464-66465	.	_	
388-19	66466-66467	4	_	
388-20	66467-66468	)	_	
388-21	66469-66472	The	_	
388-22	66473-66480	methods	_	
388-23	66481-66484	are	_	
388-24	66485-66489	well	_	
388-25	66490-66499	described	_	
388-26	66499-66500	;	_	
388-27	66501-66508	however	_	
388-28	66508-66509	,	_	
388-29	66510-66512	it	_	
388-30	66513-66515	is	_	
388-31	66516-66519	not	_	
388-32	66520-66525	clear	_	
388-33	66526-66529	why	_	
388-34	66530-66533	the	_	
388-35	66534-66541	authors	_	
388-36	66542-66549	focused	_	
388-37	66550-66552	on	_	
388-38	66553-66556	the	_	
388-39	66557-66563	globus	_	
388-40	66564-66572	pallidus	_	
388-41	66573-66581	externus	_	
388-42	66582-66583	(	_	
388-43	66583-66586	GPe	_	
388-44	66586-66587	)	_	
388-45	66588-66591	and	_	
388-46	66592-66595	did	_	
388-47	66596-66599	not	_	
388-48	66600-66603	use	_	
388-49	66604-66609	other	_	
388-50	66610-66614	seed	_	
388-51	66615-66622	regions	_	
388-52	66623-66631	involved	_	
388-53	66632-66634	in	_	
388-54	66635-66645	inhibitory	_	
388-55	66646-66653	control	_	
388-56	66654-66656	as	_	
388-57	66657-66661	well	_	
388-58	66661-66662	.	_	

#Text=Response: We focus on the GPe because our study was designed to translate the preclinical findings of Abrahao et al., 2017, which found that acute alcohol administration increased the firing rate of neurons in the GPe that project efferently.
389-1	66664-66672	Response	_	
389-2	66672-66673	:	_	
389-3	66674-66676	We	_	
389-4	66677-66682	focus	_	
389-5	66683-66685	on	_	
389-6	66686-66689	the	_	
389-7	66690-66693	GPe	_	
389-8	66694-66701	because	_	
389-9	66702-66705	our	_	
389-10	66706-66711	study	_	
389-11	66712-66715	was	_	
389-12	66716-66724	designed	_	
389-13	66725-66727	to	_	
389-14	66728-66737	translate	_	
389-15	66738-66741	the	_	
389-16	66742-66753	preclinical	_	
389-17	66754-66762	findings	_	
389-18	66763-66765	of	_	
389-19	66766-66773	Abrahao	_	
389-20	66774-66776	et	_	
389-21	66777-66779	al	_	
389-22	66779-66780	.	_	
389-23	66780-66781	,	_	
389-24	66782-66786	2017	_	
389-25	66786-66787	,	_	
389-26	66788-66793	which	_	
389-27	66794-66799	found	_	
389-28	66800-66804	that	_	
389-29	66805-66810	acute	_	
389-30	66811-66818	alcohol	_	
389-31	66819-66833	administration	_	
389-32	66834-66843	increased	_	
389-33	66844-66847	the	_	
389-34	66848-66854	firing	_	
389-35	66855-66859	rate	_	
389-36	66860-66862	of	_	
389-37	66863-66870	neurons	_	
389-38	66871-66873	in	_	
389-39	66874-66877	the	_	
389-40	66878-66881	GPe	_	
389-41	66882-66886	that	_	
389-42	66887-66894	project	_	
389-43	66895-66905	efferently	_	
389-44	66905-66906	.	_	

#Text=Based on this, we had reason to hypothesize that alcohol administration would alter GPe functional connectivity.
390-1	66907-66912	Based	_	
390-2	66913-66915	on	_	
390-3	66916-66920	this	_	
390-4	66920-66921	,	_	
390-5	66922-66924	we	_	
390-6	66925-66928	had	_	
390-7	66929-66935	reason	_	
390-8	66936-66938	to	_	
390-9	66939-66950	hypothesize	_	
390-10	66951-66955	that	_	
390-11	66956-66963	alcohol	_	
390-12	66964-66978	administration	_	
390-13	66979-66984	would	_	
390-14	66985-66990	alter	_	
390-15	66991-66994	GPe	_	
390-16	66995-67005	functional	_	
390-17	67006-67018	connectivity	_	
390-18	67018-67019	.	_	

#Text=This is described in the introduction (pages 3-4) and further, we have added the following language to emphasize this: “In this study, we aimed to extend the preclinical results of the Abrahao et al, 2017 study to a human paradigm by…”
#Text=5) No behavioral performance data are presented, yet the authors extensively discuss the stop-signal task along the lines of “reduced behavioral inhibition” or “reactive rather than proactive inhibition for individuals with more drinking.”
391-1	67020-67024	This	_	
391-2	67025-67027	is	_	
391-3	67028-67037	described	_	
391-4	67038-67040	in	_	
391-5	67041-67044	the	_	
391-6	67045-67057	introduction	_	
391-7	67058-67059	(	_	
391-8	67059-67064	pages	_	
391-9	67065-67066	3	_	
391-10	67066-67067	-	_	
391-11	67067-67068	4	_	
391-12	67068-67069	)	_	
391-13	67070-67073	and	_	
391-14	67074-67081	further	_	
391-15	67081-67082	,	_	
391-16	67083-67085	we	_	
391-17	67086-67090	have	_	
391-18	67091-67096	added	_	
391-19	67097-67100	the	_	
391-20	67101-67110	following	_	
391-21	67111-67119	language	_	
391-22	67120-67122	to	_	
391-23	67123-67132	emphasize	_	
391-24	67133-67137	this	_	
391-25	67137-67138	:	_	
391-26	67139-67140	“	_	
391-27	67140-67142	In	_	
391-28	67143-67147	this	_	
391-29	67148-67153	study	_	
391-30	67153-67154	,	_	
391-31	67155-67157	we	_	
391-32	67158-67163	aimed	_	
391-33	67164-67166	to	_	
391-34	67167-67173	extend	_	
391-35	67174-67177	the	_	
391-36	67178-67189	preclinical	_	
391-37	67190-67197	results	_	
391-38	67198-67200	of	_	
391-39	67201-67204	the	_	
391-40	67205-67212	Abrahao	_	
391-41	67213-67215	et	_	
391-42	67216-67218	al	_	
391-43	67218-67219	,	_	
391-44	67220-67224	2017	_	
391-45	67225-67230	study	_	
391-46	67231-67233	to	_	
391-47	67234-67235	a	_	
391-48	67236-67241	human	_	
391-49	67242-67250	paradigm	_	
391-50	67251-67253	by	_	
391-51	67253-67254	…	_	
391-52	67254-67255	”	_	
391-53	67256-67257	5	_	
391-54	67257-67258	)	_	
391-55	67259-67261	No	_	
391-56	67262-67272	behavioral	_	
391-57	67273-67284	performance	_	
391-58	67285-67289	data	_	
391-59	67290-67293	are	_	
391-60	67294-67303	presented	_	
391-61	67303-67304	,	_	
391-62	67305-67308	yet	_	
391-63	67309-67312	the	_	
391-64	67313-67320	authors	_	
391-65	67321-67332	extensively	_	
391-66	67333-67340	discuss	_	
391-67	67341-67344	the	_	
391-68	67345-67356	stop-signal	_	
391-69	67357-67361	task	_	
391-70	67362-67367	along	_	
391-71	67368-67371	the	_	
391-72	67372-67377	lines	_	
391-73	67378-67380	of	_	
391-74	67381-67382	“	_	
391-75	67382-67389	reduced	_	
391-76	67390-67400	behavioral	_	
391-77	67401-67411	inhibition	_	
391-78	67411-67412	”	_	
391-79	67413-67415	or	_	
391-80	67416-67417	“	_	
391-81	67417-67425	reactive	_	
391-82	67426-67432	rather	_	
391-83	67433-67437	than	_	
391-84	67438-67447	proactive	_	
391-85	67448-67458	inhibition	_	
391-86	67459-67462	for	_	
391-87	67463-67474	individuals	_	
391-88	67475-67479	with	_	
391-89	67480-67484	more	_	
391-90	67485-67493	drinking	_	
391-91	67493-67494	.	_	
391-92	67494-67495	”	_	

#Text=Either the discussion needs to be reformulated or performance data should be added to the analyses.
392-1	67496-67502	Either	_	
392-2	67503-67506	the	_	
392-3	67507-67517	discussion	_	
392-4	67518-67523	needs	_	
392-5	67524-67526	to	_	
392-6	67527-67529	be	_	
392-7	67530-67542	reformulated	_	
392-8	67543-67545	or	_	
392-9	67546-67557	performance	_	
392-10	67558-67562	data	_	
392-11	67563-67569	should	_	
392-12	67570-67572	be	_	
392-13	67573-67578	added	_	
392-14	67579-67581	to	_	
392-15	67582-67585	the	_	
392-16	67586-67594	analyses	_	
392-17	67594-67595	.	_	

#Text=Response: As explained in our response to comment #4, the aims of our analyses were to test in a human model alcohol-related changes in GPe pathways.
393-1	67597-67605	Response	_	
393-2	67605-67606	:	_	
393-3	67607-67609	As	_	
393-4	67610-67619	explained	_	
393-5	67620-67622	in	_	
393-6	67623-67626	our	_	
393-7	67627-67635	response	_	
393-8	67636-67638	to	_	
393-9	67639-67646	comment	_	
393-10	67647-67649	#4	_	
393-11	67649-67650	,	_	
393-12	67651-67654	the	_	
393-13	67655-67659	aims	_	
393-14	67660-67662	of	_	
393-15	67663-67666	our	_	
393-16	67667-67675	analyses	_	
393-17	67676-67680	were	_	
393-18	67681-67683	to	_	
393-19	67684-67688	test	_	
393-20	67689-67691	in	_	
393-21	67692-67693	a	_	
393-22	67694-67699	human	_	
393-23	67700-67705	model	_	
393-24	67706-67721	alcohol-related	_	
393-25	67722-67729	changes	_	
393-26	67730-67732	in	_	
393-27	67733-67736	GPe	_	
393-28	67737-67745	pathways	_	
393-29	67745-67746	.	_	

#Text=These pathways are theorized to be involved in response inhibition/stop-signaling (e.g., Jahfari et al., 2011).
394-1	67747-67752	These	_	
394-2	67753-67761	pathways	_	
394-3	67762-67765	are	_	
394-4	67766-67775	theorized	_	
394-5	67776-67778	to	_	
394-6	67779-67781	be	_	
394-7	67782-67790	involved	_	
394-8	67791-67793	in	_	
394-9	67794-67802	response	_	
394-10	67803-67813	inhibition	_	
394-11	67813-67814	/	_	
394-12	67814-67828	stop-signaling	_	
394-13	67829-67830	(	_	
394-14	67830-67833	e.g	_	
394-15	67833-67834	.	_	
394-16	67834-67835	,	_	
394-17	67836-67843	Jahfari	_	
394-18	67844-67846	et	_	
394-19	67847-67849	al	_	
394-20	67849-67850	.	_	
394-21	67850-67851	,	_	
394-22	67852-67856	2011	_	
394-23	67856-67857	)	_	
394-24	67857-67858	.	_	

#Text=Moreover, based on previous literature (i.e., Nikolaou et al., 2013) we know that alcohol impairs GPe function during stop-signaling.
395-1	67859-67867	Moreover	_	
395-2	67867-67868	,	_	
395-3	67869-67874	based	_	
395-4	67875-67877	on	_	
395-5	67878-67886	previous	_	
395-6	67887-67897	literature	_	
395-7	67898-67899	(	_	
395-8	67899-67902	i.e	_	
395-9	67902-67903	.	_	
395-10	67903-67904	,	_	
395-11	67905-67913	Nikolaou	_	
395-12	67914-67916	et	_	
395-13	67917-67919	al	_	
395-14	67919-67920	.	_	
395-15	67920-67921	,	_	
395-16	67922-67926	2013	_	
395-17	67926-67927	)	_	
395-18	67928-67930	we	_	
395-19	67931-67935	know	_	
395-20	67936-67940	that	_	
395-21	67941-67948	alcohol	_	
395-22	67949-67956	impairs	_	
395-23	67957-67960	GPe	_	
395-24	67961-67969	function	_	
395-25	67970-67976	during	_	
395-26	67977-67991	stop-signaling	_	
395-27	67991-67992	.	_	

#Text=Although we do not have data on changes in stop-signal neural response during intoxication (which we acknowledge in the limitations on page 20), a large portion of our analysis focused on behavioral impulsivity and trait impulsivity measures.
396-1	67993-68001	Although	_	
396-2	68002-68004	we	_	
396-3	68005-68007	do	_	
396-4	68008-68011	not	_	
396-5	68012-68016	have	_	
396-6	68017-68021	data	_	
396-7	68022-68024	on	_	
396-8	68025-68032	changes	_	
396-9	68033-68035	in	_	
396-10	68036-68047	stop-signal	_	
396-11	68048-68054	neural	_	
396-12	68055-68063	response	_	
396-13	68064-68070	during	_	
396-14	68071-68083	intoxication	_	
396-15	68084-68085	(	_	
396-16	68085-68090	which	_	
396-17	68091-68093	we	_	
396-18	68094-68105	acknowledge	_	
396-19	68106-68108	in	_	
396-20	68109-68112	the	_	
396-21	68113-68124	limitations	_	
396-22	68125-68127	on	_	
396-23	68128-68132	page	_	
396-24	68133-68135	20	_	
396-25	68135-68136	)	_	
396-26	68136-68137	,	_	
396-27	68138-68139	a	_	
396-28	68140-68145	large	_	
396-29	68146-68153	portion	_	
396-30	68154-68156	of	_	
396-31	68157-68160	our	_	
396-32	68161-68169	analysis	_	
396-33	68170-68177	focused	_	
396-34	68178-68180	on	_	
396-35	68181-68191	behavioral	_	
396-36	68192-68203	impulsivity	_	
396-37	68204-68207	and	_	
396-38	68208-68213	trait	_	
396-39	68214-68225	impulsivity	_	
396-40	68226-68234	measures	_	
396-41	68234-68235	.	_	

#Text=We, therefore feel the stop-signaling/response inhibition oriented discussion of our results is the best explanation of our findings in the context of the prior literature.
397-1	68236-68238	We	_	
397-2	68238-68239	,	_	
397-3	68240-68249	therefore	_	
397-4	68250-68254	feel	_	
397-5	68255-68258	the	_	
397-6	68259-68273	stop-signaling	_	
397-7	68273-68274	/	_	
397-8	68274-68282	response	_	
397-9	68283-68293	inhibition	_	
397-10	68294-68302	oriented	_	
397-11	68303-68313	discussion	_	
397-12	68314-68316	of	_	
397-13	68317-68320	our	_	
397-14	68321-68328	results	_	
397-15	68329-68331	is	_	
397-16	68332-68335	the	_	
397-17	68336-68340	best	_	
397-18	68341-68352	explanation	_	
397-19	68353-68355	of	_	
397-20	68356-68359	our	_	
397-21	68360-68368	findings	_	
397-22	68369-68371	in	_	
397-23	68372-68375	the	_	
397-24	68376-68383	context	_	
397-25	68384-68386	of	_	
397-26	68387-68390	the	_	
397-27	68391-68396	prior	_	
397-28	68397-68407	literature	_	
397-29	68407-68408	.	_	

#Text=We do, however, acknowledge that there may be other ways to interpret our findings (page 20).
#Text=6) The list of limitations of the study is long including not having a placebo group and a small sample size.
398-1	68409-68411	We	_	
398-2	68412-68414	do	_	
398-3	68414-68415	,	_	
398-4	68416-68423	however	_	
398-5	68423-68424	,	_	
398-6	68425-68436	acknowledge	_	
398-7	68437-68441	that	_	
398-8	68442-68447	there	_	
398-9	68448-68451	may	_	
398-10	68452-68454	be	_	
398-11	68455-68460	other	_	
398-12	68461-68465	ways	_	
398-13	68466-68468	to	_	
398-14	68469-68478	interpret	_	
398-15	68479-68482	our	_	
398-16	68483-68491	findings	_	
398-17	68492-68493	(	_	
398-18	68493-68497	page	_	
398-19	68498-68500	20	_	
398-20	68500-68501	)	_	
398-21	68501-68502	.	_	
398-22	68503-68504	6	_	
398-23	68504-68505	)	_	
398-24	68506-68509	The	_	
398-25	68510-68514	list	_	
398-26	68515-68517	of	_	
398-27	68518-68529	limitations	_	
398-28	68530-68532	of	_	
398-29	68533-68536	the	_	
398-30	68537-68542	study	_	
398-31	68543-68545	is	_	
398-32	68546-68550	long	_	
398-33	68551-68560	including	_	
398-34	68561-68564	not	_	
398-35	68565-68571	having	_	
398-36	68572-68573	a	_	
398-37	68574-68581	placebo	_	
398-38	68582-68587	group	_	
398-39	68588-68591	and	_	
398-40	68592-68593	a	_	
398-41	68594-68599	small	_	
398-42	68600-68606	sample	_	
398-43	68607-68611	size	_	
398-44	68611-68612	.	_	

#Text=However, because of the complexity of the results, the introduction and discussion would profit from a model that can integrate the different connectivity results and also provide a rationale for focusing on the GPe as seed region for the analyses.
399-1	68613-68620	However	_	
399-2	68620-68621	,	_	
399-3	68622-68629	because	_	
399-4	68630-68632	of	_	
399-5	68633-68636	the	_	
399-6	68637-68647	complexity	_	
399-7	68648-68650	of	_	
399-8	68651-68654	the	_	
399-9	68655-68662	results	_	
399-10	68662-68663	,	_	
399-11	68664-68667	the	_	
399-12	68668-68680	introduction	_	
399-13	68681-68684	and	_	
399-14	68685-68695	discussion	_	
399-15	68696-68701	would	_	
399-16	68702-68708	profit	_	
399-17	68709-68713	from	_	
399-18	68714-68715	a	_	
399-19	68716-68721	model	_	
399-20	68722-68726	that	_	
399-21	68727-68730	can	_	
399-22	68731-68740	integrate	_	
399-23	68741-68744	the	_	
399-24	68745-68754	different	_	
399-25	68755-68767	connectivity	_	
399-26	68768-68775	results	_	
399-27	68776-68779	and	_	
399-28	68780-68784	also	_	
399-29	68785-68792	provide	_	
399-30	68793-68794	a	_	
399-31	68795-68804	rationale	_	
399-32	68805-68808	for	_	
399-33	68809-68817	focusing	_	
399-34	68818-68820	on	_	
399-35	68821-68824	the	_	
399-36	68825-68828	GPe	_	
399-37	68829-68831	as	_	
399-38	68832-68836	seed	_	
399-39	68837-68843	region	_	
399-40	68844-68847	for	_	
399-41	68848-68851	the	_	
399-42	68852-68860	analyses	_	
399-43	68860-68861	.	_	

#Text=Response: In concurrence with this Reviewer’s other concerns, we have emphasized our motivation to translate the results of a mouse-model published in Abrahao et al. 2017 vis the framework of approaching alcohol-related GPe signaling in the context of the indirect pathway of response inhibition.
400-1	68862-68870	Response	_	
400-2	68870-68871	:	_	
400-3	68872-68874	In	_	
400-4	68875-68886	concurrence	_	
400-5	68887-68891	with	_	
400-6	68892-68896	this	_	
400-7	68897-68905	Reviewer	_	
400-8	68905-68906	’	_	
400-9	68906-68907	s	_	
400-10	68908-68913	other	_	
400-11	68914-68922	concerns	_	
400-12	68922-68923	,	_	
400-13	68924-68926	we	_	
400-14	68927-68931	have	_	
400-15	68932-68942	emphasized	_	
400-16	68943-68946	our	_	
400-17	68947-68957	motivation	_	
400-18	68958-68960	to	_	
400-19	68961-68970	translate	_	
400-20	68971-68974	the	_	
400-21	68975-68982	results	_	
400-22	68983-68985	of	_	
400-23	68986-68987	a	_	
400-24	68988-68999	mouse-model	_	
400-25	69000-69009	published	_	
400-26	69010-69012	in	_	
400-27	69013-69020	Abrahao	_	
400-28	69021-69023	et	_	
400-29	69024-69026	al	_	
400-30	69026-69027	.	_	
400-31	69028-69032	2017	_	
400-32	69033-69036	vis	_	
400-33	69037-69040	the	_	
400-34	69041-69050	framework	_	
400-35	69051-69053	of	_	
400-36	69054-69065	approaching	_	
400-37	69066-69081	alcohol-related	_	
400-38	69082-69085	GPe	_	
400-39	69086-69095	signaling	_	
400-40	69096-69098	in	_	
400-41	69099-69102	the	_	
400-42	69103-69110	context	_	
400-43	69111-69113	of	_	
400-44	69114-69117	the	_	
400-45	69118-69126	indirect	_	
400-46	69127-69134	pathway	_	
400-47	69135-69137	of	_	
400-48	69138-69146	response	_	
400-49	69147-69157	inhibition	_	
400-50	69157-69158	.	_	

#Text=We believe this framework effectively integrates the results.
401-1	69159-69161	We	_	
401-2	69162-69169	believe	_	
401-3	69170-69174	this	_	
401-4	69175-69184	framework	_	
401-5	69185-69196	effectively	_	
401-6	69197-69207	integrates	_	
401-7	69208-69211	the	_	
401-8	69212-69219	results	_	
401-9	69219-69220	.	_	

#Text=We have added the following language to the first paragraph of the discussion to further emphasize this as follows (page 15): “Based on preclinical work finding alcohol alters neuronal firing in the GPe, and findings that the pathway is involved in response inhibition, we hypothesized that…”
#Text=Reviewer #2: 
#Text=Major
#Text=1) Line 215: A cluster-forming threshold of p<5, pFDR<.05 is rather liberal (Eklund et al. 2016), with cluster-forming thresholds of p<.001 producing much more acceptable false-positive rates.
402-1	69221-69223	We	_	
402-2	69224-69228	have	_	
402-3	69229-69234	added	_	
402-4	69235-69238	the	_	
402-5	69239-69248	following	_	
402-6	69249-69257	language	_	
402-7	69258-69260	to	_	
402-8	69261-69264	the	_	
402-9	69265-69270	first	_	
402-10	69271-69280	paragraph	_	
402-11	69281-69283	of	_	
402-12	69284-69287	the	_	
402-13	69288-69298	discussion	_	
402-14	69299-69301	to	_	
402-15	69302-69309	further	_	
402-16	69310-69319	emphasize	_	
402-17	69320-69324	this	_	
402-18	69325-69327	as	_	
402-19	69328-69335	follows	_	
402-20	69336-69337	(	_	
402-21	69337-69341	page	_	
402-22	69342-69344	15	_	
402-23	69344-69345	)	_	
402-24	69345-69346	:	_	
402-25	69347-69348	“	_	
402-26	69348-69353	Based	_	
402-27	69354-69356	on	_	
402-28	69357-69368	preclinical	_	
402-29	69369-69373	work	_	
402-30	69374-69381	finding	_	
402-31	69382-69389	alcohol	_	
402-32	69390-69396	alters	_	
402-33	69397-69405	neuronal	_	
402-34	69406-69412	firing	_	
402-35	69413-69415	in	_	
402-36	69416-69419	the	_	
402-37	69420-69423	GPe	_	
402-38	69423-69424	,	_	
402-39	69425-69428	and	_	
402-40	69429-69437	findings	_	
402-41	69438-69442	that	_	
402-42	69443-69446	the	_	
402-43	69447-69454	pathway	_	
402-44	69455-69457	is	_	
402-45	69458-69466	involved	_	
402-46	69467-69469	in	_	
402-47	69470-69478	response	_	
402-48	69479-69489	inhibition	_	
402-49	69489-69490	,	_	
402-50	69491-69493	we	_	
402-51	69494-69506	hypothesized	_	
402-52	69507-69511	that	_	
402-53	69511-69512	…	_	
402-54	69512-69513	”	_	
402-55	69514-69522	Reviewer	_	
402-56	69523-69525	#2	_	
402-57	69525-69526	:	_	
402-58	69528-69533	Major	_	
402-59	69534-69535	1	_	
402-60	69535-69536	)	_	
402-61	69537-69541	Line	_	
402-62	69542-69545	215	_	
402-63	69545-69546	:	_	
402-64	69547-69548	A	_	
402-65	69549-69564	cluster-forming	_	
402-66	69565-69574	threshold	_	
402-67	69575-69577	of	_	
402-68	69578-69579	p	_	
402-69	69579-69580	<	_	
402-70	69580-69581	5	_	
402-71	69581-69582	,	_	
402-72	69583-69587	pFDR	_	
402-73	69587-69588	<	_	
402-74	69588-69591	.05	_	
402-75	69592-69594	is	_	
402-76	69595-69601	rather	_	
402-77	69602-69609	liberal	_	
402-78	69610-69611	(	_	
402-79	69611-69617	Eklund	_	
402-80	69618-69620	et	_	
402-81	69621-69623	al	_	
402-82	69623-69624	.	_	
402-83	69625-69629	2016	_	
402-84	69629-69630	)	_	
402-85	69630-69631	,	_	
402-86	69632-69636	with	_	
402-87	69637-69652	cluster-forming	_	
402-88	69653-69663	thresholds	_	
402-89	69664-69666	of	_	
402-90	69667-69668	p	_	
402-91	69668-69669	<	_	
402-92	69669-69673	.001	_	
402-93	69674-69683	producing	_	
402-94	69684-69688	much	_	
402-95	69689-69693	more	_	
402-96	69694-69704	acceptable	_	
402-97	69705-69719	false-positive	_	
402-98	69720-69725	rates	_	
402-99	69725-69726	.	_	

#Text=Unless there is a rationale for using a more liberal threshold with these connectivity data, the p<.001 threshold should be followed.
403-1	69727-69733	Unless	_	
403-2	69734-69739	there	_	
403-3	69740-69742	is	_	
403-4	69743-69744	a	_	
403-5	69745-69754	rationale	_	
403-6	69755-69758	for	_	
403-7	69759-69764	using	_	
403-8	69765-69766	a	_	
403-9	69767-69771	more	_	
403-10	69772-69779	liberal	_	
403-11	69780-69789	threshold	_	
403-12	69790-69794	with	_	
403-13	69795-69800	these	_	
403-14	69801-69813	connectivity	_	
403-15	69814-69818	data	_	
403-16	69818-69819	,	_	
403-17	69820-69823	the	_	
403-18	69824-69825	p	_	
403-19	69825-69826	<	_	
403-20	69826-69830	.001	_	
403-21	69831-69840	threshold	_	
403-22	69841-69847	should	_	
403-23	69848-69850	be	_	
403-24	69851-69859	followed	_	
403-25	69859-69860	.	_	

#Text=Response: We have updated our analysis to use the p<.001 cluster forming threshold per the reviewer’s recommendation.
404-1	69861-69869	Response	_	
404-2	69869-69870	:	_	
404-3	69871-69873	We	_	
404-4	69874-69878	have	_	
404-5	69879-69886	updated	_	
404-6	69887-69890	our	_	
404-7	69891-69899	analysis	_	
404-8	69900-69902	to	_	
404-9	69903-69906	use	_	
404-10	69907-69910	the	_	
404-11	69911-69912	p	_	
404-12	69912-69913	<	_	
404-13	69913-69917	.001	_	
404-14	69918-69925	cluster	_	
404-15	69926-69933	forming	_	
404-16	69934-69943	threshold	_	
404-17	69944-69947	per	_	
404-18	69948-69951	the	_	
404-19	69952-69960	reviewer	_	
404-20	69960-69961	’	_	
404-21	69961-69962	s	_	
404-22	69963-69977	recommendation	_	
404-23	69977-69978	.	_	

#Text=The results, discussion, table, figures, and supplementary materials have been updated accordingly. 
#Text=2) Lines 220-231: If I follow, the authors performed paired t-tests (pre, post) with no regressors, then paired-t tests with impulsivity and drinking regressors.
405-1	69979-69982	The	_	
405-2	69983-69990	results	_	
405-3	69990-69991	,	_	
405-4	69992-70002	discussion	_	
405-5	70002-70003	,	_	
405-6	70004-70009	table	_	
405-7	70009-70010	,	_	
405-8	70011-70018	figures	_	
405-9	70018-70019	,	_	
405-10	70020-70023	and	_	
405-11	70024-70037	supplementary	_	
405-12	70038-70047	materials	_	
405-13	70048-70052	have	_	
405-14	70053-70057	been	_	
405-15	70058-70065	updated	_	
405-16	70066-70077	accordingly	_	
405-17	70077-70078	.	_	
405-18	70080-70081	2	_	
405-19	70081-70082	)	_	
405-20	70083-70088	Lines	_	
405-21	70089-70092	220	_	
405-22	70092-70093	-	_	
405-23	70093-70096	231	_	
405-24	70096-70097	:	_	
405-25	70098-70100	If	_	
405-26	70101-70102	I	_	
405-27	70103-70109	follow	_	
405-28	70109-70110	,	_	
405-29	70111-70114	the	_	
405-30	70115-70122	authors	_	
405-31	70123-70132	performed	_	
405-32	70133-70139	paired	_	
405-33	70140-70147	t-tests	_	
405-34	70148-70149	(	_	
405-35	70149-70152	pre	_	
405-36	70152-70153	,	_	
405-37	70154-70158	post	_	
405-38	70158-70159	)	_	
405-39	70160-70164	with	_	
405-40	70165-70167	no	_	
405-41	70168-70178	regressors	_	
405-42	70178-70179	,	_	
405-43	70180-70184	then	_	
405-44	70185-70193	paired-t	_	
405-45	70194-70199	tests	_	
405-46	70200-70204	with	_	
405-47	70205-70216	impulsivity	_	
405-48	70217-70220	and	_	
405-49	70221-70229	drinking	_	
405-50	70230-70240	regressors	_	
405-51	70240-70241	.	_	

#Text=These clusters’ beta weights were then extracted and used as the outcome of a linear model conducted in R(?)
406-1	70242-70247	These	_	
406-2	70248-70256	clusters	_	
406-3	70256-70257	’	_	
406-4	70258-70262	beta	_	
406-5	70263-70270	weights	_	
406-6	70271-70275	were	_	
406-7	70276-70280	then	_	
406-8	70281-70290	extracted	_	
406-9	70291-70294	and	_	
406-10	70295-70299	used	_	
406-11	70300-70302	as	_	
406-12	70303-70306	the	_	
406-13	70307-70314	outcome	_	
406-14	70315-70317	of	_	
406-15	70318-70319	a	_	
406-16	70320-70326	linear	_	
406-17	70327-70332	model	_	
406-18	70333-70342	conducted	_	
406-19	70343-70345	in	_	
406-20	70346-70347	R	_	
406-21	70347-70348	(	_	
406-22	70348-70349	?	_	
406-23	70349-70350	)	_	

#Text=Please clarify.
407-1	70351-70357	Please	_	
407-2	70358-70365	clarify	_	
407-3	70365-70366	.	_	

#Text=Be very explicit about exactly how the analyses were performed, with a helpful step-by-step description in more depth.
408-1	70367-70369	Be	_	
408-2	70370-70374	very	_	
408-3	70375-70383	explicit	_	
408-4	70384-70389	about	_	
408-5	70390-70397	exactly	_	
408-6	70398-70401	how	_	
408-7	70402-70405	the	_	
408-8	70406-70414	analyses	_	
408-9	70415-70419	were	_	
408-10	70420-70429	performed	_	
408-11	70429-70430	,	_	
408-12	70431-70435	with	_	
408-13	70436-70437	a	_	
408-14	70438-70445	helpful	_	
408-15	70446-70458	step-by-step	_	
408-16	70459-70470	description	_	
408-17	70471-70473	in	_	
408-18	70474-70478	more	_	
408-19	70479-70484	depth	_	
408-20	70484-70485	.	_	

#Text=This section was a bit hard to follow.
409-1	70486-70490	This	_	
409-2	70491-70498	section	_	
409-3	70499-70502	was	_	
409-4	70503-70504	a	_	
409-5	70505-70508	bit	_	
409-6	70509-70513	hard	_	
409-7	70514-70516	to	_	
409-8	70517-70523	follow	_	
409-9	70523-70524	.	_	

#Text=Response: We have updated our methods to more clearly describe the Conn first and second-level processing pipeline, and our process in extracting the correlation values for use investigating the interaction between drinking history and impulsivity in the regression model in R.
410-1	70525-70533	Response	_	
410-2	70533-70534	:	_	
410-3	70535-70537	We	_	
410-4	70538-70542	have	_	
410-5	70543-70550	updated	_	
410-6	70551-70554	our	_	
410-7	70555-70562	methods	_	
410-8	70563-70565	to	_	
410-9	70566-70570	more	_	
410-10	70571-70578	clearly	_	
410-11	70579-70587	describe	_	
410-12	70588-70591	the	_	
410-13	70592-70596	Conn	_	
410-14	70597-70602	first	_	
410-15	70603-70606	and	_	
410-16	70607-70619	second-level	_	
410-17	70620-70630	processing	_	
410-18	70631-70639	pipeline	_	
410-19	70639-70640	,	_	
410-20	70641-70644	and	_	
410-21	70645-70648	our	_	
410-22	70649-70656	process	_	
410-23	70657-70659	in	_	
410-24	70660-70670	extracting	_	
410-25	70671-70674	the	_	
410-26	70675-70686	correlation	_	
410-27	70687-70693	values	_	
410-28	70694-70697	for	_	
410-29	70698-70701	use	_	
410-30	70702-70715	investigating	_	
410-31	70716-70719	the	_	
410-32	70720-70731	interaction	_	
410-33	70732-70739	between	_	
410-34	70740-70748	drinking	_	
410-35	70749-70756	history	_	
410-36	70757-70760	and	_	
410-37	70761-70772	impulsivity	_	
410-38	70773-70775	in	_	
410-39	70776-70779	the	_	
410-40	70780-70790	regression	_	
410-41	70791-70796	model	_	
410-42	70797-70799	in	_	
410-43	70800-70801	R	_	
410-44	70801-70802	.	_	

#Text=(pages 9/10)
#Text=3) Line 343: “As predicted, we found that heavier drinking individuals had more pronounced changes in GPe connectivity with the basal ganglia, OFC, and mPFC regions.
411-1	70803-70804	(	_	
411-2	70804-70809	pages	_	
411-3	70810-70811	9	_	
411-4	70811-70812	/	_	
411-5	70812-70814	10	_	
411-6	70814-70815	)	_	
411-7	70816-70817	3	_	
411-8	70817-70818	)	_	
411-9	70819-70823	Line	_	
411-10	70824-70827	343	_	
411-11	70827-70828	:	_	
411-12	70829-70830	“	_	
411-13	70830-70832	As	_	
411-14	70833-70842	predicted	_	
411-15	70842-70843	,	_	
411-16	70844-70846	we	_	
411-17	70847-70852	found	_	
411-18	70853-70857	that	_	
411-19	70858-70865	heavier	_	
411-20	70866-70874	drinking	_	
411-21	70875-70886	individuals	_	
411-22	70887-70890	had	_	
411-23	70891-70895	more	_	
411-24	70896-70906	pronounced	_	
411-25	70907-70914	changes	_	
411-26	70915-70917	in	_	
411-27	70918-70921	GPe	_	
411-28	70922-70934	connectivity	_	
411-29	70935-70939	with	_	
411-30	70940-70943	the	_	
411-31	70944-70949	basal	_	
411-32	70950-70957	ganglia	_	
411-33	70957-70958	,	_	
411-34	70959-70962	OFC	_	
411-35	70962-70963	,	_	
411-36	70964-70967	and	_	
411-37	70968-70972	mPFC	_	
411-38	70973-70980	regions	_	
411-39	70980-70981	.	_	

#Text=In these regions, individuals with patterns of heavy drinking had less coupling at baseline than individuals with lighter drinking patterns;” Figure 2 (upper right) appears to illustrate the heaviest drinkers with more coupling at baseline (r= ~.25) relative to the lightest drinkers (r= ~0) in the R.GPe-L insula/putamen, with the lighter drinkers showing the largest alcohol-induced change in connectivity.
412-1	70982-70984	In	_	
412-2	70985-70990	these	_	
412-3	70991-70998	regions	_	
412-4	70998-70999	,	_	
412-5	71000-71011	individuals	_	
412-6	71012-71016	with	_	
412-7	71017-71025	patterns	_	
412-8	71026-71028	of	_	
412-9	71029-71034	heavy	_	
412-10	71035-71043	drinking	_	
412-11	71044-71047	had	_	
412-12	71048-71052	less	_	
412-13	71053-71061	coupling	_	
412-14	71062-71064	at	_	
412-15	71065-71073	baseline	_	
412-16	71074-71078	than	_	
412-17	71079-71090	individuals	_	
412-18	71091-71095	with	_	
412-19	71096-71103	lighter	_	
412-20	71104-71112	drinking	_	
412-21	71113-71121	patterns	_	
412-22	71121-71122	;	_	
412-23	71122-71123	”	_	
412-24	71124-71130	Figure	_	
412-25	71131-71132	2	_	
412-26	71133-71134	(	_	
412-27	71134-71139	upper	_	
412-28	71140-71145	right	_	
412-29	71145-71146	)	_	
412-30	71147-71154	appears	_	
412-31	71155-71157	to	_	
412-32	71158-71168	illustrate	_	
412-33	71169-71172	the	_	
412-34	71173-71181	heaviest	_	
412-35	71182-71190	drinkers	_	
412-36	71191-71195	with	_	
412-37	71196-71200	more	_	
412-38	71201-71209	coupling	_	
412-39	71210-71212	at	_	
412-40	71213-71221	baseline	_	
412-41	71222-71223	(	_	
412-42	71223-71224	r	_	
412-43	71224-71225	=	_	
412-44	71226-71227	~	_	
412-45	71227-71230	.25	_	
412-46	71230-71231	)	_	
412-47	71232-71240	relative	_	
412-48	71241-71243	to	_	
412-49	71244-71247	the	_	
412-50	71248-71256	lightest	_	
412-51	71257-71265	drinkers	_	
412-52	71266-71267	(	_	
412-53	71267-71268	r	_	
412-54	71268-71269	=	_	
412-55	71270-71271	~	_	
412-56	71271-71272	0	_	
412-57	71272-71273	)	_	
412-58	71274-71276	in	_	
412-59	71277-71280	the	_	
412-60	71281-71288	R.GPe-L	_	
412-61	71289-71295	insula	_	
412-62	71295-71296	/	_	
412-63	71296-71303	putamen	_	
412-64	71303-71304	,	_	
412-65	71305-71309	with	_	
412-66	71310-71313	the	_	
412-67	71314-71321	lighter	_	
412-68	71322-71330	drinkers	_	
412-69	71331-71338	showing	_	
412-70	71339-71342	the	_	
412-71	71343-71350	largest	_	
412-72	71351-71366	alcohol-induced	_	
412-73	71367-71373	change	_	
412-74	71374-71376	in	_	
412-75	71377-71389	connectivity	_	
412-76	71389-71390	.	_	

#Text=Please clarify
#Text=Response: We thank the reviewer for pointing out this inconsistency.
413-1	71391-71397	Please	_	
413-2	71398-71405	clarify	_	
413-3	71406-71414	Response	_	
413-4	71414-71415	:	_	
413-5	71416-71418	We	_	
413-6	71419-71424	thank	_	
413-7	71425-71428	the	_	
413-8	71429-71437	reviewer	_	
413-9	71438-71441	for	_	
413-10	71442-71450	pointing	_	
413-11	71451-71454	out	_	
413-12	71455-71459	this	_	
413-13	71460-71473	inconsistency	_	
413-14	71473-71474	.	_	

#Text=We have revised the discussion somewhat based on our updated results, and have paid particular attention to making sure this paragraph (now page 16) more accurately reflects the findings.
414-1	71475-71477	We	_	
414-2	71478-71482	have	_	
414-3	71483-71490	revised	_	
414-4	71491-71494	the	_	
414-5	71495-71505	discussion	_	
414-6	71506-71514	somewhat	_	
414-7	71515-71520	based	_	
414-8	71521-71523	on	_	
414-9	71524-71527	our	_	
414-10	71528-71535	updated	_	
414-11	71536-71543	results	_	
414-12	71543-71544	,	_	
414-13	71545-71548	and	_	
414-14	71549-71553	have	_	
414-15	71554-71558	paid	_	
414-16	71559-71569	particular	_	
414-17	71570-71579	attention	_	
414-18	71580-71582	to	_	
414-19	71583-71589	making	_	
414-20	71590-71594	sure	_	
414-21	71595-71599	this	_	
414-22	71600-71609	paragraph	_	
414-23	71610-71611	(	_	
414-24	71611-71614	now	_	
414-25	71615-71619	page	_	
414-26	71620-71622	16	_	
414-27	71622-71623	)	_	
414-28	71624-71628	more	_	
414-29	71629-71639	accurately	_	
414-30	71640-71648	reflects	_	
414-31	71649-71652	the	_	
414-32	71653-71661	findings	_	
414-33	71661-71662	.	_	

#Text=Minor
#Text=4) Line 56: “This is largely due to organ damage caused by chronic drinking, intoxication-related car accidents and domestic violence, and the development of alcohol use disorder (AUD) [3, 4].”
415-1	71663-71668	Minor	_	
415-2	71669-71670	4	_	
415-3	71670-71671	)	_	
415-4	71672-71676	Line	_	
415-5	71677-71679	56	_	
415-6	71679-71680	:	_	
415-7	71681-71682	“	_	
415-8	71682-71686	This	_	
415-9	71687-71689	is	_	
415-10	71690-71697	largely	_	
415-11	71698-71701	due	_	
415-12	71702-71704	to	_	
415-13	71705-71710	organ	_	
415-14	71711-71717	damage	_	
415-15	71718-71724	caused	_	
415-16	71725-71727	by	_	
415-17	71728-71735	chronic	_	
415-18	71736-71744	drinking	_	
415-19	71744-71745	,	_	
415-20	71746-71766	intoxication-related	_	
415-21	71767-71770	car	_	
415-22	71771-71780	accidents	_	
415-23	71781-71784	and	_	
415-24	71785-71793	domestic	_	
415-25	71794-71802	violence	_	
415-26	71802-71803	,	_	
415-27	71804-71807	and	_	
415-28	71808-71811	the	_	
415-29	71812-71823	development	_	
415-30	71824-71826	of	_	
415-31	71827-71834	alcohol	_	
415-32	71835-71838	use	_	
415-33	71839-71847	disorder	_	
415-34	71848-71849	(	_	
415-35	71849-71852	AUD	_	
415-36	71852-71853	)	_	
415-37	71854-71855	[	_	
415-38	71855-71856	3	_	
415-39	71856-71857	,	_	
415-40	71858-71859	4	_	
415-41	71859-71860	]	_	
415-42	71860-71861	.	_	
415-43	71861-71862	”	_	

#Text=AUD is antecedent to the vast majority of the ills described here; please clarify this relationship.
416-1	71863-71866	AUD	_	
416-2	71867-71869	is	_	
416-3	71870-71880	antecedent	_	
416-4	71881-71883	to	_	
416-5	71884-71887	the	_	
416-6	71888-71892	vast	_	
416-7	71893-71901	majority	_	
416-8	71902-71904	of	_	
416-9	71905-71908	the	_	
416-10	71909-71913	ills	_	
416-11	71914-71923	described	_	
416-12	71924-71928	here	_	
416-13	71928-71929	;	_	
416-14	71930-71936	please	_	
416-15	71937-71944	clarify	_	
416-16	71945-71949	this	_	
416-17	71950-71962	relationship	_	
416-18	71962-71963	.	_	

#Text=Response: We have rephrased the sentence as follows: “This is largely due to the development of alcohol use disorder (AUD) and consequential organ damage caused by chronic drinking, intoxication-related car accidents and domestic violence [3, 4].”
#Text=5) Table 1: Though it is specified in-text, it would be helpful to discriminate the two TLFB measures; either in the table Notes or within the table, e.g., “Drinks in last Thirty Days”.
417-1	71964-71972	Response	_	
417-2	71972-71973	:	_	
417-3	71974-71976	We	_	
417-4	71977-71981	have	_	
417-5	71982-71991	rephrased	_	
417-6	71992-71995	the	_	
417-7	71996-72004	sentence	_	
417-8	72005-72007	as	_	
417-9	72008-72015	follows	_	
417-10	72015-72016	:	_	
417-11	72017-72018	“	_	
417-12	72018-72022	This	_	
417-13	72023-72025	is	_	
417-14	72026-72033	largely	_	
417-15	72034-72037	due	_	
417-16	72038-72040	to	_	
417-17	72041-72044	the	_	
417-18	72045-72056	development	_	
417-19	72057-72059	of	_	
417-20	72060-72067	alcohol	_	
417-21	72068-72071	use	_	
417-22	72072-72080	disorder	_	
417-23	72081-72082	(	_	
417-24	72082-72085	AUD	_	
417-25	72085-72086	)	_	
417-26	72087-72090	and	_	
417-27	72091-72104	consequential	_	
417-28	72105-72110	organ	_	
417-29	72111-72117	damage	_	
417-30	72118-72124	caused	_	
417-31	72125-72127	by	_	
417-32	72128-72135	chronic	_	
417-33	72136-72144	drinking	_	
417-34	72144-72145	,	_	
417-35	72146-72166	intoxication-related	_	
417-36	72167-72170	car	_	
417-37	72171-72180	accidents	_	
417-38	72181-72184	and	_	
417-39	72185-72193	domestic	_	
417-40	72194-72202	violence	_	
417-41	72203-72204	[	_	
417-42	72204-72205	3	_	
417-43	72205-72206	,	_	
417-44	72207-72208	4	_	
417-45	72208-72209	]	_	
417-46	72209-72210	.	_	
417-47	72210-72211	”	_	
417-48	72212-72213	5	_	
417-49	72213-72214	)	_	
417-50	72215-72220	Table	_	
417-51	72221-72222	1	_	
417-52	72222-72223	:	_	
417-53	72224-72230	Though	_	
417-54	72231-72233	it	_	
417-55	72234-72236	is	_	
417-56	72237-72246	specified	_	
417-57	72247-72254	in-text	_	
417-58	72254-72255	,	_	
417-59	72256-72258	it	_	
417-60	72259-72264	would	_	
417-61	72265-72267	be	_	
417-62	72268-72275	helpful	_	
417-63	72276-72278	to	_	
417-64	72279-72291	discriminate	_	
417-65	72292-72295	the	_	
417-66	72296-72299	two	_	
417-67	72300-72304	TLFB	_	
417-68	72305-72313	measures	_	
417-69	72313-72314	;	_	
417-70	72315-72321	either	_	
417-71	72322-72324	in	_	
417-72	72325-72328	the	_	
417-73	72329-72334	table	_	
417-74	72335-72340	Notes	_	
417-75	72341-72343	or	_	
417-76	72344-72350	within	_	
417-77	72351-72354	the	_	
417-78	72355-72360	table	_	
417-79	72360-72361	,	_	
417-80	72362-72365	e.g	_	
417-81	72365-72366	.	_	
417-82	72366-72367	,	_	
417-83	72368-72369	“	_	
417-84	72369-72375	Drinks	_	
417-85	72376-72378	in	_	
417-86	72379-72383	last	_	
417-87	72384-72390	Thirty	_	
417-88	72391-72395	Days	_	
417-89	72395-72396	”	_	
417-90	72396-72397	.	_	

#Text=Response: We have added the following to the Table 1 Note: “Heavy drinking days was calculated from the last 90 days as measured by the TLFB, where a heavy drinking day was defined as 4 or more drinks per day for women and 5 or more drinks per day for men.
418-1	72398-72406	Response	_	
418-2	72406-72407	:	_	
418-3	72408-72410	We	_	
418-4	72411-72415	have	_	
418-5	72416-72421	added	_	
418-6	72422-72425	the	_	
418-7	72426-72435	following	_	
418-8	72436-72438	to	_	
418-9	72439-72442	the	_	
418-10	72443-72448	Table	_	
418-11	72449-72450	1	_	
418-12	72451-72455	Note	_	
418-13	72455-72456	:	_	
418-14	72457-72458	“	_	
418-15	72458-72463	Heavy	_	
418-16	72464-72472	drinking	_	
418-17	72473-72477	days	_	
418-18	72478-72481	was	_	
418-19	72482-72492	calculated	_	
418-20	72493-72497	from	_	
418-21	72498-72501	the	_	
418-22	72502-72506	last	_	
418-23	72507-72509	90	_	
418-24	72510-72514	days	_	
418-25	72515-72517	as	_	
418-26	72518-72526	measured	_	
418-27	72527-72529	by	_	
418-28	72530-72533	the	_	
418-29	72534-72538	TLFB	_	
418-30	72538-72539	,	_	
418-31	72540-72545	where	_	
418-32	72546-72547	a	_	
418-33	72548-72553	heavy	_	
418-34	72554-72562	drinking	_	
418-35	72563-72566	day	_	
418-36	72567-72570	was	_	
418-37	72571-72578	defined	_	
418-38	72579-72581	as	_	
418-39	72582-72583	4	_	
418-40	72584-72586	or	_	
418-41	72587-72591	more	_	
418-42	72592-72598	drinks	_	
418-43	72599-72602	per	_	
418-44	72603-72606	day	_	
418-45	72607-72610	for	_	
418-46	72611-72616	women	_	
418-47	72617-72620	and	_	
418-48	72621-72622	5	_	
418-49	72623-72625	or	_	
418-50	72626-72630	more	_	
418-51	72631-72637	drinks	_	
418-52	72638-72641	per	_	
418-53	72642-72645	day	_	
418-54	72646-72649	for	_	
418-55	72650-72653	men	_	
418-56	72653-72654	.	_	

#Text=Drinks per thirty days was the total count of drinks from the past 30 days as measured by the TLFB.”
#Text=6) Line 133: What monetary amounts were used for the DDT?
419-1	72655-72661	Drinks	_	
419-2	72662-72665	per	_	
419-3	72666-72672	thirty	_	
419-4	72673-72677	days	_	
419-5	72678-72681	was	_	
419-6	72682-72685	the	_	
419-7	72686-72691	total	_	
419-8	72692-72697	count	_	
419-9	72698-72700	of	_	
419-10	72701-72707	drinks	_	
419-11	72708-72712	from	_	
419-12	72713-72716	the	_	
419-13	72717-72721	past	_	
419-14	72722-72724	30	_	
419-15	72725-72729	days	_	
419-16	72730-72732	as	_	
419-17	72733-72741	measured	_	
419-18	72742-72744	by	_	
419-19	72745-72748	the	_	
419-20	72749-72753	TLFB	_	
419-21	72753-72754	.	_	
419-22	72754-72755	”	_	
419-23	72756-72757	6	_	
419-24	72757-72758	)	_	
419-25	72759-72763	Line	_	
419-26	72764-72767	133	_	
419-27	72767-72768	:	_	
419-28	72769-72773	What	_	
419-29	72774-72782	monetary	_	
419-30	72783-72790	amounts	_	
419-31	72791-72795	were	_	
419-32	72796-72800	used	_	
419-33	72801-72804	for	_	
419-34	72805-72808	the	_	
419-35	72809-72812	DDT	_	
419-36	72812-72813	?	_	

#Text=Response: We have added the following to the description of the DDT (page 6): “Subjects were presented as their immediate reward values between $100 and $0 dollars in increments of $10, while the delayed reward was $100.
420-1	72815-72823	Response	_	
420-2	72823-72824	:	_	
420-3	72825-72827	We	_	
420-4	72828-72832	have	_	
420-5	72833-72838	added	_	
420-6	72839-72842	the	_	
420-7	72843-72852	following	_	
420-8	72853-72855	to	_	
420-9	72856-72859	the	_	
420-10	72860-72871	description	_	
420-11	72872-72874	of	_	
420-12	72875-72878	the	_	
420-13	72879-72882	DDT	_	
420-14	72883-72884	(	_	
420-15	72884-72888	page	_	
420-16	72889-72890	6	_	
420-17	72890-72891	)	_	
420-18	72891-72892	:	_	
420-19	72893-72894	“	_	
420-20	72894-72902	Subjects	_	
420-21	72903-72907	were	_	
420-22	72908-72917	presented	_	
420-23	72918-72920	as	_	
420-24	72921-72926	their	_	
420-25	72927-72936	immediate	_	
420-26	72937-72943	reward	_	
420-27	72944-72950	values	_	
420-28	72951-72958	between	_	
420-29	72959-72963	$100	_	
420-30	72964-72967	and	_	
420-31	72968-72970	$0	_	
420-32	72971-72978	dollars	_	
420-33	72979-72981	in	_	
420-34	72982-72992	increments	_	
420-35	72993-72995	of	_	
420-36	72996-72999	$10	_	
420-37	72999-73000	,	_	
420-38	73001-73006	while	_	
420-39	73007-73010	the	_	
420-40	73011-73018	delayed	_	
420-41	73019-73025	reward	_	
420-42	73026-73029	was	_	
420-43	73030-73034	$100	_	
420-44	73034-73035	.	_	

#Text=Delays were 0, 7, 14, 20, 25, or 30 days.
421-1	73036-73042	Delays	_	
421-2	73043-73047	were	_	
421-3	73048-73049	0	_	
421-4	73049-73050	,	_	
421-5	73051-73052	7	_	
421-6	73052-73053	,	_	
421-7	73054-73056	14	_	
421-8	73056-73057	,	_	
421-9	73058-73060	20	_	
421-10	73060-73061	,	_	
421-11	73062-73064	25	_	
421-12	73064-73065	,	_	
421-13	73066-73068	or	_	
421-14	73069-73071	30	_	
421-15	73072-73076	days	_	
421-16	73076-73077	.	_	

#Text=Subjects completed trials with all iterations of these parameters.”
#Text=7) Supplementary Figure 1A: Perhaps I misunderstand, but the way this is presented it appears to show a (group mean?)
422-1	73078-73086	Subjects	_	
422-2	73087-73096	completed	_	
422-3	73097-73103	trials	_	
422-4	73104-73108	with	_	
422-5	73109-73112	all	_	
422-6	73113-73123	iterations	_	
422-7	73124-73126	of	_	
422-8	73127-73132	these	_	
422-9	73133-73143	parameters	_	
422-10	73143-73144	.	_	
422-11	73144-73145	”	_	
422-12	73146-73147	7	_	
422-13	73147-73148	)	_	
422-14	73149-73162	Supplementary	_	
422-15	73163-73169	Figure	_	
422-16	73170-73172	1A	_	
422-17	73172-73173	:	_	
422-18	73174-73181	Perhaps	_	
422-19	73182-73183	I	_	
422-20	73184-73197	misunderstand	_	
422-21	73197-73198	,	_	
422-22	73199-73202	but	_	
422-23	73203-73206	the	_	
422-24	73207-73210	way	_	
422-25	73211-73215	this	_	
422-26	73216-73218	is	_	
422-27	73219-73228	presented	_	
422-28	73229-73231	it	_	
422-29	73232-73239	appears	_	
422-30	73240-73242	to	_	
422-31	73243-73247	show	_	
422-32	73248-73249	a	_	
422-33	73250-73251	(	_	
422-34	73251-73256	group	_	
422-35	73257-73261	mean	_	
422-36	73261-73262	?	_	
422-37	73262-73263	)	_	

#Text=time series from the right GPe OFF and ON alcohol.
423-1	73264-73268	time	_	
423-2	73269-73275	series	_	
423-3	73276-73280	from	_	
423-4	73281-73284	the	_	
423-5	73285-73290	right	_	
423-6	73291-73294	GPe	_	
423-7	73295-73298	OFF	_	
423-8	73299-73302	and	_	
423-9	73303-73305	ON	_	
423-10	73306-73313	alcohol	_	
423-11	73313-73314	.	_	

#Text=If so, then the stereotyped pattern from the (pre) condition resting scan is replicated in a (post) resting scan 25 min later, albeit with a small timeshift.
424-1	73315-73317	If	_	
424-2	73318-73320	so	_	
424-3	73320-73321	,	_	
424-4	73322-73326	then	_	
424-5	73327-73330	the	_	
424-6	73331-73342	stereotyped	_	
424-7	73343-73350	pattern	_	
424-8	73351-73355	from	_	
424-9	73356-73359	the	_	
424-10	73360-73361	(	_	
424-11	73361-73364	pre	_	
424-12	73364-73365	)	_	
424-13	73366-73375	condition	_	
424-14	73376-73383	resting	_	
424-15	73384-73388	scan	_	
424-16	73389-73391	is	_	
424-17	73392-73402	replicated	_	
424-18	73403-73405	in	_	
424-19	73406-73407	a	_	
424-20	73408-73409	(	_	
424-21	73409-73413	post	_	
424-22	73413-73414	)	_	
424-23	73415-73422	resting	_	
424-24	73423-73427	scan	_	
424-25	73428-73430	25	_	
424-26	73431-73434	min	_	
424-27	73435-73440	later	_	
424-28	73440-73441	,	_	
424-29	73442-73448	albeit	_	
424-30	73449-73453	with	_	
424-31	73454-73455	a	_	
424-32	73456-73461	small	_	
424-33	73462-73471	timeshift	_	
424-34	73471-73472	.	_	

#Text=It seems impossible that a resting scan would produce a stereotyped/replicated pattern as illustrated; i.e.
425-1	73473-73475	It	_	
425-2	73476-73481	seems	_	
425-3	73482-73492	impossible	_	
425-4	73493-73497	that	_	
425-5	73498-73499	a	_	
425-6	73500-73507	resting	_	
425-7	73508-73512	scan	_	
425-8	73513-73518	would	_	
425-9	73519-73526	produce	_	
425-10	73527-73528	a	_	
425-11	73529-73540	stereotyped	_	
425-12	73540-73541	/	_	
425-13	73541-73551	replicated	_	
425-14	73552-73559	pattern	_	
425-15	73560-73562	as	_	
425-16	73563-73574	illustrated	_	
425-17	73574-73575	;	_	
425-18	73576-73579	i.e	_	
425-19	73579-73580	.	_	

#Text=I would expect that the group mean resting BOLD signal would look like noise.
426-1	73581-73582	I	_	
426-2	73583-73588	would	_	
426-3	73589-73595	expect	_	
426-4	73596-73600	that	_	
426-5	73601-73604	the	_	
426-6	73605-73610	group	_	
426-7	73611-73615	mean	_	
426-8	73616-73623	resting	_	
426-9	73624-73628	BOLD	_	
426-10	73629-73635	signal	_	
426-11	73636-73641	would	_	
426-12	73642-73646	look	_	
426-13	73647-73651	like	_	
426-14	73652-73657	noise	_	
426-15	73657-73658	.	_	

#Text=Please explain what this figure is showing.
427-1	73659-73665	Please	_	
427-2	73666-73673	explain	_	
427-3	73674-73678	what	_	
427-4	73679-73683	this	_	
427-5	73684-73690	figure	_	
427-6	73691-73693	is	_	
427-7	73694-73701	showing	_	
427-8	73701-73702	.	_	

#Text=Response: This is in fact the time series of the first 50 time points of the resting state scan in the ON and OFF alcohol conditions This time series is averaged across voxels in the seed region of interest (right GPe) and across subjects.
428-1	73703-73711	Response	_	
428-2	73711-73712	:	_	
428-3	73713-73717	This	_	
428-4	73718-73720	is	_	
428-5	73721-73723	in	_	
428-6	73724-73728	fact	_	
428-7	73729-73732	the	_	
428-8	73733-73737	time	_	
428-9	73738-73744	series	_	
428-10	73745-73747	of	_	
428-11	73748-73751	the	_	
428-12	73752-73757	first	_	
428-13	73758-73760	50	_	
428-14	73761-73765	time	_	
428-15	73766-73772	points	_	
428-16	73773-73775	of	_	
428-17	73776-73779	the	_	
428-18	73780-73787	resting	_	
428-19	73788-73793	state	_	
428-20	73794-73798	scan	_	
428-21	73799-73801	in	_	
428-22	73802-73805	the	_	
428-23	73806-73808	ON	_	
428-24	73809-73812	and	_	
428-25	73813-73816	OFF	_	
428-26	73817-73824	alcohol	_	
428-27	73825-73835	conditions	_	
428-28	73836-73840	This	_	
428-29	73841-73845	time	_	
428-30	73846-73852	series	_	
428-31	73853-73855	is	_	
428-32	73856-73864	averaged	_	
428-33	73865-73871	across	_	
428-34	73872-73878	voxels	_	
428-35	73879-73881	in	_	
428-36	73882-73885	the	_	
428-37	73886-73890	seed	_	
428-38	73891-73897	region	_	
428-39	73898-73900	of	_	
428-40	73901-73909	interest	_	
428-41	73910-73911	(	_	
428-42	73911-73916	right	_	
428-43	73917-73920	GPe	_	
428-44	73920-73921	)	_	
428-45	73922-73925	and	_	
428-46	73926-73932	across	_	
428-47	73933-73941	subjects	_	
428-48	73941-73942	.	_	

#Text=This time series is also post-preprocessing, so noise reduction steps have already been carried out as reflected in this time course.
429-1	73943-73947	This	_	
429-2	73948-73952	time	_	
429-3	73953-73959	series	_	
429-4	73960-73962	is	_	
429-5	73963-73967	also	_	
429-6	73968-73986	post-preprocessing	_	
429-7	73986-73987	,	_	
429-8	73988-73990	so	_	
429-9	73991-73996	noise	_	
429-10	73997-74006	reduction	_	
429-11	74007-74012	steps	_	
429-12	74013-74017	have	_	
429-13	74018-74025	already	_	
429-14	74026-74030	been	_	
429-15	74031-74038	carried	_	
429-16	74039-74042	out	_	
429-17	74043-74045	as	_	
429-18	74046-74055	reflected	_	
429-19	74056-74058	in	_	
429-20	74059-74063	this	_	
429-21	74064-74068	time	_	
429-22	74069-74075	course	_	
429-23	74075-74076	.	_	

#Text=We have added the following description to the caption of the supplementary figure as follows: “Shows the first 50 time points of the timeseries of the preprocessed BOLD signal from the right GPe (averaged across voxels within the right GPe and across subjects…”
#Text=8) Interestingly, alcohol-increased connectivity was mostly ipsilateral for left GPe, but mostly contralateral for right GPe.
430-1	74077-74079	We	_	
430-2	74080-74084	have	_	
430-3	74085-74090	added	_	
430-4	74091-74094	the	_	
430-5	74095-74104	following	_	
430-6	74105-74116	description	_	
430-7	74117-74119	to	_	
430-8	74120-74123	the	_	
430-9	74124-74131	caption	_	
430-10	74132-74134	of	_	
430-11	74135-74138	the	_	
430-12	74139-74152	supplementary	_	
430-13	74153-74159	figure	_	
430-14	74160-74162	as	_	
430-15	74163-74170	follows	_	
430-16	74170-74171	:	_	
430-17	74172-74173	“	_	
430-18	74173-74178	Shows	_	
430-19	74179-74182	the	_	
430-20	74183-74188	first	_	
430-21	74189-74191	50	_	
430-22	74192-74196	time	_	
430-23	74197-74203	points	_	
430-24	74204-74206	of	_	
430-25	74207-74210	the	_	
430-26	74211-74221	timeseries	_	
430-27	74222-74224	of	_	
430-28	74225-74228	the	_	
430-29	74229-74241	preprocessed	_	
430-30	74242-74246	BOLD	_	
430-31	74247-74253	signal	_	
430-32	74254-74258	from	_	
430-33	74259-74262	the	_	
430-34	74263-74268	right	_	
430-35	74269-74272	GPe	_	
430-36	74273-74274	(	_	
430-37	74274-74282	averaged	_	
430-38	74283-74289	across	_	
430-39	74290-74296	voxels	_	
430-40	74297-74303	within	_	
430-41	74304-74307	the	_	
430-42	74308-74313	right	_	
430-43	74314-74317	GPe	_	
430-44	74318-74321	and	_	
430-45	74322-74328	across	_	
430-46	74329-74337	subjects	_	
430-47	74337-74338	…	_	
430-48	74338-74339	”	_	
430-49	74340-74341	8	_	
430-50	74341-74342	)	_	
430-51	74343-74356	Interestingly	_	
430-52	74356-74357	,	_	
430-53	74358-74375	alcohol-increased	_	
430-54	74376-74388	connectivity	_	
430-55	74389-74392	was	_	
430-56	74393-74399	mostly	_	
430-57	74400-74411	ipsilateral	_	
430-58	74412-74415	for	_	
430-59	74416-74420	left	_	
430-60	74421-74424	GPe	_	
430-61	74424-74425	,	_	
430-62	74426-74429	but	_	
430-63	74430-74436	mostly	_	
430-64	74437-74450	contralateral	_	
430-65	74451-74454	for	_	
430-66	74455-74460	right	_	
430-67	74461-74464	GPe	_	
430-68	74464-74465	.	_	

#Text=What do the authors make of this?
431-1	74466-74470	What	_	
431-2	74471-74473	do	_	
431-3	74474-74477	the	_	
431-4	74478-74485	authors	_	
431-5	74486-74490	make	_	
431-6	74491-74493	of	_	
431-7	74494-74498	this	_	
431-8	74498-74499	?	_	

#Text=Response: We have added this discussion to the supplementary materials: “Alcohol has previously been shown to reduce the lateralization of specific functions, particularly in terms of greater left lateral increases and right lateral decreases in connectivity at rest (Volkow et al., 2008).
432-1	74500-74508	Response	_	
432-2	74508-74509	:	_	
432-3	74510-74512	We	_	
432-4	74513-74517	have	_	
432-5	74518-74523	added	_	
432-6	74524-74528	this	_	
432-7	74529-74539	discussion	_	
432-8	74540-74542	to	_	
432-9	74543-74546	the	_	
432-10	74547-74560	supplementary	_	
432-11	74561-74570	materials	_	
432-12	74570-74571	:	_	
432-13	74572-74573	“	_	
432-14	74573-74580	Alcohol	_	
432-15	74581-74584	has	_	
432-16	74585-74595	previously	_	
432-17	74596-74600	been	_	
432-18	74601-74606	shown	_	
432-19	74607-74609	to	_	
432-20	74610-74616	reduce	_	
432-21	74617-74620	the	_	
432-22	74621-74635	lateralization	_	
432-23	74636-74638	of	_	
432-24	74639-74647	specific	_	
432-25	74648-74657	functions	_	
432-26	74657-74658	,	_	
432-27	74659-74671	particularly	_	
432-28	74672-74674	in	_	
432-29	74675-74680	terms	_	
432-30	74681-74683	of	_	
432-31	74684-74691	greater	_	
432-32	74692-74696	left	_	
432-33	74697-74704	lateral	_	
432-34	74705-74714	increases	_	
432-35	74715-74718	and	_	
432-36	74719-74724	right	_	
432-37	74725-74732	lateral	_	
432-38	74733-74742	decreases	_	
432-39	74743-74745	in	_	
432-40	74746-74758	connectivity	_	
432-41	74759-74761	at	_	
432-42	74762-74766	rest	_	
432-43	74767-74768	(	_	
432-44	74768-74774	Volkow	_	
432-45	74775-74777	et	_	
432-46	74778-74780	al	_	
432-47	74780-74781	.	_	
432-48	74781-74782	,	_	
432-49	74783-74787	2008	_	
432-50	74787-74788	)	_	
432-51	74788-74789	.	_	

#Text=The greater left-side increases in connectivity (both from ipsi- and contralateral GPe regions) may reflect this pattern as well.
433-1	74790-74793	The	_	
433-2	74794-74801	greater	_	
433-3	74802-74811	left-side	_	
433-4	74812-74821	increases	_	
433-5	74822-74824	in	_	
433-6	74825-74837	connectivity	_	
433-7	74838-74839	(	_	
433-8	74839-74843	both	_	
433-9	74844-74848	from	_	
433-10	74849-74853	ipsi	_	
433-11	74853-74854	-	_	
433-12	74855-74858	and	_	
433-13	74859-74872	contralateral	_	
433-14	74873-74876	GPe	_	
433-15	74877-74884	regions	_	
433-16	74884-74885	)	_	
433-17	74886-74889	may	_	
433-18	74890-74897	reflect	_	
433-19	74898-74902	this	_	
433-20	74903-74910	pattern	_	
433-21	74911-74913	as	_	
433-22	74914-74918	well	_	
433-23	74918-74919	.	_	

#Text=We would point out that there were mostly contralateral alcohol-decreases in connectivity from the left GPe, suggesting reductions in connectivity on the right side.
434-1	74920-74922	We	_	
434-2	74923-74928	would	_	
434-3	74929-74934	point	_	
434-4	74935-74938	out	_	
434-5	74939-74943	that	_	
434-6	74944-74949	there	_	
434-7	74950-74954	were	_	
434-8	74955-74961	mostly	_	
434-9	74962-74975	contralateral	_	
434-10	74976-74993	alcohol-decreases	_	
434-11	74994-74996	in	_	
434-12	74997-75009	connectivity	_	
434-13	75010-75014	from	_	
434-14	75015-75018	the	_	
434-15	75019-75023	left	_	
434-16	75024-75027	GPe	_	
434-17	75027-75028	,	_	
434-18	75029-75039	suggesting	_	
434-19	75040-75050	reductions	_	
434-20	75051-75053	in	_	
434-21	75054-75066	connectivity	_	
434-22	75067-75069	on	_	
434-23	75070-75073	the	_	
434-24	75074-75079	right	_	
434-25	75080-75084	side	_	
434-26	75084-75085	.	_	

#Text=We would also point out from the perspective of the role of the GPe pathways, previous work finds that connectivity strength in right-lateralized hyperdirect and indirect basal ganglia/frontal pathways predicted successful response inhibition (Jahfari et al., 2011).
435-1	75086-75088	We	_	
435-2	75089-75094	would	_	
435-3	75095-75099	also	_	
435-4	75100-75105	point	_	
435-5	75106-75109	out	_	
435-6	75110-75114	from	_	
435-7	75115-75118	the	_	
435-8	75119-75130	perspective	_	
435-9	75131-75133	of	_	
435-10	75134-75137	the	_	
435-11	75138-75142	role	_	
435-12	75143-75145	of	_	
435-13	75146-75149	the	_	
435-14	75150-75153	GPe	_	
435-15	75154-75162	pathways	_	
435-16	75162-75163	,	_	
435-17	75164-75172	previous	_	
435-18	75173-75177	work	_	
435-19	75178-75183	finds	_	
435-20	75184-75188	that	_	
435-21	75189-75201	connectivity	_	
435-22	75202-75210	strength	_	
435-23	75211-75213	in	_	
435-24	75214-75231	right-lateralized	_	
435-25	75232-75243	hyperdirect	_	
435-26	75244-75247	and	_	
435-27	75248-75256	indirect	_	
435-28	75257-75262	basal	_	
435-29	75263-75270	ganglia	_	
435-30	75270-75271	/	_	
435-31	75271-75278	frontal	_	
435-32	75279-75287	pathways	_	
435-33	75288-75297	predicted	_	
435-34	75298-75308	successful	_	
435-35	75309-75317	response	_	
435-36	75318-75328	inhibition	_	
435-37	75329-75330	(	_	
435-38	75330-75337	Jahfari	_	
435-39	75338-75340	et	_	
435-40	75341-75343	al	_	
435-41	75343-75344	.	_	
435-42	75344-75345	,	_	
435-43	75346-75350	2011	_	
435-44	75350-75351	)	_	
435-45	75351-75352	.	_	

#Text=On the other hand, increases in left ipsilateral connectivity in individuals with chronic alcohol use has been associated with compensatory function (Chanraud et al., 2011).
436-1	75353-75355	On	_	
436-2	75356-75359	the	_	
436-3	75360-75365	other	_	
436-4	75366-75370	hand	_	
436-5	75370-75371	,	_	
436-6	75372-75381	increases	_	
436-7	75382-75384	in	_	
436-8	75385-75389	left	_	
436-9	75390-75401	ipsilateral	_	
436-10	75402-75414	connectivity	_	
436-11	75415-75417	in	_	
436-12	75418-75429	individuals	_	
436-13	75430-75434	with	_	
436-14	75435-75442	chronic	_	
436-15	75443-75450	alcohol	_	
436-16	75451-75454	use	_	
436-17	75455-75458	has	_	
436-18	75459-75463	been	_	
436-19	75464-75474	associated	_	
436-20	75475-75479	with	_	
436-21	75480-75492	compensatory	_	
436-22	75493-75501	function	_	
436-23	75502-75503	(	_	
436-24	75503-75511	Chanraud	_	
436-25	75512-75514	et	_	
436-26	75515-75517	al	_	
436-27	75517-75518	.	_	
436-28	75518-75519	,	_	
436-29	75520-75524	2011	_	
436-30	75524-75525	)	_	
436-31	75525-75526	.	_	

#Text=Taken together, the lateralization pattern may reflect alcohol related impairment of standard inhibitory pathways and increases in “alternative” neural communication routes.” 
#Text=9) Line 239: “The number of drinks consumed per 30 days prior to screening had a significant effect on alcohol-related change in connectivity.”
437-1	75527-75532	Taken	_	
437-2	75533-75541	together	_	
437-3	75541-75542	,	_	
437-4	75543-75546	the	_	
437-5	75547-75561	lateralization	_	
437-6	75562-75569	pattern	_	
437-7	75570-75573	may	_	
437-8	75574-75581	reflect	_	
437-9	75582-75589	alcohol	_	
437-10	75590-75597	related	_	
437-11	75598-75608	impairment	_	
437-12	75609-75611	of	_	
437-13	75612-75620	standard	_	
437-14	75621-75631	inhibitory	_	
437-15	75632-75640	pathways	_	
437-16	75641-75644	and	_	
437-17	75645-75654	increases	_	
437-18	75655-75657	in	_	
437-19	75658-75659	“	_	
437-20	75659-75670	alternative	_	
437-21	75670-75671	”	_	
437-22	75672-75678	neural	_	
437-23	75679-75692	communication	_	
437-24	75693-75699	routes	_	
437-25	75699-75700	.	_	
437-26	75700-75701	”	_	
437-27	75703-75704	9	_	
437-28	75704-75705	)	_	
437-29	75706-75710	Line	_	
437-30	75711-75714	239	_	
437-31	75714-75715	:	_	
437-32	75716-75717	“	_	
437-33	75717-75720	The	_	
437-34	75721-75727	number	_	
437-35	75728-75730	of	_	
437-36	75731-75737	drinks	_	
437-37	75738-75746	consumed	_	
437-38	75747-75750	per	_	
437-39	75751-75753	30	_	
437-40	75754-75758	days	_	
437-41	75759-75764	prior	_	
437-42	75765-75767	to	_	
437-43	75768-75777	screening	_	
437-44	75778-75781	had	_	
437-45	75782-75783	a	_	
437-46	75784-75795	significant	_	
437-47	75796-75802	effect	_	
437-48	75803-75805	on	_	
437-49	75806-75821	alcohol-related	_	
437-50	75822-75828	change	_	
437-51	75829-75831	in	_	
437-52	75832-75844	connectivity	_	
437-53	75844-75845	.	_	
437-54	75845-75846	”	_	

#Text=Please reword to reflect “association”; the current wording implies directionality and causation.
438-1	75847-75853	Please	_	
438-2	75854-75860	reword	_	
438-3	75861-75863	to	_	
438-4	75864-75871	reflect	_	
438-5	75872-75873	“	_	
438-6	75873-75884	association	_	
438-7	75884-75885	”	_	
438-8	75885-75886	;	_	
438-9	75887-75890	the	_	
438-10	75891-75898	current	_	
438-11	75899-75906	wording	_	
438-12	75907-75914	implies	_	
438-13	75915-75929	directionality	_	
438-14	75930-75933	and	_	
438-15	75934-75943	causation	_	
438-16	75943-75944	.	_	

#Text=Response: We have reworded this to: “The number of drinks consumed per 30 days prior to screening was significantly associated with alcohol-related changes in connectivity.”
#Text=10) Figure 2 legend: “B.i.
439-1	75945-75953	Response	_	
439-2	75953-75954	:	_	
439-3	75955-75957	We	_	
439-4	75958-75962	have	_	
439-5	75963-75971	reworded	_	
439-6	75972-75976	this	_	
439-7	75977-75979	to	_	
439-8	75979-75980	:	_	
439-9	75981-75982	“	_	
439-10	75982-75985	The	_	
439-11	75986-75992	number	_	
439-12	75993-75995	of	_	
439-13	75996-76002	drinks	_	
439-14	76003-76011	consumed	_	
439-15	76012-76015	per	_	
439-16	76016-76018	30	_	
439-17	76019-76023	days	_	
439-18	76024-76029	prior	_	
439-19	76030-76032	to	_	
439-20	76033-76042	screening	_	
439-21	76043-76046	was	_	
439-22	76047-76060	significantly	_	
439-23	76061-76071	associated	_	
439-24	76072-76076	with	_	
439-25	76077-76092	alcohol-related	_	
439-26	76093-76100	changes	_	
439-27	76101-76103	in	_	
439-28	76104-76116	connectivity	_	
439-29	76116-76117	.	_	
439-30	76117-76118	”	_	
439-31	76119-76121	10	_	
439-32	76121-76122	)	_	
439-33	76123-76129	Figure	_	
439-34	76130-76131	2	_	
439-35	76132-76138	legend	_	
439-36	76138-76139	:	_	
439-37	76140-76141	“	_	
439-38	76141-76144	B.i	_	
439-39	76144-76145	.	_	

#Text=Heschl’s Gyrus…” appears to be labeled “ii.” on the figure diagram.
440-1	76146-76152	Heschl	_	
440-2	76152-76153	’	_	
440-3	76153-76154	s	_	
440-4	76155-76160	Gyrus	_	
440-5	76160-76161	…	_	
440-6	76161-76162	”	_	
440-7	76163-76170	appears	_	
440-8	76171-76173	to	_	
440-9	76174-76176	be	_	
440-10	76177-76184	labeled	_	
440-11	76185-76186	“	_	
440-12	76186-76188	ii	_	
440-13	76188-76189	.	_	
440-14	76189-76190	”	_	
440-15	76191-76193	on	_	
440-16	76194-76197	the	_	
440-17	76198-76204	figure	_	
440-18	76205-76212	diagram	_	
440-19	76212-76213	.	_	

#Text=Response: We have corrected this to be labeled “i.” on the diagram.
#Text=11) Figure 3 legend: “Reported clusters clusters of connectivity with GPe area correspond to the following regions: i. – Orbitofrontal cortex extending into subgenual anterior cingulate; ii. – Angular/supramarginal gyrus; iii.
441-1	76214-76222	Response	_	
441-2	76222-76223	:	_	
441-3	76224-76226	We	_	
441-4	76227-76231	have	_	
441-5	76232-76241	corrected	_	
441-6	76242-76246	this	_	
441-7	76247-76249	to	_	
441-8	76250-76252	be	_	
441-9	76253-76260	labeled	_	
441-10	76261-76262	“	_	
441-11	76262-76263	i	_	
441-12	76263-76264	.	_	
441-13	76264-76265	”	_	
441-14	76266-76268	on	_	
441-15	76269-76272	the	_	
441-16	76273-76280	diagram	_	
441-17	76280-76281	.	_	
441-18	76282-76284	11	_	
441-19	76284-76285	)	_	
441-20	76286-76292	Figure	_	
441-21	76293-76294	3	_	
441-22	76295-76301	legend	_	
441-23	76301-76302	:	_	
441-24	76303-76304	“	_	
441-25	76304-76312	Reported	_	
441-26	76313-76321	clusters	_	
441-27	76322-76330	clusters	_	
441-28	76331-76333	of	_	
441-29	76334-76346	connectivity	_	
441-30	76347-76351	with	_	
441-31	76352-76355	GPe	_	
441-32	76356-76360	area	_	
441-33	76361-76371	correspond	_	
441-34	76372-76374	to	_	
441-35	76375-76378	the	_	
441-36	76379-76388	following	_	
441-37	76389-76396	regions	_	
441-38	76396-76397	:	_	
441-39	76398-76399	i	_	
441-40	76399-76400	.	_	
441-41	76401-76402	–	_	
441-42	76403-76416	Orbitofrontal	_	
441-43	76417-76423	cortex	_	
441-44	76424-76433	extending	_	
441-45	76434-76438	into	_	
441-46	76439-76448	subgenual	_	
441-47	76449-76457	anterior	_	
441-48	76458-76467	cingulate	_	
441-49	76467-76468	;	_	
441-50	76469-76471	ii	_	
441-51	76471-76472	.	_	
441-52	76473-76474	–	_	
441-53	76475-76482	Angular	_	
441-54	76482-76483	/	_	
441-55	76483-76496	supramarginal	_	
441-56	76497-76502	gyrus	_	
441-57	76502-76503	;	_	
441-58	76504-76507	iii	_	
441-59	76507-76508	.	_	

#Text=Frontal pole.”
442-1	76509-76516	Frontal	_	
442-2	76517-76521	pole	_	
442-3	76521-76522	.	_	
442-4	76522-76523	”	_	

#Text=It seems that “GPe area” should be described as “left GPe”.
443-1	76524-76526	It	_	
443-2	76527-76532	seems	_	
443-3	76533-76537	that	_	
443-4	76538-76539	“	_	
443-5	76539-76542	GPe	_	
443-6	76543-76547	area	_	
443-7	76547-76548	”	_	
443-8	76549-76555	should	_	
443-9	76556-76558	be	_	
443-10	76559-76568	described	_	
443-11	76569-76571	as	_	
443-12	76572-76573	“	_	
443-13	76573-76577	left	_	
443-14	76578-76581	GPe	_	
443-15	76581-76582	”	_	
443-16	76582-76583	.	_	

#Text=No mention is made of “iv”, “v”, or “vi”.
444-1	76584-76586	No	_	
444-2	76587-76594	mention	_	
444-3	76595-76597	is	_	
444-4	76598-76602	made	_	
444-5	76603-76605	of	_	
444-6	76606-76607	“	_	
444-7	76607-76609	iv	_	
444-8	76609-76610	”	_	
444-9	76610-76611	,	_	
444-10	76612-76613	“	_	
444-11	76613-76614	v	_	
444-12	76614-76615	”	_	
444-13	76615-76616	,	_	
444-14	76617-76619	or	_	
444-15	76620-76621	“	_	
444-16	76621-76623	vi	_	
444-17	76623-76624	”	_	
444-18	76624-76625	.	_	

#Text=Response: We have updated the figure legend to correspond to the updated results based on requested revisions; as such, Figure 3 is now Figure 4.
445-1	76626-76634	Response	_	
445-2	76634-76635	:	_	
445-3	76636-76638	We	_	
445-4	76639-76643	have	_	
445-5	76644-76651	updated	_	
445-6	76652-76655	the	_	
445-7	76656-76662	figure	_	
445-8	76663-76669	legend	_	
445-9	76670-76672	to	_	
445-10	76673-76683	correspond	_	
445-11	76684-76686	to	_	
445-12	76687-76690	the	_	
445-13	76691-76698	updated	_	
445-14	76699-76706	results	_	
445-15	76707-76712	based	_	
445-16	76713-76715	on	_	
445-17	76716-76725	requested	_	
445-18	76726-76735	revisions	_	
445-19	76735-76736	;	_	
445-20	76737-76739	as	_	
445-21	76740-76744	such	_	
445-22	76744-76745	,	_	
445-23	76746-76752	Figure	_	
445-24	76753-76754	3	_	
445-25	76755-76757	is	_	
445-26	76758-76761	now	_	
445-27	76762-76768	Figure	_	
445-28	76769-76770	4	_	
445-29	76770-76771	.	_	

#Text=Figure 4 and its legend no longer refer to roman numerals, and we have specified the laterality of the GPe seed.
#Text=12) Figure 5: “Diagram of Drinking/Impulsivity Mediation column” is not present in the attached figures.
446-1	76772-76778	Figure	_	
446-2	76779-76780	4	_	
446-3	76781-76784	and	_	
446-4	76785-76788	its	_	
446-5	76789-76795	legend	_	
446-6	76796-76798	no	_	
446-7	76799-76805	longer	_	
446-8	76806-76811	refer	_	
446-9	76812-76814	to	_	
446-10	76815-76820	roman	_	
446-11	76821-76829	numerals	_	
446-12	76829-76830	,	_	
446-13	76831-76834	and	_	
446-14	76835-76837	we	_	
446-15	76838-76842	have	_	
446-16	76843-76852	specified	_	
446-17	76853-76856	the	_	
446-18	76857-76867	laterality	_	
446-19	76868-76870	of	_	
446-20	76871-76874	the	_	
446-21	76875-76878	GPe	_	
446-22	76879-76883	seed	_	
446-23	76883-76884	.	_	
446-24	76885-76887	12	_	
446-25	76887-76888	)	_	
446-26	76889-76895	Figure	_	
446-27	76896-76897	5	_	
446-28	76897-76898	:	_	
446-29	76899-76900	“	_	
446-30	76900-76907	Diagram	_	
446-31	76908-76910	of	_	
446-32	76911-76919	Drinking	_	
446-33	76919-76920	/	_	
446-34	76920-76931	Impulsivity	_	
446-35	76932-76941	Mediation	_	
446-36	76942-76948	column	_	
446-37	76948-76949	”	_	
446-38	76950-76952	is	_	
446-39	76953-76956	not	_	
446-40	76957-76964	present	_	
446-41	76965-76967	in	_	
446-42	76968-76971	the	_	
446-43	76972-76980	attached	_	
446-44	76981-76988	figures	_	
446-45	76988-76989	.	_	

#Text=Only 3 columns are displayed in Fig 5.
447-1	76990-76994	Only	_	
447-2	76995-76996	3	_	
447-3	76997-77004	columns	_	
447-4	77005-77008	are	_	
447-5	77009-77018	displayed	_	
447-6	77019-77021	in	_	
447-7	77022-77025	Fig	_	
447-8	77026-77027	5	_	
447-9	77027-77028	.	_	

#Text=Response: We have corrected this error by updating the note to reflect the current version of the figure.
448-1	77029-77037	Response	_	
448-2	77037-77038	:	_	
448-3	77039-77041	We	_	
448-4	77042-77046	have	_	
448-5	77047-77056	corrected	_	
448-6	77057-77061	this	_	
448-7	77062-77067	error	_	
448-8	77068-77070	by	_	
448-9	77071-77079	updating	_	
448-10	77080-77083	the	_	
448-11	77084-77088	note	_	
448-12	77089-77091	to	_	
448-13	77092-77099	reflect	_	
448-14	77100-77103	the	_	
448-15	77104-77111	current	_	
448-16	77112-77119	version	_	
448-17	77120-77122	of	_	
448-18	77123-77126	the	_	
448-19	77127-77133	figure	_	
448-20	77133-77134	.	_	

#Text=Note that the order of the figures has been updated based on the requested revisions and Fig 5.
449-1	77135-77139	Note	_	
449-2	77140-77144	that	_	
449-3	77145-77148	the	_	
449-4	77149-77154	order	_	
449-5	77155-77157	of	_	
449-6	77158-77161	the	_	
449-7	77162-77169	figures	_	
449-8	77170-77173	has	_	
449-9	77174-77178	been	_	
449-10	77179-77186	updated	_	
449-11	77187-77192	based	_	
449-12	77193-77195	on	_	
449-13	77196-77199	the	_	
449-14	77200-77209	requested	_	
449-15	77210-77219	revisions	_	
449-16	77220-77223	and	_	
449-17	77224-77227	Fig	_	
449-18	77228-77229	5	_	
449-19	77229-77230	.	_	

#Text=Is now Fig. 3.
#Text=10.1371/journal.pone.0224906.r003
#Text=Decision Letter 1
#Text=Pattij
#Text=Tommy
#Text=This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
#Text= 19 Feb 2020 
#Text=PONE-D-19-29169R1
#Text=Alcohol Effects on Globus Pallidus Connectivity: Role of Impulsivity and Binge Drinking
#Text=PLOS ONE
#Text=Dear Dr.
450-1	77231-77233	Is	_	
450-2	77234-77237	now	_	
450-3	77238-77241	Fig	_	
450-4	77241-77242	.	_	
450-5	77243-77244	3	_	
450-6	77244-77245	.	_	
450-7	77246-77253	10.1371	_	
450-8	77253-77254	/	_	
450-9	77254-77266	journal.pone	_	
450-10	77266-77274	.0224906	_	
450-11	77274-77275	.	_	
450-12	77275-77279	r003	_	
450-13	77280-77288	Decision	_	
450-14	77289-77295	Letter	_	
450-15	77296-77297	1	_	
450-16	77298-77304	Pattij	_	
450-17	77305-77310	Tommy	_	
450-18	77311-77315	This	_	
450-19	77316-77318	is	_	
450-20	77319-77321	an	_	
450-21	77322-77326	open	_	
450-22	77327-77333	access	_	
450-23	77334-77341	article	_	
450-24	77342-77353	distributed	_	
450-25	77354-77359	under	_	
450-26	77360-77363	the	_	
450-27	77364-77369	terms	_	
450-28	77370-77372	of	_	
450-29	77373-77376	the	_	
450-30	77377-77385	Creative	_	
450-31	77386-77393	Commons	_	
450-32	77394-77405	Attribution	_	
450-33	77406-77413	License	_	
450-34	77413-77414	,	_	
450-35	77415-77420	which	_	
450-36	77421-77428	permits	_	
450-37	77429-77441	unrestricted	_	
450-38	77442-77445	use	_	
450-39	77445-77446	,	_	
450-40	77447-77459	distribution	_	
450-41	77459-77460	,	_	
450-42	77461-77464	and	_	
450-43	77465-77477	reproduction	_	
450-44	77478-77480	in	_	
450-45	77481-77484	any	_	
450-46	77485-77491	medium	_	
450-47	77491-77492	,	_	
450-48	77493-77501	provided	_	
450-49	77502-77505	the	_	
450-50	77506-77514	original	_	
450-51	77515-77521	author	_	
450-52	77522-77525	and	_	
450-53	77526-77532	source	_	
450-54	77533-77536	are	_	
450-55	77537-77545	credited	_	
450-56	77545-77546	.	_	
450-57	77548-77550	19	_	
450-58	77551-77554	Feb	_	
450-59	77555-77559	2020	_	
450-60	77561-77567	PONE-D	_	
450-61	77567-77568	-	_	
450-62	77568-77570	19	_	
450-63	77570-77571	-	_	
450-64	77571-77578	29169R1	_	
450-65	77579-77586	Alcohol	_	
450-66	77587-77594	Effects	_	
450-67	77595-77597	on	_	
450-68	77598-77604	Globus	_	
450-69	77605-77613	Pallidus	_	
450-70	77614-77626	Connectivity	_	
450-71	77626-77627	:	_	
450-72	77627-77628	 	_	
450-73	77628-77632	Role	_	
450-74	77633-77635	of	_	
450-75	77636-77647	Impulsivity	_	
450-76	77648-77651	and	_	
450-77	77652-77657	Binge	_	
450-78	77658-77666	Drinking	_	
450-79	77667-77671	PLOS	_	
450-80	77672-77675	ONE	_	
450-81	77676-77680	Dear	_	
450-82	77681-77683	Dr	_	
450-83	77683-77684	.	_	

#Text=Momenan,
#Text=Thank you for submitting your manuscript to PLOS ONE.
451-1	77685-77692	Momenan	_	
451-2	77692-77693	,	_	
451-3	77694-77699	Thank	_	
451-4	77700-77703	you	_	
451-5	77704-77707	for	_	
451-6	77708-77718	submitting	_	
451-7	77719-77723	your	_	
451-8	77724-77734	manuscript	_	
451-9	77735-77737	to	_	
451-10	77738-77742	PLOS	_	
451-11	77743-77746	ONE	_	
451-12	77746-77747	.	_	

#Text=After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands.
452-1	77748-77753	After	_	
452-2	77754-77761	careful	_	
452-3	77762-77775	consideration	_	
452-4	77775-77776	,	_	
452-5	77777-77779	we	_	
452-6	77780-77784	feel	_	
452-7	77785-77789	that	_	
452-8	77790-77792	it	_	
452-9	77793-77796	has	_	
452-10	77797-77802	merit	_	
452-11	77803-77806	but	_	
452-12	77807-77811	does	_	
452-13	77812-77815	not	_	
452-14	77816-77821	fully	_	
452-15	77822-77826	meet	_	
452-16	77827-77831	PLOS	_	
452-17	77832-77835	ONE	_	
452-18	77835-77836	’	_	
452-19	77836-77837	s	_	
452-20	77838-77849	publication	_	
452-21	77850-77858	criteria	_	
452-22	77859-77861	as	_	
452-23	77862-77864	it	_	
452-24	77865-77874	currently	_	
452-25	77875-77881	stands	_	
452-26	77881-77882	.	_	

#Text=Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
453-1	77883-77892	Therefore	_	
453-2	77892-77893	,	_	
453-3	77894-77896	we	_	
453-4	77897-77903	invite	_	
453-5	77904-77907	you	_	
453-6	77908-77910	to	_	
453-7	77911-77917	submit	_	
453-8	77918-77919	a	_	
453-9	77920-77927	revised	_	
453-10	77928-77935	version	_	
453-11	77936-77938	of	_	
453-12	77939-77942	the	_	
453-13	77943-77953	manuscript	_	
453-14	77954-77958	that	_	
453-15	77959-77968	addresses	_	
453-16	77969-77972	the	_	
453-17	77973-77979	points	_	
453-18	77980-77986	raised	_	
453-19	77987-77993	during	_	
453-20	77994-77997	the	_	
453-21	77998-78004	review	_	
453-22	78005-78012	process	_	
453-23	78012-78013	.	_	

#Text=Both reviewers indicated that all points have been carefully addressed in the revised version. 
454-1	78014-78018	Both	_	
454-2	78019-78028	reviewers	_	
454-3	78029-78038	indicated	_	
454-4	78039-78043	that	_	
454-5	78044-78047	all	_	
454-6	78048-78054	points	_	
454-7	78055-78059	have	_	
454-8	78060-78064	been	_	
454-9	78065-78074	carefully	_	
454-10	78075-78084	addressed	_	
454-11	78085-78087	in	_	
454-12	78088-78091	the	_	
454-13	78092-78099	revised	_	
454-14	78100-78107	version	_	
454-15	78107-78108	.	_	
454-16	78108-78109	 	_	

#Text=A residual point that needs to be addressed in the discussion section is the interpretation of reduced behavioral inhibition in changed GPe pathway functioning in individuals with more drinking.
455-1	78109-78110	A	_	
455-2	78111-78119	residual	_	
455-3	78120-78125	point	_	
455-4	78126-78130	that	_	
455-5	78131-78136	needs	_	
455-6	78137-78139	to	_	
455-7	78140-78142	be	_	
455-8	78143-78152	addressed	_	
455-9	78153-78155	in	_	
455-10	78156-78159	the	_	
455-11	78160-78170	discussion	_	
455-12	78171-78178	section	_	
455-13	78179-78181	is	_	
455-14	78182-78185	the	_	
455-15	78186-78200	interpretation	_	
455-16	78201-78203	of	_	
455-17	78204-78211	reduced	_	
455-18	78212-78222	behavioral	_	
455-19	78223-78233	inhibition	_	
455-20	78234-78236	in	_	
455-21	78237-78244	changed	_	
455-22	78245-78248	GPe	_	
455-23	78249-78256	pathway	_	
455-24	78257-78268	functioning	_	
455-25	78269-78271	in	_	
455-26	78272-78283	individuals	_	
455-27	78284-78288	with	_	
455-28	78289-78293	more	_	
455-29	78294-78302	drinking	_	
455-30	78302-78303	.	_	

#Text=I agree with reviewer 2, that without the support of behavioral data in the current data set, this interpretation indeed should be toned down.
456-1	78304-78305	I	_	
456-2	78306-78311	agree	_	
456-3	78312-78316	with	_	
456-4	78317-78325	reviewer	_	
456-5	78326-78327	2	_	
456-6	78327-78328	,	_	
456-7	78329-78333	that	_	
456-8	78334-78341	without	_	
456-9	78342-78345	the	_	
456-10	78346-78353	support	_	
456-11	78354-78356	of	_	
456-12	78357-78367	behavioral	_	
456-13	78368-78372	data	_	
456-14	78373-78375	in	_	
456-15	78376-78379	the	_	
456-16	78380-78387	current	_	
456-17	78388-78392	data	_	
456-18	78393-78396	set	_	
456-19	78396-78397	,	_	
456-20	78398-78402	this	_	
456-21	78403-78417	interpretation	_	
456-22	78418-78424	indeed	_	
456-23	78425-78431	should	_	
456-24	78432-78434	be	_	
456-25	78435-78440	toned	_	
456-26	78441-78445	down	_	
456-27	78445-78446	.	_	

#Text=We would appreciate receiving your revised manuscript by Apr 04 2020 11:59PM.
457-1	78447-78449	We	_	
457-2	78450-78455	would	_	
457-3	78456-78466	appreciate	_	
457-4	78467-78476	receiving	_	
457-5	78477-78481	your	_	
457-6	78482-78489	revised	_	
457-7	78490-78500	manuscript	_	
457-8	78501-78503	by	_	
457-9	78504-78507	Apr	_	
457-10	78508-78510	04	_	
457-11	78511-78515	2020	_	
457-12	78516-78518	11	_	
457-13	78518-78519	:	_	
457-14	78519-78523	59PM	_	
457-15	78523-78524	.	_	

#Text=When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
458-1	78525-78529	When	_	
458-2	78530-78533	you	_	
458-3	78534-78537	are	_	
458-4	78538-78543	ready	_	
458-5	78544-78546	to	_	
458-6	78547-78553	submit	_	
458-7	78554-78558	your	_	
458-8	78559-78567	revision	_	
458-9	78567-78568	,	_	
458-10	78569-78572	log	_	
458-11	78573-78575	on	_	
458-12	78576-78578	to	_	
458-13	78579-78584	https	_	
458-14	78584-78585	:	_	
458-15	78585-78586	/	_	
458-16	78586-78587	/	_	
458-17	78587-78611	www.editorialmanager.com	_	
458-18	78611-78612	/	_	
458-19	78612-78616	pone	_	
458-20	78616-78617	/	_	
458-21	78618-78621	and	_	
458-22	78622-78628	select	_	
458-23	78629-78632	the	_	
458-24	78633-78634	'	_	
458-25	78634-78645	Submissions	_	
458-26	78646-78653	Needing	_	
458-27	78654-78662	Revision	_	
458-28	78662-78663	'	_	
458-29	78664-78670	folder	_	
458-30	78671-78673	to	_	
458-31	78674-78680	locate	_	
458-32	78681-78685	your	_	
458-33	78686-78696	manuscript	_	
458-34	78697-78701	file	_	
458-35	78701-78702	.	_	

#Text=If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.
459-1	78703-78705	If	_	
459-2	78706-78709	you	_	
459-3	78710-78715	would	_	
459-4	78716-78720	like	_	
459-5	78721-78723	to	_	
459-6	78724-78728	make	_	
459-7	78729-78736	changes	_	
459-8	78737-78739	to	_	
459-9	78740-78744	your	_	
459-10	78745-78754	financial	_	
459-11	78755-78765	disclosure	_	
459-12	78765-78766	,	_	
459-13	78767-78773	please	_	
459-14	78774-78781	include	_	
459-15	78782-78786	your	_	
459-16	78787-78794	updated	_	
459-17	78795-78804	statement	_	
459-18	78805-78807	in	_	
459-19	78808-78812	your	_	
459-20	78813-78818	cover	_	
459-21	78819-78825	letter	_	
459-22	78825-78826	.	_	

#Text=To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future.
460-1	78827-78829	To	_	
460-2	78830-78837	enhance	_	
460-3	78838-78841	the	_	
460-4	78842-78857	reproducibility	_	
460-5	78858-78860	of	_	
460-6	78861-78865	your	_	
460-7	78866-78873	results	_	
460-8	78873-78874	,	_	
460-9	78875-78877	we	_	
460-10	78878-78887	recommend	_	
460-11	78888-78892	that	_	
460-12	78893-78895	if	_	
460-13	78896-78906	applicable	_	
460-14	78907-78910	you	_	
460-15	78911-78918	deposit	_	
460-16	78919-78923	your	_	
460-17	78924-78934	laboratory	_	
460-18	78935-78944	protocols	_	
460-19	78945-78947	in	_	
460-20	78948-78960	protocols.io	_	
460-21	78960-78961	,	_	
460-22	78962-78967	where	_	
460-23	78968-78969	a	_	
460-24	78970-78978	protocol	_	
460-25	78979-78982	can	_	
460-26	78983-78985	be	_	
460-27	78986-78994	assigned	_	
460-28	78995-78998	its	_	
460-29	78999-79002	own	_	
460-30	79003-79013	identifier	_	
460-31	79014-79015	(	_	
460-32	79015-79018	DOI	_	
460-33	79018-79019	)	_	
460-34	79020-79024	such	_	
460-35	79025-79029	that	_	
460-36	79030-79032	it	_	
460-37	79033-79036	can	_	
460-38	79037-79039	be	_	
460-39	79040-79045	cited	_	
460-40	79046-79059	independently	_	
460-41	79060-79062	in	_	
460-42	79063-79066	the	_	
460-43	79067-79073	future	_	
460-44	79073-79074	.	_	

#Text=For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols
#Text=Please include the following items when submitting your revised manuscript:
#Text=A rebuttal letter that responds to each point raised by the academic editor and reviewer(s).
461-1	79075-79078	For	_	
461-2	79079-79091	instructions	_	
461-3	79092-79095	see	_	
461-4	79095-79096	:	_	
461-5	79097-79101	http	_	
461-6	79101-79102	:	_	
461-7	79102-79103	/	_	
461-8	79103-79104	/	_	
461-9	79104-79121	journals.plos.org	_	
461-10	79121-79122	/	_	
461-11	79122-79129	plosone	_	
461-12	79129-79130	/	_	
461-13	79130-79131	s	_	
461-14	79131-79132	/	_	
461-15	79132-79153	submission-guidelines	_	
461-16	79153-79154	#	_	
461-17	79154-79178	loc-laboratory-protocols	_	
461-18	79179-79185	Please	_	
461-19	79186-79193	include	_	
461-20	79194-79197	the	_	
461-21	79198-79207	following	_	
461-22	79208-79213	items	_	
461-23	79214-79218	when	_	
461-24	79219-79229	submitting	_	
461-25	79230-79234	your	_	
461-26	79235-79242	revised	_	
461-27	79243-79253	manuscript	_	
461-28	79253-79254	:	_	
461-29	79255-79256	A	_	
461-30	79257-79265	rebuttal	_	
461-31	79266-79272	letter	_	
461-32	79273-79277	that	_	
461-33	79278-79286	responds	_	
461-34	79287-79289	to	_	
461-35	79290-79294	each	_	
461-36	79295-79300	point	_	
461-37	79301-79307	raised	_	
461-38	79308-79310	by	_	
461-39	79311-79314	the	_	
461-40	79315-79323	academic	_	
461-41	79324-79330	editor	_	
461-42	79331-79334	and	_	
461-43	79335-79343	reviewer	_	
461-44	79343-79344	(	_	
461-45	79344-79345	s	_	
461-46	79345-79346	)	_	
461-47	79346-79347	.	_	

#Text=This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
462-1	79348-79352	This	_	
462-2	79353-79359	letter	_	
462-3	79360-79366	should	_	
462-4	79367-79369	be	_	
462-5	79370-79378	uploaded	_	
462-6	79379-79381	as	_	
462-7	79382-79390	separate	_	
462-8	79391-79395	file	_	
462-9	79396-79399	and	_	
462-10	79400-79407	labeled	_	
462-11	79408-79409	'	_	
462-12	79409-79417	Response	_	
462-13	79418-79420	to	_	
462-14	79421-79430	Reviewers	_	
462-15	79430-79431	'	_	
462-16	79431-79432	.	_	

#Text=A marked-up copy of your manuscript that highlights changes made to the original version.
463-1	79433-79434	A	_	
463-2	79435-79444	marked-up	_	
463-3	79445-79449	copy	_	
463-4	79450-79452	of	_	
463-5	79453-79457	your	_	
463-6	79458-79468	manuscript	_	
463-7	79469-79473	that	_	
463-8	79474-79484	highlights	_	
463-9	79485-79492	changes	_	
463-10	79493-79497	made	_	
463-11	79498-79500	to	_	
463-12	79501-79504	the	_	
463-13	79505-79513	original	_	
463-14	79514-79521	version	_	
463-15	79521-79522	.	_	

#Text=This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
464-1	79523-79527	This	_	
464-2	79528-79532	file	_	
464-3	79533-79539	should	_	
464-4	79540-79542	be	_	
464-5	79543-79551	uploaded	_	
464-6	79552-79554	as	_	
464-7	79555-79563	separate	_	
464-8	79564-79568	file	_	
464-9	79569-79572	and	_	
464-10	79573-79580	labeled	_	
464-11	79581-79582	'	_	
464-12	79582-79589	Revised	_	
464-13	79590-79600	Manuscript	_	
464-14	79601-79605	with	_	
464-15	79606-79611	Track	_	
464-16	79612-79619	Changes	_	
464-17	79619-79620	'	_	
464-18	79620-79621	.	_	

#Text=An unmarked version of your revised paper without tracked changes.
465-1	79622-79624	An	_	
465-2	79625-79633	unmarked	_	
465-3	79634-79641	version	_	
465-4	79642-79644	of	_	
465-5	79645-79649	your	_	
465-6	79650-79657	revised	_	
465-7	79658-79663	paper	_	
465-8	79664-79671	without	_	
465-9	79672-79679	tracked	_	
465-10	79680-79687	changes	_	
465-11	79687-79688	.	_	

#Text=This file should be uploaded as separate file and labeled 'Manuscript'.
466-1	79689-79693	This	_	
466-2	79694-79698	file	_	
466-3	79699-79705	should	_	
466-4	79706-79708	be	_	
466-5	79709-79717	uploaded	_	
466-6	79718-79720	as	_	
466-7	79721-79729	separate	_	
466-8	79730-79734	file	_	
466-9	79735-79738	and	_	
466-10	79739-79746	labeled	_	
466-11	79747-79748	'	_	
466-12	79748-79758	Manuscript	_	
466-13	79758-79759	'	_	
466-14	79759-79760	.	_	

#Text=Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available.
467-1	79761-79767	Please	_	
467-2	79768-79772	note	_	
467-3	79773-79778	while	_	
467-4	79779-79786	forming	_	
467-5	79787-79791	your	_	
467-6	79792-79800	response	_	
467-7	79800-79801	,	_	
467-8	79802-79804	if	_	
467-9	79805-79809	your	_	
467-10	79810-79817	article	_	
467-11	79818-79820	is	_	
467-12	79821-79829	accepted	_	
467-13	79829-79830	,	_	
467-14	79831-79834	you	_	
467-15	79835-79838	may	_	
467-16	79839-79843	have	_	
467-17	79844-79847	the	_	
467-18	79848-79859	opportunity	_	
467-19	79860-79862	to	_	
467-20	79863-79867	make	_	
467-21	79868-79871	the	_	
467-22	79872-79876	peer	_	
467-23	79877-79883	review	_	
467-24	79884-79891	history	_	
467-25	79892-79900	publicly	_	
467-26	79901-79910	available	_	
467-27	79910-79911	.	_	

#Text=The record will include editor decision letters (with reviews) and your responses to reviewer comments.
468-1	79912-79915	The	_	
468-2	79916-79922	record	_	
468-3	79923-79927	will	_	
468-4	79928-79935	include	_	
468-5	79936-79942	editor	_	
468-6	79943-79951	decision	_	
468-7	79952-79959	letters	_	
468-8	79960-79961	(	_	
468-9	79961-79965	with	_	
468-10	79966-79973	reviews	_	
468-11	79973-79974	)	_	
468-12	79975-79978	and	_	
468-13	79979-79983	your	_	
468-14	79984-79993	responses	_	
468-15	79994-79996	to	_	
468-16	79997-80005	reviewer	_	
468-17	80006-80014	comments	_	
468-18	80014-80015	.	_	

#Text=If eligible, we will contact you to opt in or out.
469-1	80016-80018	If	_	
469-2	80019-80027	eligible	_	
469-3	80027-80028	,	_	
469-4	80029-80031	we	_	
469-5	80032-80036	will	_	
469-6	80037-80044	contact	_	
469-7	80045-80048	you	_	
469-8	80049-80051	to	_	
469-9	80052-80055	opt	_	
469-10	80056-80058	in	_	
469-11	80059-80061	or	_	
469-12	80062-80065	out	_	
469-13	80065-80066	.	_	

#Text=We look forward to receiving your revised manuscript.
470-1	80067-80069	We	_	
470-2	80070-80074	look	_	
470-3	80075-80082	forward	_	
470-4	80083-80085	to	_	
470-5	80086-80095	receiving	_	
470-6	80096-80100	your	_	
470-7	80101-80108	revised	_	
470-8	80109-80119	manuscript	_	
470-9	80119-80120	.	_	

#Text=Kind regards,
#Text=Tommy Pattij, Ph.D.
471-1	80121-80125	Kind	_	
471-2	80126-80133	regards	_	
471-3	80133-80134	,	_	
471-4	80135-80140	Tommy	_	
471-5	80141-80147	Pattij	_	
471-6	80147-80148	,	_	
471-7	80149-80153	Ph.D	_	
471-8	80153-80154	.	_	

#Text=Academic Editor
#Text=PLOS ONE
#Text=[Note: HTML markup is below.
472-1	80155-80163	Academic	_	
472-2	80164-80170	Editor	_	
472-3	80171-80175	PLOS	_	
472-4	80176-80179	ONE	_	
472-5	80180-80181	[	_	
472-6	80181-80185	Note	_	
472-7	80185-80186	:	_	
472-8	80187-80191	HTML	_	
472-9	80192-80198	markup	_	
472-10	80199-80201	is	_	
472-11	80202-80207	below	_	
472-12	80207-80208	.	_	

#Text=Please do not edit.]
473-1	80209-80215	Please	_	
473-2	80216-80218	do	_	
473-3	80219-80222	not	_	
473-4	80223-80227	edit	_	
473-5	80227-80228	.	_	
473-6	80228-80229	]	_	

#Text=Reviewers' comments:
#Text=Reviewer's Responses to Questions
#Text=Comments to the Author
#Text=1.
474-1	80230-80239	Reviewers	_	
474-2	80239-80240	'	_	
474-3	80241-80249	comments	_	
474-4	80249-80250	:	_	
474-5	80251-80261	Reviewer's	_	
474-6	80262-80271	Responses	_	
474-7	80272-80274	to	_	
474-8	80275-80284	Questions	_	
474-9	80285-80293	Comments	_	
474-10	80294-80296	to	_	
474-11	80297-80300	the	_	
474-12	80301-80307	Author	_	
474-13	80308-80309	1	_	
474-14	80309-80310	.	_	

#Text=If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.
475-1	80311-80313	If	_	
475-2	80314-80317	the	_	
475-3	80318-80325	authors	_	
475-4	80326-80330	have	_	
475-5	80331-80341	adequately	_	
475-6	80342-80351	addressed	_	
475-7	80352-80356	your	_	
475-8	80357-80365	comments	_	
475-9	80366-80372	raised	_	
475-10	80373-80375	in	_	
475-11	80376-80377	a	_	
475-12	80378-80386	previous	_	
475-13	80387-80392	round	_	
475-14	80393-80395	of	_	
475-15	80396-80402	review	_	
475-16	80403-80406	and	_	
475-17	80407-80410	you	_	
475-18	80411-80415	feel	_	
475-19	80416-80420	that	_	
475-20	80421-80425	this	_	
475-21	80426-80436	manuscript	_	
475-22	80437-80439	is	_	
475-23	80440-80443	now	_	
475-24	80444-80454	acceptable	_	
475-25	80455-80458	for	_	
475-26	80459-80470	publication	_	
475-27	80470-80471	,	_	
475-28	80472-80475	you	_	
475-29	80476-80479	may	_	
475-30	80480-80488	indicate	_	
475-31	80489-80493	that	_	
475-32	80494-80498	here	_	
475-33	80499-80501	to	_	
475-34	80502-80508	bypass	_	
475-35	80509-80512	the	_	
475-36	80513-80514	“	_	
475-37	80514-80522	Comments	_	
475-38	80523-80525	to	_	
475-39	80526-80529	the	_	
475-40	80530-80536	Author	_	
475-41	80536-80537	”	_	
475-42	80538-80545	section	_	
475-43	80545-80546	,	_	
475-44	80547-80552	enter	_	
475-45	80553-80557	your	_	
475-46	80558-80566	conflict	_	
475-47	80567-80569	of	_	
475-48	80570-80578	interest	_	
475-49	80579-80588	statement	_	
475-50	80589-80591	in	_	
475-51	80592-80595	the	_	
475-52	80596-80597	“	_	
475-53	80597-80609	Confidential	_	
475-54	80610-80612	to	_	
475-55	80613-80619	Editor	_	
475-56	80619-80620	”	_	
475-57	80621-80628	section	_	
475-58	80628-80629	,	_	
475-59	80630-80633	and	_	
475-60	80634-80640	submit	_	
475-61	80641-80645	your	_	
475-62	80646-80647	"	_	
475-63	80647-80653	Accept	_	
475-64	80653-80654	"	_	
475-65	80655-80669	recommendation	_	
475-66	80669-80670	.	_	

#Text=Reviewer #1: All comments have been addressed
#Text=Reviewer #2: All comments have been addressed
#Text=**********
#Text=2.
476-1	80671-80679	Reviewer	_	
476-2	80680-80682	#1	_	
476-3	80682-80683	:	_	
476-4	80684-80687	All	_	
476-5	80688-80696	comments	_	
476-6	80697-80701	have	_	
476-7	80702-80706	been	_	
476-8	80707-80716	addressed	_	
476-9	80717-80725	Reviewer	_	
476-10	80726-80728	#2	_	
476-11	80728-80729	:	_	
476-12	80730-80733	All	_	
476-13	80734-80742	comments	_	
476-14	80743-80747	have	_	
476-15	80748-80752	been	_	
476-16	80753-80762	addressed	_	
476-17	80763-80764	*	_	
476-18	80764-80765	*	_	
476-19	80765-80766	*	_	
476-20	80766-80767	*	_	
476-21	80767-80768	*	_	
476-22	80768-80769	*	_	
476-23	80769-80770	*	_	
476-24	80770-80771	*	_	
476-25	80771-80772	*	_	
476-26	80772-80773	*	_	
476-27	80774-80775	2	_	
476-28	80775-80776	.	_	

#Text=Is the manuscript technically sound, and do the data support the conclusions?
477-1	80777-80779	Is	_	
477-2	80780-80783	the	_	
477-3	80784-80794	manuscript	_	
477-4	80795-80806	technically	_	
477-5	80807-80812	sound	_	
477-6	80812-80813	,	_	
477-7	80814-80817	and	_	
477-8	80818-80820	do	_	
477-9	80821-80824	the	_	
477-10	80825-80829	data	_	
477-11	80830-80837	support	_	
477-12	80838-80841	the	_	
477-13	80842-80853	conclusions	_	
477-14	80853-80854	?	_	

#Text=The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions.
478-1	80855-80858	The	_	
478-2	80859-80869	manuscript	_	
478-3	80870-80874	must	_	
478-4	80875-80883	describe	_	
478-5	80884-80885	a	_	
478-6	80886-80897	technically	_	
478-7	80898-80903	sound	_	
478-8	80904-80909	piece	_	
478-9	80910-80912	of	_	
478-10	80913-80923	scientific	_	
478-11	80924-80932	research	_	
478-12	80933-80937	with	_	
478-13	80938-80942	data	_	
478-14	80943-80947	that	_	
478-15	80948-80956	supports	_	
478-16	80957-80960	the	_	
478-17	80961-80972	conclusions	_	
478-18	80972-80973	.	_	

#Text=Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes.
479-1	80974-80985	Experiments	_	
479-2	80986-80990	must	_	
479-3	80991-80995	have	_	
479-4	80996-81000	been	_	
479-5	81001-81010	conducted	_	
479-6	81011-81021	rigorously	_	
479-7	81021-81022	,	_	
479-8	81023-81027	with	_	
479-9	81028-81039	appropriate	_	
479-10	81040-81048	controls	_	
479-11	81048-81049	,	_	
479-12	81050-81061	replication	_	
479-13	81061-81062	,	_	
479-14	81063-81066	and	_	
479-15	81067-81073	sample	_	
479-16	81074-81079	sizes	_	
479-17	81079-81080	.	_	

#Text=The conclusions must be drawn appropriately based on the data presented.
480-1	81081-81084	The	_	
480-2	81085-81096	conclusions	_	
480-3	81097-81101	must	_	
480-4	81102-81104	be	_	
480-5	81105-81110	drawn	_	
480-6	81111-81124	appropriately	_	
480-7	81125-81130	based	_	
480-8	81131-81133	on	_	
480-9	81134-81137	the	_	
480-10	81138-81142	data	_	
480-11	81143-81152	presented	_	
480-12	81152-81153	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: Yes
#Text=**********
#Text=3.
481-1	81155-81163	Reviewer	_	
481-2	81164-81166	#1	_	
481-3	81166-81167	:	_	
481-4	81168-81171	Yes	_	
481-5	81172-81180	Reviewer	_	
481-6	81181-81183	#2	_	
481-7	81183-81184	:	_	
481-8	81185-81188	Yes	_	
481-9	81189-81190	*	_	
481-10	81190-81191	*	_	
481-11	81191-81192	*	_	
481-12	81192-81193	*	_	
481-13	81193-81194	*	_	
481-14	81194-81195	*	_	
481-15	81195-81196	*	_	
481-16	81196-81197	*	_	
481-17	81197-81198	*	_	
481-18	81198-81199	*	_	
481-19	81200-81201	3	_	
481-20	81201-81202	.	_	

#Text=Has the statistical analysis been performed appropriately and rigorously?
482-1	81203-81206	Has	_	
482-2	81207-81210	the	_	
482-3	81211-81222	statistical	_	
482-4	81223-81231	analysis	_	
482-5	81232-81236	been	_	
482-6	81237-81246	performed	_	
482-7	81247-81260	appropriately	_	
482-8	81261-81264	and	_	
482-9	81265-81275	rigorously	_	
482-10	81275-81276	?	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: Yes
#Text=**********
#Text=4.
483-1	81278-81286	Reviewer	_	
483-2	81287-81289	#1	_	
483-3	81289-81290	:	_	
483-4	81291-81294	Yes	_	
483-5	81295-81303	Reviewer	_	
483-6	81304-81306	#2	_	
483-7	81306-81307	:	_	
483-8	81308-81311	Yes	_	
483-9	81312-81313	*	_	
483-10	81313-81314	*	_	
483-11	81314-81315	*	_	
483-12	81315-81316	*	_	
483-13	81316-81317	*	_	
483-14	81317-81318	*	_	
483-15	81318-81319	*	_	
483-16	81319-81320	*	_	
483-17	81320-81321	*	_	
483-18	81321-81322	*	_	
483-19	81323-81324	4	_	
483-20	81324-81325	.	_	

#Text=Have the authors made all data underlying the findings in their manuscript fully available?
484-1	81326-81330	Have	_	
484-2	81331-81334	the	_	
484-3	81335-81342	authors	_	
484-4	81343-81347	made	_	
484-5	81348-81351	all	_	
484-6	81352-81356	data	_	
484-7	81357-81367	underlying	_	
484-8	81368-81371	the	_	
484-9	81372-81380	findings	_	
484-10	81381-81383	in	_	
484-11	81384-81389	their	_	
484-12	81390-81400	manuscript	_	
484-13	81401-81406	fully	_	
484-14	81407-81416	available	_	
484-15	81416-81417	?	_	

#Text=The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file).
485-1	81418-81421	The	_	
485-2	81422-81426	PLOS	_	
485-3	81427-81431	Data	_	
485-4	81432-81438	policy	_	
485-5	81439-81447	requires	_	
485-6	81448-81455	authors	_	
485-7	81456-81458	to	_	
485-8	81459-81463	make	_	
485-9	81464-81467	all	_	
485-10	81468-81472	data	_	
485-11	81473-81483	underlying	_	
485-12	81484-81487	the	_	
485-13	81488-81496	findings	_	
485-14	81497-81506	described	_	
485-15	81507-81509	in	_	
485-16	81510-81515	their	_	
485-17	81516-81526	manuscript	_	
485-18	81527-81532	fully	_	
485-19	81533-81542	available	_	
485-20	81543-81550	without	_	
485-21	81551-81562	restriction	_	
485-22	81562-81563	,	_	
485-23	81564-81568	with	_	
485-24	81569-81573	rare	_	
485-25	81574-81583	exception	_	
485-26	81584-81585	(	_	
485-27	81585-81591	please	_	
485-28	81592-81597	refer	_	
485-29	81598-81600	to	_	
485-30	81601-81604	the	_	
485-31	81605-81609	Data	_	
485-32	81610-81622	Availability	_	
485-33	81623-81632	Statement	_	
485-34	81633-81635	in	_	
485-35	81636-81639	the	_	
485-36	81640-81650	manuscript	_	
485-37	81651-81654	PDF	_	
485-38	81655-81659	file	_	
485-39	81659-81660	)	_	
485-40	81660-81661	.	_	

#Text=The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository.
486-1	81662-81665	The	_	
486-2	81666-81670	data	_	
486-3	81671-81677	should	_	
486-4	81678-81680	be	_	
486-5	81681-81689	provided	_	
486-6	81690-81692	as	_	
486-7	81693-81697	part	_	
486-8	81698-81700	of	_	
486-9	81701-81704	the	_	
486-10	81705-81715	manuscript	_	
486-11	81716-81718	or	_	
486-12	81719-81722	its	_	
486-13	81723-81733	supporting	_	
486-14	81734-81745	information	_	
486-15	81745-81746	,	_	
486-16	81747-81749	or	_	
486-17	81750-81759	deposited	_	
486-18	81760-81762	to	_	
486-19	81763-81764	a	_	
486-20	81765-81771	public	_	
486-21	81772-81782	repository	_	
486-22	81782-81783	.	_	

#Text=For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available.
487-1	81784-81787	For	_	
487-2	81788-81795	example	_	
487-3	81795-81796	,	_	
487-4	81797-81799	in	_	
487-5	81800-81808	addition	_	
487-6	81809-81811	to	_	
487-7	81812-81819	summary	_	
487-8	81820-81830	statistics	_	
487-9	81830-81831	,	_	
487-10	81832-81835	the	_	
487-11	81836-81840	data	_	
487-12	81841-81847	points	_	
487-13	81848-81854	behind	_	
487-14	81855-81860	means	_	
487-15	81860-81861	,	_	
487-16	81862-81869	medians	_	
487-17	81870-81873	and	_	
487-18	81874-81882	variance	_	
487-19	81883-81891	measures	_	
487-20	81892-81898	should	_	
487-21	81899-81901	be	_	
487-22	81902-81911	available	_	
487-23	81911-81912	.	_	

#Text=If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.
488-1	81913-81915	If	_	
488-2	81916-81921	there	_	
488-3	81922-81925	are	_	
488-4	81926-81938	restrictions	_	
488-5	81939-81941	on	_	
488-6	81942-81950	publicly	_	
488-7	81951-81958	sharing	_	
488-8	81959-81967	data—e.g	_	
488-9	81967-81968	.	_	
488-10	81969-81980	participant	_	
488-11	81981-81988	privacy	_	
488-12	81989-81991	or	_	
488-13	81992-81995	use	_	
488-14	81996-81998	of	_	
488-15	81999-82003	data	_	
488-16	82004-82008	from	_	
488-17	82009-82010	a	_	
488-18	82011-82016	third	_	
488-19	82017-82028	party—those	_	
488-20	82029-82033	must	_	
488-21	82034-82036	be	_	
488-22	82037-82046	specified	_	
488-23	82046-82047	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: No
#Text=**********
#Text=5.
489-1	82048-82056	Reviewer	_	
489-2	82057-82059	#1	_	
489-3	82059-82060	:	_	
489-4	82061-82064	Yes	_	
489-5	82065-82073	Reviewer	_	
489-6	82074-82076	#2	_	
489-7	82076-82077	:	_	
489-8	82078-82080	No	_	
489-9	82081-82082	*	_	
489-10	82082-82083	*	_	
489-11	82083-82084	*	_	
489-12	82084-82085	*	_	
489-13	82085-82086	*	_	
489-14	82086-82087	*	_	
489-15	82087-82088	*	_	
489-16	82088-82089	*	_	
489-17	82089-82090	*	_	
489-18	82090-82091	*	_	
489-19	82092-82093	5	_	
489-20	82093-82094	.	_	

#Text=Is the manuscript presented in an intelligible fashion and written in standard English?
490-1	82095-82097	Is	_	
490-2	82098-82101	the	_	
490-3	82102-82112	manuscript	_	
490-4	82113-82122	presented	_	
490-5	82123-82125	in	_	
490-6	82126-82128	an	_	
490-7	82129-82141	intelligible	_	
490-8	82142-82149	fashion	_	
490-9	82150-82153	and	_	
490-10	82154-82161	written	_	
490-11	82162-82164	in	_	
490-12	82165-82173	standard	_	
490-13	82174-82181	English	_	
490-14	82181-82182	?	_	

#Text=PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous.
491-1	82183-82187	PLOS	_	
491-2	82188-82191	ONE	_	
491-3	82192-82196	does	_	
491-4	82197-82200	not	_	
491-5	82201-82209	copyedit	_	
491-6	82210-82218	accepted	_	
491-7	82219-82230	manuscripts	_	
491-8	82230-82231	,	_	
491-9	82232-82234	so	_	
491-10	82235-82238	the	_	
491-11	82239-82247	language	_	
491-12	82248-82250	in	_	
491-13	82251-82260	submitted	_	
491-14	82261-82269	articles	_	
491-15	82270-82274	must	_	
491-16	82275-82277	be	_	
491-17	82278-82283	clear	_	
491-18	82283-82284	,	_	
491-19	82285-82292	correct	_	
491-20	82292-82293	,	_	
491-21	82294-82297	and	_	
491-22	82298-82309	unambiguous	_	
491-23	82309-82310	.	_	

#Text=Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
492-1	82311-82314	Any	_	
492-2	82315-82328	typographical	_	
492-3	82329-82331	or	_	
492-4	82332-82343	grammatical	_	
492-5	82344-82350	errors	_	
492-6	82351-82357	should	_	
492-7	82358-82360	be	_	
492-8	82361-82370	corrected	_	
492-9	82371-82373	at	_	
492-10	82374-82382	revision	_	
492-11	82382-82383	,	_	
492-12	82384-82386	so	_	
492-13	82387-82393	please	_	
492-14	82394-82398	note	_	
492-15	82399-82402	any	_	
492-16	82403-82411	specific	_	
492-17	82412-82418	errors	_	
492-18	82419-82423	here	_	
492-19	82423-82424	.	_	

#Text=Reviewer #1: Yes
#Text=Reviewer #2: Yes
#Text=**********
#Text=6.
493-1	82425-82433	Reviewer	_	
493-2	82434-82436	#1	_	
493-3	82436-82437	:	_	
493-4	82438-82441	Yes	_	
493-5	82442-82450	Reviewer	_	
493-6	82451-82453	#2	_	
493-7	82453-82454	:	_	
493-8	82455-82458	Yes	_	
493-9	82459-82460	*	_	
493-10	82460-82461	*	_	
493-11	82461-82462	*	_	
493-12	82462-82463	*	_	
493-13	82463-82464	*	_	
493-14	82464-82465	*	_	
493-15	82465-82466	*	_	
493-16	82466-82467	*	_	
493-17	82467-82468	*	_	
493-18	82468-82469	*	_	
493-19	82470-82471	6	_	
493-20	82471-82472	.	_	

#Text=Review Comments to the Author
#Text=Please use the space provided to explain your answers to the questions above.
494-1	82473-82479	Review	_	
494-2	82480-82488	Comments	_	
494-3	82489-82491	to	_	
494-4	82492-82495	the	_	
494-5	82496-82502	Author	_	
494-6	82503-82509	Please	_	
494-7	82510-82513	use	_	
494-8	82514-82517	the	_	
494-9	82518-82523	space	_	
494-10	82524-82532	provided	_	
494-11	82533-82535	to	_	
494-12	82536-82543	explain	_	
494-13	82544-82548	your	_	
494-14	82549-82556	answers	_	
494-15	82557-82559	to	_	
494-16	82560-82563	the	_	
494-17	82564-82573	questions	_	
494-18	82574-82579	above	_	
494-19	82579-82580	.	_	

#Text=You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics.
495-1	82581-82584	You	_	
495-2	82585-82588	may	_	
495-3	82589-82593	also	_	
495-4	82594-82601	include	_	
495-5	82602-82612	additional	_	
495-6	82613-82621	comments	_	
495-7	82622-82625	for	_	
495-8	82626-82629	the	_	
495-9	82630-82636	author	_	
495-10	82636-82637	,	_	
495-11	82638-82647	including	_	
495-12	82648-82656	concerns	_	
495-13	82657-82662	about	_	
495-14	82663-82667	dual	_	
495-15	82668-82679	publication	_	
495-16	82679-82680	,	_	
495-17	82681-82689	research	_	
495-18	82690-82696	ethics	_	
495-19	82696-82697	,	_	
495-20	82698-82700	or	_	
495-21	82701-82712	publication	_	
495-22	82713-82719	ethics	_	
495-23	82719-82720	.	_	

#Text=(Please upload your review as an attachment if it exceeds 20,000 characters)
#Text=Reviewer #1: The authors did a good job in addressing most of my concerns.
496-1	82721-82722	(	_	
496-2	82722-82728	Please	_	
496-3	82729-82735	upload	_	
496-4	82736-82740	your	_	
496-5	82741-82747	review	_	
496-6	82748-82750	as	_	
496-7	82751-82753	an	_	
496-8	82754-82764	attachment	_	
496-9	82765-82767	if	_	
496-10	82768-82770	it	_	
496-11	82771-82778	exceeds	_	
496-12	82779-82785	20,000	_	
496-13	82786-82796	characters	_	
496-14	82796-82797	)	_	
496-15	82798-82806	Reviewer	_	
496-16	82807-82809	#1	_	
496-17	82809-82810	:	_	
496-18	82811-82814	The	_	
496-19	82815-82822	authors	_	
496-20	82823-82826	did	_	
496-21	82827-82828	a	_	
496-22	82829-82833	good	_	
496-23	82834-82837	job	_	
496-24	82838-82840	in	_	
496-25	82841-82851	addressing	_	
496-26	82852-82856	most	_	
496-27	82857-82859	of	_	
496-28	82860-82862	my	_	
496-29	82863-82871	concerns	_	
496-30	82871-82872	.	_	

#Text=Without behavioral measurements, the data of this study are not supporting the discussion that changes in GPe pathways in individuals with more drinking are associated with reduced behavioral inhibition.
497-1	82873-82880	Without	_	
497-2	82881-82891	behavioral	_	
497-3	82892-82904	measurements	_	
497-4	82904-82905	,	_	
497-5	82906-82909	the	_	
497-6	82910-82914	data	_	
497-7	82915-82917	of	_	
497-8	82918-82922	this	_	
497-9	82923-82928	study	_	
497-10	82929-82932	are	_	
497-11	82933-82936	not	_	
497-12	82937-82947	supporting	_	
497-13	82948-82951	the	_	
497-14	82952-82962	discussion	_	
497-15	82963-82967	that	_	
497-16	82968-82975	changes	_	
497-17	82976-82978	in	_	
497-18	82979-82982	GPe	_	
497-19	82983-82991	pathways	_	
497-20	82992-82994	in	_	
497-21	82995-83006	individuals	_	
497-22	83007-83011	with	_	
497-23	83012-83016	more	_	
497-24	83017-83025	drinking	_	
497-25	83026-83029	are	_	
497-26	83030-83040	associated	_	
497-27	83041-83045	with	_	
497-28	83046-83053	reduced	_	
497-29	83054-83064	behavioral	_	
497-30	83065-83075	inhibition	_	
497-31	83075-83076	.	_	

#Text=The response of the authors that they were testing alcohol-related changes in GPe pathways in a human model should have enabled them to apply a response inhibition task, if that was one of the main hypothesis of the study.
498-1	83077-83080	The	_	
498-2	83081-83089	response	_	
498-3	83090-83092	of	_	
498-4	83093-83096	the	_	
498-5	83097-83104	authors	_	
498-6	83105-83109	that	_	
498-7	83110-83114	they	_	
498-8	83115-83119	were	_	
498-9	83120-83127	testing	_	
498-10	83128-83143	alcohol-related	_	
498-11	83144-83151	changes	_	
498-12	83152-83154	in	_	
498-13	83155-83158	GPe	_	
498-14	83159-83167	pathways	_	
498-15	83168-83170	in	_	
498-16	83171-83172	a	_	
498-17	83173-83178	human	_	
498-18	83179-83184	model	_	
498-19	83185-83191	should	_	
498-20	83192-83196	have	_	
498-21	83197-83204	enabled	_	
498-22	83205-83209	them	_	
498-23	83210-83212	to	_	
498-24	83213-83218	apply	_	
498-25	83219-83220	a	_	
498-26	83221-83229	response	_	
498-27	83230-83240	inhibition	_	
498-28	83241-83245	task	_	
498-29	83245-83246	,	_	
498-30	83247-83249	if	_	
498-31	83250-83254	that	_	
498-32	83255-83258	was	_	
498-33	83259-83262	one	_	
498-34	83263-83265	of	_	
498-35	83266-83269	the	_	
498-36	83270-83274	main	_	
498-37	83275-83285	hypothesis	_	
498-38	83286-83288	of	_	
498-39	83289-83292	the	_	
498-40	83293-83298	study	_	
498-41	83298-83299	.	_	

#Text=This part of the discussion needs to be toned down or clearly noted as a limitation of the study.
499-1	83300-83304	This	_	
499-2	83305-83309	part	_	
499-3	83310-83312	of	_	
499-4	83313-83316	the	_	
499-5	83317-83327	discussion	_	
499-6	83328-83333	needs	_	
499-7	83334-83336	to	_	
499-8	83337-83339	be	_	
499-9	83340-83345	toned	_	
499-10	83346-83350	down	_	
499-11	83351-83353	or	_	
499-12	83354-83361	clearly	_	
499-13	83362-83367	noted	_	
499-14	83368-83370	as	_	
499-15	83371-83372	a	_	
499-16	83373-83383	limitation	_	
499-17	83384-83386	of	_	
499-18	83387-83390	the	_	
499-19	83391-83396	study	_	
499-20	83396-83397	.	_	

#Text=Reviewer #2: (No Response)
#Text=**********
#Text=7.
500-1	83398-83406	Reviewer	_	
500-2	83407-83409	#2	_	
500-3	83409-83410	:	_	
500-4	83411-83412	(	_	
500-5	83412-83414	No	_	
500-6	83415-83423	Response	_	
500-7	83423-83424	)	_	
500-8	83425-83426	*	_	
500-9	83426-83427	*	_	
500-10	83427-83428	*	_	
500-11	83428-83429	*	_	
500-12	83429-83430	*	_	
500-13	83430-83431	*	_	
500-14	83431-83432	*	_	
500-15	83432-83433	*	_	
500-16	83433-83434	*	_	
500-17	83434-83435	*	_	
500-18	83436-83437	7	_	
500-19	83437-83438	.	_	

#Text=PLOS authors have the option to publish the peer review history of their article (what does this mean?).
501-1	83439-83443	PLOS	_	
501-2	83444-83451	authors	_	
501-3	83452-83456	have	_	
501-4	83457-83460	the	_	
501-5	83461-83467	option	_	
501-6	83468-83470	to	_	
501-7	83471-83478	publish	_	
501-8	83479-83482	the	_	
501-9	83483-83487	peer	_	
501-10	83488-83494	review	_	
501-11	83495-83502	history	_	
501-12	83503-83505	of	_	
501-13	83506-83511	their	_	
501-14	83512-83519	article	_	
501-15	83520-83521	(	_	
501-16	83521-83525	what	_	
501-17	83526-83530	does	_	
501-18	83531-83535	this	_	
501-19	83536-83540	mean	_	
501-20	83540-83541	?	_	
501-21	83541-83542	)	_	
501-22	83542-83543	.	_	

#Text=If published, this will include your full peer review and any attached files.
502-1	83544-83546	If	_	
502-2	83547-83556	published	_	
502-3	83556-83557	,	_	
502-4	83558-83562	this	_	
502-5	83563-83567	will	_	
502-6	83568-83575	include	_	
502-7	83576-83580	your	_	
502-8	83581-83585	full	_	
502-9	83586-83590	peer	_	
502-10	83591-83597	review	_	
502-11	83598-83601	and	_	
502-12	83602-83605	any	_	
502-13	83606-83614	attached	_	
502-14	83615-83620	files	_	
502-15	83620-83621	.	_	

#Text=If you choose “no”, your identity will remain anonymous but your review may still be made public.
503-1	83622-83624	If	_	
503-2	83625-83628	you	_	
503-3	83629-83635	choose	_	
503-4	83636-83637	“	_	
503-5	83637-83639	no	_	
503-6	83639-83640	”	_	
503-7	83640-83641	,	_	
503-8	83642-83646	your	_	
503-9	83647-83655	identity	_	
503-10	83656-83660	will	_	
503-11	83661-83667	remain	_	
503-12	83668-83677	anonymous	_	
503-13	83678-83681	but	_	
503-14	83682-83686	your	_	
503-15	83687-83693	review	_	
503-16	83694-83697	may	_	
503-17	83698-83703	still	_	
503-18	83704-83706	be	_	
503-19	83707-83711	made	_	
503-20	83712-83718	public	_	
503-21	83718-83719	.	_	

#Text=Do you want your identity to be public for this peer review?
504-1	83720-83722	Do	_	
504-2	83723-83726	you	_	
504-3	83727-83731	want	_	
504-4	83732-83736	your	_	
504-5	83737-83745	identity	_	
504-6	83746-83748	to	_	
504-7	83749-83751	be	_	
504-8	83752-83758	public	_	
504-9	83759-83762	for	_	
504-10	83763-83767	this	_	
504-11	83768-83772	peer	_	
504-12	83773-83779	review	_	
504-13	83779-83780	?	_	

#Text=For information about this choice, including consent withdrawal, please see our Privacy Policy.
505-1	83781-83784	For	_	
505-2	83785-83796	information	_	
505-3	83797-83802	about	_	
505-4	83803-83807	this	_	
505-5	83808-83814	choice	_	
505-6	83814-83815	,	_	
505-7	83816-83825	including	_	
505-8	83826-83833	consent	_	
505-9	83834-83844	withdrawal	_	
505-10	83844-83845	,	_	
505-11	83846-83852	please	_	
505-12	83853-83856	see	_	
505-13	83857-83860	our	_	
505-14	83861-83868	Privacy	_	
505-15	83869-83875	Policy	_	
505-16	83875-83876	.	_	

#Text=Reviewer #1: No
#Text=Reviewer #2: No
#Text=[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site.
506-1	83877-83885	Reviewer	_	
506-2	83886-83888	#1	_	
506-3	83888-83889	:	_	
506-4	83890-83892	No	_	
506-5	83893-83901	Reviewer	_	
506-6	83902-83904	#2	_	
506-7	83904-83905	:	_	
506-8	83906-83908	No	_	
506-9	83909-83910	[	_	
506-10	83910-83914	NOTE	_	
506-11	83914-83915	:	_	
506-12	83916-83918	If	_	
506-13	83919-83927	reviewer	_	
506-14	83928-83936	comments	_	
506-15	83937-83941	were	_	
506-16	83942-83951	submitted	_	
506-17	83952-83954	as	_	
506-18	83955-83957	an	_	
506-19	83958-83968	attachment	_	
506-20	83969-83973	file	_	
506-21	83973-83974	,	_	
506-22	83975-83979	they	_	
506-23	83980-83984	will	_	
506-24	83985-83987	be	_	
506-25	83988-83996	attached	_	
506-26	83997-83999	to	_	
506-27	84000-84004	this	_	
506-28	84005-84010	email	_	
506-29	84011-84014	and	_	
506-30	84015-84025	accessible	_	
506-31	84026-84029	via	_	
506-32	84030-84033	the	_	
506-33	84034-84044	submission	_	
506-34	84045-84049	site	_	
506-35	84049-84050	.	_	

#Text=Please log into your account, locate the manuscript record, and check for the action link "View Attachments".
507-1	84051-84057	Please	_	
507-2	84058-84061	log	_	
507-3	84062-84066	into	_	
507-4	84067-84071	your	_	
507-5	84072-84079	account	_	
507-6	84079-84080	,	_	
507-7	84081-84087	locate	_	
507-8	84088-84091	the	_	
507-9	84092-84102	manuscript	_	
507-10	84103-84109	record	_	
507-11	84109-84110	,	_	
507-12	84111-84114	and	_	
507-13	84115-84120	check	_	
507-14	84121-84124	for	_	
507-15	84125-84128	the	_	
507-16	84129-84135	action	_	
507-17	84136-84140	link	_	
507-18	84141-84142	"	_	
507-19	84142-84146	View	_	
507-20	84147-84158	Attachments	_	
507-21	84158-84159	"	_	
507-22	84159-84160	.	_	

#Text=If this link does not appear, there are no attachment files to be viewed.]
508-1	84161-84163	If	_	
508-2	84164-84168	this	_	
508-3	84169-84173	link	_	
508-4	84174-84178	does	_	
508-5	84179-84182	not	_	
508-6	84183-84189	appear	_	
508-7	84189-84190	,	_	
508-8	84191-84196	there	_	
508-9	84197-84200	are	_	
508-10	84201-84203	no	_	
508-11	84204-84214	attachment	_	
508-12	84215-84220	files	_	
508-13	84221-84223	to	_	
508-14	84224-84226	be	_	
508-15	84227-84233	viewed	_	
508-16	84233-84234	.	_	
508-17	84234-84235	]	_	

#Text=While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/.
509-1	84236-84241	While	_	
509-2	84242-84250	revising	_	
509-3	84251-84255	your	_	
509-4	84256-84266	submission	_	
509-5	84266-84267	,	_	
509-6	84268-84274	please	_	
509-7	84275-84281	upload	_	
509-8	84282-84286	your	_	
509-9	84287-84293	figure	_	
509-10	84294-84299	files	_	
509-11	84300-84302	to	_	
509-12	84303-84306	the	_	
509-13	84307-84316	Preflight	_	
509-14	84317-84325	Analysis	_	
509-15	84326-84329	and	_	
509-16	84330-84340	Conversion	_	
509-17	84341-84347	Engine	_	
509-18	84348-84349	(	_	
509-19	84349-84353	PACE	_	
509-20	84353-84354	)	_	
509-21	84355-84362	digital	_	
509-22	84363-84373	diagnostic	_	
509-23	84374-84378	tool	_	
509-24	84378-84379	,	_	
509-25	84380-84385	https	_	
509-26	84385-84386	:	_	
509-27	84386-84387	/	_	
509-28	84387-84388	/	_	
509-29	84388-84394	pacev2	_	
509-30	84394-84395	.	_	
509-31	84395-84412	apexcovantage.com	_	
509-32	84412-84413	/	_	
509-33	84413-84414	.	_	

#Text=PACE helps ensure that figures meet PLOS requirements.
510-1	84415-84419	PACE	_	
510-2	84420-84425	helps	_	
510-3	84426-84432	ensure	_	
510-4	84433-84437	that	_	
510-5	84438-84445	figures	_	
510-6	84446-84450	meet	_	
510-7	84451-84455	PLOS	_	
510-8	84456-84468	requirements	_	
510-9	84468-84469	.	_	

#Text=To use PACE, you must first register as a user.
511-1	84470-84472	To	_	
511-2	84473-84476	use	_	
511-3	84477-84481	PACE	_	
511-4	84481-84482	,	_	
511-5	84483-84486	you	_	
511-6	84487-84491	must	_	
511-7	84492-84497	first	_	
511-8	84498-84506	register	_	
511-9	84507-84509	as	_	
511-10	84510-84511	a	_	
511-11	84512-84516	user	_	
511-12	84516-84517	.	_	

#Text=Registration is free.
512-1	84518-84530	Registration	_	
512-2	84531-84533	is	_	
512-3	84534-84538	free	_	
512-4	84538-84539	.	_	

#Text=Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool.
513-1	84540-84544	Then	_	
513-2	84544-84545	,	_	
513-3	84546-84551	login	_	
513-4	84552-84555	and	_	
513-5	84556-84564	navigate	_	
513-6	84565-84567	to	_	
513-7	84568-84571	the	_	
513-8	84572-84578	UPLOAD	_	
513-9	84579-84582	tab	_	
513-10	84582-84583	,	_	
513-11	84584-84589	where	_	
513-12	84590-84593	you	_	
513-13	84594-84598	will	_	
513-14	84599-84603	find	_	
513-15	84604-84612	detailed	_	
513-16	84613-84625	instructions	_	
513-17	84626-84628	on	_	
513-18	84629-84632	how	_	
513-19	84633-84635	to	_	
513-20	84636-84639	use	_	
513-21	84640-84643	the	_	
513-22	84644-84648	tool	_	
513-23	84648-84649	.	_	

#Text=If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.
514-1	84650-84652	If	_	
514-2	84653-84656	you	_	
514-3	84657-84666	encounter	_	
514-4	84667-84670	any	_	
514-5	84671-84677	issues	_	
514-6	84678-84680	or	_	
514-7	84681-84685	have	_	
514-8	84686-84689	any	_	
514-9	84690-84699	questions	_	
514-10	84700-84704	when	_	
514-11	84705-84710	using	_	
514-12	84711-84715	PACE	_	
514-13	84715-84716	,	_	
514-14	84717-84723	please	_	
514-15	84724-84729	email	_	
514-16	84730-84732	us	_	
514-17	84733-84735	at	_	
514-18	84736-84743	figures	_	
514-19	84743-84744	@	_	
514-20	84744-84752	plos.org	_	
514-21	84752-84753	.	_	

#Text=Please note that Supporting Information files do not need this step.
#Text=10.1371/journal.pone.0224906.r004
#Text=Author response to Decision Letter 1
#Text= 25 Feb 2020 
#Text=We believe that in this revision of discussion our interpretation of reduced behavioral inhibition is softened.
515-1	84754-84760	Please	_	
515-2	84761-84765	note	_	
515-3	84766-84770	that	_	
515-4	84771-84781	Supporting	_	
515-5	84782-84793	Information	_	
515-6	84794-84799	files	_	
515-7	84800-84802	do	_	
515-8	84803-84806	not	_	
515-9	84807-84811	need	_	
515-10	84812-84816	this	_	
515-11	84817-84821	step	_	
515-12	84821-84822	.	_	
515-13	84823-84830	10.1371	_	
515-14	84830-84831	/	_	
515-15	84831-84843	journal.pone	_	
515-16	84843-84851	.0224906	_	
515-17	84851-84852	.	_	
515-18	84852-84856	r004	_	
515-19	84857-84863	Author	_	
515-20	84864-84872	response	_	
515-21	84873-84875	to	_	
515-22	84876-84884	Decision	_	
515-23	84885-84891	Letter	_	
515-24	84892-84893	1	_	
515-25	84895-84897	25	_	
515-26	84898-84901	Feb	_	
515-27	84902-84906	2020	_	
515-28	84908-84910	We	_	
515-29	84911-84918	believe	_	
515-30	84919-84923	that	_	
515-31	84924-84926	in	_	
515-32	84927-84931	this	_	
515-33	84932-84940	revision	_	
515-34	84941-84943	of	_	
515-35	84944-84954	discussion	_	
515-36	84955-84958	our	_	
515-37	84959-84973	interpretation	_	
515-38	84974-84976	of	_	
515-39	84977-84984	reduced	_	
515-40	84985-84995	behavioral	_	
515-41	84996-85006	inhibition	_	
515-42	85007-85009	is	_	
515-43	85010-85018	softened	_	
515-44	85018-85019	.	_	

#Text=As such, we have added alternative mechanisms that may explain our findings throughout the Discussion section.
516-1	85020-85022	As	_	
516-2	85023-85027	such	_	
516-3	85027-85028	,	_	
516-4	85029-85031	we	_	
516-5	85032-85036	have	_	
516-6	85037-85042	added	_	
516-7	85043-85054	alternative	_	
516-8	85055-85065	mechanisms	_	
516-9	85066-85070	that	_	
516-10	85071-85074	may	_	
516-11	85075-85082	explain	_	
516-12	85083-85086	our	_	
516-13	85087-85095	findings	_	
516-14	85096-85106	throughout	_	
516-15	85107-85110	the	_	
516-16	85111-85121	Discussion	_	
516-17	85122-85129	section	_	
516-18	85129-85130	.	_	

#Text=We have also added to the last paragraph of the limitations section (line 452/453) as follows: “Because we do not have behavioral data on response inhibition in the alcohol intoxication state, there are other potential explanations for our findings.”
517-1	85131-85133	We	_	
517-2	85134-85138	have	_	
517-3	85139-85143	also	_	
517-4	85144-85149	added	_	
517-5	85150-85152	to	_	
517-6	85153-85156	the	_	
517-7	85157-85161	last	_	
517-8	85162-85171	paragraph	_	
517-9	85172-85174	of	_	
517-10	85175-85178	the	_	
517-11	85179-85190	limitations	_	
517-12	85191-85198	section	_	
517-13	85199-85200	(	_	
517-14	85200-85204	line	_	
517-15	85205-85208	452	_	
517-16	85208-85209	/	_	
517-17	85209-85212	453	_	
517-18	85212-85213	)	_	
517-19	85214-85216	as	_	
517-20	85217-85224	follows	_	
517-21	85224-85225	:	_	
517-22	85226-85227	“	_	
517-23	85227-85234	Because	_	
517-24	85235-85237	we	_	
517-25	85238-85240	do	_	
517-26	85241-85244	not	_	
517-27	85245-85249	have	_	
517-28	85250-85260	behavioral	_	
517-29	85261-85265	data	_	
517-30	85266-85268	on	_	
517-31	85269-85277	response	_	
517-32	85278-85288	inhibition	_	
517-33	85289-85291	in	_	
517-34	85292-85295	the	_	
517-35	85296-85303	alcohol	_	
517-36	85304-85316	intoxication	_	
517-37	85317-85322	state	_	
517-38	85322-85323	,	_	
517-39	85324-85329	there	_	
517-40	85330-85333	are	_	
517-41	85334-85339	other	_	
517-42	85340-85349	potential	_	
517-43	85350-85362	explanations	_	
517-44	85363-85366	for	_	
517-45	85367-85370	our	_	
517-46	85371-85379	findings	_	
517-47	85379-85380	.	_	
517-48	85380-85381	”	_	

#Text=We hope the manuscript in its revised form merits publication in PLOS ONE.
#Text=10.1371/journal.pone.0224906.r005
#Text=Decision Letter 2
#Text=Pattij
#Text=Tommy
#Text=This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
#Text= 4 Mar 2020 
#Text=Alcohol Effects on Globus Pallidus Connectivity: Role of Impulsivity and Binge Drinking
#Text=PONE-D-19-29169R2
#Text=Dear Dr.
518-1	85382-85384	We	_	
518-2	85385-85389	hope	_	
518-3	85390-85393	the	_	
518-4	85394-85404	manuscript	_	
518-5	85405-85407	in	_	
518-6	85408-85411	its	_	
518-7	85412-85419	revised	_	
518-8	85420-85424	form	_	
518-9	85425-85431	merits	_	
518-10	85432-85443	publication	_	
518-11	85444-85446	in	_	
518-12	85447-85451	PLOS	_	
518-13	85452-85455	ONE	_	
518-14	85455-85456	.	_	
518-15	85457-85464	10.1371	_	
518-16	85464-85465	/	_	
518-17	85465-85477	journal.pone	_	
518-18	85477-85485	.0224906	_	
518-19	85485-85486	.	_	
518-20	85486-85490	r005	_	
518-21	85491-85499	Decision	_	
518-22	85500-85506	Letter	_	
518-23	85507-85508	2	_	
518-24	85509-85515	Pattij	_	
518-25	85516-85521	Tommy	_	
518-26	85522-85526	This	_	
518-27	85527-85529	is	_	
518-28	85530-85532	an	_	
518-29	85533-85537	open	_	
518-30	85538-85544	access	_	
518-31	85545-85552	article	_	
518-32	85553-85564	distributed	_	
518-33	85565-85570	under	_	
518-34	85571-85574	the	_	
518-35	85575-85580	terms	_	
518-36	85581-85583	of	_	
518-37	85584-85587	the	_	
518-38	85588-85596	Creative	_	
518-39	85597-85604	Commons	_	
518-40	85605-85616	Attribution	_	
518-41	85617-85624	License	_	
518-42	85624-85625	,	_	
518-43	85626-85631	which	_	
518-44	85632-85639	permits	_	
518-45	85640-85652	unrestricted	_	
518-46	85653-85656	use	_	
518-47	85656-85657	,	_	
518-48	85658-85670	distribution	_	
518-49	85670-85671	,	_	
518-50	85672-85675	and	_	
518-51	85676-85688	reproduction	_	
518-52	85689-85691	in	_	
518-53	85692-85695	any	_	
518-54	85696-85702	medium	_	
518-55	85702-85703	,	_	
518-56	85704-85712	provided	_	
518-57	85713-85716	the	_	
518-58	85717-85725	original	_	
518-59	85726-85732	author	_	
518-60	85733-85736	and	_	
518-61	85737-85743	source	_	
518-62	85744-85747	are	_	
518-63	85748-85756	credited	_	
518-64	85756-85757	.	_	
518-65	85759-85760	4	_	
518-66	85761-85764	Mar	_	
518-67	85765-85769	2020	_	
518-68	85771-85778	Alcohol	_	
518-69	85779-85786	Effects	_	
518-70	85787-85789	on	_	
518-71	85790-85796	Globus	_	
518-72	85797-85805	Pallidus	_	
518-73	85806-85818	Connectivity	_	
518-74	85818-85819	:	_	
518-75	85819-85820	 	_	
518-76	85820-85824	Role	_	
518-77	85825-85827	of	_	
518-78	85828-85839	Impulsivity	_	
518-79	85840-85843	and	_	
518-80	85844-85849	Binge	_	
518-81	85850-85858	Drinking	_	
518-82	85859-85865	PONE-D	_	
518-83	85865-85866	-	_	
518-84	85866-85868	19	_	
518-85	85868-85869	-	_	
518-86	85869-85876	29169R2	_	
518-87	85877-85881	Dear	_	
518-88	85882-85884	Dr	_	
518-89	85884-85885	.	_	

#Text=Momenan,
#Text=We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.
519-1	85886-85893	Momenan	_	
519-2	85893-85894	,	_	
519-3	85895-85897	We	_	
519-4	85898-85901	are	_	
519-5	85902-85909	pleased	_	
519-6	85910-85912	to	_	
519-7	85913-85919	inform	_	
519-8	85920-85923	you	_	
519-9	85924-85928	that	_	
519-10	85929-85933	your	_	
519-11	85934-85944	manuscript	_	
519-12	85945-85948	has	_	
519-13	85949-85953	been	_	
519-14	85954-85960	judged	_	
519-15	85961-85975	scientifically	_	
519-16	85976-85984	suitable	_	
519-17	85985-85988	for	_	
519-18	85989-86000	publication	_	
519-19	86001-86004	and	_	
519-20	86005-86009	will	_	
519-21	86010-86012	be	_	
519-22	86013-86021	formally	_	
519-23	86022-86030	accepted	_	
519-24	86031-86034	for	_	
519-25	86035-86046	publication	_	
519-26	86047-86051	once	_	
519-27	86052-86054	it	_	
519-28	86055-86063	complies	_	
519-29	86064-86068	with	_	
519-30	86069-86072	all	_	
519-31	86073-86084	outstanding	_	
519-32	86085-86094	technical	_	
519-33	86095-86107	requirements	_	
519-34	86107-86108	.	_	

#Text=Within one week, you will receive an e-mail containing information on the amendments required prior to publication.
520-1	86109-86115	Within	_	
520-2	86116-86119	one	_	
520-3	86120-86124	week	_	
520-4	86124-86125	,	_	
520-5	86126-86129	you	_	
520-6	86130-86134	will	_	
520-7	86135-86142	receive	_	
520-8	86143-86145	an	_	
520-9	86146-86152	e-mail	_	
520-10	86153-86163	containing	_	
520-11	86164-86175	information	_	
520-12	86176-86178	on	_	
520-13	86179-86182	the	_	
520-14	86183-86193	amendments	_	
520-15	86194-86202	required	_	
520-16	86203-86208	prior	_	
520-17	86209-86211	to	_	
520-18	86212-86223	publication	_	
520-19	86223-86224	.	_	

#Text=When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.
521-1	86225-86229	When	_	
521-2	86230-86233	all	_	
521-3	86234-86242	required	_	
521-4	86243-86256	modifications	_	
521-5	86257-86261	have	_	
521-6	86262-86266	been	_	
521-7	86267-86276	addressed	_	
521-8	86276-86277	,	_	
521-9	86278-86281	you	_	
521-10	86282-86286	will	_	
521-11	86287-86294	receive	_	
521-12	86295-86296	a	_	
521-13	86297-86303	formal	_	
521-14	86304-86314	acceptance	_	
521-15	86315-86321	letter	_	
521-16	86322-86325	and	_	
521-17	86326-86330	your	_	
521-18	86331-86341	manuscript	_	
521-19	86342-86346	will	_	
521-20	86347-86354	proceed	_	
521-21	86355-86357	to	_	
521-22	86358-86361	our	_	
521-23	86362-86372	production	_	
521-24	86373-86383	department	_	
521-25	86384-86387	and	_	
521-26	86388-86390	be	_	
521-27	86391-86400	scheduled	_	
521-28	86401-86404	for	_	
521-29	86405-86416	publication	_	
521-30	86416-86417	.	_	

#Text=Shortly after the formal acceptance letter is sent, an invoice for payment will follow.
522-1	86418-86425	Shortly	_	
522-2	86426-86431	after	_	
522-3	86432-86435	the	_	
522-4	86436-86442	formal	_	
522-5	86443-86453	acceptance	_	
522-6	86454-86460	letter	_	
522-7	86461-86463	is	_	
522-8	86464-86468	sent	_	
522-9	86468-86469	,	_	
522-10	86470-86472	an	_	
522-11	86473-86480	invoice	_	
522-12	86481-86484	for	_	
522-13	86485-86492	payment	_	
522-14	86493-86497	will	_	
522-15	86498-86504	follow	_	
522-16	86504-86505	.	_	

#Text=To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information.
523-1	86506-86508	To	_	
523-2	86509-86515	ensure	_	
523-3	86516-86518	an	_	
523-4	86519-86528	efficient	_	
523-5	86529-86539	production	_	
523-6	86540-86543	and	_	
523-7	86544-86551	billing	_	
523-8	86552-86559	process	_	
523-9	86559-86560	,	_	
523-10	86561-86567	please	_	
523-11	86568-86571	log	_	
523-12	86572-86576	into	_	
523-13	86577-86586	Editorial	_	
523-14	86587-86594	Manager	_	
523-15	86595-86597	at	_	
523-16	86598-86603	https	_	
523-17	86603-86604	:	_	
523-18	86604-86605	/	_	
523-19	86605-86606	/	_	
523-20	86606-86630	www.editorialmanager.com	_	
523-21	86630-86631	/	_	
523-22	86631-86635	pone	_	
523-23	86635-86636	/	_	
523-24	86636-86637	,	_	
523-25	86638-86643	click	_	
523-26	86644-86647	the	_	
523-27	86648-86649	"	_	
523-28	86649-86655	Update	_	
523-29	86656-86658	My	_	
523-30	86659-86670	Information	_	
523-31	86670-86671	"	_	
523-32	86672-86676	link	_	
523-33	86677-86679	at	_	
523-34	86680-86683	the	_	
523-35	86684-86687	top	_	
523-36	86688-86690	of	_	
523-37	86691-86694	the	_	
523-38	86695-86699	page	_	
523-39	86699-86700	,	_	
523-40	86701-86704	and	_	
523-41	86705-86711	update	_	
523-42	86712-86716	your	_	
523-43	86717-86721	user	_	
523-44	86722-86733	information	_	
523-45	86733-86734	.	_	

#Text=If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.
524-1	86735-86737	If	_	
524-2	86738-86741	you	_	
524-3	86742-86746	have	_	
524-4	86747-86750	any	_	
524-5	86751-86758	billing	_	
524-6	86759-86766	related	_	
524-7	86767-86776	questions	_	
524-8	86776-86777	,	_	
524-9	86778-86784	please	_	
524-10	86785-86792	contact	_	
524-11	86793-86796	our	_	
524-12	86797-86803	Author	_	
524-13	86804-86811	Billing	_	
524-14	86812-86822	department	_	
524-15	86823-86831	directly	_	
524-16	86832-86834	at	_	
524-17	86835-86848	authorbilling	_	
524-18	86848-86849	@	_	
524-19	86849-86857	plos.org	_	
524-20	86857-86858	.	_	

#Text=If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact.
525-1	86859-86861	If	_	
525-2	86862-86866	your	_	
525-3	86867-86878	institution	_	
525-4	86879-86881	or	_	
525-5	86882-86894	institutions	_	
525-6	86895-86899	have	_	
525-7	86900-86901	a	_	
525-8	86902-86907	press	_	
525-9	86908-86914	office	_	
525-10	86914-86915	,	_	
525-11	86916-86922	please	_	
525-12	86923-86929	notify	_	
525-13	86930-86934	them	_	
525-14	86935-86940	about	_	
525-15	86941-86945	your	_	
525-16	86946-86954	upcoming	_	
525-17	86955-86960	paper	_	
525-18	86961-86963	to	_	
525-19	86964-86970	enable	_	
525-20	86971-86975	them	_	
525-21	86976-86978	to	_	
525-22	86979-86983	help	_	
525-23	86984-86992	maximize	_	
525-24	86993-86996	its	_	
525-25	86997-87003	impact	_	
525-26	87003-87004	.	_	

#Text=If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance.
526-1	87005-87007	If	_	
526-2	87008-87012	they	_	
526-3	87013-87017	will	_	
526-4	87018-87020	be	_	
526-5	87021-87030	preparing	_	
526-6	87031-87036	press	_	
526-7	87037-87046	materials	_	
526-8	87047-87050	for	_	
526-9	87051-87055	this	_	
526-10	87056-87066	manuscript	_	
526-11	87066-87067	,	_	
526-12	87068-87071	you	_	
526-13	87072-87076	must	_	
526-14	87077-87083	inform	_	
526-15	87084-87087	our	_	
526-16	87088-87093	press	_	
526-17	87094-87098	team	_	
526-18	87099-87101	as	_	
526-19	87102-87106	soon	_	
526-20	87107-87109	as	_	
526-21	87110-87118	possible	_	
526-22	87119-87122	and	_	
526-23	87123-87125	no	_	
526-24	87126-87131	later	_	
526-25	87132-87136	than	_	
526-26	87137-87139	48	_	
526-27	87140-87145	hours	_	
526-28	87146-87151	after	_	
526-29	87152-87161	receiving	_	
526-30	87162-87165	the	_	
526-31	87166-87172	formal	_	
526-32	87173-87183	acceptance	_	
526-33	87183-87184	.	_	

#Text=Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication.
527-1	87185-87189	Your	_	
527-2	87190-87200	manuscript	_	
527-3	87201-87205	will	_	
527-4	87206-87212	remain	_	
527-5	87213-87218	under	_	
527-6	87219-87225	strict	_	
527-7	87226-87231	press	_	
527-8	87232-87239	embargo	_	
527-9	87240-87245	until	_	
527-10	87246-87247	2	_	
527-11	87248-87250	pm	_	
527-12	87251-87258	Eastern	_	
527-13	87259-87263	Time	_	
527-14	87264-87266	on	_	
527-15	87267-87270	the	_	
527-16	87271-87275	date	_	
527-17	87276-87278	of	_	
527-18	87279-87290	publication	_	
527-19	87290-87291	.	_	

#Text=For more information, please contact onepress@plos.org.
528-1	87292-87295	For	_	
528-2	87296-87300	more	_	
528-3	87301-87312	information	_	
528-4	87312-87313	,	_	
528-5	87314-87320	please	_	
528-6	87321-87328	contact	_	
528-7	87329-87337	onepress	_	
528-8	87337-87338	@	_	
528-9	87338-87346	plos.org	_	
528-10	87346-87347	.	_	

#Text=With kind regards,
#Text=Tommy Pattij, Ph.D.
529-1	87348-87352	With	_	
529-2	87353-87357	kind	_	
529-3	87358-87365	regards	_	
529-4	87365-87366	,	_	
529-5	87367-87372	Tommy	_	
529-6	87373-87379	Pattij	_	
529-7	87379-87380	,	_	
529-8	87381-87385	Ph.D	_	
529-9	87385-87386	.	_	

#Text=Academic Editor
#Text=PLOS ONE
#Text=Additional Editor Comments (optional):
#Text=Reviewers' comments:
#Text=10.1371/journal.pone.0224906.r006
#Text=Acceptance letter
#Text=Pattij
#Text=Tommy
#Text=This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
#Text= 6 Mar 2020 
#Text=PONE-D-19-29169R2 
#Text=Alcohol Effects on Globus Pallidus Connectivity: Role of Impulsivity and Binge Drinking 
#Text=Dear Dr.
530-1	87387-87395	Academic	_	
530-2	87396-87402	Editor	_	
530-3	87403-87407	PLOS	_	
530-4	87408-87411	ONE	_	
530-5	87412-87422	Additional	_	
530-6	87423-87429	Editor	_	
530-7	87430-87438	Comments	_	
530-8	87439-87440	(	_	
530-9	87440-87448	optional	_	
530-10	87448-87449	)	_	
530-11	87449-87450	:	_	
530-12	87451-87460	Reviewers	_	
530-13	87460-87461	'	_	
530-14	87462-87470	comments	_	
530-15	87470-87471	:	_	
530-16	87472-87479	10.1371	_	
530-17	87479-87480	/	_	
530-18	87480-87492	journal.pone	_	
530-19	87492-87500	.0224906	_	
530-20	87500-87501	.	_	
530-21	87501-87505	r006	_	
530-22	87506-87516	Acceptance	_	
530-23	87517-87523	letter	_	
530-24	87524-87530	Pattij	_	
530-25	87531-87536	Tommy	_	
530-26	87537-87541	This	_	
530-27	87542-87544	is	_	
530-28	87545-87547	an	_	
530-29	87548-87552	open	_	
530-30	87553-87559	access	_	
530-31	87560-87567	article	_	
530-32	87568-87579	distributed	_	
530-33	87580-87585	under	_	
530-34	87586-87589	the	_	
530-35	87590-87595	terms	_	
530-36	87596-87598	of	_	
530-37	87599-87602	the	_	
530-38	87603-87611	Creative	_	
530-39	87612-87619	Commons	_	
530-40	87620-87631	Attribution	_	
530-41	87632-87639	License	_	
530-42	87639-87640	,	_	
530-43	87641-87646	which	_	
530-44	87647-87654	permits	_	
530-45	87655-87667	unrestricted	_	
530-46	87668-87671	use	_	
530-47	87671-87672	,	_	
530-48	87673-87685	distribution	_	
530-49	87685-87686	,	_	
530-50	87687-87690	and	_	
530-51	87691-87703	reproduction	_	
530-52	87704-87706	in	_	
530-53	87707-87710	any	_	
530-54	87711-87717	medium	_	
530-55	87717-87718	,	_	
530-56	87719-87727	provided	_	
530-57	87728-87731	the	_	
530-58	87732-87740	original	_	
530-59	87741-87747	author	_	
530-60	87748-87751	and	_	
530-61	87752-87758	source	_	
530-62	87759-87762	are	_	
530-63	87763-87771	credited	_	
530-64	87771-87772	.	_	
530-65	87774-87775	6	_	
530-66	87776-87779	Mar	_	
530-67	87780-87784	2020	_	
530-68	87786-87792	PONE-D	_	
530-69	87792-87793	-	_	
530-70	87793-87795	19	_	
530-71	87795-87796	-	_	
530-72	87796-87803	29169R2	_	
530-73	87805-87812	Alcohol	_	
530-74	87813-87820	Effects	_	
530-75	87821-87823	on	_	
530-76	87824-87830	Globus	_	
530-77	87831-87839	Pallidus	_	
530-78	87840-87852	Connectivity	_	
530-79	87852-87853	:	_	
530-80	87853-87854	 	_	
530-81	87854-87858	Role	_	
530-82	87859-87861	of	_	
530-83	87862-87873	Impulsivity	_	
530-84	87874-87877	and	_	
530-85	87878-87883	Binge	_	
530-86	87884-87892	Drinking	_	
530-87	87894-87898	Dear	_	
530-88	87899-87901	Dr	_	
530-89	87901-87902	.	_	

#Text=Momenan:
#Text=I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE.
531-1	87903-87910	Momenan	_	
531-2	87910-87911	:	_	
531-3	87912-87913	I	_	
531-4	87914-87916	am	_	
531-5	87917-87924	pleased	_	
531-6	87925-87927	to	_	
531-7	87928-87934	inform	_	
531-8	87935-87938	you	_	
531-9	87939-87943	that	_	
531-10	87944-87948	your	_	
531-11	87949-87959	manuscript	_	
531-12	87960-87963	has	_	
531-13	87964-87968	been	_	
531-14	87969-87975	deemed	_	
531-15	87976-87984	suitable	_	
531-16	87985-87988	for	_	
531-17	87989-88000	publication	_	
531-18	88001-88003	in	_	
531-19	88004-88008	PLOS	_	
531-20	88009-88012	ONE	_	
531-21	88012-88013	.	_	

#Text=Congratulations!
532-1	88014-88029	Congratulations	_	
532-2	88029-88030	!	_	

#Text=Your manuscript is now with our production department.
533-1	88031-88035	Your	_	
533-2	88036-88046	manuscript	_	
533-3	88047-88049	is	_	
533-4	88050-88053	now	_	
533-5	88054-88058	with	_	
533-6	88059-88062	our	_	
533-7	88063-88073	production	_	
533-8	88074-88084	department	_	
533-9	88084-88085	.	_	

#Text=If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact.
534-1	88087-88089	If	_	
534-2	88090-88094	your	_	
534-3	88095-88106	institution	_	
534-4	88107-88109	or	_	
534-5	88110-88122	institutions	_	
534-6	88123-88127	have	_	
534-7	88128-88129	a	_	
534-8	88130-88135	press	_	
534-9	88136-88142	office	_	
534-10	88142-88143	,	_	
534-11	88144-88150	please	_	
534-12	88151-88157	notify	_	
534-13	88158-88162	them	_	
534-14	88163-88168	about	_	
534-15	88169-88173	your	_	
534-16	88174-88182	upcoming	_	
534-17	88183-88188	paper	_	
534-18	88189-88191	at	_	
534-19	88192-88196	this	_	
534-20	88197-88202	point	_	
534-21	88202-88203	,	_	
534-22	88204-88206	to	_	
534-23	88207-88213	enable	_	
534-24	88214-88218	them	_	
534-25	88219-88221	to	_	
534-26	88222-88226	help	_	
534-27	88227-88235	maximize	_	
534-28	88236-88239	its	_	
534-29	88240-88246	impact	_	
534-30	88246-88247	.	_	

#Text=If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours.
535-1	88248-88250	If	_	
535-2	88251-88255	they	_	
535-3	88256-88260	will	_	
535-4	88261-88263	be	_	
535-5	88264-88273	preparing	_	
535-6	88274-88279	press	_	
535-7	88280-88289	materials	_	
535-8	88290-88293	for	_	
535-9	88294-88298	this	_	
535-10	88299-88309	manuscript	_	
535-11	88309-88310	,	_	
535-12	88311-88317	please	_	
535-13	88318-88324	inform	_	
535-14	88325-88328	our	_	
535-15	88329-88334	press	_	
535-16	88335-88339	team	_	
535-17	88340-88346	within	_	
535-18	88347-88350	the	_	
535-19	88351-88355	next	_	
535-20	88356-88358	48	_	
535-21	88359-88364	hours	_	
535-22	88364-88365	.	_	

#Text=Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication.
536-1	88366-88370	Your	_	
536-2	88371-88381	manuscript	_	
536-3	88382-88386	will	_	
536-4	88387-88393	remain	_	
536-5	88394-88399	under	_	
536-6	88400-88406	strict	_	
536-7	88407-88412	press	_	
536-8	88413-88420	embargo	_	
536-9	88421-88426	until	_	
536-10	88427-88428	2	_	
536-11	88429-88431	pm	_	
536-12	88432-88439	Eastern	_	
536-13	88440-88444	Time	_	
536-14	88445-88447	on	_	
536-15	88448-88451	the	_	
536-16	88452-88456	date	_	
536-17	88457-88459	of	_	
536-18	88460-88471	publication	_	
536-19	88471-88472	.	_	

#Text=For more information please contact onepress@plos.org.
537-1	88473-88476	For	_	
537-2	88477-88481	more	_	
537-3	88482-88493	information	_	
537-4	88494-88500	please	_	
537-5	88501-88508	contact	_	
537-6	88509-88517	onepress	_	
537-7	88517-88518	@	_	
537-8	88518-88526	plos.org	_	
537-9	88526-88527	.	_	

#Text=For any other questions or concerns, please email plosone@plos.org.
538-1	88528-88531	For	_	
538-2	88532-88535	any	_	
538-3	88536-88541	other	_	
538-4	88542-88551	questions	_	
538-5	88552-88554	or	_	
538-6	88555-88563	concerns	_	
538-7	88563-88564	,	_	
538-8	88565-88571	please	_	
538-9	88572-88577	email	_	
538-10	88578-88585	plosone	_	
538-11	88585-88586	@	_	
538-12	88586-88594	plos.org	_	
538-13	88594-88595	.	_	

#Text=Thank you for submitting your work to PLOS ONE.
539-1	88597-88602	Thank	_	
539-2	88603-88606	you	_	
539-3	88607-88610	for	_	
539-4	88611-88621	submitting	_	
539-5	88622-88626	your	_	
539-6	88627-88631	work	_	
539-7	88632-88634	to	_	
539-8	88635-88639	PLOS	_	
539-9	88640-88643	ONE	_	
539-10	88643-88644	.	_	

#Text=With kind regards,
#Text=PLOS ONE Editorial Office Staff
#Text=on behalf of
#Text=Dr.
540-1	88645-88649	With	_	
540-2	88650-88654	kind	_	
540-3	88655-88662	regards	_	
540-4	88662-88663	,	_	
540-5	88664-88668	PLOS	_	
540-6	88669-88672	ONE	_	
540-7	88673-88682	Editorial	_	
540-8	88683-88689	Office	_	
540-9	88690-88695	Staff	_	
540-10	88696-88698	on	_	
540-11	88699-88705	behalf	_	
540-12	88706-88708	of	_	
540-13	88709-88711	Dr	_	
540-14	88711-88712	.	_	

#Text=Tommy Pattij 
#Text=Academic Editor
#Text=PLOS ONE
541-1	88713-88718	Tommy	_	
541-2	88719-88725	Pattij	_	
541-3	88727-88735	Academic	_	
541-4	88736-88742	Editor	_	
541-5	88743-88747	PLOS	_	
541-6	88748-88751	ONE	_	
